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A B S T R A C T
Background
Cognitive impairment, a defining feature of dementia, plays an important role in the compromised functional independence that
characterises the condition. Cognitive training (CT) is an approach that uses guided practice on structured tasks with the direct aim of
improving or maintaining cognitive abilities.
Objectives
• To assess effects of CT on cognitive and non-cognitive outcomes for people with mild to moderate dementia and their caregivers.
• To compare effects of CT with those of other non-pharmacological interventions, including cognitive stimulation or rehabilitation,
for people with mild to moderate dementia and their caregivers.
• To identify and explore factors related to intervention and trial design that may be associated with the efficacy of CT for people with
mild to moderate dementia and their caregivers.
Search methods
We searched ALOIS, the Cochrane Dementia and Cognitive ImprovementGroup Specialised Register, on 5 July 2018. ALOIS contains
records of clinical trials identified through monthly searches of several major healthcare databases and numerous trial registries and
grey literature sources. In addition to this, we searched MEDLINE, Embase, PsycINFO, CINAHL, LILACS, Web of Science Core
Collection, ClinicalTrials.gov, and the World Health Organization’s trials portal, ICTRP, to ensure that searches were comprehensive
and up-to-date.
Selection criteria
We included randomised controlled trials (RCTs) that described interventions for people withmild tomoderate dementia and compared
CT versus a control or alternative intervention.
Data collection and analysis
We extracted relevant data from published manuscripts and through contact with trial authors if required. We assessed risk of bias using
the Cochrane ’Risk of bias’ tool. We divided comparison conditions into active or passive control conditions and alternative treatments.
We used a large number of measures and data to evaluate 19 outcomes at end of treatment, as well as 16 outcomes at follow-up in the
medium term; we pooled this information in meta-analyses. We calculated pooled estimates of treatment effect using a random-effects
model, and we estimated statistical heterogeneity using a standard Chi² statistic. We graded the evidence using GradePro.
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Main results
The 33 included trials were published between 1988 and 2018 and were conducted in 12 countries; most were unregistered, parallel-
group, single-site RCTs, with samples ranging from 12 to 653 participants. Interventions were between two and 104 weeks long.
We classified most experimental interventions as ’straight CT’, but we classified some as ’augmented CT’, and about two-thirds as
multi-domain interventions. Researchers investigated 18 passive and 13 active control conditions, along with 15 alternative treatment
conditions, including occupational therapy, mindfulness, reminiscence therapy, and others.
The methodological quality of studies varied, but we rated nearly all studies as having high or unclear risk of selection bias due to lack
of allocation concealment, and high or unclear risk of performance bias due to lack of blinding of participants and personnel.
We used data from 32 studies in the meta-analysis of at least one outcome. Relative to a control condition, we found moderate-quality
evidence showing a small to moderate effect of CT on our first primary outcome, composite measure of global cognition at end of
treatment (standardised mean difference (SMD) 0.42, 95% confidence interval (CI) 0.23 to 0.62), and high-quality evidence showing
a moderate effect on the secondary outcome of verbal semantic fluency (SMD 0.52, 95% CI 0.23 to 0.81) at end of treatment, with
these gains retained in the medium term (3 to 12 months post treatment). In relation to many other outcomes, including our second
primary outcome of clinical disease severity in the medium term, the quality of evidence was very low, so we were unable to determine
whether CT was associated with any meaningful gains.
When compared with an alternative treatment, we found that CT may have little to no effect on our first primary outcome of global
cognition at end of treatment (SMD 0.21, 95% CI -0.23 to 0.64), but the quality of evidence was low. No evidence was available to
assess our second primary outcome of clinical disease severity in the medium term. We found moderate-quality evidence showing that
CT was associated with improved mood of the caregiver at end of treatment, but this was based on a single trial. The quality of evidence
in relation to many other outcomes at end of treatment and in the medium term was too low for us to determine whether CT was
associated with any gains, but we are moderately confident that CT did not lead to any gains in mood, behavioural and psychological
symptoms, or capacity to perform activities of daily living.
Authors’ conclusions
Relative to a control intervention, but not to a variety of alternative treatments, CT is probably associated with small to moderate
positive effects on global cognition and verbal semantic fluency at end of treatment, and these benefits appear to be maintained in the
medium term. Our certainty in relation to many of these findings is low or very low. Future studies should take stronger measures to
mitigate well-established risks of bias, and should provide long-term follow-up to improve our understanding of the extent to which
observed gains are retained. Future trials should also focus on direct comparison of CT versus alternative treatments rather than passive
or active control conditions.
P L A I N L A N G U A G E S U M M A R Y
Cognitive training for people with mild to moderate dementia
Background
Dementia due to Alzheimer’s and other diseases is a leading cause of disability and an enormous health and societal problem. More
than 40 million people in the world currently live with dementia, and this number is expected to increase to more than 115 million
by the year 2050. Effective treatments to reduce the burden of dementia are urgently needed. Cognitive training (CT) is a non-
pharmacological form of treatment that focuses on guided practice on tasks that target specific cognitive functions, such as memory,
attention, or problem-solving. Whether CT can help people with mild to moderate dementia maintain or improve their thinking, well-
being, and general functioning remains unclear.
Main findings
We analysed data from 33 studies of CT that included a total of approximately 2000 participants and were conducted in 12 countries.
We found that, compared with receiving usual treatment or engaging in non-specific activities, people completing CT may show some
benefits in overall cognition, as well as in more specific cognitive abilities such as verbal fluency, and that improvements may last for
at least a few months. We did not find any evidence that participating in CT was associated with increased burden for participants.
However, we also found no evidence that CT was better than participating in other active treatments.
Limitations of this review
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The quality of the studies we reviewed varied but overall was not very high, so our certainty in some of these findings is low. Future
studies should continue improving on quality, should continue comparing CT with other treatments, and should follow participants
for a longer period to understand whether observed benefits for cognition last beyond the short or medium term.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Cognitive training compared to control immediately post intervention for people with mild to moderate dementia
Patient or population: people with mild to moderate dementia
Setting: Community dwelling or in residential care
Intervention: cognit ive training
Comparison: control immediately post intervent ion
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with control im-
mediately post inter-
vention
Risk with cognitive
training
Change in a global mea-
sure of cognit ion (com-
posite)
Mean change in a
global measure of cog-
nit ion (composite) was
0
SMD 0.42 higher
(0.23 higher to 0.62
higher)
- 1389
(27 RCTs)
⊕⊕⊕©
MODERATEa
Cognit ive training prob-
ably has a modest ef -
fect on global cognit ion
(based on a composite
score)
Change in a global mea-
sure of cognit ion
Mean change in a
global measure of cog-
nit ion was 0
SMD 0.65 higher
(0.26 higher to 1.05
higher)
- 1288
(20 RCTs)
⊕⊕©©
LOWb
Cognit ive training may
have a moderate ef -
fect on performance in
global cognit ion (based
on a screening mea-
sure)
Change in delayed
memory
Mean change in de-
layed memory was 0
SMD 0.81 higher
(0.29 higher to 1.32
higher)
- 543
(11 RCTs)
⊕©©©
VERY LOWb,c
We are unable to deter-
m ine whether there is
any ef fect on delayed
memory due to the very
low quality of evidence
4
C
o
g
n
itiv
e
tra
in
in
g
fo
r
p
e
o
p
le
w
ith
m
ild
to
m
o
d
e
ra
te
d
e
m
e
n
tia
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
9
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
Change in part icipants’
mood
Mean change in part ici-
pants’ mood was 0
SMD 0.72 higher
(0.1 lower to 1.54
higher)
- 577
(8 RCTs)
⊕©©©
VERY LOWb,d
We are unable to de-
term ine whether there
is any ef fect on part ici-
pants’ mood due to the
very low quality of evi-
dence
Change in capacity for
act ivit ies of daily living
Mean change in capac-
ity for act ivit ies of daily
living was 0 SD
SMD 0.12 SD higher
(0.11 lower to 0.35
higher)
- 687
(10 RCTs)
⊕⊕©©
LOWd
Cognit ive training may
not have an ef fect on
capacity for act ivit ies
of daily living
Part icipant burden (re-
tent ion rates)
Study populat ion OR 0.73
(0.37 to 1.43)
1282
(17 RCTs)
⊕⊕©©
LOWe
Cognit ive training may
not be associated with
an increase in part ic-
ipant burden as re-
f lected in retent ion
rates
908 per 1000 878 per 1000
(784 to 934)
Change in mood and
well-being (caregiver)
Mean change in mood
and well-being (care-
giver) was 0
SMD 0.98 higher
(0.27 higher to 1.68
higher)
- 36
(1 RCT)
⊕⊕⊕©
MODERATEf,g
Cognit ive training prob-
ably has a large ef fect
on mood and well-being
in the caregiver
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SMD: standardised mean dif ference
GRADE Working Group grades of evidence.
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
a Inconsistency: downgraded 1 point for serious concerns regarding heterogeneity in ef fect size, which is moderate and
stat ist ically signif icant. Heterogeneity does not seem to be well explained by invest igated ef fect moderators.5
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bInconsistency: downgraded 2 points for very serious concerns regarding heterogeneity in ef fect size, which is relat ively large
and stat ist ically signif icant. Heterogeneity does not seem to be well explained by invest igated ef fect moderators.
cPublicat ion bias: downgraded 1 point for strongly suspected publicat ion bias based on visual inspect ion of the funnel plot,
raising the possibility that small negat ive studies may remain unpublished.
d Imprecision: downgraded 1 point for serious concerns related to imprecision because the conf idence interval crosses the no
treatment threshold.
eImprecision: downgraded 2 points for very serious concerns related to imprecision because the conf idence interval includes
posit ive ef fect, negligible ef fect, and ef fect in the direct ion of the control group.
fRisk of bias: outcome est imation is based on a single study with several lim itat ions related to unclear or high risk of bias in
several domains.
g Imprecision: downgraded 1 point for serious concerns related to imprecision because the analysis is based on fewer than
400 part icipants; however the conf idence interval does not cross the no ef fect threshold.
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B A C K G R O U N D
Description of the condition
Dementia is a clinical syndrome in which functional indepen-
dence is compromised due to intellectual and cognitive impair-
ment (mostly of gradual onset). Dementia typically is caused by
age-related pathophysiological processes. Alzheimer’s disease (AD)
and mixed AD and cerebrovascular disease are the most common
causes of dementia in older people (Alzheimer’s Association 2018).
Other common causes include Lewy body pathology (in demen-
tia with Lewy bodies (DLB) and in Parkinson’s disease dementia
(PDD)) and frontotemporal lobar degeneration (in the frontotem-
poral dementias (FTDs), there are numerous other, rarer causes)
(Alzheimer’s Disease International 2009).
Dementia due to most neurodegenerative conditions is usu-
ally associated with aggregates of folded or misfolded proteins
(Villemagne 2018). In the case of dementia due to AD, this in-
cludes aggregates of the Aβ protein that form into plaques in
the space between neurons, as well as aggregates of misfolded tau
protein that form neurofibrillary tangles inside neurons. Other
protein aggregates are implicated in other neurodegenerative dis-
eases (e.g. TDP-43 in FTD, alpha-synuclein protein aggregates in
dementia with Lewy bodies). Aggregated proteinopathies usually
spread in a predictable and well-described manner through corti-
cal and subcortical regions (Braak & Braak 2012). In the case of
most dementia aetiologies, the pathophysiological chain of events
commences years or even decades before the onset of obvious clin-
ical symptoms, at which stage individuals are increasingly brought
to clinical attention (Alzheimer’s Association 2018).
Regardless of cause, dementia usually has an insidious onset and a
progressive course (although in some cases, e.g. vascular cognitive
impairment, a more rapid onset may be seen) (Wilson 2012). Al-
though the clinical presentation at early or mild stages may vary
according to underlying disease aetiology, global cognitive impair-
ment, changes in personality and behaviour, and compromised
functional independence are common characteristics with clinical
progression. Cognitive impairment (in the case of AD and vas-
cular disease) and behavioural, personality, or language changes
(in the case of frontotemporal neurodegeneration) are typically
present well before a clinical diagnosis is made, but at early stages,
these can be difficult to differentiate from common age-related
changes, or from symptoms associated with common psychiatric
conditions (e.g. depression) - a factor that often leads to delays
in bringing the situation to medical attention. During the pre-
dementia phase, individuals usually present with mild cognitive
impairment during a period in which cognitive impairment can
be detected on formal examination (Albert 2011; Petersen 2004),
but the individual usually shows no, or only minimal, impairment
in ability to carry out most activities of daily living. In mild to
moderate stages of dementia, cognitive impairment becomes more
profound and widespread, functional disability becomes increas-
ingly evident - particularly in relation to more complex activities -
and caregiver burden tends to significantly increase (Berger 2005;
Gaugler 2000). In more advanced stages of dementia, most cog-
nitive and functional abilities are profoundly impaired, and be-
havioural changes such as apathy, depression, aggression, and ag-
itation are frequently observed (Förstl 1999).
Despite some overlap, the cognitive symptom signature that char-
acterises the different disease aetiologies that tend to develop into
dementia can often be distinguished, at least at early stages. In the
case of dementia due to AD, the earliest cognitive signs on formal
neuropsychological examination are almost invariably related to
episodic memory function. Within thememory domain, themost
striking deficits are usually observed in measures of new learning
anddelayed recall - deficits that precede the diagnosis of ADby sev-
eral years (Weintraub 2012). Once deficits in measures of learning
and memory have developed, individuals often show increasing
difficulty performing tasks related to semantic memory, language,
executive functions, and visuospatial/constructional abilities. In
dementia with Lewy bodies, early cognitive impairments are more
likely to involve striking visuospatial deficits, fluctuating attention,
and reduced working memory capacity, along with the develop-
ment of vivid hallucinations. In dementias related to frontotem-
poral lobar degeneration, early symptoms may be predominantly
behavioural and may be related to social cognition in behavioural-
variant FTD, or in temporal subtypes may involve predominantly
language skills and verbal expression (Weintraub 2012). Although
impaired performance on measures of episodic memory is central
to vascular dementia, people with this condition typically display
a more striking deficit on executive and attention tasks, as well
as on measures of semantic knowledge and visuospatial function
(Graham 2004).
Dementia is highly prevalent in older people, is a leading cause
of disability worldwide, and is associated with enormous finan-
cial, emotional, and societal burden (Wimo 2017), making re-
search in this area a global priority (World Health Organization
2012). Despite years of research and numerous clinical trials, no
cure is yet available for any of the irreversible causes of demen-
tia. Cholinesterase inhibitors remain the primary pharmacologi-
cal treatment for cognitive symptoms in AD and related demen-
tias; however, the effects of these drugs are not universal and are
always temporary (Birks 2006). A range of non-pharmacological
interventions (NPIs) that target different aspects of the clinical
syndrome, associated disability, and caregiver burden are available
(for a comprehensive systematic review, see Olazaran 2010). NPIs
generally are not disease-specific and do not directly engage under-
lying biological targets; they are therefore not ’disease-modifying’.
On the other hand, NPIs are more likely to target a broader spec-
trum of clinically meaningful outcomes and are less likely to cause
adverse reactions. Within the broad category of NPIs, cognition-
oriented treatments, particularly CT, have been a topic of much
interest among researchers, clinicians, and the general public.
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Description of the intervention
’Cognition-oriented treatments’ (COTs), referred to previously as
’cognition-focused interventions’ (Clare 2002; Clare 2004), is an
umbrella term referring to a group of NPIs in which a range of
techniques are applied to engage thinking and cognition with var-
ious degrees of breadth and specificity. Unlike NPIs, which are
primarily oriented towards outcomes that are behavioural (e.g.
wandering), emotional (e.g. anxiety), or physical (e.g. sedentary
lifestyle), in COTs, the goals include improving or maintaining
cognitive processes or addressing the impact of impairment in
cognitive processes on associated functional ability in daily life
(Bahar-Fuchs 2013; Clare 2004). CT, sometimes described in the
literature as ’brain training’, ’retraining’, or ’remediation’, typically
involves guided practice of a set of structured - usually standard-
ised - tasks, designed to train individuals on relatively well-de-
fined cognitive processes and abilities such as speed of information
processing, attention, memory, or problem-solving (Bahar-Fuchs
2013; Mowszowski 2010). Other COTs described in the litera-
ture include cognitive stimulation therapy (CST) and cognitive
rehabilitation (CR); these approaches are regarded as distinct in
terms of their underlying theoretical assumptions and core ele-
ments, as well as the contexts or populations in which they have
been traditionally applied, but it is acknowledged that some over-
lap exists, and that differentiating between these approaches is
not always straightforward (Bahar-Fuchs 2013; Gates 2014). In-
deed, these terms have been and continue to be applied some-
what interchangeably in the literature (e.g. Fernandez-Prado 2012;
Giordano 2010), despite the availability of broad definitions and
descriptions of these distinct forms of intervention (Bahar-Fuchs
2013; Clare 2004; Woods 2012). Table 1 (below) summarises
key defining features and common properties of these approaches.
Cognitive stimulation is the focus of a separate Cochrane Review,
which concluded that general cognitive stimulation consistently
produces improvements in general cognition and, in some cases,
in self-reported quality of life and well-being, primarily for peo-
ple with mild to moderate dementia (Woods 2012). Cognitive re-
habilitation, which is an inherently individualised approach em-
phasising collaborative goal-setting and a functional orientation
(Bahar-Fuchs 2016; Clare 2001), has been considered alongside
CT in previous versions of this Cochrane Review (Bahar-Fuchs
2013; Clare 2004); however, as the body of evidence for this ap-
proach has increased in recent years, and as it involves different
methods and targets different outcomes, cognitive rehabilitation
will be considered in a separate Cochrane Review, and the current
review accordingly will focus only on CT.
Cognitive training
Cognitive training (CT) is historically couched within the broader
field of neuropsychological rehabilitation of individuals with brain
injury and neurological diseases, with efforts to systematically re-
train specific cognitive functions originally described by clini-
cal researchers such as Leonard Diller and Yehuda Ben-Yishay in
their pioneering work with victims of stroke and head trauma
throughout the 1970s (Ben-Yishay 1978; Diller 1974). In the
early 1980s, the principles of CT began to be applied in cogni-
tively healthy older adults with subjective cognitive complaints
(e.g. Zarit, 1981); however it was not until the late 1980s that CT
was first attempted with people with dementia (e.g. Beck 1988). A
central assumption underlying CT is that practice has the poten-
tial to improve or at least maintain functioning in the given cogni-
tive domain. A further important assumption is that any effects of
practice will generalise beyond the immediate training context. In
other words, improved performance on a given task should lead to
improved performance on other, related tasks that depend on the
same cognitive process or ability. Although this last assumption
often has not been supported by the evidence (Owen 2010; Papp
2009), some have argued that failure to produce transferable bene-
fits is related in part to problems with task design (Jaeggi 2010). As
noted above,CT traditionally involves the repeated practice of a set
of structured tasks designed to target particular cognitive processes
and abilities. Some study authors have proposed that CT should
be divided into subtypes of cognitive exercise and strategy training
(Gates 2011), the latter of which involves instruction and practice
in the use of specific cognitive strategies designed to further en-
hance performance, or minimise the impact of impaired cognition
(e.g. method of loci, visual imagery) (Hampstead 2016). CT is
different from the type of skill training often exercised by occupa-
tional therapists, in that the target is usually an underlying process
or ability, rather than a specific skill. Early versions of CT tended to
be delivered in an inflexible ’one size fits all’ approach; however, in
recent years, technological developments are leading to increased
tailoring of training focus based on the individual cognitive profile
and adaptive difficulty level (Bahar-Fuchs 2017; Peretz 2011). CT
may be offered through individual sessions (Davis 2001; de Vreese
1998a; de Vreese 1998b; Farina 2002; Koltai 2001; Loewenstein
2004), it may be provided in group sessions (Cahn-Weiner 2003;
Ermini Fuenfsch 1995; Kesslak 1997; Koltai 2001; Moore 2001),
or it may be facilitated by family members with therapist support
(Neely 2009; Quayhagen 1995a; Quayhagen 2000). Initially de-
livered mainly in paper-and-pencil format, computerised cogni-
tive training (CCT) programmes have largely replacedmore tradi-
tional methods over the past two decades (Davis 2001; de Vreese
1998; Quayhagen 1995; Quayhagen 2000). In some cases, the
tasks or activities that form the focus of practice/training are ana-
logues of actual daily activities, such as doing online shopping or
setting up a dinner table (Farina 2002; Loewenstein 2004; Neely
2009; Zanetti 1994; Zanetti 1997; Zanetti 2001), and in these
cases the distinction between CT and functional skills training
becomes more difficult. Skills-oriented interventions in which the
target task is well structured and is broken into relatively well-de-
fined underlying cognitive performance elements, and where the
outcomes of interest are cognitive processes rather than merely
performance of the intervention task itself (e.g. Neely 2009), ap-
8Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
pear to fit the conceptual framework of CT. Conversely, when the
focus of the intervention is a specific skill and there is no expecta-
tion to improve an underlying cognitive ability/process, and where
cognitive underpinnings are unclear or are only vaguely addressed,
the intervention might be best classified as ‘functional skills train-
ing’. In accordance with the suggestion that CT may enhance ef-
fects of pharmacological therapy (Newhouse 1997), some studies
have evaluated the efficacy of CT in combination with the use of
cholinesterase inhibitors (Cahn-Weiner 2003; de Vreese 1998a;
de Vreese 1998b; Loewenstein 2004), or given with other medi-
cations (Heiss 1993; Yesavage 1981).
Table 1. Selected characteristics of cognitive training, rehabilitation, and stimulation
Cognitive training Cognitive rehabilitation Cognitive stimulation
Target Impairment Participation restriction Participation restriction
Context Structured tasks and environ-
ments
The person’s natural environ-
ment
Usually a clinic/residential care
or daycare setting
Focus of intervention Specific cognitive abilities and
processes; psychoeducation and
strategy training sometimes in-
cluded
Groups of cognitive abilities
and processes required to per-
form individually relevant ev-
eryday tasks; behaviour, envi-
ronment, and everyday activity.
Psychoeducation and strategy
training sometimes included
Orientation, global cognitive
status
Format Individualised or group Individualised Typically group
Proposed mechanism of ac-
tion
Mainly restorative;mechanisms
related to neuroplasticity
Combination of restorative and
compensatory approaches; re-
duction of ’excess disability’
Improved orientation; general
activation
Goals Improved or maintained ability
in specific cognitive domains
Performance and functioning
in relation to collaboratively set
behavioural or functional goals
Improved overall orientation
and engagement in pleasant
abilities
How the intervention might work
Cognitive training (CT) aims to improve or maintain specific cog-
nitive processes or global cognitive ability; when used as an inter-
vention approach in clinical populations, it is expected that im-
provements in cognition will generalise to improvement in func-
tional outcomes.Much has beenwritten about the lack of unifying
theories in the field of NPIs, including in relation to interventions
aimed at changing behaviour (Michie 2008), in relation to cog-
nition and function (Wilson 2002), and in relation to rehabilita-
tion in general (Hart 2014). Indeed, no single theory exists that
comprehensively explains such issues as why or how CT should
lead to improved cognitive and functional outcomes, whether and
why some cognitive domains are more likely to respond to train-
ing than others, whether training should target single or multiple
cognitive domains, or whether training should focus on improv-
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ing impaired functions or building on preserved ones. To various
extents, CT interventions in healthy and in clinical populations
draw instead on a range of theories and discoveries grounded in
cognitive neuroscience (e.g. Jaeggi 2008; Sohlberg 1987), or in
clinical practice and rehabilitation of patients with neurological
injuries and diseases (Ponsford 2012; Stuss 1999); CT continues
to be shaped in response to relevant technological developments
including those reported in the gaming industry (Anguera 2015).
Unfortunately, many CT interventions have been and continue
to be developed without clear reference to any relevant theoretical
work.
A central assumption held by many advocates of CT is that train-
ing in an underlying cognitive ability or process will lead to gener-
alised improvements that go beyond the training context (Lampit
2014). In cognitively healthy younger and older adults, and to a
lesser extent in individualswithmild cognitive impairment (MCI),
there is little doubt that CT leads to improvement in trained or
’criterion’ tasks. However, in both healthy and clinical popula-
tions, the evidence concerning learning transfer remains mixed,
and the issue is hotly debated, with much debate concerning iden-
tification of barriers and enablers of transfer of gains to untrained
tasks that reflect the cognitive domain targeted by the training
(near transfer) and other untrained cognitive domains, as well as
non-cognitive outcomes (far transfer) (Jaeggi 2010). In a recent
comprehensive review and critique of the commercial CT indus-
try, Simons and colleagues pointed out that discussion concerning
transfer of learning can be traced back to very early theoretical
accounts (Simons 2016), such as the so-called formal discipline
theory and the theory of transfer by identical elements proposed
by Edward Thorndike in the early 20th century. It is beyond the
scope of this review to cover these theories in detail, but a critical
discussion of these accounts in relation to theCT literature and in-
dustry is included in the review by Simons and colleagues (Simons
2016). Contemporary empirical findings suggest that factors that
appear to be implicated in CT-related gain-transfer include de-
gree of similarity or overlap among elements of trained and trans-
fer tasks, extent of actual gain on trained tasks, baseline cognitive
abilities, and age (Zinke 2014).
In addition to theories of learning and transfer, knowledge and
expertise related to brain-behaviour relationships - as well as to
mechanisms of injury, disease, and recovery - are critical in inform-
ing the development of COTs, including CT, in the context of
work with persons with acquired disorders of the central nervous
system (including traumatic brain injury, stroke, and neurodegen-
erative conditions). Historically, such interventions have reflected
two broad conceptual frameworks for recovery of function after
brain illness or injury: a restorative approach, and a contextualised
or compensatory approach (Ylvisaker 2002). Techniques usually
associated with cognitive rehabilitation, such as optimising resid-
ual cognitive abilities in impaired domains andmaking themost of
unimpaired cognitive abilities, lend themselves more to compen-
satory approaches (Clare 2001b). In contrast, techniques usually
associated with CT, such as the repeated exercise of standardised
cognitive tests of increasing difficulty and the targeting of spe-
cific cognitive domains, tend to reflect restorative principles and
“thrive on the lure of neuroplasticity” (Rabipour & Raz 2012).
Indeed, a range of neuroplasticity-related observations in animal
and human studies, including changes at the molecular, synaptic,
structural, and functional levels associated with enriched environ-
ments and a structured training programme, are routinely cited
as the proposed mechanisms of action in CT (Valenzuela 2012).
In recent years, growing evidence has shown that CT is associated
with changes in patterns of neural activation in key brain regions
among healthy older adults (Belleville 2014), as well as in peo-
ple with MCI (Belleville 2011; Hampstead 2011). Such increased
brain activation may be the result of processes of synaptic growth
and repair triggered by repeated practice on standardised tests.
Why it is important to do this review
The Alzheimer’s disease drug development pipeline is slow, and
trials of disease-modifying treatments have generally failed to pro-
duce improvement in any clinically meaningful outcomes, al-
though they have succeeded in disrupting targeted pathophysio-
logical processes (Cummings 2014; Cummings 2016; Salomone
2012), leading some to question the relevance of the dominant
amyloid cascade hypothesis when it comes to the development of
an effective treatment for dementia as a clinical syndrome (D’Alton
2011).NPIs aimed at developingways of living betterwith demen-
tia, in part by targeting relevant clinical outcomes and caregiver
burden, are assuming an increasingly central role in the manage-
ment of dementia and are recognised as an important adjunct, and
even alternative, to available pharmacological treatments. A recent
Lancet Commission on Dementia Prevention, Intervention, and
Care argued that some NPIs can already play an important role
in managing some of the cognitive, behavioural, and neuropsy-
chiatric symptoms of dementia, and pointed to positive findings
for cognitive stimulation therapy and preliminary supportive evi-
dence on cognitive rehabilitation (Livingston 2017).
In healthy older adults (Edwards 2017; Lampit 2014), and in
persons with MCI (Chandler 2016; Hill 2017), systematic review
findings on effects of CT on cognitive and several non-cognitive
outcomes have been generally encouraging, and factors associated
with increased intervention efficacy in CT are becoming better
understood. Indeed, recently published clinical practice guidelines
for MCI have classified CT as supported by Level C evidence,
meaning that clinicians may recommend this form of intervention
(Petersen 2018).
In contrast, most systematic reviews of CT for persons with
dementia have to date produced largely negative findings (e.g.
Bahar-Fuchs 2013; Hill 2017; but see Sitzer 2006). Our previous
Cochrane Review on CT for persons with dementia included 11
randomised controlled trials but provided no evidence to support
CT in relation to any of the examined outcomes. We noted, how-
10Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
ever, that the certainty of these findings may be reduced by the
relatively small number of highly heterogenous studies, which of-
ten were of low methodological quality. Against the background
of a heavily divided scientific community and an ever growing in-
dustry of commercial CT products that have at times made highly
misleading claims, it is vital that clinicians, policy-makers, and
the general public are presented with an up-to-date, rigorous, and
unbiased review of the current literature on CT for persons with
mild to moderate dementia.
O B J E C T I V E S
• To assess effects of CT on cognitive and non-cognitive
outcomes for people with mild to moderate dementia and their
caregivers.
• To compare effects of CT with those of other non-
pharmacological interventions, including cognitive stimulation
or rehabilitation, for people with mild to moderate dementia and
their caregivers.
• To identify and explore factors related to intervention and
trial design that may be associated with the efficacy of CT for
people with mild to moderate dementia and their caregivers.
M E T H O D S
Criteria for considering studies for this review
Types of studies
In keeping with the previous version of this review, and to en-
sure the inclusion of unbiased estimates of treatment effects only
(Reeves 2011), we considered only randomised controlled trials
(RCTs) for inclusion. Wherever possible, we did not exclude stud-
ies published in a language other than English, and we made every
effort to obtain an English translation from the study authors. In
cases where we could not obtain a translation from study authors,
we engaged in reasonable efforts to obtain a reliable translation,
and we excluded a study only if these efforts were unsuccessful.
Types of participants
We included trials in which all participants had received a medical
diagnosis of dementia, of any subtype, as long as the underlying
aetiology was assumed to be non-reversible. It was expected that
the diagnosis of dementia was generally made on the basis of es-
tablished clinical or research diagnostic criteria, including criteria
specified by the following.
• The Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (DSM-V; APA 2013) or earlier versions (APA
1995).
• The International Classification of Diseases, Tenth Revision
(ICD-10) (WHO 1992).
• The National Institute of Neurological and Communicative
Disorders and Stroke - Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA) (McKhann 1984).
• The National Institutes of Health - Alzheimer’s Association
(NIH-AA) (McKhann 2011).
• The Association Internationale pour la Recherché et
l’Enseignement en Neurosciences (NINDS-AIREN) (Roman
1993).
• Vascular Impairment of Cognition Classification Consensus
Study (McKeith 1996; McKeith 2006; McKeith 2017).
• The International Behavioural Variant FTD Criteria
Consortium (FTDC) (Skrobot 2017).
On average, participants in included studies were classified as hav-
ing amild tomoderate level of severity.Dementia severity was usu-
ally determined in primary trials on the basis of groupmean scores,
ranges of scores, or individual scores on a standardised scale, such
as scores over 12 on the Mini Mental State Examination (MMSE;
Folstein 1975), or scores of 0.5 to 2 on the Clinical Dementia
Rating scale (CDR 2; Hughes 1982).
• Studies in which it was clear that only a small proportion of
participants (i.e. < 15%) fell within the more severe range or the
questionable dementia range were considered acceptable if this
information was clearly indicated in the study.
• Qualifying participants generally resided at home, or in a
residential care facility. We excluded studies in which recruited
participants could be long-term residents of psychiatric hospitals,
where pre-existing psychiatric conditions are likely to be present.
• We set no specific age restrictions, although it was expected
that, with the exception of participants with younger-onset
dementia (YOD), most participants would be 65 years of age or
older.
• No restrictions were placed on current pharmacological
treatment. When available, information about participants’ use
of cholinesterase inhibitors was noted.
• Primary studies that included a mixture of participants,
only some of whom meet our inclusion criteria (e.g. dementia,
MCI), were eligible for inclusion as long as outcomes were
reported separately for the group of interest, or as long as we
could obtain that information from trial authors.
Types of interventions
Experimental interventions
Interventions meeting our definition of CT were eligible for in-
clusion. As the terms used to refer to CT vary considerably, in-
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terventions may be referred to as ’brain’ or ’mental’ training, and
theymay be described as ’retraining’, ’exercise’, ’stimulation’, ’reha-
bilitation’, ’therapy’, ’remediation’, ’support’, etc.; our operational
definition of eligible interventions included the following criteria.
• Participants were trained on tasks designed to target one or
more cognitive processes either directly or indirectly. Training
generally took the form of repeated practice. Trials in which the
primary goal was to compare performances of participants who
learned how to perform a task under different learning
conditions (e.g. errorless vs errorful) in a single session (single
trial training) were not eligible for inclusion.
• Tasks were completed in pen-and-paper format or through
computerised exercises, or were structured analogues of everyday
tasks in which the cognitive underpinnings are explicit, and the
intervention targeted a cognitive ability or process rather than a
specific skill. The nature of the intervention (i.e. computerised or
pen-and-paper or analogues of daily activities) was noted.
• Interventions were delivered on commercially available
platforms, or were designed specifically for the purposes of the
study.
• Interventions could target single or multiple cognitive
domains.
• Level of difficulty was expected to vary; however, this did
not form part of the inclusion criteria.
• We excluded from this review interventions in which CT
was combined with another distinct experimental intervention
(e.g. physical activity, brain stimulation), but this did not apply
to standard treatments, as participants were generally expected to
remain on their standard (usually pharmacological) treatment.
• Modified/alternative CT: it was acknowledged that CT and
other cognition-oriented treatment approaches (i.e. cognitive
stimulation or rehabilitation) may share some features, some of
which could not be distinguished in a straightforward manner.
Hence, we will include trials of complex cognition-oriented
treatments that also include elements of cognitive stimulation
(e.g. orientation), rehabilitation (e.g. goal setting), or
psychoeducation (e.g. using cognitive strategies), if it was
determined by consensus that CT was clearly the predominant
component. When relevant and indicated by statistical
heterogeneity, we considered these interventions separately in
subgroup analyses.
Comparator interventions
• Wait-list. In studies of this type, the experimental
intervention was offered to the control group after the study had
ended.
• No treatment/standard treatment. Unless otherwise specified,
whenever groups were described as ’no treatment’ in individual
studies, we assumed that this referred to usual/standard
treatment, and not to withholding of treatment. ’Usual or
standard treatment’ referred to what would normally be provided
in the study locality to participants with mild dementia, and
might include provision of medication, clinic consultations, and
contact with a community mental health team or daycare, or
support from voluntary organisations, but not a specific CT
intervention.
• Active control. This referred to conditions in which
participants engaged in some form of activity, typically for an
equivalent number of sessions or visits, and received similar levels
of contact with the researchers, but during which no structured
intervention was offered.
• Alternative treatments. These were distinct, alternative
treatments that might (e.g. cognitive stimulation) or might not
have been cognition-focused (e.g. physical activity).
All interventions
• We did not include interventions conducted in individual
or group format, with or without involvement of family
caregivers.
• We did not impose restrictions regarding intervention dose-
related parameters, including overall duration of the intervention
or number of treatment sessions. However, as described above,
we excluded single-session treatments.
Types of outcome measures
We considered outcomes within the following broad categories as
relevant for this review.
• Clinical disease progression.
• Cognitive outcomes.
• Psychosocial outcomes for the person with dementia.
• Psychosocial outcomes for the primary caregiver.
• Surrogate/mechanism/biomarker outcomes.
• Economic outcomes.
Although it is acknowledged that surrogate and economic out-
comes are important, we determined them to be beyond the scope
of the current review; therefore we selected the main primary and
secondary outcomes from the top four categories, as further out-
lined below.
Primary outcomes
Outcomes for the person with dementia
• Global cognitive status at end of treatment (i.e. immediately
post intervention).We measured this by determining change in
scores on a composite measure of global cognition derived from
all cognitive measures included in each trial, with additional
analyses focusing on global cognition, as reflected on screening
measures of global cognition (e.g. MMSE)
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• Clinical disease severity in the medium term.We measured
this by determining change in scores on measures of clinical
disease progression (e.g. Clinical Dementia Rating Scale (CDR),
Dementia Rating Scale (DRS)) in a follow-up assessment
conducted between 3 and 12 months after treatment cessation
Secondary outcomes
Outcomes for the person with dementia
• Global cognitive status in the medium term.We measured
this by determining change in scores on a composite measure of
global cognition at the relevant follow-up assessment, with
additional analyses focusing on global cognition as reflected on
screening measures of global cognition (e.g. MMSE)
• Clinical disease severity at end of treatment.We measured this
by determining change in scores on measures of clinical disease
progression (e.g. CDR, DRS) in the immediate post-treatment
assessment
• Domain-specific cognitive status at end of treatment. We
measured this by determining change in scores on
neuropsychological measures of speed of processing, immediate
memory, delayed memory, attention and working memory,
language (naming), verbal letter fluency, verbal category fluency,
and executive function
• Domain-specific cognitive status in the medium term (3 and
12 months after treatment cessation). We measured this by
determining change in scores on neuropsychological measures of
speed of processing, immediate memory, delayed memory,
attention and working memory, language (naming), verbal letter
fluency, verbal category fluency, and executive function
• Meta-cognition (subjective beliefs regarding cognition -
self-reported) at end of treatment and in the medium term
• Meta-cognition (subjective beliefs regarding cognition -
informant-reported) at end of treatment and in the medium term
• Mood (as reflected in change in self- or informant-reported
measures of depression, anxiety, etc.) at end of treatment and in
the medium term
• Capacity for activities of daily living at end of treatment
and in the medium term
• Behavioural and psychological symptoms of dementia
(BPSD) at end of treatment and in the medium term
• General health or quality of life at end of treatment and in
the medium term
• Participant burden as reflected in rates of retention of trial
participants at end of treatment
Outcomes for the primary caregiver at end of treatment
• Mood and well-being (as reflected in change in self-
reported measures of depression, anxiety, etc.) at end of
treatment and in the medium term
• Burden of care at end of treatment and in the medium term
• Quality of life at end of treatment and in the medium term
Outcome measures
Where possible, we used data from published and validated tests,
questionnaires, or techniques for evaluation of a given outcome.
In cases in which an outcome was evaluated by an unpublished or
non-established measure, we made every effort to source informa-
tion about statistical properties of the test or scale in question, be-
fore determining whether or not to accept the measure. We classi-
fied cognitive measures to specific cognitive domains according to
established authoritative texts (Spreen 1998), wherever possible,
and by consensus between study authors as required.
Outcome evaluation
We included trials if they included, at minimum, a baseline eval-
uation and one post-treatment evaluation.
Search methods for identification of studies
Electronic searches
We searched ALOIS (www.medicine.ox.ac.uk/alois), the Spe-
cialised Register of the Cochrane Dementia and Cognitive Im-
provement Group (CDCIG), on 5 July 2018.
ALOIS, which is maintained by the Information Specialists for
CDCIG, contains studies that fall within the areas of dementia
prevention, dementia treatment and management, and cognitive
enhancement in healthy elderly populations. These studies are
identified by:
• searching several major healthcare databases: MEDLINE,
Embase, Cumulative Index to Nursing and Allied Health
Literature (CINAHL), and PsycINFO;
• searching several trial registers: ClinicalTrials.gov and the
International Clinical Trials Register Platform (ICTRP) of the
World Health Organization (WHO), which includes
International Standard Randomized Controlled Trials Number
(ISRCTN); the Chinese Clinical Trials Register; the German
Clinical Trials Register; the Iranian Registry of Clinical Trials;
and the Netherlands National Trials Register, plus others;
• searching the Central Register of Controlled Trials, in the
Cochrane Library (CENTRAL); and
• searching grey literature sources: Institute for Scientific
Information (ISI) Web of Science Core Collection.
To view a list of all sources searched for ALOIS, please visit the
ALOIS website ( www.medicine.ox.ac.uk/alois).
Details of the search strategies run in healthcare bibliographic
databases, used for retrieval of reports of dementia, cognitive im-
provement, and cognitive enhancement trials, can be viewed on
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the website of the Cochrane Dementia and Cognitive Improve-
ment Group at http://dementia.cochrane.org/searches.
We ran additional searches in MEDLINE, Embase, PsycINFO,
CINAHL, Latin American Caribbean Health Sciences Literature
(LILACS), ClinicalTrials.gov, and the WHO Portal/ICTRP, to
ensure that searches for this review were as comprehensive and as
up-to-date as possible. Search strategies used and the number of
hits retrieved can be seen in Appendix 1.
Searching other resources
We screened reference lists from included trials, as well as reference
lists of recent systematic reviews, and relevant recent guidelines.
We contacted experts in the field to request additional randomised
trial reports not identified by the search.
Data collection and analysis
Selection of studies
One review author (AM) reviewed titles and abstracts from the
complete de-duplicated list of search results, and we split the
records for an independent screening by two additional review
authors (ABF, AG), to identify all potentially relevant RCTs of
CT for people with dementia and to remove obviously irrelevant
studies. Whenever there was doubt regarding the eligibility of a
trial, we selected it for full review of the methods. Following the
initial screening, we applied the same approach for evaluation of
full methods from short-listed articles. We identified and merged
multiple reports from the same study, and we contacted study au-
thors to clarify issues related to the eligibility of a trial for inclu-
sion. We settled discrepancies in the classification of trials through
discussion between two review authors and ruling of a senior re-
view author who is a content area expert (LC). The study selection
process was unblinded.
Data extraction and management
JS extracted data from study reports onto a standardised, struc-
tured data entry form under supervision of the lead review au-
thor (ABF), who also independently extracted data for variables re-
quiring some judgement (e.g. intervention integrity/fidelity), and
we subsequently entered the data into Review Manager 5 soft-
ware (ReviewManager 5).We sought additional information from
study authors as appropriate. Data extracted from each trial in-
cluded detailed characteristics of trials (e.g. settings, outcomes),
design features (e.g. delivery format, blinding), participant charac-
teristics (e.g. diagnoses, age, gender, education, medications), and
elements of experimental and control interventions (e.g. intensity,
frequency, duration, key intervention features). We also extracted
information about additional variables of interest for the investi-
gation of effect moderators, including registration status, sources
of funding, conflicts of interest, adherence and retention, type of
control, whether intervention integrity/fidelity was addressed, and
adverse events. For each outcome of interest, we extracted mean
scores and standard deviations on relevant measures from all avail-
able evaluations.
Assessment of risk of bias in included studies
Pairs of review authors independently conducted assessment of risk
of bias using Cochrane’s ’Risk of bias’ tool (Higgins 2017). We re-
solved disagreements by discussion with a third review author who
is a subject matter expert (LC). Consistent with Cochrane’s ’Risk
of bias’ tool, we assessed bias in the following domains: sequence
generation, allocation concealment, blinding of participants and
investigators, incomplete outcome data, and selective reporting of
outcomes. We rated studies as ’low risk’, ’high risk’, or ’unclear
risk’ in each of these domains.
Measures of treatment effect
Wegenerally calculated effect estimates in primary trials alongwith
their 95% confidence intervals (CIs) using change-from-baseline
scores. Calculations of the standard deviation of change scores
were based on the assumption that the correlation between mea-
surements at baseline and those at subsequent time points is r =
0.8, in keeping with other relevant reviews (e.g. Lampit 2014).
However, for consistency with previous versions of this review, we
also conducted sensitivity analyses of the primary outcome with a
conservative r = 0 assumption, which overestimates the standard
deviation of the change. We treated outcome measures as mea-
sured on a continuous scale. In some cases, we derived outcomes
from ordinal rating scales; provided these contained a reasonably
large number of categories (more than 10), we treated data as con-
tinuous variables arising from a normal distribution. For dichoto-
mous outcomes (e.g. participant retention), we expressed effects
as risk ratios (RRs) along with 95% CIs.
Unit of analysis issues
We expected four types of unit of analysis issues: cross-over trial
designs, multiple-armed trials (more than one treatment/control
condition), repeated assessments, and availability of multiple mea-
sures of the same outcome in primary trials. Our approach to the
management of these issues was as follows.
• Cross-over trials: we used only data from the first treatment
period (before cross-over).
• Multiple conditions:
◦ experimental conditions: in trials that include at least
three conditions, assuming that at least one condition satisfies our
definition of a comparison condition (see above), we combined
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data from all conditions that we judged to fit our definition of
CT into a single group using a relevant formula (Higgins 2017).
We excluded from this review trials that include two relevant
experimental conditions but no eligible control condition; and
◦ control conditions: we combined data from two
control conditions of the same broad type (i.e. no treatment). In
the event that a trial included different types of control
comparisons that are not alternative treatments (e.g. it included
both no treatment and active control groups), we used in the
analysis data from both these control conditions by splitting the
sample size of the experimental condition into two separate
groups, according to the procedure described in Chapter 7 of the
Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2017).
• Repeated post-intervention assessments: we conducted separate
comparisons to assess primary and secondary outcomes at end of
treatment (i.e. immediately post intervention), and in the short
to medium term (up to 12 months post intervention). Within
this follow-up period, we used in the analysis data from the last
available assessment. We did not use data from follow-up
assessments conducted more than 12 months following the end
of treatment assessment.
• Multiple measures of the same outcome: in primary trials in
which multiple measures of the same outcome were used, the
following principles guided the selection of measures for data
extraction:
◦ general principles: we used a composite outcome
measure if one was derived by the study authors. If no composite
was available, we generally used data from a test that matched
the most commonly used measure in other studies that
contributed data to the particular outcome. Established/
published measures of the outcome were preferred over measures
developed for the specific study. If more than one established
measure of an outcome was used, and no measure was identified
that was used by most trials contributing to the specific outcome,
we created a simple composite score from standardised scores on
the different measures and used it in the analysis;
◦ cognitive outcomes: for each trial, we computed a
global composite cognitive score by calculating a standardised
change-from-baseline score for each measure (change score
divided by the standard deviation of the change score), and
deriving a simple mean and standard deviation of the z-scores
associated with all cognitive measures from a trial. In addition,
for evaluation of domain-specific cognitive scores, we used the
following principles:
⋄ Psychomotor information processing speed: we
preferred visuospatial measures where available.
⋄ Attention, immediate and delayed memory: we
preferred auditory-verbal measures for evaluation of attention
and immediate and delayed memory. We preferred tasks that
involve the learning of information over several trials (i.e. word
lists) over tasks in which the information is presented only once
(e.g. story or figure recall). We preferred measures of free recall
over measures of cued/recognition where available.
⋄ Executive functions: we preferred tasks that
reflect planning, organisation, decision-making, regulation of
performance, and set-shifting aspects of executive functions over
tasks that are more strongly associated with volition or purposive
action aspects of executive functions (Lezak 2004). In the event
that several measures of executive function were used in a study,
we computed a composite executive function score by taking the
mean of standardised scores for each of these measures.
◦ Meta-cognitive outcomes: we generally preferred self-
reported measures of contentment/satisfaction with one’s
cognitive ability over informant-reported measures;
◦ Mood outcomes: we generally preferred measures of
depression over measures of anxiety or apathy, and self-reported
measures over informant-reported measures; and
◦ Activities of daily living (ADLs): we preferred measures
of instrumental ADLs over measures of basic ADLs, and
informant-reported measures over self-reported measures. This is
based on the finding that self- and informant-reported daily
functions show significant discrepancy in people with dementia,
and that informant reports of daily function are more closely
associated with actual memory performance (Farias 2005).
Dealing with missing data
We extracted the number of participants who commenced and
completed the intervention in each condition, and this contributed
to our assessment of risk of bias due to incomplete outcome data.
Wherever possible, we contacted trial authors in an effort to ob-
tain relevant unreported data. In general, we assumed that data
were missing at random, and that analyses in individual studies
were generally performed on a per-protocol (PP) rather than on an
intention-to-treat (ITT) basis. When a trial report included rele-
vant data from both ITT and PP samples, we generally used the
PP data for consistency with most of the trials. We evaluated the
impact of missing data on pooled effect estimates by performing
sensitivity analyses (see below).
Assessment of heterogeneity
In addition to a visual inspection of the forest plots, we assessed
statistical heterogeneity using a standard Chi² statistic and the
associated l² statistic. Consistent with recommendations (Deeks
2017), we deemed heterogeneity to be present when the Chi²
statistic is significant at the P = 0.1 level, or when l² suggests that
more than 40% of the variability in the effect estimate is due
to heterogeneity. Where substantial heterogeneity was detected,
we explored the sources of heterogeneity by conducting subgroup
analyses (see below).
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Assessment of reporting biases
For primary outcomes, we first evaluated the presence of reporting
bias through visual examination of funnel plots for small-study
effects. We examined the significance of any apparent asymmetry
by using Egger’s test (Egger 1997), and by providing follow-up
with the ’trim and fill’ test (Duval 2000), if asymmetry of the plot
was confirmed.
Data synthesis
We performed data synthesis using Review Manager 5 software.
In relation to each of themain outcomes of interest, we undertook
the following separate comparisons.
• CT versus control (no/standard treatment/wait-list or active
control) at end of treatment (i.e. immediately post intervention).
• CT versus control (no/standard treatment/wait-list or active
control) in the medium term (3 to 12 months following end of
treatment).
• CT versus alternative treatment at end of treatment (i.e.
immediately post intervention).
• CT versus alternative treatment in the medium term (3 to
12 months following end of treatment).
Within each of the planned comparisons, we pooled data in rela-
tion to each outcome of interest when data from at least two trials
were available.
We performed inverse-variance, random-effects meta-analyses for
all outcomes. We used mean differences (MDs) with 95% CIs
whenever studies used the same outcomemeasure, whereaswe used
standardised mean differences (SMDs), which show the absolute
mean difference divided by the pooled standard deviation, when
the same outcome was assessed by different measures.
Subgroup analysis and investigation of heterogeneity
In relation to each outcome, we carried out subgroup analyses to
evaluate the potential impact of categorical treatment modifiers.
We carried out subgroup analyses only when statistical hetero-
geneity was suggested by the relevant statistics (I² ≥ 40%) (Deeks
2017), and when at least three studies were available for each sub-
group. We examined the following categorical effect modifiers.
• Type of intervention 1: ’straight’ CT versus ’augmented’
CT - in which CT was combined with elements of cognitive
rehabilitation or cognitive stimulation (or both).
• Type of intervention 2: multi-domain CT versus single-
domain CT (e.g. working memory).
• Intervention dose: more intense (i.e. more than three
formal sessions per week) versus less intense interventions (i.e. up
to three formal sessions per week).
• Intervention duration: longer interventions (i.e. more than
three months) versus shorter interventions (i.e. three months or
less).
• Follow-up period: we compared studies with follow-up in
the short term (up to three months after treatment cessation)
versus trials that included longer-term follow-up (up to 12
months after treatment cessation).
• Risk of bias: studies with high risk of bias in at least two
critical domains versus other studies with lower risk of bias. For
the purposes of these analyses, critical domains were sequence
generation, blinding of outcome assessment, incomplete data,
and selective reporting. Although we acknowledge that allocation
concealment is increasingly regarded as a critical domain, this
remains a relatively infrequent practice in these types of studies.
• Funding source: trials funded by commercial entities versus
those based on competitive funding.
• Registration: registration status of the trial (prospective/
retrospective vs not registered/not reported).
Sensitivity analysis
To determine whether findings for the primary outcomes were
affected by assumptions made regarding strength of the correla-
tion between scores before and after the interventions, we repeated
analyses of the primary outcomes after applying the zero corre-
lation assumption, which overestimates the standard deviation of
change scores. We repeated evaluation of primary outcomes by
performing a further sensitivity analysis using post-intervention
scores only, thus avoiding the need to estimate the standard devi-
ation of change scores.
GRADE and ’Summary of findings’ tables
We expressed our overall confidence in the evidence for each out-
come using GRADE, and we presented this in ’Summary of find-
ings’ tables and in the review text. We described the quality of evi-
dence as ’high’, ’moderate’, ’low’, or ’very low’, using the GRADE
framework, which we applied to all primary and secondary out-
comes in each comparison. In relation to each outcome, we con-
sidered certainly in the estimates in relation to risk of bias, indi-
rectness, inconsistency, imprecision, and publication bias for stud-
ies contributing data to estimation of the outcome. Two review
authors (ABF and JS) worked together to grade the evidence. We
considered estimates based on data from a single study against the
same parameters, with the exception of inconsistency and pub-
lication bias dimensions. In relation to risk of bias, we generally
downgraded by 1 point, reflecting serious concern, when sensi-
tivity analysis in which we removed studies classified as at overall
’high risk’ led to a difference in the estimate of effect of between
0.2 standard deviation (SD) and 0.3 SD. We downgraded by 2
points, reflecting very serious concern, when sensitivity analysis
led to a difference in the estimate of effect that was greater than
0.3 SD. We generally downgraded by 1 point for serious con-
cerns regarding inconsistency when moderate heterogeneity was
observed (40% < l² < 75%) and when subgroup analyses (when
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relevant; see below) did not seem to explain heterogeneity in the
estimates. We generally downgraded by 2 points when high het-
erogeneity (l² > 75%) was observed and when subgroup analyses
(when relevant) did not seem to explain the heterogeneity. Con-
cerning imprecision, following the rule of thumb in the GRADE
Handbook, we downgraded by 1 point when the sample size on
which the estimate was based was smaller than 400 participants, or
in the event that the confidence interval of the estimate included
both a potentially important effect and a clinically unimportant
effect (defined as an effect smaller than 0.2 in either direction
for continuous outcomes). We downgraded by 2 points when the
estimate was based on fewer than 400 participants (for continu-
ous outcomes), and when the CI of the estimate included both
a potentially important effect and no effect, or in the event that
the CI included all relevant possibilities (positive effect, no effect,
and effect in the opposite direction), irrespective of the sample
size. Regarding publication bias, we indicated that it was ’strongly
suspected’ in cases where on visual inspection, asymmetry in the
funnel plot for a relevant outcome was reasonably evident. We did
not conduct formal tests of asymmetry, and we inspected funnel
plots only when at least 10 studies contributed to the outcome.
Hence, we could not evaluate this for many outcomes, including
all outcomes in the comparison between cognitive training and
use of an alternative treatment. Finally, we generally regarded the
correspondence between findings in relation to various outcomes
and the review question as specified in the PICO to be adequate,
so we decided not to downgrade the evidence on the basis of in-
directness.
We generated ’Summary of findings’ tables using GRADEpro
GDT software (GRADEpro GDT), and we imported these
into the review. Summary of findings for the main comparison,
Summary of findings 2, Summary of findings 3, and Summary of
findings 4 include the following primary and secondary outcomes.
• Global cognition at end of intervention.
• Clinical disease severity at latest follow-up, up to 12
months following treatment cessation.
• Delayed memory ability at end of intervention.
• Capacity to perform activities of daily living.
• Mood and well-being of participant.
• Mood and well-being of informant/caregiver.
• Treatment burden (retention rates).
R E S U L T S
Description of studies
Results of the search
The flow of studies through the search and screening process can
be seen in Figure 1 (review flow chart). After de-duplication, 1166
records underwent full title and abstract review, on the basis of
which we deemed 157 titles to be potentially relevant; we then
reviewed the full text of these studies (when available) to confirm
eligibility. The full-text review revealed that 33 studies met our
inclusion criteria and 32 studies contributed data for at least one
meta-analysis. Of these, 10 studies were included in a previous
Cochrane Review on CT and rehabilitation for people with mild
to moderate dementia (Bahar-Fuchs 2013).
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Figure 1. Study flow diagram.
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Included studies
Pertinent details of the included studies, extracted from the pub-
lished manuscript and, where noted, provided by study authors,
are presented in the Characteristics of included studies table. Fur-
ther details concerning the characteristics of participants in in-
cluded studies are presented in Table 1, and details concerning
dose and duration of the interventions are shown in Table 2. The
33 studies selected for inclusion in the current review were pub-
lished between 1988 and 2018. With the exception of Davis 2001
and Barban 2016, which did not use a cross-over design, all tri-
als were parallel-group RCTs. Amieva 2016, Barban 2016, Beck
1988, Jelcic 2014, Kallio 2018, Kao 2016, Lee 2013, and Tsantali
2017 were described as multi-site trials; all others were assumed
to be single-site trials. Only three of the included trials made ref-
erence to registration in a public trial registry; Brueggen 2017
and Kallio 2018 were prospectively registered, whereas Kao 2016
was retrospectively registered. We assumed that all other trials
were unregistered. The included trials were conducted in 12 coun-
tries, with six conducted in the USA (Beck 1988; Cahn-Weiner
2003; Davis 2001; Koltai 2001; Quayhagen 1995; Quayhagen
2000), two in Germany (Brueggen 2017; Heiss 1993), 12 in Italy
(Bergamaschi 2013; Cavallo 2016; de Vreese 1998; Galante 2007;
Giovagnoli 2017; Giuli 2016; Jelcic 2012; Jelcic 2014; Mapelli
2013; Serino 2017; Trebbastoni 2018; Venturelli 2016 ), one in
Sweden (Neely 2009), one in Japan (Kawashima 2005), three
in France (Amieva 2016; Boller 2011; Goudour 2011), two in
Spain (Fernández-Calvo 2011; Quintana Hernandez 2014), two
in China (Kao 2016; Lee 2013), one in Korea (Kim 2015), one in
Greece (Tsantali 2017), and one in Finland (Kallio 2018). Barban
2016 was a multi-country trial with recruitment in Italy, Greece,
Norway, and Spain. It is worth noting that approximately one-
third of all included studies (13) were conducted in Italy, 10 of
these in the past six years. We further note that no eligible trials
were found from the UK, Canada, or Australia, and that no eligi-
ble studies were found that were conducted in the USA since 2003
(these studies were all included in a previous review - Bahar-Fuchs
2013). Samples in the included studies ranged from 12 partici-
pants in Galante 2007 to 653 participants in Amieva 2016, and 13
of the included studies had samples of more than 50 participants.
Of the 33 included studies, 30 were published in English, two in
Spanish, and one in French. A member of the review team (JS)
translated essential information from Spanish and French studies
to English.
General characteristics of participants
Participants in all trials had a diagnosis of mild to moderate de-
mentia according to the published paper. Diagnosis was based ex-
clusively on NINCDS-ADRDA criteria in 12 of the included tri-
als, whereas six studies used either NINCDS-ADRDA or DSM-
IV criteria, and one study used either NINCDS-ADRDA or Mi-
lan Overall Dementia Scale (MODS) criteria. In four studies, di-
agnoses were supported by scores on the Mini Mental State Ex-
amination (MMSE) test alone, and one study used MMSE in
combination with the Global Deterioration Scale (GDS). Two
studies used DSM-IV alone, three used the Clinical Dementia
Rating Scale (CDR) alone, and one used the Chinese version of
the Dementia Rating Scale (DRS) alone. Two studies used the
DRS in combination with the GDS, and one study used physician
judgement as the basis for diagnosis. In almost all trials, the pre-
sumed aetiology was AD, but other aetiologies were suspected in
some studies: probable mixed dementia (Beck 1988); cardiovas-
cular dementia or Parkinson’s disease (Quayhagen 2000); vascular
dementia (Neely 2009); and Parkinson’s disease, vascular demen-
tia, Lewy body dementia, or unknown dementia (Kallio 2018).
With the exception of a small number of studies in which partici-
pants were recruited fromhospital or nursing home facilities (Beck
1988; Cavallo 2016; Kawashima 2005; Mapelli 2013; Venturelli
2016), participants generally resided in the community. Severity
of dementia among participants residing in a nursing home en-
vironment may have been somewhat greater, with MMSE scores
ranging between 15 and 20 in Beck 1988, between 7 and 30 in
Kawashima 2005, between 14 and 24 in Mapelli 2013, and be-
tween 10 and 15 in Venturelli 2016.
In two studies, the mean age of participants was greater than 65,
but less than 70 years (Heiss 1993; Goudour 2011). In 19 of the
included studies, the mean age of participants was between 70
and 80 years (Cavallo 2016; Quayhagen 1995; Tsantali 2017). In
ten of the included trials, the mean age of participants was greater
than 80 years (Boller 2011; Kawashima 2005; Kallio 2018). Two
studies did not report the mean age of participants although, in
both of them, they were 50 years and above (Brueggen 2017; Lee
2013)
General characteristics of experimental interventions
All studies included at least one condition that met our criteria
for CT. In six studies, two conditions met our criteria for CT
(Boller 2011; Fernández-Calvo 2011; Jelcic 2014; Koltai 2001;
Lee 2013; Neely 2009), and for these studies, data from the two
conditions were combined as specified in the protocol to form a
single experimental condition. Of a total of 39 CT interventions,
26 were classified as multi-domain interventions and 13 as sin-
gle-domain interventions (Boller 2011; Cahn-Weiner 2003;Davis
2001; Goudour 2011; Jelcic 2012; Jelcic 2014; Kao 2016; Lee
2013; Neely 2009).We classified most experimental interventions
as ’straight CT’, but we classified 13 experimental interventions
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as ’augmented CT’ due to the inclusion of additional elements,
usually associated with reality orientation, cognitive stimulation,
or cognitive rehabilitation, as was the case with de Vreese 1998 or
Davis 2001,Mapelli 2013 orKim 2015, for example.We classified
23 of the 39 experimental interventions as primarily individual
training (although in some cases, participants could receive some
assistance from their caregivers) and 11 as group training. Two
experimental conditions involved a combination of group and in-
dividual training (Kallio 2018; Kim 2015), and one experimental
treatment involved dyads (Neely 2009). The remaining studies
provided insufficient detail to show whether participants in the
experimental conditions were trained individually or in a group
(Boller 2011; Kao 2016).
General characteristics of comparison conditions
In seven studies, two conditions met our criteria for a compari-
son condition (Brueggen 2017; de Vreese 1998; Giovagnoli 2017;
Kao 2016; Mapelli 2013; Venturelli 2016; Tsantali 2017). In a
further two studies (Amieva 2016; Quintana Hernandez 2014),
three conditions met our criteria for comparison conditions, and
in one study (Quayhagen 2000), four conditions could be clas-
sified as comparison conditions. We classified 17 of the compar-
ison conditions as passive controls (involving a wait-list condi-
tion, a no-contact condition, placebo medication, or usual care
(i.e. continuing with usual activities of the nursing home or hospi-
tal, or receiving conventional medical care)) and 14 as active con-
trols (including social support groups, activities similar to those
in the experimental condition but with a passive approach, un-
structured conversation or discussion, educational information,
semi-structured interviews, clinical support, unstructured or non-
specific cognitive activity, and other non-specific activities). We
considered that 15 interventions met our criteria for an alter-
native treatment. These included a new medication (de Vreese
1998); dyadic counselling, dual supportive seminar groups, and
early-stage daycare programmes (Quayhagen 2000); occupational
therapy (Mapelli 2013); mindfulness and muscular relaxation
(Quintana Hernandez 2014); reminiscence therapy and cognitive
rehabilitation (Amieva 2016; Brueggen 2017); and spaced retrieval
combined with Montessori activities (Kao 2016), aerobic exercise
(Venturelli 2016), cognitive stimulation (Tsantali 2017), and mu-
sic therapy and neuroeducation (Giovagnoli 2017).
Intervention dose and duration
The duration of interventions ranged from two weeks in Boller
2011 to approximately 104 weeks in Quintana Hernandez 2014.
In seven of the 33 studies, the intervention lasted three months or
longer (Amieva 2016; Bergamaschi 2013; Heiss 1993; Kawashima
2005; Quintana Hernandez 2014; Trebbastoni 2018; Tsantali
2017). In nine studies, researchers delivered the intervention in
more than three sessions per week (Bergamaschi 2013; Boller
2011; Brueggen2017;Kao2016;Kawashima2005;Mapelli 2013;
Quayhagen 1995; Quintana Hernandez 2014; Venturelli 2016).
Excluded studies
We have summarised the characteristics of excluded studies in the
Characteristics of excluded studies table.
Risk of bias in included studies
We have summarised risk of bias for individual studies, along with
a justification for our ratings, in the Characteristics of included
studies tables.Wehave summarised risk of bias for specific domains
across studies in Figure 2 and Figure 3.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Although all studies are described as randomised trials, many stud-
ies provided insufficient detail regarding the randomisation pro-
cedure to determine whether the sequence was indeed random;
accordingly we rated these as having unclear risk of bias. We rated
two studies as having high risk of selection bias, generating the se-
quence in a manner that was unlikely to be truly random (Galante
2007; Jelcic 2014). We rated studies in which a remote, comput-
erised randomisation method was carried out as low risk in rela-
tion to allocation concealment, as this is intrinsic to the method
(e.g. Amieva 2016; Kallio 2018). However, we assumed that allo-
cation was not concealed in studies that generated the sequence in
a manner that did not guarantee allocation concealment or that
provided insufficient detail concerning the randomisation proce-
dure, and did not state explicitly that allocation was concealed
(e.g. Beck 1988; Kawashima 2005).
Blinding
In most studies, post-intervention assessments were performed by
research staff, who were unaware of the condition to which par-
ticipants were assigned, although a small number of studies pro-
vided insufficient detail to ensure that this was done (Kawashima
2005; Quayhagen 1995; Quintana Hernandez 2014). However,
in approximately 25% of trials (Barban 2016; Beck 1988; Boller
2011; Brueggen 2017;Giuli 2016;Heiss 1993; Koltai 2001;Neely
2009; Serino 2017), unmasked personnel completed outcome as-
sessments, leading to increased risk of detection bias. In relation
to performance bias, because blinding of those delivering the in-
tervention typically is not possible in studies of CT, we focused
our assessment of risk on the extent to which participants were
blinded to whether they were assigned to an experimental or con-
trol intervention. This is not possible in studies that included only
a passive (e.g. treatment as usual) control condition; we therefore
rated these studies as having high risk of performance bias. We
rated studies that used an active control or an alternative treat-
ment as having unclear risk of performance bias if no mention was
made of an attempt to mask whether the allocated condition was
an experimental or control intervention. We rated approximately
90% of studies as having high or unclear risk of performance bias.
Incomplete outcome data
In approximately 50% of the included studies, we found no ev-
idence of attrition bias; however, we judged about half of the
remaining studies to have unclear risk (e.g. Giovagnoli 2017;
Quayhagen 2000), and we judged half to be at high risk of bias
due to attrition (e.g. de Vreese 1998; Tsantali 2017).
Selective reporting
In most cases, studies seem to have reported all outcomes, or study
authors provided them in the required format upon request. We
sought information from trial registries to determine whether all
pre-specified outcomes were reported, but we found no published
protocols for any of the included studies.
Effects of interventions
See: Summary of findings for the main comparison Cognitive
training compared to control immediately post intervention for
people with mild to moderate dementia; Summary of findings
2 Cognitive training compared to control in the medium term
(3 to 12 months post intervention) for people with mild to
moderate dementia; Summary of findings 3 Cognitive training
compared to alternative treatment immediately post intervention
for people withmild tomoderate dementia; Summary of findings
4 Cognitive training compared to alternative treatment in the
medium term (3 to 12 months post intervention) for people with
mild to moderate dementia
We summarised main outcomes when CT was compared with
control interventions at end of treatment in Summary of findings
for the main comparison.
We summarised main outcomes when CT was compared with
control interventions in themedium term in Summary of findings
2.
We summarised main outcomes when CT was compared with
alternative treatments at end of treatment in Summary of findings
3.
We summarised main outcomes when CT was compared with
alternative treatments in themedium term in Summary of findings
4.
Participant outcomes
Global cognition (composite outcome measure) at end of
treatment (primary outcome) and in the medium term
(secondary outcome)
Comparison with control
We found a small to moderate effect favouring CT relative to a
control condition on the primary outcome, namely, global cogni-
tion measured with a composite cognitive score at end of training
(standardised mean difference (SMD) 0.42, 95% confidence in-
terval (CI) 0.23 to 0.61; 27 trials; 1389 participants; Analysis 1.1;
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Figure 4). Our certainty in this finding is moderate due to hetero-
geneity in effect estimates, which was not explained by planned
subgroup analyses. We did not detect clear evidence of publication
bias when examining the funnel plot in Figure 5. We performed
a more conservative sensitivity analysis in which we assumed no
correlation between observations before and after the intervention
and still found moderate-quality evidence of a small beneficial ef-
fect of CT relative to a control on global cognition at end of treat-
ment (SMD 0.24, 95% CI 0.12 to 0.36; Analysis 1.2).
Figure 4. Forest plot of comparison: 1 Cognitive training vs control immediately post intervention,
outcome: 1.1 Change in a global measure of cognition (composite).
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Figure 5. Funnel plot of comparison: 1 Cognitive training vs control immediately post intervention,
outcome: 1.1 Change in a global measure of cognition (composite).
We were uncertain whether CT had an effect relative to a con-
trol condition on a composite measure of global cognition in the
medium term (i.e. between 3 and 12 months post treatment)
due to the very low quality of evidence, both in our main anal-
ysis (SMD 0.65, 95% CI 0.11 to 1.2, 8 trials; 387 participants;
Analysis 2.1) and in a sensitivity analysis in which we assumed no
correlation between observations before and after the intervention
(SMD0.40, 95%CI 0.09 to 0.71; Analysis 2.2). Quality concerns
were related to risk of bias, heterogeneity, and imprecision.
Comparison with an alternative treatment
In comparison with an alternative treatment, we found no clear
evidence of an effect of CT on a global measure of cognition at
end of treatment, but the quality of evidence for this finding is
low due to very serious imprecision (SMD 0.21, 95% CI -0.23
to 0.64; 7 trials; 769 participants; Analysis 3.1; Figure 6). In a
more conservative sensitivity analysis, assuming zero correlation
between observations before and after the intervention, we found
there may be little or no effect of CT (SMD -0.03, 95% CI -0.23
to 0.17; Analysis 3.2) on a composite global cognition score at end
of training. The quality of evidence related to this outcome is also
low.
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Figure 6. Forest plot of comparison: 3 Cognitive training vs alternative treatment immediately post
intervention, outcome: 3.1 Change in a global measure of cognition (composite).
In the medium term, we were unable to determine whether CT
was associated with any gains in global cognition relative to an
alternative treatment because of the very low quality of evidence
(SMD 1.31, 95% CI -1.03 to 3.65; 2 studies; 73 participants;
Analysis 4.1 Analysis 4.2).
Global cognition (screening measures) at end of treatment
and in the medium term (secondary outcomes)
Comparison with control
Findings were similar when global cognition was assessed using
a screening measure, typically the MMSE (although nine stud-
ies used another measure as well as the MMSE, including the
Alzheimer’s Disease Assessment Scale - cognitive subscale (ADAS-
Cog), the Milan Overall Dementia Scale (MODA), the Cam-
bridgeCognitive Assessment (CAMCOG), and the complete neu-
ropsychological battery (ENB-2), and one study used only the
ADAS-Cog). We found low-quality evidence suggesting a mod-
erate effect of CT on global cognition at end of training (SMD
0.65, 95% CI 0.26 to 1.05; 20 trials; 1288 participants; Analysis
1.3; Figure 7) and a smaller but still beneficial effect in our more
conservative sensitivity analysis (SMD0.27, 95%CI 0.04 to 0.50;
Analysis 1.4).
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Figure 7. Forest plot of comparison: 1 Cognitive training vs control immediately post intervention,
outcome: 1.3 Change in a global measure of cognition.
We are unable to determine whether there is any effect on global
cognition assessed with screening measures in the medium term
due to the very low quality of evidence, including following a
sensitivity analysis (6 trials; 387 participants; Analysis 2.3 Analysis
2.4). Quality concerns were related to risk of bias, heterogeneity,
and imprecision.
Comparison with an alternative treatment
We are uncertain of any effect of CT on a global measure of
cognitionwhen compared to an alternative treatment immediately
after the interventiondue to the very lowquality of evidence (SMD
0.16, 95% CI -0.28 to 0.60; 7 trials; 724 participants; Analysis
3.3). This was also true in the medium term (SMD 3.20, 95% CI
-2.89 to 9.29; 2 trials; 73 participants; Analysis 4.3).
Subgroup analyses
To explore the sources of heterogeneity in our main comparison
for global cognition, we performed several pre-specified subgroup
analyses, including type of control condition (see Analysis 10.3),
type of CT (see Analysis 8.3; Analysis 9.3), dose delivered (fre-
quency and duration; see Analysis 6.3; Analysis 7.3), and risk of
bias (see Analysis 5.3). We found no significant differences be-
tween subgroups in any of the subgroup analyses in relation to
global cognition, although we found non-significant trends sug-
gesting that trials in which the intervention was delivered at a
frequency greater than three times per week were associated with
larger effects than trials in which the intervention was delivered
up to three times per week (Analysis 6.3), and that traditional CT
trials were associated with larger effect sizes than ’augmented’ CT
trials (Analysis 8.1).
Clinical disease severity at end of treatment (secondary
outcome)
Comparison with control
We found a large effect of CT relative to a control condition on the
secondary outcome of clinical disease severity at end of treatment
(SMD 1.07, 95% CI 0.59 to 1.55; 6 trials; 215 participants;
Analysis 1.5).However, owing to concerns regardingheterogeneity
and imprecision, our certainty in the accuracy of the estimate is
low.
Comparison with an alternative treatment
When compared with an alternative treatment, we found no evi-
dence of an effect of CT on clinical disease severity, and the quality
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of the evidence was low due to very serious imprecision (SMD
0.15, 95% CI -0.33 to 0.63; 3 trials; 131 participants; Analysis
3.5).
Clinical disease severity in the medium term (primary
outcome)
Comparison with control
We were unable to determine whether there is an effect of CT
relative to a control intervention on the primary outcome of clin-
ical disease severity in the medium term (3 to 12 months post
treatment), as the quality of the evidence is very low due to con-
cerns regarding risk of bias and imprecision (SMD 0.55, 95% CI
0.12 to 0.98; 2 trials; 98 participants; Analysis 2.5 Figure 8). We
performed a sensitivity analysis in which a conservative assump-
tion of no correlation between observations before and after the
intervention was applied to the data, and we were again unable to
determine whether there was any effect of CT relative to a control
condition on clinical disease severity in the medium term due to
the very low quality of evidence (SMD 0.28, 95% CI -0.14 to
0.71; Analysis 2.6).
Figure 8. Forest plot of comparison: 2 Cognitive training vs control in the medium term (3 to 12 months
post intervention), outcome: 2.5 Change in disease progression.
Comparison with an alternative treatment
None of the included studies measured this outcome in the
medium term.
Specific cognitive domains (secondary outcomes)
Comparison with control
Results comparing effects CT versus a control condition at end
of treatment on specific cognitive domains (secondary outcomes)
are depicted in Analysis 1.6 Analysis 1.7 Analysis 1.8 Analysis 1.9
Analysis 1.10 Analysis 1.11 Analysis 1.12 Analysis 1.13 and Figure
9. CT showed a positive effect in immediate and delayed mem-
ory, attention and working memory, language (naming), executive
functions, and verbal category fluency immediately after the inter-
vention. However, with the exception of findings regarding cate-
gory fluency (high certainty), our certainty in findings concerning
specific cognitive domains was generally very low to low. As can
also be seen in Analysis 2.7 Analysis 2.8 Analysis 2.9 Analysis 2.10
Analysis 2.11 Analysis 2.12 Analysis 2.13 and Analysis 2.14, gains
in some of the specific cognitive domains (delayed memory, nam-
ing, executive functions, and verbal category fluency) were main-
tained in the medium term. However, again, with the exception
of category fluency scores (high certainty), our certainty in these
findings ranges from low to very low.
We performed pre-specified subgroup analyses to explore effects
of sources of heterogeneity in the comparison of CT versus control
interventions on scores in specific cognitive domains, including
high risk of bias studies versus lower risk of bias studies, type of
CT (traditional vs augmented), type of domain (multi-domain
vs single domain), and type of control group (passive vs active).
Subgroup analyses suggest that the intervention dose moderated
effects of CT on verbal letter fluency (Chi² = 3.96, df = 1, P =
0.05), and larger effects were associated with interventions deliv-
ered more than three times per week (SMD 1.0, 95% CI 0.09 to
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1.92; 3 trials; 84 participants) relative to interventions delivered
up to three times per week (SMD 0.05, 95% CI -0.13 to 0.24;
9 trials; 460 participants; Analysis 6.9; Figure 10). In addition,
subgroup analyses suggest that type of CT moderated effects on
verbal category fluency (Chi² = 4.81, df = 1, P = 0.03), and multi-
domain training was associated with larger effects (SMD 0.70,
95% CI 0.38 to 1.02; 6 trials; 371 participants) than single-do-
main training (SMD 0.14, 95% CI -0.25 to 0.52; 3 trials; 104
participants; Analysis 9.12; Figure 11). We found no other expla-
nations of heterogeneity in other subgroup analyses.
Figure 9. Forest plot of comparison: 1 Cognitive training vs control immediately post intervention,
outcome: 1.6 Change in delayed memory.
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Figure 10. Forest plot of comparison: 6 Cognitive training vs control immediately post intervention -
intervention dose, outcome: 6.9 Change in verbal letter fluency.
Figure 11. Forest plot of comparison: 9 Cognitive training vs control immediately post intervention - type
of CT (multi-domain vs single domain), outcome: 9.12 Change in verbal category fluency.
Comparison with an alternative treatment
Results comparing effects of CT versus an alternative treatment
at end of treatment on specific cognitive domains are depicted in
Analysis 3.6 Analysis 3.7 Analysis 3.8 Analysis 3.9 Analysis 3.10
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Analysis 3.11 Analysis 3.12 and Analysis 3.13. Due to the very
low quality of evidence, we could not determine whether CT is as-
sociated with any benefit for specific cognitive domains compared
with an alternative treatment at the end of the intervention. Re-
sults for comparison of CT versus an alternative treatment in the
medium term are depicted in Analysis 4.6 Analysis 4.7 Analysis
4.8 Analysis 4.9 Analysis 4.10 Analysis 4.11 Analysis 4.12 and
Analysis 4.13. As can be seen, with the exception of immediate and
delayed memory, other specific cognitive domains were evaluated
by a single study; therefore we could not perform meta-analyses.
The quality of evidence in relation to all of these outcomes was low
to very low, so we are unable to determine whether, relative to an
alternative treatment, CT is associated with any gains in specific
cognitive domains in the medium term.
Meta cognition - self-reported (secondary outcome)
Comparison with control
We found no evidence that CT had an effect on self-rated cogni-
tive ability immediately post treatment (SMD0.12, 95%CI -0.87
to 1.12; 2 trials; 41 participants; Analysis 1.14; Analysis 2.15).
However, the quality of evidence was low, and the findings were
very imprecise. Data for this outcome in the medium term were
available from only one trial (Lee 2013), in which participants in
the experimental condition (which combined data from two ex-
perimental conditions - a computerised version and a non-com-
puterised version of the training) reported fewer difficulties related
to prospective memory following treatment relative to control.
However, this is a very small trial (n = 19), which we rated to be at
high risk of attrition bias due to incomplete outcome data and at
high risk of selection bias due to lack of allocation concealment.
Given the subjective nature of the outcome, and use of a ’no treat-
ment’ control condition, our certainty in this finding is very low.
Therefore, we are unable to determine whether CT is associated
with any gains in meta cognition in the medium term relative to
a control treatment.
Comparison with an alternative treatment
Data concerning this outcome were not available in the compar-
ison of CT versus an alternative treatment in the immediate or
medium term.
Meta cognition - informant-reported (secondary outcome)
Comparison with control
Weare unable to determinewhether relative to a control condition,
CThad an effect on informant-rated cognitive ability immediately
post training due to very low quality of the evidence (SMD -0.01,
95% CI -1.29 to 1.26; 2 trials; 56 participants; Analysis 1.15). In
the medium term, a single study found no evidence of an effect
of CT on informant-rated cognition in the medium term (SMD -
0.06, 95% CI -0.73 to 0.62; Analysis 2.16), but the quality of the
evidence was low (Cahn-Weiner 2003).
Comparison with an alternative treatment
No studies contributed to this outcome when comparing CT ver-
sus alternative treatments in the immediate or medium term.
Mood (secondary outcome)
Comparison with control
Weare unable to determinewhether relative to a control condition,
CT had an effect on participants’ mood, as reflected on measures
of depression, because the quality of the evidence was very low due
to concerns related to inconsistency and imprecision (SMD 0.72,
95% CI -0.10 to 1.54; 8 trials; 577 participants; Analysis 1.16,
Figure 12).We found no evidence of an effect of CT over a control
condition in the medium term. The quality of evidence was low
due to very serious imprecision; thus, our results were inconclusive
(i.e. between 3 and 12 months post treatment; SMD 0.21, 95%
CI -0.54 to 0.96; 2 trials; 30 participants; Analysis 2.17). We
performed pre-specified subgroup analyses to explore the sources
of heterogeneity in participants’ mood when CT was compare
with control, including type of control condition and type of CT
(traditional vs augmented). The test for subgroupdifferences could
not explain heterogeneity in traditional CT versus augmented CT
(P = 0.64), nor in passive control versus active control (P = 0.71)
(Analysis 8.15 Analysis 10.15).
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Figure 12. Forest plot of comparison: 1 Cognitive training vs control immediately post intervention,
outcome: 1.16 Change in participants’ mood.
Comparison with an alternative treatment
When compared with an alternative treatment, we found that CT
probably had little or no effect on participants’ mood immediately
post treatment; we are moderately certain of this finding (SMD
-0.11, 95% CI -0.29 to 0.07; 3 trials; 543 participants; Analysis
3.16). Only one study contributed to this same outcome in the
medium term (Giovagnoli 2017); therefore we could not perform
a meta-analysis. Results of this study suggest that benefits in the
medium term may favour an alternative treatment (SMD -0.66,
95% CI -1.35 to 0.02). However, due to very serious concerns
related to imprecision, the quality of the evidence was low; there-
fore, the results are inconclusive.
Capacity for activities of daily living (secondary outcome)
Comparison with control
Relative to a control intervention, we found that CT may have
little to no effect on capacity for activities of daily living immedi-
ately post treatment (SMD 0.12, 95% CI -0.11 to 0.35; 10 trials;
687 participants; Analysis 1.17 Figure 13); however the quality of
the evidence was low due to concerns related to risk of bias and
imprecision. Therefore clear evidence is lacking.
Figure 13. Forest plot of comparison: 1 Cognitive training vs control immediately post intervention,
outcome: 1.17 Change in capacity for activities of daily living.
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We also found no evidence that CT has an effect on activities of
daily living in themedium term (SMD0.22, 95%CI -0.5 to 0.94;
3 trials; 64 participants; Analysis 2.18); the quality of evidence
was again low due to very serious concerns regarding imprecision.
Therefore clear evidence is lacking.
Comparison with an alternative treatment
We are moderately certain that CT, when compared with an al-
ternative treatment, has little or no effect on participants’ capacity
for activities of daily living at end of treatment (SMD -0.25, 95%
CI -0.43 to -0.07; 3 trials; 525 participants; Analysis 3.17). No
studies evaluated this outcome in the medium term.
General health and quality of life (secondary outcome)
Comparison with control
Because the quality of evidence was very low, we are unable to de-
termine whether, relative to a control condition, CT had an effect
on general health and quality of life immediately post intervention
(SMD -0.04, 95% CI -0.38 to 0.29; 5 trials; 630 participants;
Analysis 1.18). In the medium term, only one study contributed
to this outcome; therefore, we could not perform a meta-analysis
(Kallio 2018). This study found no evidence of any CT relative to
a control condition (SMD -0.02, 95% CI -0.39 to 0.35; Analysis
2.19), but the quality of the evidence was low due to very serious
imprecision.
Comparison with an alternative treatment
In comparison with an alternative treatment, the quality of the
evidence was low. We found that an alternative treatment may
be favoured, but these results were imprecise, so there could be
little or no effect of CT immediately post intervention (SMD -
0.49, 95%CI -1 to 0.02; 4 trials; 631 participants; Analysis 3.18).
Only one study contributed to this outcome in the medium term,
finding no evidence of a positive effect of CT relative to alternative
treatment (SMD 0.33, 95% CI -0.34 to 1; Analysis 4.18), but
the quality of evidence was low, so the results are inconclusive
(Giovagnoli 2017).
Behavioural and psychological symptoms of dementia
(secondary outcome)
Comparison with control
The quality of the evidence was very low due to serious concerns
related to heterogeneity and imprecision, so we are unable to de-
termine whether, relative to a control treatment, CT had an effect
on behavioural and psychological symptoms of dementia imme-
diately post intervention (SMD 0.44, 95% CI -0.34 to 1.22; 6
trials; 493 participants).
In the medium term, only one study contributed to this outcome
and found no evidence of an effect of CT on general health and
quality of life (SMD -1.34, 95% CI -2.75 to 0.07; 1 trial; 11
participants; Analysis 2.20) (Galante 2007). However, we have
low certainty in this result.
Comparison with an alternative treatment
We found moderate-quality evidence showing that CT probably
has no effect relative to an alternative treatment immediately post
intervention (SMD -0.11, 95% CI -0.27 to 0.06; 3 studies; 672
participants; Analysis 3.19). No trials compared CT versus an
alternative treatment on this outcome in the medium term.
Participant burden (retention rates at end of treatment)
(secondary outcome)
Meta-analyses of participant retention rates at end of treatment
showed that participants receiving CT were not more likely to dis-
continue participating in the trial relative to participants receiving
a control (odds ratio (OR) 0.73, 95% CI 0.37 to 1.43; 17 trials;
1282 participants; Analysis 1.20 Figure 14) or an alternative treat-
ment (OR 0.78, 95% CI 0.24 to 2.57; 4 trials; 639 participants;
Analysis 3.20), but our certainty in these findings is very low to
low due to imprecision; therefore, our results are inconclusive.
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Figure 14. Forest plot of comparison: 1 Cognitive training vs control immediately post intervention,
outcome: 1.20 Participant burden (retention rates).
Caregiver outcomes
Comparison with control
Results concerning caregiver outcomes are depicted in Analysis
1.21 Analysis 1.22 Analysis 1.23 Analysis 3.21 Analysis 3.22
Analysis 3.23 and Figure 15. The quality of evidence in relation to
quality of life of the caregiver immediately at the end of treatment
was low, and we found no evidence of any effects of CT relative
to a control condition (SMD 0.16, 95% CI -0.50 to 0.83; 1 trial;
36 participants; Analysis 1.22). We also found moderate-quality
evidence showing that CT was not associated with lower burden
of care at end of treatment relative to a control treatment (SMD
-0.11, 95% CI -0.36 to 0.15; 2 trials; 405 participants; Analysis
1.21). One study found a positive effect of CT on caregiver mood
at end of treatment relative to control (SMD 0.98, 95% CI 0.27
to 1.68; 1 trial; 36 participants; Analysis 1.23) (Quayhagen 2000).
We have moderate certainty in this finding.
Figure 15. Forest plot of comparison: 1 Cognitive training vs control immediately post intervention,
outcome: 1.23 Change in mood and well-being (CAREGIVER).
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Comparison with an alternative treatment
Based on one study (Quayhagen 2000), we found moderate-qual-
ity evidence of a positive effect of CT on caregiver mood at end
of treatment relative to alternative treatment (SMD 1.5, 95% CI
0.96 to 2.04; 1 trial; 88 participants; Analysis 3.23). No available
studies evaluated caregiver outcomes in the medium term.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Cognitive training compared to control in the medium term (3 to 12 months post intervention) for people with mild to moderate dementia
Patient or population: people with mild to moderate dementia
Setting: Community dwelling or in residential care
Intervention: cognit ive training
Comparison: control in the medium term (3 to 12 months post intervent ion)
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with control in the
medium term (3 to 12
months post interven-
tion)
Risk with cognitive
training
Change in a global mea-
sure of cognit ion (com-
posite)
Mean change in a
global measure of cog-
nit ion (composite) was
set at 0 SDs
SMD 0.65 higher
(0.11 higher to 1.2
higher)
- 387
(8 RCTs)
⊕©©©
VERY LOWa,b,c
We are unable to de-
term ine whether there
is any ef fect on global
cognit ion (composite)
due to the very low qual-
ity of evidence
Change on global
cognit ion (screening)
(Global cog)
Mean change in global
cognit ion (screening)
was set at 0 SDs
SMD 1.33 higher
(0.31 higher to 2.34
higher)
- 387
(6 RCTs)
⊕©©©
VERY LOWa,d,e
We are unable to de-
term ine whether there
is any ef fect on perfor-
mance in global cogni-
t ion due to the very low
quality of evidence
Change in disease pro-
gression
Mean change in dis-
ease progression was
set at 0 SDs
SMD 0.55 higher
(0.12 higher to 0.98
higher)
- 98
(3 RCTs)
⊕©©©
VERY LOWa,c
We are unable to deter-
m ine whether CT slows
down disease progres-
sion due to the very low
quality of evidence
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Change in delayed
memory
Mean change in de-
layed memory was set
at 0 SDs
SMD 0.97 SD higher
(0.02 higher to 1.92
higher)
- 253
(4 RCTs)
⊕©©©
VERY LOWa,c,d
We are unable to de-
term ine whether there
is any ef fect on perfor-
mance in delayed mem-
ory due to the very low
quality of evidence
Change in capacity for
act ivit ies of daily living
Mean change in capac-
ity for act ivit ies of daily
living was set at 0 SDs
SMD 0.22 higher
(0.5 lower to 0.94
higher)
- 64
(3 RCTs)
⊕⊕©©
LOWc
Cognit ive training may
not have an ef fect on
capacity for act ivit ies
of daily living
Change in part icipants’
mood
Mean change in part ici-
pants’ mood was set at
0 SDs
SMD 0.21 higher
(0.54 lower to 0.96
higher)
- 30
(2 RCTs)
⊕⊕©©
LOWc
Cognit ive training may
not have an ef fect on
part icipants’ mood
Change in mood and
well-being (caregiver)
- See comment - (0 studies) - No studies have eval-
uated this outcome in
the intermediate term
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; CT: cognit ive training; OR: odds rat io; RCT: randomised controlled trial; SD: standard deviat ion; SMD: standardised mean dif ference
GRADE Working Group grades of evidence.
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
aRisk of bias: downgraded 2 points for very serious concerns related to risk of bias: removal of high-risk studies leads to
reasonably large changes in the ef fect est imate.
bInconsistency: downgraded 1 point for serious concerns regarding heterogeneity in ef fect size, which is large and stat ist ically
signif icant. However, heterogeneity seems to be part ially explained by invest igated ef fect moderators.
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cImprecision: downgraded 2 points for very serious concerns related to imprecision because the analysis is based on fewer
than 400 part icipants, and the conf idence interval crosses the no ef fect threshold.
d Inconsistency: downgraded 2 points for very serious concerns regarding heterogeneity in ef fect size, which is relat ively large
and stat ist ically signif icant. Heterogeneity does not seem to be well explained by invest igated ef fect moderators.
eImprecision: downgraded 1 point for serious concerns related to imprecision because the analysis is based on fewer than
400 part icipants; however the conf idence interval does not cross the no ef fect threshold.
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Cognitive training compared to alternative treatment immediately post intervention for people with mild to moderate dementia
Patient or population: people with mild to moderate dementia
Setting: Community dwelling or in residential care
Intervention: cognit ive training
Comparison: alternat ive treatment immediately post intervent ion
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with alternative
treatment immediately
post intervention
Risk with cognitive
training
Change in a global mea-
sure of cognit ion (com-
posite)
Mean change in a
global measure of cog-
nit ion (composite) was
0 SD
SMD 0.21 SD higher
(0.23 lower to 0.64
higher)
- 769
(7 RCTs)
⊕⊕©©
LOWa
Cognit ive training may
not have an ef fect on
global cognit ion
Change in a global mea-
sure of cognit ion
Mean change in a
global measure of cog-
nit ion was 0
SMD 0.16 higher
(0.28 lower to 0.6
higher)
- 724
(7 RCTs)
⊕©©©
VERY LOWa,b
We are unable to de-
term ine whether there
is any ef fect on global
cognit ion (as measured
by a screening tool) due
to very low quality of ev-
idence
Change in delayed
memory
Mean change in de-
layed memory was 0
SMD 0.71 higher
(0.33 lower to 1.75
higher)
- 147
(3 RCTs)
⊕©©©
VERY LOWc,d
We are unable to de-
term ine whether there
is any ef fect on perfor-
mance in delayed mem-
ory due to very low qual-
ity of the evidence
Change in part icipants’
mood
Mean change in part ici-
pants’ mood was 0
SMD 0.11 lower
(0.29 lower to 0.07
higher)
- 543
(3 RCTs)
⊕⊕⊕©
MODERATEe
Cognit ive training prob-
ably has no ef fect on
part icipants’ mood38
C
o
g
n
itiv
e
tra
in
in
g
fo
r
p
e
o
p
le
w
ith
m
ild
to
m
o
d
e
ra
te
d
e
m
e
n
tia
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
9
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
Change in capacity for
act ivit ies of daily living
Mean change in capac-
ity for act ivit ies of daily
living was 0
SMD 0.25 lower
(0.43 lower to 0.07
lower)
- 525
(3 RCTs)
⊕⊕⊕©
MODERATEe
Cognit ive training prob-
ably has no ef fect on ca-
pacity for act ivit ies of
daily living
Part icipant burden (re-
tent ion rates)
Study populat ion OR 0.78
(0.24 to 2.57)
639
(4 RCTs)
⊕©©©
VERY LOWa,b
We are unable to de-
term ine whether cogni-
t ive training increases
part icipant burden (as
measured by retent ion
rates)
773 per 1000 727 per 1000
(450 to 898)
Change in mood and
well-being (caregiver)
Mean change in mood
and well-being (care-
giver) was 0
SMD 1.5 higher
(0.96 higher to 2.04
higher)
- 88
(1 RCT)
⊕⊕⊕©
MODERATEf
Cognit ive training prob-
ably has a large ef fect
on mood and well-being
in the caregiver
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SD: standard deviat ion; SMD: standardised mean dif ference
GRADE Working Group grades of evidence.
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
a Imprecision: downgraded 2 points for very serious concerns related to imprecision because the conf idence interval includes
posit ive ef fect, negligible ef fect, and ef fect in the direct ion of the control group.
bInconsistency: downgraded 1 point for serious concerns regarding heterogeneity in ef fect size, which is moderate and
stat ist ically signif icant. Heterogeneity does not seem to be well explained by invest igated ef fect moderators.
cInconsistency: downgraded 2 points for very serious concerns regarding heterogeneity in ef fect size, which is relat ively large
and stat ist ically signif icant. Heterogeneity does not seem to be well explained by invest igated ef fect moderators.
d Imprecision: downgraded 2 points for very serious concerns related to imprecision because the analysis is based on fewer
than 400 part icipants, and the conf idence interval crosses the no ef fect threshold.
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eImprecision: downgraded 1 point for serious concerns related to imprecision because the sample size includes fewer than
400 part icipants.
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Cognitive training compared to alternative treatment in the medium term (3 to 12 months post intervention) for people with mild to moderate dementia
Patient or population: people with mild to moderate dementia
Setting: Community dwelling or in residential care
Intervention: cognit ive training
Comparison: alternat ive treatment in the medium term (3 to 12 months post intervent ion)
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with alterna-
tive treatment in the
medium term (3 to 12
months post interven-
tion)
Risk with cognitive
training
Change in a global mea-
sure of cognit ion (com-
posite)
Mean change in a
global measure of cog-
nit ion (composite) was
set at 0 SDs
SMD 1.31 SD higher
(1.03 lower to 3.65
higher)
- 73
(2 RCTs)
⊕©©©
VERY LOW
We are unable to de-
term ine whether there
is any ef fect on global
cognit ion (composite)
due to very low quality
of the evidence
Change in a global mea-
sure of cognit ion
Mean change in a
global measure of cog-
nit ion was set at 0 SDs
SMD 3.2 higher
(2.89 lower to 9.29
higher)
- 73
(2 RCTs)
⊕©©©
VERY LOW
We are unable to de-
term ine whether there
is any ef fect on perfor-
mance in a screening
measure of global cog-
nit ion due to very low
quality of the evidence
Change in disease pro-
gression
- See comment - (0 studies) - None of the included
studies have evaluated
this outcome
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Change in delayed
memory
Mean change in de-
layed memory was set
at 0 SDs
SMD 3.13 higher
(3.57 lower to 9.83
higher)
- 73
(2 RCTs)
⊕©©©
VERY LOW
We are unable to de-
term ine whether there
is any ef fect on perfor-
mance in delayed mem-
ory due to very low qual-
ity of the evidence
Change in part icipants’
mood
Mean change in part ici-
pants’ mood was set at
0 SDs
SMD 0.66 lower
(1.35 lower to 0.02
higher)
- 39
(1 RCT)
⊕⊕©©
LOWa
Cognit ive training may
not have an ef fect on a
part icipants’ mood
Change in capacity for
act ivit ies of daily living
- See comment - (0 studies) - None of the included
studies have evaluated
this outcome
Change in mood and
well-being (caregiver)
- See comment - (0 studies) - None of the included
studies have evaluated
this outcome
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; OR: odds rat io; RCT: randomised controlled trial; SD: standard deviat ion; SMD: standardised mean dif ference
GRADE Working Group grades of evidence.
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
a Imprecision: downgraded 2 points for very serious concerns related to imprecision because the conf idence interval includes
posit ive ef fect, negligible ef fect, and ef fect in the direct ion of the control group.
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D I S C U S S I O N
Summary of main results
The aim of the current review was to evaluate current evidence
regarding effects of cognitive training (CT) interventions on sev-
eral key outcomes for people with mild to moderate dementia; we
found 33 studies that met our inclusion criteria. We carried out
separate comparisons of CT versus a control intervention (passive
or active) and CT versus an alternative treatment. Key findings
of this review are that CT probably has small to moderate posi-
tive effects on global cognition, as well as on the specific cognitive
domain of verbal semantic fluency immediately after treatment,
and these gains may be maintained in the medium term when
compared with a passive or active control intervention. Although
improvements at the end of treatment were found in several other
cognitive domains or processes, the quality of evidence was gen-
erally low, so our certainty in these findings is low. Beyond cogni-
tion, CTmay be associated with slower clinical progression imme-
diately following treatment and in the medium term, but again,
we are very uncertain of this finding. We found no evidence of in-
creased participant burden associated with CT (as reflected in dis-
continuation rates). We carried out several prespecified subgroup
analyses to explore potential effect modifiers but found that none
were significant.
In contrast, we found no strong evidence of any benefit associated
with CT relative to other treatments in relation to our primary
outcomes of global cognition at end of treatment and clinical
disease severity in the medium term, but our certainty in many
of these findings is low. We also found no benefit associated with
CT in relation to any of the secondary outcomes included in this
review, and in fact, alternative treatments may have been favoured
in relation to participants’ mood, behavioural and psychological
symptoms, or capacity for activities of daily living, but findings
were imprecise and our confidence in them is low.
Overall completeness and applicability of
evidence
Numbers and sources of studies that met review
criteria
The current review included 33 randomised controlled trials
(RCTs) with a total of 1924 participants, making it the largest
systematic review on this topic to date. Eighteen studies, i.e. more
than half of the total included studies, were published since 2013,
when a previous Cochrane Review that covered CT studies and
included only 10 studies was published (Bahar-Fuchs 2013). The
large number of studies published in recent years was somewhat
unexpected, given that in recent years, the focus of many interven-
tion trials has shifted to the pre-dementia phase of mild cognitive
impairment (MCI) and cognitively unimpaired older adults at risk
of dementia. In addition, previous reviews, including Cochrane
and other reviews (e.g. Hill 2017; Oltra-Cucarella 2016), gener-
ally found little evidence to support CT for people with dementia.
Against this context, the increasing number of trials of CT for
people with dementia was surprising, but the availability of a rela-
tively large number of studies generally strengthens our confidence
in the findings of this current review. The included studies were
conducted in over 12 countries, and in the current review, we did
not restrict inclusion to studies published in English. It is worth
noting, however, that a vast majority of studies, particularly those
published in recent years, were conducted in European countries,
and 11 of those were conducted in Italy alone. We found no el-
igible studies that were conducted in English-speaking countries
such as the UK, Canada, or Australia, and all included studies
that were conducted in the USAwere included in previous reviews
preceding 2013. The reasons for this trend are not clear, but the
extent to which findings of the current review are applicable to
individuals in other countries is not completely clear.
Issues related to definition and scope of interventions
Although we classified all experimental interventions in the in-
cluded studies as CT, interventions nevertheless were clinically
heterogeneous, with some delivered through paper and pencil and
others via computerised platforms, some targeting single cognitive
domains and others multiple domains simultaneously, and some
focusing primarily on drill and practice while others employed
a range of learning and performance strategies. The settings and
doses at which the interventions were delivered were also diverse,
with some delivered at home and others in community settings
including daycare and hospital settings, and some delivered one or
two times per week and others as many as five times per week. It is
therefore more appropriate to think of the interventions included
in the current review as consisting of a class or family of interven-
tions with some shared features and, accordingly, that the inter-
ventions do not measure the exact same effect; this is reflected in
our decision to conduct a random-effects meta-analysis, which is
more suitable under these circumstances (Deeks 2017). Although
observed clinical heterogeneity is most likely responsible for some
of the observed statistical heterogeneity in effect estimates from
individual trials, our pre-specified subgroup analyses, carried out
in cases where we found at least moderate heterogeneity and a suf-
ficient number of available trials, did not reveal strong evidence of
differences that would justify separate meta-analyses for different
subgroups.
Outcomes and measures
Our review focused on a large number of primary and secondary
outcomes for the person with dementia and for their caregivers,
and we made a distinction between outcomes immediately post
intervention and outcomes reported in the medium term (3 to 12
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months post treatment). Across studies, outcomes were evaluated
with over 200 measures; however, in many cases, a given measure
was counted multiple times owing to minor differences in naming
across countries or in versions of the instrument, or the provision
of insufficient detail to determine which exact measure was used.
When studies provided individual subtest scores from test batteries
or global indices, we counted each subtest as a measure. In some
cases, studies used unpublished tests developed for the purpose of
that particular study. In many cases, it was difficult to classify cog-
nitive measures into a single cognitive domain; many other studies
used multiple measures of the same cognitive outcome domain,
and we followed our pre-specified plan (see Unit of analysis issues
underMethods) in selectingmeasures for meta-analysis. Although
we acknowledge that this method has limitations and may have
not always resulted in an optimal assessment of a given cognitive
domain, we adopted the procedure to reduce the likelihood of bias
introduced by selecting a measure on the basis of effect size.
Our first primary outcome - change in global (composite) cog-
nitive ability immediately post treatment - was evaluated by 33
studies with a total of 1914 participants. In contrast, our second
primary outcome - change in disease progression in the medium
term, an outcome thatmay be of greater importance to people with
dementia and decision-makers - was evaluated in only two studies
with a total of 98 participants, using a dementia severity rating
scale. Although researchers found a moderate effect of CT relative
to control treatment in relation to change in clinical disease sever-
ity, our certainty in this finding is very low. Many other important
outcomes (e.g. change in caregiver mood, burden, or quality of life
in the medium term) were evaluated by a single study so that no
meta-analysis could be performed; other outcomes (e.g. changes
in behavioural and psychological symptoms in the medium term,
change in caregiver mood post treatment) were evaluated by a very
small number of studies, or were not evaluated at all. It is impor-
tant to note that although we were able to perform a meta-analysis
based on large numbers of studies and participants for the primary
outcome of global cognition, and despite our findings suggesting
at least a small to moderate effect of CT relative to control treat-
ments, the extent to which observed cognitive benefits are clini-
cally meaningful remains unclear. Indeed, we found no evidence
that CT leads to changes in people’s capacity to perform activi-
ties of daily living immediately post treatment or in the medium
term, although the quality of the evidence was low and findings
are therefore inconclusive.
Intervention fidelity and participant adherence
Adherence to a prescribed intervention protocol is frequently a
barrier for lifestyle interventions, particularly unsupervised, self-
delivered, home-based interventions, and interpretation of the
actual effects of interventions may be biased in the context of
suboptimal adherence. However, reference to intervention adher-
ence was made only by a small number of mostly recent studies
(Amieva 2016; Brueggen 2017; Cahn-Weiner 2003; Giovagnoli
2017; Kallio 2018; Trebbastoni 2018), and none of these prospec-
tively defined ’adherence’. It is therefore difficult to knowhow sim-
ilar or dissimilar adherences rates in different studies were, and to
what extent effect estimates from individual studies were affected
by issues of adherence. Similarly, with the exception of a small
number of studies (Amieva 2016; Brueggen 2017; Cahn-Weiner
2003; Giovagnoli 2017), no study made reference to taking steps
associated with assessing or monitoring the fidelity with which an
intervention was delivered, including whether or not any changes
to the intervention protocol were made after recruitment com-
menced, whether a manualised intervention protocol was fol-
lowed, or whether those delivering the intervention underwent
specific training. Lack of adequate measures to ensure fidelity has
implications for the replicability of behavioural intervention stud-
ies; it is therefore more difficult to know whether findings from a
trial observed in one context are likely to be seen when the inter-
vention is applied in another context.
Quality of the evidence
Weused theGRADE approach to evaluate our confidence in study
findings in relation to themain outcomes of this review, with grad-
ing incorporating the risk of bias in included studies, inconsis-
tency and imprecision in the results, directness of the evidence,
and publication bias (GRADEHandbook; GRADEproGDT). In
comparing CTwith a control intervention, from the large number
of outcomes assessed, we are highly confident only in our find-
ings in relation to a single outcome immediately after treatment,
namely, verbal category fluency. Our confidence in trial findings
was moderate for several other outcomes immediately following
the intervention, including our primary outcome of global cog-
nition as measured by a composite score, as well as caregiver out-
comes of burden of care and mood and well-being. Our certainty
in the findings of other outcomes, including our second primary
outcome of clinical progression in the medium term, was very
low. When CT was compared with an alternative treatment, we
have moderate confidence in relation to our findings on change in
participant mood, behavioural and psychological symptoms, and
capacity for activities of daily living, as well as caregiver mood and
well-being at end of treatment. Our confidence in our findings on
all other assessed outcomes at end of treatment and in themedium
term is low or very low.
Risk of bias
Although we rated most studies as having high risk of bias in at
least two domains, our approach to the classification of studies
into ’high’ and ’low’ risk of bias for the purposes of subgroup
analyses and grading of the evidence was relatively lenient and led
to only seven studies rated as ’high-risk’ studies. However, with the
exception of ’immediate memory’ in our primary comparison (CT
vs control intervention immediately post intervention), in which
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studies classified as ’high risk’ were associated with smaller pooled
effect estimates relative to ’low-risk’ studies, risk of bias did not
seem to account for much of the heterogeneity in effect estimates.
We pre-defined ’high-risk’ studies in this review as studies that
were rated as having ’high risk’ on at least two critical domains.
For our purposes, we defined critical domains as randomisation,
blinding of outcome assessment, incomplete outcome data, and
selective reporting. We acknowledge the importance of allocation
concealment andblinding of participants andpersonnel.However,
allocation concealment is rarely reported in CT trials to date, and
most studies would be classified as having high risk if we classified
this as a ’critical domain’. Similarly, blinding of those delivering
the interventions is typically not possible in trials of this nature,
and blinding of participants can be attempted only in trials with
active control or alternative treatment.
Inconsistency
In relation to our primary outcomes, we downgraded 1 point
evidence of our findings on global cognition for serious concerns
regarding inconsistencywhenCTwas compared to a control group
immediately after the intervention, but we did not find these issues
when CT was compared to an alternative treatment. For disease
progression in the medium term, we again found no issues related
to inconsistency. For most other outcomes, we rated inconsistency
as not serious, typically due to relatively small heterogeneity or
moderate heterogeneity, which was explained at least in part by
at least one of the subgroup analyses. However, in many cases,
we rated inconsistency as serious or very serious. For eight of the
outcomes included in our primary comparison,we found very high
heterogeneity in effect estimates (I² > 80%) and heterogeneity that
was not generally well explained by any of the prognostic features
included in our subgroup analyses.
Indirectness
Overall, outcomes evaluated in these studies and themeasures used
to assess them seem to be well mapped to our PICO question,
so we did not downgrade the evidence in relation to any assessed
outcomes for indirectness. Although measures of cognition and
cognitive test scores do not directly correspond with quality of
performance of daily activities, cognitive scores based on psycho-
metric evaluation are considered a true reflection of one’s objective
cognitive abilities. Similarly, in measuring clinical disease status,
most studies that reported this outcome did so with widely used
clinical staging measures such as the Clinical Dementia Rating
Scale (e.g.Mapelli 2013) or the Rapid Disability Rating Scale (e.g.
Quintana Hernandez 2014), while none of the included studies
used possibly more direct indications of clinical progression, such
as admission to residential care. Unlike changes in mood, cog-
nition, or behavioural symptoms, clinical disease progression is
a longer-term outcome, in the context of mild dementia in par-
ticular, and assessment of this outcome requires large, adequately
powered trials providing long-term follow-up.
Imprecision
For our primary comparison (CT vs control at end of treatment),
we had no major concerns related to imprecision in the effect esti-
mate of our primary outcome, namely, global cognition. However,
we had serious or very serious concerns in relation to imprecision
regarding most secondary outcomes, including all non-cognitive
outcomes and several specific cognitive domains. These concerns
were mainly due to large confidence intervals of effect estimates
that included potentially meaningful effects, no effects, and effects
favouring the control condition. In our additional comparisons
(CT vs control in the medium term, and CT vs alternative treat-
ment at end of treatment and in the medium term), we found
that imprecision was a serious or a very serious concern in relation
to all outcomes, including our primary outcome of clinical pro-
gression in the medium term. For these additional comparisons,
imprecision was a concern due to the much smaller number of
participants on which many of the effect estimates were based, as
well as the large confidence intervals of these estimates. Hence,
in relation to many outcomes of interest, we found that primary
studies sometimes disagreed not only on the size, but also on the
direction, of effects of CT.
Publication bias
Our search results suggested that several trials registered in recent
years and interventions undertaken as part of student research
projects might never have been published, raising some concern
about positive publication bias. However, with the exception of
a few outcomes (e.g. change in immediate and delayed memory,
verbal letter fluency, executive function at end of treatment), we
could not ascertain the presence of publication bias with much
confidence on the basis of visual inspection of funnel plots for each
outcome. In addition, asymmetry in funnel plots may be caused
by factors other than publication bias, so we decided to take a
conservative approach; we downgraded the evidence for suspected
publication bias only in cases in which asymmetry in the funnel
plot was reasonably evident, and a minimum of 10 studies had
assessed the relevant outcome. Our approach may have resulted
in an underestimation of the true extent of concerns related to the
presence of publication bias.
Potential biases in the review process
We conducted a thorough search for articles and performed a rig-
orous screening procedure and risk of bias assessments, conducted
independently by two review authors, with disagreements resolved
by a third reviewer. Similarly, grading of the evidence was also
completed by two of the review authors, who resolved disagree-
ments by discussion until consensus was reached. The review team
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includes researchers at all stages of their professional career and
with various levels of dementia-specific expertise, further reducing
the likelihood of systematic bias in the review process. None of
the included studies were conducted by one of the review authors,
and no conflicts of interest have been identified. Although un-
likely, we cannot rule out the possibility that difficulties associated
with forming an accurate judgement in relation to some areas of
potential bias might have led to a systematic overestimation (e.g.
risk of selection bias due to lack of allocation concealment) or un-
derestimation (e.g. publication bias) of the actual risk of bias.
Agreements and disagreements with other
studies or reviews
In recent years, numerous systematic reviews with and without
meta-analyses of cognition-oriented treatments for older adults
with and without dementia have been completed, and we have
recently reviewed this large body of work (Malmberg Gavelin).
Of particular relevance to the current review are several recent re-
views focused on CT for persons with dementia, including Alves
2013, Bahar-Fuchs 2013, Huntley 2015, Folkerts 2017, and Hill
2017. Alves and colleagues conducted a systematic review with
a meta-analysis on four studies that met their inclusion criteria
(three of which were included in the present review; Cahn-Weiner
2003 Davis 2001 Heiss 1993). Closer inspection suggested that
the fourth study included in that review was of cognitive stimula-
tion therapy and therefore would not meet criteria for the current
review. Alves found that the intervention was beneficial, relative to
a control intervention, only in relation to global cognition at end
of treatment, as reflected in the Mini Mental State Examination
(MMSE). Although the effect was large, the meta-analysis was
based on only three studies (one of which was the cognitive stim-
ulation study) and 104 participants, so precision was likely low.
The other estimates were generally based on one or two studies
only, so the conclusions drawn were naturally very limited. More
recently, the Huntley 2015 systematic review conducted a meta-
analysis of cognition-oriented treatment trials for people with de-
mentia and provided separate effect estimates for global cognition
from four studies classified as CT (all of which were included in
the present review) and seven studies classified as mixed CT and
stimulation (three of which were included in the current review
and coded as ’augmented CT’). Based on three studies, those re-
view authors did not find strong evidence of an effect of CT rela-
tive to an active control condition on global cognition, as reflected
on the MMSE (standardised mean difference (SMD) 0.22, 95%
confidence interval (CI) -0.74 to 1.18). Findings also suggested
there were no benefits of mixed CT and stimulation on global
cognition, whether compared with a passive (SMD 0.44, 95% CI
-0.56 to 1.46) or an active control treatment (SMD 0.25, 95%
CI -0.18 to 0.68). In contrast, in the current review, change in
global cognition as reflected by a composite score and on the basis
of a screening measure (such as the MMSE) was greater at end
of treatment in the CT group relative to the control condition,
based on 20 studies, and effect estimates were similar in magni-
tude when active (k = 8; SMD 0.61) and passive (k = 12; SMD
0.69) control conditions were directly contrasted. It is interesting
to note that results of the current review show a trend suggesting
that although ’traditional’ CT (k = 13) is associated with large
effect relative to control treatment (SMD 0.83, 95% CI 0.30 to
1.39), ’augmented’ CT (k = 7) is associated with a relatively small
effect estimate (SMD0.25, 95%CI -0.21 to 0.70), and differences
between the two subgroups approached significance (Chi² = 2.68,
df = 1, P = 0.10). Folkerts 2017 recently reported a systematic re-
view with meta-analysis of cognition-oriented treatments for peo-
ple with dementia living in residential care; six trials were classified
as CT, two of which contributed data for meta-analysis (both stud-
ies - Kawashima 2005; Mapelli 2013 - are included in the current
review). On the basis of these two studies with 47 participants,
these review authors found that CT was superior to passive con-
trol treatment in relation to global cognition (SMD 1.16, 95% CI
0.52 to 1.79) - a finding that is likely to be very imprecise due to
the small number of participants on which it is based, but that is
nonetheless in agreement with the findings of the current review.
Finally, Hill 2017, a comprehensive systematic review, performed
meta-analysis of computerised CT for people with mild cognitive
impairment (MCI) and dementia, and reported effects separately
for each population. Based on a meta-analysis of 12 studies with
a total of 389 participants, that review found a small effect of CT
relative to a control treatment on global cognition at end of treat-
ment (SMD 0.26, 95% CI 0.01 to 0.52) but found no effects in
other cognitive domains.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
For people with mild to moderate dementia, relative to usual
treatment or non-specific activities, standardised cognitive train-
ing (CT) may lead to at least small improvements in overall cog-
nition at end of treatment, and these improvements may be sus-
tained over the medium term after treatment cessation (between
3 and 12 months). Benefits in the short and medium term may
also be observed in more specific areas of cognition, such as verbal
fluency. The evidence regarding gains associated with CT in clin-
ical disease progression, mood, activities of daily living, or care-
giver burden relative to usual or non-specific activities is not clear.
No evidence suggests that CT is associated with any harm to the
person with dementia in terms of negative impact on important
outcomes such as mood and well-being, accelerated cognitive or
functional decline, or worsening caregiver burden. For many im-
portant outcomes, particularly in the medium term, the overall
quality of evidence was low, so further publication of high-quality
evidence may lead to changes in observed effects. It is important
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to note that no evidence suggests that CT provides any benefit
when compared to alternative treatments, such as cognitive stimu-
lation therapy or physical exercise. The decision of whether a per-
son with dementia should commence a formal cognitive training
intervention to improve his or her cognition should be made with
consideration of the balance of potentially modest effects on cog-
nition in the short to medium term and any possible contraindica-
tions related to personal values and preferences, available resources
in the person’s locality, and other possible trade-offs. Clinicians
should work together with the person with dementia and his or
her significant others to carefully balance the various considera-
tions, including the specific context of the patient, in deciding
whether or not a formal CT intervention should be started. Al-
though it is beyond the scope of this review to discuss all relevant
health policy-related considerations, evidence from the current re-
view should be interpreted within the broader context of evidence
for treatments, including pharmacological treatments, for people
with mild to moderate dementia. In particular, observed effects
of CT on global cognition at end of treatment may be compara-
ble or stronger than effects on cognition associated with approved
medications (Birks 2015; Birks 2018), but without some of the
adverse effects associated with these medications. Further work
is required to better understand cost-effectiveness associated with
cognitive training for people with mild to moderate dementia, to
better inform health-related policy.
Implications for research
A relatively large body of work on the effects of CT for various
outcomes among people with dementia is now available; unfor-
tunately, despite improvement in some areas, the quality of these
studies often is still low, leading to low confidence in the accuracy
of some of these review findings. To increase our confidence in
the findings of the current review, it is important that any further
studies of CT for people with dementia are conducted with rig-
orous methodological standards, to ensure that risks of bias are
adequately mitigated. In particular, trial registration and separate
publication of detailed trial protocols including plans for analyses
and dissemination are critical for reducing risk of bias due to selec-
tive reporting, and for identifying issues related to trial fidelity. It
is recommended that ethical review boards ensure trials are regis-
tered before they give final approval for recruitment to commence,
and that publication of a trial protocol is specified as a milestone
when funding applications are made, and during ethical approval
of the application. It is also important that key design features are
adequately implemented and clearly reported in published reports,
particularly aroundmethods of randomisation, allocation conceal-
ment, andmasking of participants and personnel. Althoughmask-
ing is not possible in behavioural interventions involving a passive
or ’treatment as usual’ comparison condition, it can be achieved in
studies using active control conditions or alternative treatments.
Our findings do not provide strong support for the use of active
(“placebo”) control conditions as far as effects of the interventions
are concerned. However, more studies in which CT is compared
with other specific interventions are needed to build a stronger
evidence base that would allow consumers and decision-makers
to make more informed choices between alternative treatments
that may offer some benefit to people with dementia. To reduce
some of the statistical heterogeneity observed in these studies, it is
important that, wherever possible, evaluation of outcomes is done
on the basis of published measures with established psychometric
properties. It is important that future studies are better designed
to explore dose-response-related issues, as well as issues related to
maintenance or waning of treatment effects. Understanding of
the long-term impact of CT on clinically relevant outcomes, in-
cluding admission to residential care, quality of life, and caregiver
burden, remains and important goal of future research. Several
recent publications have provided further important advice and
minimum standards for the conduct of cognitive training research
(e.g. Simons 2016), and an international working party including
several experts in this area is currently working to develop research
guidelines in this area (Bahar-Fuchs 2014).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Amieva 2016
Methods A multi-centre randomised parallel-group trial comparing effects of CT, reminiscence
therapy, and an individualised cognitive rehabilitation programme in AD vs usual care
Participants 653 community-dwelling participants aged 50 and above with mild to moderate AD
(according to MMSE, score range 16 to 26, and to the Global Deterioration Scale, score
range 2 to 5) were recruited at 40 French clinical sites
Interventions Participants in the CT condition (n = 170) were trained on a programme consisting
of a set of standard tasks that covered different cognitive functions, as well as activities
of daily life. The intervention was delivered to groups of 5 to 8 participants. Separate
sessions were provided for the caregivers
Participants in the reminiscence therapy condition (n = 172) also received training in
small groups, and each sessions focused on a different personal theme (e.g. schooldays,
weddings, holidays)
Participants in the individualised cognitive rehabilitation therapy condition (n = 157)
received a tailored programme that focused on activities that were meaningful for both
participant and caregiver
The 3 interventions lasted for 24 months, with 3 months of weekly 1.5-hours-long ses-
sions, followed by maintenance sessions every 6 weeks for the next 21 months. Psychol-
ogists with at least 3 years’ experience in the field of dementia delivered the interventions
Participants in the reference condition (n = 154) received usual medical care
Outcomes Primary outcome was rate of participants alive and without moderately severe to severe
dementia at 2 years, as measured with the MMSE
Secondary outcomes were institutionalisation, cognitive function, functional disability,
behavioural disturbance, apathy, quality of life, depression, caregiver burden, and re-
source utilisation
All assessments were conducted at 3 and 24 months after initiation of the interventions;
they were performed by physicians and psychologists blinded to allocation status
Country France
Registration status&#160; No information provided. Presumed to be unregistered
Conflict of Interests&#160; No
Notes Study authors sent a table with all scores on all assessment occasions
Risk of bias
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Amieva 2016 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were randomised through an
independent and remote telephone ran-
domisation service provided by the clinical
trial unit”
“Balanced randomisation (1:1:1:1) was
used”
Allocation concealment (selection bias) Low risk Study authors stated that they used a re-
mote computerised randomisation system.
Allocation concealment is intrinsic to this
method
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Participants and clinical staff were aware
of the trial arm to which the study partici-
pants were allocated”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors were blinded to allocation status
Incomplete outcome data (attrition bias)
All outcomes
Low risk A flow chart shows attrition
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk We did not detect any other major sources
of bias
Barban 2016
Methods A multi-site RCT targeting cognitively healthy older adults, persons with MCI, and
persons with mild AD to assess the efficacy of process-based CT combined with remi-
niscence therapy compared to a control
Participants 348 older adult (over 65 years of age) participants from Italy, Greece, Spain, and Norway
were cognitively unimpaired, had MCI (MMSE 25 to 30), or had mild AD (MMSE 20
to 24). Participants had a minimum of 5 years of education
Interventions Participants in the experimental condition (n = 42) were trained on a programme (SO-
CIABLE) that was provided on a touch-screen computer, and that delivered multi-com-
ponent process-based CT combined with reminiscence training
Participants were trained twice a week, for 12 weeks, individually or in small groups;
training was supervised by a trained cognitive therapist
Participants in the control condition received no treatment other than usual care
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Barban 2016 (Continued)
Outcomes Primary outcomes were effects of training on memory and executive functions
Secondary outcome was the effect of training on functional abilities, as reflected in
instrumental activities of daily living. Assessments were performed at baseline, at 3
months, and at 6 months (after the study had concluded)
Country Italy, Greece, Norway, and Spain
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes Study authors sent the data for Arm A and Arm B at T0 and T1 (before the cross-over)
for MMSE, RAVLT, ROCF, PF, ADL, and Trail Making Test A. They reported that only
a scant minority of individuals with mild AD were able to execute the TMT B, so they
did not send these scores
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although the study was described as a ran-
domised controlled trial (cross-over design)
, no information on the method of ran-
domisation was provided
Allocation concealment (selection bias) Unclear risk Study authors stated that the allocation
procedure was concealed from the raters
but provided no details regarding the
method of achieving this and how effective
it was
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding-
related procedures of participants or re-
search personnel; this could not in fact
be done in this type of cross-over trial
- ’no treatment’ RCT. Study authors did
not mention blinding of participants. The
study included a passive control condition
(cross-over design), so blinding was not
possible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No details were provided to suggest that
outcome assessment was blind; it is likely
that this was not the case
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcomes were reported only for those
who completed post-intervention assess-
ments. The number of participants with
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Barban 2016 (Continued)
dementia who were randomised is un-
known, and researchers did not report
discontinuation rates within each group.
Overall dropout was greater in the control
condition, and this could have been the case
in the dementia group, introducing risk of
attrition bias
Selective reporting (reporting bias) Low risk The published manuscript presented com-
plete outcome data only for outcomes that
were found to show an interaction between
time and condition. We could obtain re-
maining scores from study authors
Other bias Low risk We did not detect any other major sources
of bias
Beck 1988
Methods An RCT targeting persons with AD or mixed dementia and comparing a cognitive skills
remediation training programme vs a control
Participants Twenty participants (12 females, 8 males) who ranged in age between 68 and 93 (mean
75) years, andwhohad clinical findings compatible with ADor probablemixed dementia
(MMSE 15 to 20) were recruited from the geriatric unit of a hospital and from 4 nursing
homes in the USA. All participants completed at least grade school
Interventions Participants in the experimental condition (n = 10) were trained on a cognitive skills
remediation training programme 3 times a week for 6 weeks. Training was focused on
paying attention and reading, concentrating on details, and remembering. The difficulty
of tasks increased gradually
Participants in the control condition (n = 10) received no intervention but continued
with all conventional treatments
Treatments were administered by research assistants
Outcomes Outcomes included paying attention and reading and remembering and concentrating
on details. Assessments were conducted before and immediately after the training period
Country United States of America
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes
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Beck 1988 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although the study was described as a ran-
domised controlled trial, no information
on the method of randomisation was pro-
vided
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment. For this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding of
participants. The study included a passive
control condition, so blinding was not pos-
sible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Study authors did not mention blinding of
outcome assessments. Probably thiswas not
done
Incomplete outcome data (attrition bias)
All outcomes
Low risk Outcome data are available for the 20 par-
ticipants in the study
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk We did not detect any other major sources
of bias
Bergamaschi 2013
Methods An RCT targeting persons with AD taking cholinesterase inhibitors (ChEIs) and com-
paring effects of CT and ChEIs with a non-specific cognitive treatment and ChEIs alone
(control group) on cognitive performance
Participants 32 participants with mild to moderate AD (according to DSM-IV and NINCDS-
ADRDA) with anMMSE score range of 18 to 24/30 were recruited from the Alzheimer’s
Evaluation Unit of Cremona, Italy. Mean age across groups was 77.95, and mean edu-
cation level across groups was 6.43 years
Interventions Participants in the experimental condition (combined treatment; n = 16) received an
intervention of combined CT+ChEIs in five 1-month cycles (20 sessions per cycle, with a
break of 4weeks in between each cycle). Treatment aimed to stimulate spatial orientation,
memory, attention, perception, visual analysis, and recognition of emotional expressions.
Treatment was administered by an expert neuropsychologist
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Bergamaschi 2013 (Continued)
Participants in the control condition (n = 16) received non-specific cognitive treat-
ment+ChEIs at a daily centre
Participants in both conditions attended the sessions in groups of 4
Outcomes Outcomes included global cognition, as well as measures of memory, spatial reasoning,
language, and executive function. Non-cognitive outcomes included mood and activities
of daily living. Assessments were carried out at baseline and after the intervention had
been completed (12 months)
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Study authors stated: “patients were as-
signed to two groups using a computer ran-
domisation program”
Allocation concealment (selection bias) Unclear risk Study authors stated that they used a com-
puterised randomisation system. It is likely
that allocation concealment was done, but
this is not specified
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Researchers referred to the study as a single-
blind study, but it isn’t clear whether they
meant that assessors or participants were
blinded. Most likely, they were referring to
assessors only. Participants probably were
not blinded, but as they were in a placebo
condition, they might have had expecta-
tions to improve, so actual risk of bias here
is not clear
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The examiner was unaware of which group
participants were in
Incomplete outcome data (attrition bias)
All outcomes
Low risk No outcome data were missing
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
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Bergamaschi 2013 (Continued)
Other bias Low risk We did not detect any other major sources
of bias
Boller 2011
Methods An RCT targeting community-dwelling older adults with AD and comparing effects
of the repetition lag procedure, recognition practice, and a no-contact condition on
memory recall
Participants 36 participants with a diagnosis of probable AD dementia according to NINCDS-
ADRDA and DSM-IV criteria. Dementia had to be considered mild to moderate with
MMSE scores of 19 or above. Mean age of participants was 81.1, and mean education
level was 11.3
Interventions Participants in the recollection training condition (n = 12) engaged in an activity adapted
from the repetition-lag procedure developed by Jennings and Jacoby (2003), in which
they had to remember a series of nouns and then recognise them from longer lists of
words
Participants in the recognition practice condition (n = 12) received training on a cognitive
training procedure, which shared some characteristics with the one designed for the other
experimental condition
Participants in both training conditions received 4 training sessions per day 3 days a
week for 2 weeks
Remaining participants (n = 12) were randomised to a no-contact control condition
Outcomes Outcomes included working memory, immediate and delayedmemory, and recognition
Country France
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes Study authors provided clarification on one of the scores, as it was not clear due to a
typing error
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although the study was described as a ran-
domised controlled trial, no information
on the method of randomisation was pro-
vided
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Boller 2011 (Continued)
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment. For this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors did not mention blinding of
participants. The study included a passive
control condition, so blinding was not pos-
sible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk This is usually stated. As study authors did
not mention it, it is unlikely that this has
been done
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data are available for 36 participants in the
study
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk We did not detect any other major sources
of bias
Brueggen 2017
Methods A controlled partial-randomised design trial comparing CT with a group cognitive re-
habilitation intervention (active control group) in persons with AD dementia
Participants 20 community-dwelling participants with probable or possible AD according to
NINCDS-ADRDA criteria who were living in Germany. Age range of participants was
53 to 83, and all had received over 10 years of education
Interventions Participants in the intervention condition (n = 8) received standardised CT in the form
of a single daily task that participants had to complete by themselves in the form of
homework. Participants met with researchers every 4 weeks to evaluate the homework
Participants in the control condition (n = 10) were trained on a cognitive rehabilitation
programme that was based on a manual-guided approach combining neuropsycholog-
ical and psychotherapeutic elements (CORDIAL). A psychologist and an occupational
therapist delivered the intervention
Both interventions lasted 3 months
Outcomes Study authors stated that the change from baseline in capacity to perform activities of
daily living was their primary outcome
Secondary outcomes included cognitive abilities related to daily living (such as everyday
memory abilities and planning and organizational skills), functional cognitive state, and
non-cognitive outcomes including depression, consciousness, neurobehavioural distur-
bance, and caregiver burden
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Brueggen 2017 (Continued)
Assessments were conducted at baseline and after the interventions were finished
Country Germany
Registration status&#160; Prospectively registered
Conflict of Interests&#160; Not stated
Notes Study authors designed the CT intervention group as the comparison group. For the
purpose of this review, the CT group was selected as the experimental group
Two participants cancelled their participation before the intervention was started (CT
group)
Study authors advised that the trial had been prospectively registered and provided a
table with follow-up scores upon request
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “Five subjects originated from a pilot trial
waiting group and were already predeter-
mined for the intervention group”
“We conducted a partial-randomization to
assign the remaining subjects using a com-
puter-based balanced randomisation”
Allocation concealment (selection bias) High risk Some participants already knew they were
going to participate in the intervention
group
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors did not mention blinding
of participants. CT was compared to an
alternative treatment, so blinding may have
been possible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Study authors provided no details to sug-
gest that outcome assessment was blind. It
is likely that this was not the case
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Two participants allocated to the interven-
tiondroppedout before commencing treat-
ment, and 2 participants allocated to the
control condition dropped out during the
intervention period; reasons seem to be un-
related. However, analyses were carried out
without their baseline data; the impact of
this is unknown, given the small sample size
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Brueggen 2017 (Continued)
Selective reporting (reporting bias) Unclear risk We were able to obtain all scores with the
exception of the NPI upon request
Other bias Low risk We did not detect any other major sources
of bias
Cahn-Weiner 2003
Methods An RCT targeting people with probable AD that aimed to assess efficacy for word-list
recall and recognition relative to a control condition
Participants 39 participants who were referred from a university-based AD and memory disorder
clinic in theUSAwhohad a diagnosis of probable AD (according toNINCDS-ADRDA)
. Mean age across groups was 76.9. All participants were taking donepezil
Interventions Intervention condition: memory training programme of 6 weeks’ duration to improve
word list recall and recognition
Active control: participants in the control condition received didactic presentations but
no formal memory training
A clinical neuropsychologist delivered the interventions
Outcomes Cognitive performance in several domains, including verbal learning, verbal and visual
memory, and reasoning, were assessed, as were everyday memory functioning and activ-
ities of daily living
Assessments were conducted at baseline, post intervention, and 8 weeks after completion
of the intervention
Country United States of America
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes 39 persons enrolled in the study. 5 of them withdrew. Only 1 attended a session. The
rest withdrew after baseline assessment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “All participants were randomly assigned to
one of two groups by a coin toss performed
at the time consent was obtained”
Allocation concealment (selection bias) Unclear risk Study authors stated that they used a coin
for randomisation of participants. It is not
clear whether allocation was concealed
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Cahn-Weiner 2003 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “Neither the patients nor their caregivers
were informed as to which group (training
vs. control) they had been assigned)”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Neuropsychological assessment was carried
out by a trained psychometrist who was
blinded to group assignment (1 exception)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data were balanced in numbers
across groups; reasons formissing datawere
similar across groups
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk The study appears to be free of other
sources of bias
Cavallo 2016
Methods An RCT targeting persons with early-stage AD conducted to assess effects at a neuropsy-
chological level of computerised CT compared to a control intervention
Participants 80 participants (29 males, 51 females) with a diagnosis of early-stage probable AD
(according to NINCDS-ADRDA) were recruited in an Assisted Health Residence in
Italy. Mean age of participants was 76.41, and mean years of formal education was 8.32
Interventions Participants in the experimental condition (n = 40) received individual computerised
CT, delivered by the rehabilitative software Brainer1 (https://www.brainer.it/), which
includes over 100 exercises targeting different cognitive domains
Control intervention was delivered 1-on-1 by a neuropsychologist. Participants in this
condition (n=40) could choose between readingnewspaper articles online anddiscussing
them with the neuropsychologist, playing online games and solving puzzles, or visiting
websites suiting their interests
Both interventions conditions were delivered by a neuropsychologist over a 12-month
period, with 30-minute sessions held 3 times per week
Outcomes Outcomes included cognitive performance in the domains of memory, semantic knowl-
edge, language, visuospatial abilities, and executive functions, as well as anxiety and de-
pression
All participants were evaluated before and after training, and at 6-month follow-up
assessment
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
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Cavallo 2016 (Continued)
Conflict of Interests&#160; Not stated
Notes Study authors sent us the scores for the post-intervention assessment
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Study authors stated that participants were
“randomised into two different groups by
means of a random number generator with
mixed block sizes”
Allocation concealment (selection bias) Unclear risk Study authors stated that they used a com-
puterised randomisation system. It is likely
that allocation concealment was done, but
this is not specified
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors did not mention blinding
of participants. They compared CT vs an
active condition, so blindingmay have been
possible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors were blind to the purpose of the
study and to the group to which each par-
ticipant belonged
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing outcome data were balanced in
numbers across intervention groups, and
reasons for missing data were similar
Selective reporting (reporting bias) Low risk Findings regarding the various outcomes
were not presented in a consistent way, but
we were able to obtain the relevant data
from study authors
Other bias Low risk The study appears to be free of other
sources of bias
Davis 2001
Methods An RCT with a cross-over design comparing a cognitive intervention vs a placebo con-
dition in people with AD
Participants 37 participants (16 men, 21 women) with probable AD (according to NINCDS-
ADRDA). Mean MMSE score of the sample was 22.31, and mean age was 70.62. Av-
erage years of education for participants was 14.01
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Davis 2001 (Continued)
Interventions Participants in the intervention condition (n = 19) were engaged in individual 1-hour
sessions of face-name association and recall using spaced retrieval once weekly, in addition
to 30-minute home practice with the caregiver 6 days a week over 5 weeks
Participants in the “placebo condition” (n = 18) were engaged in five 1-hour weekly
sessions of unstructured conversation and questioning by an examiner; they also watched
videotapes related to health issues
Outcomes Outcomes included cognitive performance on measures of global cognition, delayed
memory recall, working memory and attention, language, and psychomotor abilities.
Depression and quality of life were also assessed
All evaluations were conducted at baseline and after 5 weeks of treatment. A third
assessment was carried out on participants originally in the placebo condition but who
commenced the intervention after the cross-over
Country United States of America
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although the study was described as a ran-
domised controlled trial, no information
on the method of randomisation was pro-
vided
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment. For this reason, we assumed
that this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “Patients and their caregivers were not in-
formed of which condition (placebo or in-
tervention) they would participate in first”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessments were conducted by examiners
who were blinded to the treatment condi-
tion
Incomplete outcome data (attrition bias)
All outcomes
Low risk No information was provided about at-
trition. However, it appears that all ran-
domised participants were included in the
post-treatment assessment
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Davis 2001 (Continued)
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk The study appears to be free of other
sources of bias
de Vreese 1998
Methods An RCT comparing “cognitive retraining”+AChE-I condition vs AChE-I alone and a
placebo drug condition in persons with mild-to-moderate AD. Initially, the trial also
included a cognitive retraining only condition (without a drug), but this condition was
removed after the study commenced, and data from this group (n = 6) were not reported
Participants 27 participants who had a clinical diagnosis of AD (NINCDS-ADRDA, DSM-IV). All
were between 61 and 83 years old, with a mean age of 72.6
Interventions Participants in the “cognitive retraining” (CR) condition received two 45-minute sessions
of CR per week over a 3-month period, with focus on memory, language, and executive
abilities
Those in the AChE-I condition received treatment with acetylcholinesterase inhibitors
Participants in the CR+AChE-I condition received 3 months of AChE-I, then began to
receive CR in addition to AChE-I
Participants in the placebo condition received a placebo medication
Outcomes Outcomes included global cognitive functioning asmeasured byMMSEandADAS-Cog.
Non-cognitive outcomes included instrumental activities of daily living and behavioural
symptoms
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes Study authors provided a table with scores and stated that the condition did not differ in
demographic and baseline characteristics. However, group level data were not available
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although the study was described as a ran-
domised controlled trial, no information
on the method of randomisation was pro-
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vided
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment. For this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding of
participants. The study included a passive
control condition, so blinding was not pos-
sible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The study was described as a ’single-blind’
study. It appears assessments were con-
ducted by blinded personnel
Incomplete outcome data (attrition bias)
All outcomes
High risk It appears that changes to the study proto-
col were made after the trial commenced,
and that the CT-only arm of the study has
been discontinued. Data from participants
who took part in this arm (n = 6) were not
reported
Selective reporting (reporting bias) High risk The trial was not registered and no proto-
col was available. It appears the study in-
cluded cognitive measures for ADLs and
behavioural measures. However, the data
table sent by study authors included means
and SDs for cognitive measures (ADAS,
MMSE) and the IADL scale only
Other bias Low risk The study appears to be free of other
sources of bias
Fernández-Calvo 2011
Methods An RCT comparing in persons with AD the effects of a computerised CT programme,
Big BrainAcademy (BBA), vs the Integrated Psychostimulation Program (IPP), a classical
CT tool, and a wait-list control condition on cognitive and functional measures and on
psychological and behavioural symptoms
Participants 45 participants with a diagnosis of probable AD (according to NINCDS-ADRDA) who
were receiving anti-dementia drug therapy. Mean age of the sample was 75.75, and
educational attainment was on average 7.71 years
Interventions Participants in the BBA condition (n = 15) were trained on a programme that involved
various games at different levels of difficulty. Exercises were classified under 5 areas of
stimulation: perception, memory, calculation, analysis, and acuity. Participants received
continuous encouragement from researchers
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Participants in the IPP condition (n = 15) received an intervention programme that tar-
geted several cognitive areas: reasoning, attention, and concentration; verbal and written
language; praxis; gnosis; arithmetic and calculation, and association-order
Participants in both conditions received treatment for 12 weeks, with three 60-minute
sessions per week (total = 36 individual sessions); each session was delivered by an
occupational therapist and a psychologist
Participants in the control condition (n = 15) did not receive treatment until the trial
had been completed
Outcomes Outcomes included global cognitive ability as reflected in MMSE scores, neuropsychi-
atric symptoms, and clinical disease severity
Participants were assessed before and after the intervention
Country Spain
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes Study authors provided the number of participants in each condition and scores on the
MMSE upon request (although these were not analysed in the results)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although the study was described as a ran-
domised controlled trial, no information
on the method of randomisation was pro-
vided
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment. For this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding of
participants. The study included a passive
control condition, so blinding was not pos-
sible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Study authors stated that all assessments
were conducted by blinded assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk The published manuscript provided no in-
formation on the number of participants
allocated to each condition and no dropout
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rates. Study authors supplied information
on request suggesting that each condition
included 15 participants, but it is not clear
whether this represents the number of par-
ticipants recruited or the number retained.
It is relatively uncommon for studies in this
area to have no attrition at all
Selective reporting (reporting bias) Low risk The published manuscript did not report
outcome data for MMSE, even though it
was administered on both occasions. How-
ever, study authors provided these data
upon request
Other bias Low risk The study appears to be free of other
sources of bias
Galante 2007
Methods A single-blind RCT comparing a computer-based cognitive intervention to an active
control in persons with AD
Participants Participants (n = 12) had a diagnosis of probable AD (according to NINCDS-ADRDA
criteria). Mean age of participants was 76.0 years (6.0), and mean education level was 6.
3 (2.2) years
Interventions Participants in the experimental condition (n = 7) were trained on a computerised
programme comprising tasks selected from Software TNP (Training Neuropsicologico,
by Tonetta 1998)
Participants in the control condition (n = 5) engaged in a non-specific treatment that
included a semi-structured interviewon current affairs and events relevant to participants’
lives
Both interventions lasted for 4 weeks with 3 individual 1-hour sessions per week and
were delivered by a neuropsychologist
Outcomes Outcomes included global cognition and tasks measuring specific cognitive domains
including attention and working memory, learning and memory, language and executive
function, and visuospatial abilities. In addition, behavioural and neuropsychiatric out-
comes and capacity for activities of daily living were assessed. Evaluations were performed
at baseline, immediately after 12-week treatment, and 3 months later. Global cognition
was also assessed at 9-month follow-up
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
77Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Galante 2007 (Continued)
Conflict of Interests&#160; Not stated
Notes No information was provided on the extent to which groups were matched on relevant
variables before the intervention
Mean age and years of education for 11 participants were analysed, and 1 participant
was excluded for poor compliance
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Participants were assigned to groups in or-
der of recruiting
Allocation concealment (selection bias) High risk Participants were assigned to groups in or-
der of recruiting. For this reason, allocation
concealment was not possible in this case
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors described the study as a sin-
gle-blindRCT(the person in charge of con-
ducting the assessments was blinded)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Each participant was evaluated by a neu-
ropsychologist who was blinded to the par-
ticipants’ group allocation
Incomplete outcome data (attrition bias)
All outcomes
Low risk The sample was small, and 1 person was ex-
cluded due to poor compliance. No miss-
ing data were recorded, implying that the
remaining 11 persons completed the study
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk The study appears to be free of other
sources of bias
Giovagnoli 2017
Methods An RCT (single-blind) comparing CT with active music therapy and neuroeducation in
people with mild to moderate dementia
Participants 39 participants (24 female) with diagnosis of probable AD were included in the study.
Mean age was 73.64 (SD 7.11) years, and mean years of education was 8.23 (SD 4.29)
Participants were recruited from “one centre”; however, no details were provided about
the nature of this centre nor about the living situation of participants
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Interventions The CT condition (n = 13) comprised verbal and visuospatial stimuli targeting attention,
information processing, executive function, and memory. A neuropsychologist delivered
the intervention
Active music therapy (n = 13) was provided by a music therapist; participants selected
and played an instrument of their choice
Neuroeducation (n = 13) was co-ordinated by a neurologist; it comprised 3 sessions
focused on brain anatomy and function, symptoms of cognitive decline, coping with
dementia, nutrition and eating, physical exercise, relaxation, coping, and leisure
Outcomes Primary outcome was initiation, as assessed by the Word Fluency test on phonemic cue
score. Secondary outcome was episodic memory, as assessed by the Short Story test.
Numerous other cognitive measures were included, covering several cognitive domains
including memory, attention, language, and executive function. Additional outcomes
included mood (depression and anxiety) and social networks
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A computer-generated list of random
numbers was used”
Allocation concealment (selection bias) Unclear risk Study authors state they used a comput-
erised randomisation system. It is likely that
allocation concealment was done, but this
is not specified
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors describe the study as a sin-
gle-blind RCT (the person in charge of
conducting the assessments was blinded).
Participants were not blinded, however, as
all conditions were forms of intervention
(including the education condition) and
therefore may have had treatment-related
expectations; whether lack of blinding in-
creased performance bias remains unclear
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Study authors state that all assessments
were conducted by blinded assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Eleven participants dropped out after ran-
domisation and, according to study au-
thors, at an early stage of treatment. Num-
bers were more or less equally distributed
across conditions. Analysis was per-proto-
col rather than by intent-to-treat, but the
reasons for this are not explained. Whether
dropout had an effect on outcomes remains
unclear
Selective reporting (reporting bias) Unclear risk The token testwas reported in the “Results”
section but not in the “Methods” section.
Whether all relevant measures given were
reported is unknown, and whether risk of
bias due to selective reporting was elevated
remains unclear
Other bias Low risk Study appears to be free of other sources of
bias
Giuli 2016
Methods An RCT comparing a comprehensive CT intervention vs a control condition in cogni-
tively unimpaired older adults, people with mild cognitive impairment, and people with
mild to moderate AD
Participants 321 community-dwelling participants living in the Marche Region (Italy) who were 65
and over with a diagnosis of mild to moderate AD (according to DSM-IV or NINCDS-
ADRDA). Most participants were women
Interventions Participants in the experimental condition received treatment with comprehensive CT,
which was adapted depending on the diagnostic group of the participant. The AD group
(n = 51) was trained on a programme that targeted several cognitive functions including
attention, orientation, planning, and episodic and prospectivememory. Participants were
asked to complete homework exercises every day with the support of a carer
AD participants assigned to the control condition (n = 50) received psychoeducation
(including suggestions and simple strategies to improve their memory and health)
All participants with AD attended 10 individual sessions once a week at the INRCA
Hospital in Fermo (Italy)
Outcomes Outcomes included global cognition and performance on tasks measuring several cog-
nitive domains, including attention, learning and memory, and language. In addition,
mood, stress, capacity for activities of daily living, and clinical disease severity outcomes
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were assessed
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes We tried to contact study authors to ask about assessment occasions (in weeks and
months) and to request test scores that were missing (Phonemic Word Fluency test and
CDR), but we were not able to reach them
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The subjects were randomly assigned 1:1
to…”
“Randomization was performed separately
for each group, by using a computerized
random number generator”
Allocation concealment (selection bias) Unclear risk Study authors stated that they used a com-
puterised randomisation system. It is likely
that allocation concealment was done, but
this is not specified
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors did not mention blinding
of participants. They compared CT vs an
active condition, so blindingmay have been
possible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Study authors provided no details to sug-
gest that outcome assessment was blind; it
is likely that this was not the case
Incomplete outcome data (attrition bias)
All outcomes
Low risk Study authors stated that they consid-
ered only participants who completed both
baseline and the follow-up assessments.
However, among 101 participants in the
dementia group, only 6 discontinued (5%;
3 in each condition), so impact on out-
comes is unlikely to be significant and risk
of attrition bias is likely to be low
Selective reporting (reporting bias) High risk Study authors did not report data related to
2 outcome measures (CDR and phonemic
fluency), and we received no response from
study authors when we contacted them
81Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Giuli 2016 (Continued)
Other bias Low risk Study appears to be free of other sources of
bias
Goudour 2011
Methods An RCT comparing effects of semantic stimulation vs psychological support in relation
to semantic memory in people with Alzheimer’s disease
Participants Ten participants, between 57 and 78 years of age, who were followed by CMRR of the
White House Hospital of Reims (France). All participants had a diagnosis of probable
AD (according toDSM-IV andNINCDS-ADRDA) withMMSE scores of 17 and above
Interventions Participants in the experimental condition (n = 5) were trained on a CT programme that
focused on semantic abilities related to music and human actions
Participants in the control condition (n = 5) received clinical psychological support,
which aimed to maintain self-esteem and favour exchanges
Both interventions were conducted by a neuropsychologist and lasted for 12 weeks, with
1 weekly individual session of approximately 50 minutes’ duration
Outcomes Outcomes included global cognition and measures of semantic memory, as well as mood
(depression), capacity for activities of daily living, and carer burden
These outcomes were assessed before and after the intervention period. Two other as-
sessments (only on semantic cluster) were conducted at week 6 and at week 11
Country France
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes Study authors answered some questions about study design. We then asked for a table
with scores but received no reply
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Study authors responded to an email in
which they described the study as ran-
domised; however, they provided no details
about the randomisation process
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Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors did not mention blinding
of participants. They compared CT vs an
active condition, so blindingmay have been
possible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All visits were conducted by a neuropsy-
chologist (blind to the type of intervention
given to participants and blind to the aims
of the study)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No specific details could be ascertained
about recruitment and retention of partic-
ipants. It seems that each condition per-
tained to 5 participants, but it is unclear
whether numbers recruited, retained, and
analysed were the same
Selective reporting (reporting bias) Unclear risk Study was published in French; whether all
specified outcomes were reported remains
unclear
Other bias Low risk Study appears to be free of other sources of
bias
Heiss 1993
Methods An RCT comparing effects of a CT programme provided alone or in combination with
pyritinol or phosphatidylserine, as well as effects a social support programme for people
with AD
Participants 80 community-dwelling participants between 48 and 79 years of age whomet the criteria
for AD (according to NINCDS-ADRDA) and had an MMSE score between 13 and 26
were recruited in Cologne, Germany. Data were available for 70 of these
Interventions Participants in the CT condition (n = 18) were engaged in a computerised training
programme that focused on memory and perceptual and motor tasks, with varying
degrees of difficulty. Paritcipants attended 1-hour sessions twice a week
Participants in the CT+pyritinol condition (n = 17) received the same intervention, in
combination with oral pyritinol 600 mg twice a day
Participants in the CT+phosphatidylserine condition (n = 18) also received CT, but in
combination with oral phosphatidylserine 200 mg twice a day
Participants in the social support condition (n = 17) discussed their personal difficulties
and daily life during 1-hour sessions, once per week
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For the purpose of this review, social support served as the comparison condition
Outcomes Outcomes evaluated included clinical dementia severity, as well as cognitive domains
such as orientation and praxis, psychomotor speed, reaction time, attention, memory,
and language capacity Functional imaging outcomes (PET and EEG) were also evaluated
Assessments were conducted before and after the treatment period. Some domains were
assessed at weeks 8 and 16 of the intervention
Country Germany
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although the study was described as a ran-
domised controlled trial, no information
on the method of randomisation was pro-
vided
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors did not mention blinding
of participants. They compared CT vs an
active condition, so blindingmay have been
possible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Study authors did not mention blinding of
outcome assessments; this probablywas not
done
Incomplete outcome data (attrition bias)
All outcomes
High risk On balance, it appears that inconsistent
reporting in the 2 reports from this trial,
changes made to the protocol, and lack of
detail regarding reasons for (and distribu-
tion of ) missing data suggest that elevated
risk of bias is significant
Selective reporting (reporting bias) Low risk The 1994 paper seems to be the more com-
plete report from this trial. Overall, and by
acceptable standards at the time, it seems
that study authors have generally described
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relevant outcomes in the “Methods” sec-
tion and reported them all more or less con-
sistently in the “Results” section
Other bias Low risk Study appears to be free of other sources of
bias
Jelcic 2012
Methods An RCT comparing effects on memory of a focused lexical-semantic stimulation (LSS)
intervention vs an unstructured cognitive stimulation treatment in persons with early
AD
Participants 40 participants with a diagnosis of probable AD (according to NINCDS-ADRDA) who
were not on anti-dementia drug therapy and had anMMSE score of 26 and above. Seven
participants were male and 33 were female. Mean age of the sample was 82.3, and mean
educational attainment was 7.5 years. All participants were presumed to be community-
dwelling persons (not stated)
Interventions Participants in the LSS condition (n = 20) were trained on a programme that included
focused lexical-semantic rehabilitation exercises, which aimed to enhance semantic verbal
processing and focused on interpretation of written words, sentences, and stories
Participants in the UCS condition (n = 20) were involved in exercises consisting of
creative work (practisingmanual skills, manufacturing externalmemory aids, stimulating
fantasy and creativeness, reading the newspaper, and improving verbal communication)
Treatments for both conditions were delivered by the same neuropsychologist in two 60-
minute small-group sessions per week over a 3-month period
Outcomes Primary outcomes were global cognition, lexical-semantic ability, and verbal memory.
Secondary outcomes included cognitive performance on measures of working memory,
visuospatial memory, attention, and executive functions as well as capacity for instrumen-
tal activities of daily living. Assessments were conducted at baseline and after 3 months
of treatment. Participants in the experimental condition were also assessed at 6-month
follow-up
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes We tried to contact study authors to ask for all follow-up scores and Trail Making Test
B scores at post-intervention assessment, but we received no reply
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Study authors stated that participants were
allocated to groups “by using a simple com-
puterized technique”
Allocation concealment (selection bias) Unclear risk Study authors stated that they used a com-
puterised randomisation system. It is likely
that allocation concealment was done, but
it is not intrinsic to this method
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The same therapist delivered both experi-
mental and control interventions, includ-
ing blinding. This may have led to in-
creased risk of performance bias. Study au-
thors did not mention blinding of partici-
pants
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The assessor was blinded to the treatment
group to which each participant was allo-
cated
Incomplete outcome data (attrition bias)
All outcomes
Low risk No outcome data were missing. A flow
chart shows that no participants dropped
out of the study. All were included in the
analysis
Selective reporting (reporting bias) High risk Results from Trail Making Test B are miss-
ing
Other bias Low risk Study appears to be free of other sources of
bias
Jelcic 2014
Methods An RCT comparing LSS delivered through telecommunication technology vs the same
training delivered face to face and with unstructured cognitive treatment in persons with
early AD
Participants 27 participants residing in daycare centres for the elderly in Venice, Italy, with a diagnosis
of probable AD, according to NINCDS-ADRDA, who were not on anti-dementia drug
therapy. Mean age of participants was 83.7, and they had received a minimum of 6
years of formal education. Twenty-one were female and 6 were male. Participants are
presumed to be community-dwelling persons
Interventions Participants in the LSS-direct intervention condition (n = 10) received face-to-face train-
ing on lexical tasks that aimed to enhance semantic verbal processing
Participants in the LSS-telecondition (n = 7) received the LSS intervention through
telecommunication
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Participants in the control condition (n = 10) completed face-to-face exercises, such as
practising manual skills or reading the newspaper and engaging in discussion
The same therapist delivered all interventions, which lasted for 3 months and included
two 1-hour small-group sessions per week. Between sessions, caregivers were encouraged
to deliver non-specific cognitive reinforcement
Outcomes Primary outcomes were global cognitive performance, lexical-semantic abilities, and
episodic verbal memory
Secondary outcomes were changes in attention, working memory, executive functions,
and visual-spatial abilities
These domains were assessed by a neuropsychologist at baseline and after 3 months of
treatment
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes We tried to contact study authors to ask for mean, SD, and sample size for Trail Making
Test (A and B), NPI, and ROCF Copy Test at baseline and at post-intervention assess-
ment, but we received no reply
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk No information is provided regarding the
method of randomisation. However, study
authors state, “The unequal distribution
among the three treatment groups was due
to the preference of two patients, initially
enrolled in the LSS-tele group, to not be in-
volved with computer technology and who
were shifted into the other two treatment
arms”
Allocation concealment (selection bias) High risk Two participants who were initially en-
rolled in the LSS-tele group were then allo-
cated to the other 2 conditions, with their
preferences considered. For this reason, al-
location concealment was not possible in
these cases
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors did not mention blinding
of participants. They compared CT vs an
active condition, so blindingmay have been
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possible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All assessments were carried out by an
experienced neuropsychologist who was
blinded to the treatment group to which
each participant was allocated
Incomplete outcome data (attrition bias)
All outcomes
Low risk No outcome data were missing. No partic-
ipants dropped out of the study; all were
included in the analysis
Selective reporting (reporting bias) High risk Results of Trail Making Tests A and B (sec-
ondary outcome measures) were not re-
ported
Other bias Low risk Study appears to be free of other sources of
bias
Kallio 2018
Methods A single-blind RCT comparing effect of CTs vs a control intervention on cognition and
health-related quality of life (HRQoL) in community-dwelling persons with dementia
Participants 147 community-dwelling participants attending daycare (106 female). Education was
split around 8 years, with 68 having more than 8 years of education. Most participants
had AD (122), but 11 had received a diagnosis of vascular dementia, 4 had Parkinson’s
disease or Lewy body dementia, and 10 had other or unknown dementia
Interventions Participants in the intervention condition (n = 76) received CT treatment sessions that
involved paper-and-pencil tasks in small groups of 2 to 4 participants, or individually
when needed
Participants in both intervention and control conditions received routine treatment at
the daycare centre twice a week for 6 hours each day in groups of 12 to 16 persons
The intervention was delivered by trained psychology students under the supervision of
an experienced neuropsychologist
Outcomes Primary outcomes were global cognition and health-related quality of life
Evaluations were carried out at baseline, at 3 months, and at 9-month follow-up
Country Finland
Registration status&#160; This trial was prospectively registered at the Australian and New Zealand Clinical Trials
Registry; identifier ACTRN12614000976684
Conflict of Interests&#160; No
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Notes The CT programme reflected a relevant modification of cognitive remediation ther-
apy, which is a training-based intervention aimed at improving executive functioning of
chronic psychiatric patients. Study authors noted that this cognition-focused treatment
was adapted in the trial by decreasing the difficulty level of the tasks, reducing the number
of sessions (from 44 to 24), and increasing font size in the tasks. Techniques of repeated
practice, errorless learning (reducing the opportunity to make errors), immediate feed-
back, scaffolding (44tpro’;rviding strategies when needed, and gradually increasing task
complexity), and facilitated planning and self-monitoring were used during training.
Study authors noted that 2-year follow-up would be completed by the end of 2018.
Study authors provided mean and SD for each measure at all assessment occasions for
each group separately
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were assigned to groups via
“computer-generated randomly allocated
numbers received by telephone from a ran-
domisation center”
Allocation concealment (selection bias) Low risk Study authors stated that they used a re-
mote, computerised randomisation system.
Allocation concealment is intrinsic to this
method
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors described a single-blind
RCT (the neuropsychologist in charge of
conducting the assessments was blinded)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Study authors stated that all assessments
were conducted by blinded assessors
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk By 9-month follow-up, 10% of experimen-
tal participants (8) and 30% of control
participants (22) had dropped out - rea-
sons seem to be similar, but proportion was
much greater in the control condition; no
details on baseline characteristics of those
who dropped out were provided to ensure
that they are not different from those who
were retained
Selective reporting (reporting bias) Unclear risk Several outcomes that were specified in the
published protocol are not mentioned in
the outcome paper. We were able to obtain
some but not all of these from the study
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authors, who stated that the article was still
under review
Other bias Low risk Study appears to be free of other sources of
bias
Kao 2016
Methods A 2-step cluster-randomised trial to compare the long-term effects of spaced retrieval
(SR) training and SR training combinedwithMontessori activities (SR+M) and a control
condition in persons with dementia suffering from hyperphagia
Participants 148 participants, recruited from8 dementia special care units in China, who had received
a diagnosis of dementia and hyperphagia-related behaviours from a physician
Interventions Participants in the SRcondition (n=48) and in the SR+Mcondition (n= 52) participated
in thirty 40-minute sessions over 6 weeks, which were held in dementia special care units.
The SR sessions involved learning and reviewing a memory message. SR+M sessions
involved the same activity, as well as practice-based structured Montessori activities
Interventions were delivered by 2 memory trainers who had received training in SR and
Montessori activity methods
Participants in the control condition (n = 48) participated in the usual activities of the
institution, which did not involve any particular memory training activities
Outcomes Outcomes included hyperphagic behaviours, measured by a 19-item scale of hyperphagia
in residents with dementia, and associated caregiver distress, measured by a scale of
distress of the caregiver in response to hyperphagic behaviours
Participants were assessed at baseline, immediately after the training period, and at
months 1, 3, and 6 after completion of the training
Country China
Registration status&#160; Retrospectively registered
Conflict of Interests&#160; No
Notes We contacted study authors to ask for relevant scores (at all assessment occasions) and
to find out more details about the scales used (“scale for hyperphagia in residents with
dementia”, and “scale of distress of the caregiver to hyperphagic behaviour”). No response
was received
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although the study was described as a ran-
domised controlled trial, no information
on the method of randomisation was pro-
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vided
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors described the study as a sin-
gle-blind RCT; however, this refers to the
outcome assessment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The research assistants were blinded to the
randomisation of subjects”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No outcome data were missing. Study au-
thors reported the results of those who
completed the study and explained the rea-
sons why some participants dropped out.
They provided a flow diagram of the study
that is adherent to CONSORT
Selective reporting (reporting bias) High risk Study authors did not present findings for
some of the outcomes mentioned in the
“Methods” section
Other bias Low risk Study appears to be free of other sources of
bias
Kawashima 2005
Methods An RCT comparing a training programme in reading and arithmetic problems (learning
therapy) vs a control condition in older adults with AD
Participants 32 participants living in a nursing home in Japan (mean age 85.7, range 76 to 96) with a
diagnosis of Alzheimer’s-type dementia according to DSM-IV (mean MMSE score 19.
8, range 7 to 30)
Interventions Participants in the experimental condition (n = 16) were trained on a programme (Learn-
ing Therapy) that focused on reading aloud and solving arithmetic problems, provided
at learning centres in Euju-no-Sato, with 2 to 6 sessions per week for about 20 minutes
per day for longer than 6 months
Participants in the control condition (n = 16) were presumed to have had a no-contact
condition
Outcomes Outcomes included change in global cognition and measures of executive functioning,
verbal communication capacity, and functional independence. Assessments were con-
ducted at baseline and after completion of the intervention (6 months)
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Country Japan
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes Study authors sent MMSE scores at post-intervention assessment, which were missing
from the published report, as well as overall scores for the Frontal Assessment Battery
(FAB)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although study authors described the study
as an RCT, they provided no information
on the method of randomisation
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors described the study as a
single-blind RCT (research assistants in
charge of conducting the observation were
blinded)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Noblinding; outcomes could have been in-
fluenced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk No outcome data were missing
Selective reporting (reporting bias) Low risk Study authors did not report scores for
MMSE at post-intervention assessment,
but we obtained them upon request
Other bias Low risk Study appears to be free of other sources of
bias
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Kim 2015
Methods An RCT comparing the effect of “cognitive rehabilitation” (including CT tasks) relative
to a control condition in relation to performance of everyday activities in older adults
with early-stage AD
Participants 43 participants (15 males, 28 females) with early-stage AD (as indicated byMMSE) who
were recruited from a daycare centre in South Korea. Mean age and educational level of
the sample were 70.9 and 8.6, respectively
Interventions Participants in the experimental condition (n = 22) were trained on a CR programme
that included individual sessions (focused on a personally meaningful goal) and group
sessions, which involved CT tasks and focused on practicing time-and-place orientation
and memory, and sustaining attention. Participants in this condition attended a total
of 8 sessions, each lasting 1 hour (30 minutes individually and 30 minutes in a group),
once a week for 8 weeks. A researcher delivered the intervention
Participants in the control condition (n = 21) also participated in 8 sessions, each lasting
1 hour, once a week. This was an active control condition that involved participating
in unstructured conversation and questioning with the examiner and watching health-
related videos
Outcomes Outcomes included ratings of goal performance and satisfaction, self-care, mobility-
related activities of daily living, quality of life, orientation, and memory. Assessments
were undertaken before the intervention and once it was completed
Country Korea
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although study authors described the study
as an RCT, the provided no information on
the method of randomisation
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors did not mention blinding
of participants. They compared CT vs an
active condition, so blindingmay have been
possible
93Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
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Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded assessors administered assessments
Incomplete outcome data (attrition bias)
All outcomes
Low risk Study authorsmade nomentionof attrition
among participants in this trial
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk Study appears to be free of other sources of
bias
Koltai 2001
Methods An RCT comparing effects of a Memory and Coping Program (MCP), in both indi-
vidual and group formats, vs those of a control condition on measures of cognition and
emotional adjustment in people with mild to moderate dementia who had difficulty
adjusting to their cognitive losses
Participants 24 participants who were over 60 years old (mean age 73.5) and had received a diagnosis
of mild to moderate dementia, according to the Clinical Dementia Rating (CDR) scale.
Average years of education for the sample was 15
Interventions Participants in the individual MCP condition (n = 8) attended an average of 6 weekly
intervention sessions focused on cognitive and affective functioning. When available,
caregivers joined the sessions for the last 10 to 15 minutes
Participants assigned to the group MCP condition (n = 8) attended 5 one-hour weekly
sessions in groups of 2 to 4 persons
Participants in the wait-list control condition (n = 8) received small-group MCP after
the intervention and assessments had been completed
Outcomes Outcomes included performance on measures of general cognition (including global
cognition, memory, language, and construction), mood (depression), subjective memory
ability (meta-memory), and awareness of cognitive deficits
Assessments were conducted before and after the intervention
Country United States of America
Registration status&#160; Study authors provided no information; trial presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes
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Koltai 2001 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Randomisation process not described, but
interventions were divided (by order of en-
rolment) into 2 groups of 4
Allocation concealment (selection bias) High risk Study authors did not mention allocation;
for this reason, we assumed this was not
done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding of
participants, and the study included a pas-
sive control condition (wait-list), so blind-
ing was not possible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Noblinding; outcomes could have been in-
fluenced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Two participants from the treatment con-
dition withdrew from the study due to
serious illness. No participants withdrew
from the control condition.Nodetails were
provided regarding the 2 participants who
withdrew, and analysis was based only on
participants who completed treatment, so
it is unclear whether bias may have been
due to incomplete data
Selective reporting (reporting bias) High risk Study authors did not report the CERAD
memory task, abbreviated “Boston Nam-
ing Test,” categorical fluency, and Rosen
figures of constructional praxis
Other bias Low risk Study appears to be free of other sources of
bias
Lee 2013
Methods An RCT comparing a computerised errorless learning-based memory training pro-
gramme (CELP) vs a therapist-led errorless programme (TELP) and a control condition
in people with mild AD
Participants 19 Chinese persons who were 60 years of age and older, had early dementia (according
to their scores on the Chinese Dementia Rating Scale), and were recruited from psy-
chogeriatric day hospitals, an elderly daycare centre in Kwai Chung District, and Kwai
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Lee 2013 (Continued)
Chung Hospital (outpatients)
Interventions Participants in the 2 experimental conditions were trained on an errorless learning-based
memory training programme. Participants in the CELP condition (n = 6) were trained
on a computerised version of this programme, and participants in the TELP condition
(n = 6) completed a therapist-led version of this programme
These 2 interventions lasted for approximately 6 weeks; a total of twelve 30-minute
individual training sessions were delivered twice a week
Occupational therapists who received specialist training delivered the interventions
The control condition (n = 7) was a wait-list condition
Outcomes Primary outcomes were global cognition, verbal learning, and memory and prospective
memory
Secondary outcomes included mood (depression), self-care, and instrumental activities
of daily living
Participants were evaluated before and after the intervention period, and at 3-month
follow-up assessment
Country China
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although study authors described an RCT,
they provided no information on the
method of randomisation
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants in all 3 conditions were en-
gaged in some activity, and it is not clear
whether participants were aware of the con-
dition theywere given or of the research hy-
pothesis. Interventions were led by trained
OTs, and the same feedback was provided
to participants in both experimental groups
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Lee 2013 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Assessors who performed the evaluation
were blinded
Incomplete outcome data (attrition bias)
All outcomes
High risk Five participants who were found eligible
for the study dropped out due to ’deteriora-
tion in their medical condition’, but study
authors provided no details as to the stage
at which this occurred, whether baseline
characteristics were different, or to which
conditions participants had been allocated.
Non-inclusion of their data is likely to have
introduced bias due to incomplete report-
ing
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk Study appears to be free of other sources of
bias
Mapelli 2013
Methods An RCT comparing effects of a structured cognitive stimulation treatment, an occu-
pational therapy intervention, and a usual care control condition on cognition and be-
havioural symptoms in people with dementia
Participants 30 persons with mild to moderate dementia (mean MMSE score 19.5, range 14 to 24)
living in a nursing home in Italy. Mean age of the sample was 83.93
Interventions Participants in the experimental condition (n = 10) were trained on a cognitive stimu-
lation programme that started with personal, spatial, and temporal orientation sessions
and proceeded with individual exercises to stimulate specific cognitive domains. A ther-
apist administered the intervention
Participants in the occupational therapy “placebo condition” (n = 10) received occupa-
tional therapy involving a series of activities, such as reading and debating the newspaper,
playing bingo, or singing
Both interventions lasted 8 weeks, with 5 one-hour sessions per week
Participants assigned to the control condition (n = 10) continued with usual activities
of the nursing home
Outcomes Outcomes included clinical dementia severity, cognitive abilities in several domains,
mood (depression), functional status, behavioural symptoms, and caregiver burden
Assessments were conducted at baseline and after 8 weeks of intervention
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Country Italy
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes We contacted study authors to ask for additional scores not presented in Table 1 in the
published report, for each group, at baseline and at post-intervention assessment (Digit
Span tasks, Trail Making Tests A and B, Token Test, Cognitive Estimation Test, Intricate
Figures Test, House Figure Copy, Daisy Drawing Test, Ideomotor Apraxia Test, Activity
of Daily Living Scale, and Geriatric Depression Scale); however, we received no reply
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were randomized into three
groups, i.e. experimental, placebo, and con-
trol groups, following a simple computer-
ized randomisation technique”
Allocation concealment (selection bias) Unclear risk Study authors stated that they used a com-
puterised randomisation system. It is likely
that allocation concealment was done, but
this is not specified
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding of
participants; the study included a passive
control condition, so blinding was not pos-
sible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Participants were evaluated by a blinded
rater
Incomplete outcome data (attrition bias)
All outcomes
Low risk No outcome data were missing. A flow
chart shows that all participants completed
the final assessment and all were included
in the analysis
Selective reporting (reporting bias) High risk Study authors did not present findings for
some of the outcomes mentioned in the
“Methods” section
Other bias Low risk Study appears to be free of other sources of
bias
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Neely 2009
Methods An RCT comparing a collaborative memory intervention vs an identical intervention
delivered individually, and vs a control condition, in people with mild to moderate AD
and vascular dementia and their caregiving spouses
Participants 30 dyads, including a community dwelling person with mild tomoderate AD or vascular
dementia, according toDSM-IV, who had received the diagnosis within 8months before
the intervention, and their caregiving spouse
Mean age of participants with dementia was 75.4 years
Interventions In the collaborative intervention condition (PwD; n = 10), participant dyads practised
together strategies to enhance everyday mnemonic and occupational performance, with
focus on spaced retrieval and hierarchical cueing
In the individual programme (PwD; n = 10), participants received the same training but
without involvement of the caregiver
Both programmes involved 1-hour weekly sessions over a period of 8 weeks and were
delivered by a research assistant
Dyads in the control condition (PwD; n = 10) received no intervention
Outcomes Outcomes included individual and collaborative recall. Burden and depressive symptoms
among caregivers were also assessed
Country Sweden
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although study authors described an RCT,
they provided no information on the
method of randomisation
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding of
participants; study included a passive con-
trol condition, so blinding was not possible
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Blinding of outcome assessment (detection
bias)
All outcomes
High risk No blinding; the outcome could have been
influenced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes
Low risk No data were missing, other than memory
test performance for 1 participant; no rea-
son was given for this
Selective reporting (reporting bias) High risk Study authors did not present results for
all outcomes mentioned in the “Methods”
section
Other bias Low risk Study appears to be free of other sources of
bias
Quayhagen 1995
Methods An RCT comparing effects of a cognitive remediation intervention and a placebo and a
wait-list control on functional outcomes in persons with AD
Participants 95 dyads (care recipient+carer) participated in the study. Care recipients were commu-
nity-dwelling persons with a diagnosis of possible or probable Alzheimer’s disease, with
mild to moderate decline. Mean age of the sample was 73.6 (8.0) years, and average
education level was 12.6 (4.1) years. 51 participants were male and 27 were female.
Participants were white (85%), African-American (3%), and Hispanic (11%)
Interventions Participants in the experimental condition (n = 25) trained on a cognitive remediation
intervention, which consisted of active cognitive stimulation focusing on memory, prob-
lem solving, and conversation activities, and was executed by the family caregiver 1 hour
daily, 6 days a week, in the home
Participants in the “placebo condition” (n = 28) participated in similar activities to those
in the experimental condition, but using a passive approach
The care recipient and caregivers from both treatment conditions attended 12 consec-
utive weekly in-home sessions, where they were trained in programme implementation
techniques
Participants in the wait-list control condition (n = 25) did not receive any intervention
until the trial had been completed
Outcomes Outcomes included global cognition, as well performance in specific cognitive domains
such as memory, fluency, problem-solving, attention, and behavioural function. Assess-
ments occurred at baseline, immediately after the intervention, and 6 months later
Country United States of America
Registration status&#160; No information provided; presumed to be unregistered
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Quayhagen 1995 (Continued)
Conflict of Interests&#160; Not stated
Notes Comparison of the training programme vs a shortened version used in subsequent work
is covered in Quayhagen & Quayhagen 2001
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although study authors described an RCT,
they provided no information on the
method of randomisation
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding of
participants; the study included a passive
control condition, so blinding was not pos-
sible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Given the numerous subjective outcomes
and the lack of detail regarding the num-
ber of situations in which blinding was not
kept, it is unclear whether risk of bias was
increased
Incomplete outcome data (attrition bias)
All outcomes
High risk “Data is available only for the participants
who completed the study”
Insufficient information is provided re-
garding reasons for attrition (only 79 of the
95 initially included families completed the
study)
Selective reporting (reporting bias) High risk Results were not presented for all outcomes
mentioned in the “Methods” section
Other bias Low risk
Quayhagen 2000
Methods An RCT comparing 4 treatment conditions (cognitive stimulation, dyadic counselling,
dual supportive seminar, and early-stage daycare) and a wait-list control condition in
people with dementia and their caregivers (spouses)
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Quayhagen 2000 (Continued)
Participants 103 participant dyads (caregiver and dementia-diagnosed spouse) were recruited for
the study. Participants (65 men/38 women, mean age 74.5, mean education level 14.5
years) had to receive a diagnosis of possible or probable AD, cardiovascular dementia, or
Parkinson’s dementia, all at mild to moderate stages
Interventions Participants in the cognitive stimulation condition (n = 21) completed a home-based
remediation programme in which the caregiver was the intervening agent who helped
to cognitively stimulate the person with dementia
Participants in the dyadic counselling condition (n = 29) also completed a home-based
intervention involving take-home tasks used to enhance the interaction and to improve
learning of problem-solving skills. The intervention had an affective orientation
Participants in the dual supportive seminar intervention condition (n = 22) participated
in meetings that aimed to enhance communication between persons with dementia and
their caregivers
Participants in the early-stage daycare programme condition (n = 16) took part in group-
based activities. Persons with dementia met for 4 hours per week and engaged in struc-
tured activities that aimed to enhance their remaining strengths and abilities. Caregivers
met once a month in a support group
Each of the interventions was delivered over 8 weeks. The first 3 interventions were
delivered over a total of 1.5 hours per week, whereas the early-stage daycare programme
was delivered for a total of 4 weekly hours for patients, and in 2 sessions for caregivers
Trained graduate students and licensed clinical personnel from psychology, social work,
and nursing delivered the interventions and assessments
Participants in the wait-list control condition (n = 15) received no treatment but were
instead randomised to 1 of the 4 treatment conditions at the end of the study
Outcomes Both patient and caregiver outcomes were measured. Patient outcomes included im-
mediate and delayed memory, verbal fluency, problem-solving, and behavioural symp-
toms. Caregiver outcomes included marital satisfaction, emotional status, morale, phys-
ical health status, stress, coping, and social support
Country United States of America
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; Not stated
Notes Although study authors reported in the article that treatment groups did not differ in
terms of age, education, or racial distribution, they did not provide demographic data
at the group level
Risk of bias
Bias Authors’ judgement Support for judgement
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Quayhagen 2000 (Continued)
Random sequence generation (selection
bias)
Unclear risk Although study authors described an RCT,
they provided no information on the
method of randomisation
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding of
participants; the study included a passive
control condition, so blinding was not pos-
sible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The assessment team was blinded to the
condition to which the unit was ran-
domised”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Study authors provided no information on
whether all randomised dyads had com-
pleted the post-treatment evaluation
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk Study appears to be free of other sources of
bias
Quintana Hernandez 2014
Methods AnRCTcomparing effects of 3 treatments (mindfulness, progressivemuscular relaxation,
and cognitive stimulation) and a control intervention on AD
Participants 127 participants over 65 years of age with a diagnosis of probable AD, according to
NINCDS-ADRDA (MMSE scores over 18). All were community dwellers and were
taking donepezil. Most had completed primary studies. Mean age across groups was 80.
11 (6.74)
Interventions Participants in the IPP condition (n = 32) were trained on an integral psychostimulation
programme 3 times a week over 2 years, in 90-minute sessions
Participants in both mindfulness (n = 36) and muscular relaxation (n = 34) conditions
were trained with the same frequency, for the same length of time
Three independent clinical psychologists delivered the interventions
Participants in the control condition (n = 25) received no intervention
Outcomes Outomes included global cognition, neuropsychiatric symptoms, and clinical dementia
severity. Participants were assessed before and after the intervention period, and 3 addi-
tional evaluations were conducted at 6, 12, and 18 months during the intervention years
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Country Spain
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although study authors described a ran-
domised controlled trial, they provided no
information on the method of randomisa-
tion
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Study is described as using a double-blind
design
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear; study authors stated, “assessments
were carried out by the neuropsychologist,
who was not involved in the delivery of the
treatments”
Incomplete outcome data (attrition bias)
All outcomes
Low risk The study flow chart shows that 7 partici-
pants died while the study was being con-
ducted. Remaining participants completed
the interventions and were analysed
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk Study appears to be free of other sources of
bias
Serino 2017
Methods A single-centre RCT evaluating whether a novel VR-based training protocol can improve
general spatial abilities in patients with AD
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Participants 20 participants aged 65 years old were recruited from an Italian social senior centre. All
met NINCDS-ARDRA criteria, and all met criteria for probable dementia on theMilan
Overall Dementia Scale
Mean age of participants in the VR condition (9 women, 1 man) was 86.60 (SD 6.13),
and average years of education was 9.80 (SD 3.97)
Participants in the control condition (8 women, 2 men) had a mean age of 88.70 (SD
3.59), and on average they received 7.00 years of education (SD 5.00)
8 cognitively unimpaired age-matched participants (4 women, 4 men) also received VR-
based training. Mean age for this group was 86.62 (SD 6.19); mean education level was
9.12 years (SD 5.05)
Interventions Participants in the virtual reality (VR)-based condition (AD; n = 10) underwent a VR
programme developed to train their ability to sync between allocentric viewpoint-depen-
dent and allocentric viewpoint-independent representations. The training programme
consisted of 10 sessions for 3 to 4 consecutive weeks, with approximately 3 sessions each
week. Each session contained an “encoding phase” and a “retrieval phase” and was based
on (virtually) navigating a virtual city to find hidden objects
Participants in the control condition (n = 10) participated in “traditional cognitive
rehabilitative activities” (i.e. cognitive stimulation programs, such as card games, naming,
fluency, and music listening)
Eight cognitively healthy age-matchedparticipants also participated inVR-based training
(“VR Group - Normal Aging”). This group was not taken into consideration for this
review
Both interventions were delivered by neuropsychologists
Outcomes Outcomes included global cognitive function, as well as performance in specific cognitive
domains such as executive functions, selective attention, short-term memory abilities,
and short and long-term spatial memory abilities. The battery was given at baseline and
then after the intervention, 3 to 4 weeks later
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes Study authors sent a table with post-intervention scores upon request; they clarified that
participants had mild to moderate dementia
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although study authors described an RCT,
they provided no information on the
method of randomisation
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Serino 2017 (Continued)
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Study authors did not mention blinding
of participants; they compared CT vs an
active condition, so blindingmay have been
possible
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Study authors provided no details to sug-
gest that outcome assessment was blind; it
is likely that this was not the case
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Study authors providednodetails regarding
any discontinuation, but equally, whether
all participants were assessed post interven-
tion remains unclear
Selective reporting (reporting bias) Low risk Some scores for the post-intervention as-
sessment are missing, but we were able to
obtain them from study authors
Other bias Low risk Study appears to be free of other sources of
bias
Trebbastoni 2018
Methods A single-blind RCT comparing effects on cognition of a group CT programme vs a no
intervention control condition for persons with mild to moderate AD
Participants 140 community-dwelling participants (78 women) between 50 and 85 years of age with a
diagnosis of Alzheimer-type dementia, according to NINCDS-ADRDA, were recruited
in Rome, Italy
Interventions Participants in the intervention condition (n = 54) participated in group CT sessions
that involved paper-and-pencil tasks, as well as verbal-learning exercises. Participants
were trained twice a week over 24 weeks
Participants assigned to the control condition (n = 86) received usual care at the hospital
Outcomes Oucomes included performance on several cognitive domains, including memory, at-
tention, language, visuospatial functions, frontal functions, and praxis
Participants were assessed at baseline, post intervention, and 6 months later
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
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Conflict of Interests&#160; No
Notes Six participants from the experimental group (n = 54) were included only in the first
part of the study (from T0 to T1), but not from T1 to T2. They were excluded because
they had attended less than 80% of the sessions. Between T1 and T2, 3 participants
were excluded from this group (1 loss to follow-up; 1 decision to withdraw; 1 death).
Therefore, 54 participants in the experimental group were assessed at T1, but only 45
were assessed at T2 (6 months’ follow-up)
Study authors provided the original paper along with clarification on a discrepancy
between the same score in 2 different tables
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The ratio of intended numbers of partic-
ipants in each of the comparison groups
depended on the resources available at our
site. Hence, we used a random numbering
with an unequal allocation ratio of 1:2 (1
treated:2 untreated). Ten days prior to the
commencement of the training, we com-
puter-generated a randomisation list that
assigned the patients belonging to the TG
to nine treatment sub-groups”
Allocation concealment (selection bias) Unclear risk Study authors stated that they used a com-
puterised randomisation system. It is likely
that allocation concealment was done, but
this is not specified
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors did not mention blinding of
participants; the study included a passive
control condition, so blinding was not pos-
sible
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “Independent expert evaluators, who were
blinded to the treated or untreated status
of the patients, recorded the outcome mea-
sures at T0, T1 and T2”
Incomplete outcome data (attrition bias)
All outcomes
High risk Researchers stated, “We analysed the data
of all the participants who concluded the
study and were tested at T2”
Nine participants in the experimental con-
dition and one in the control condition
dropped out during the study; their data
were not reported, which is likely to intro-
duce attrition bias
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Trebbastoni 2018 (Continued)
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
Other bias Low risk Study appears to be free of other sources of
bias
Tsantali 2017
Methods An RCT comparing effects of CT vs cognitive stimulation (CS) on general cognitive
function and memory in mild Alzheimer’s disease (mAD)
Participants 63 mild AD outpatients (according to NINCDS-ADRDA and DSM-IV criteria) were
recruited from 2 memory clinics in Greece. Mean age of the sample was 73.7 (5.3), and
age range was 67 to 82 years. Participants had an average of 9.8 years of education (4.1)
, with a range of 6 to 16 years
Interventions Participants in the CT condition (n = 17) and in the CS condition (n = 17) received a
4-month individual intervention programme consisting of 3 individual sessions of 90
minutes per week
Participants in the CS condition engaged in non-complicated cognitive tasks that were
not focused on a specific cognitively impaired ability (e.g. drawing, painting, copying
figures, listening to music)
Programmes were administered by 4 licensed psychologists
Participants in the control condition (CD) (n = 21) received no treatment
Outcomes Outcomes included global cognition, as well as performance on specific domains such
as memory, attention, and language
Evaluations were conducted immediately post intervention and 8months after treatment
had been completed
Country Greece
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes We contacted study authors to request missing scores (mean and SD for each group for
general cognitive state measures immediately post intervention), but we did not obtain
a reply
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Study authors stated that participants were
allocated by lot
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Tsantali 2017 (Continued)
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors described a single-blind
RCT; however, blinding referred to the out-
come assessment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Study authors stated that all post-baseline
assessments were conducted by blinded as-
sessors
Incomplete outcome data (attrition bias)
All outcomes
High risk 8 participants (4 from each treatment con-
dition) were not seen for post-interven-
tion assessment because they did not com-
plete the intervention for “health reasons”.
All participants from the control condition
were seen post treatment. No details were
provided about participants who dropped
out
Selective reporting (reporting bias) High risk Some scores for the post-intervention as-
sessment are missing
Other bias Low risk Study appears to be free of other sources of
bias
Venturelli 2016
Methods An RCT aiming to determine whether aerobic exercise (AE) and CT treatments were
effective in reducing sundowning symptoms via downregulation of cortisol levels in AD
patients. Possible additive effects of combined AE+CT were also assessed
Participants 80 AD participants residing in nursing homes who were between 65 and 75 years old,
had an MMSE score between 10 and 15, and had a clinical diagnosis of dementia and
neurobehavioural symptoms of sundown syndrome. 58 participants were female and
only 22 were male
Interventions Participants in the CT condition (n = 20) engaged in a cognition-oriented psychosocial
intervention that was based on the reality orientation (RO) method
Participants in the AE intervention condition (n = 20) were engaged in walking at
moderate intensity
Participants in the AE+CT intervention condition (n = 20) were engaged in the same
activity as those in the AE group, but with the caregiver providing cognitive stimulation
via the RO method during walking
20 participants in the control condition received no specific treatment beyond standard
therapy
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Venturelli 2016 (Continued)
Outcomes Outcomes included global cognition, neuropsychiatric symptoms, agitation, and saliva
cortisol as a measure of stress
Assessments were conducted at baseline and immediately post intervention
Country Italy
Registration status&#160; No information provided; presumed to be unregistered
Conflict of Interests&#160; No
Notes We contacted study authors to request data in the format required (means and SDs for
each measure at all assessment occasions, for each group separately), but we received no
reply
For the purposes of this review, we used CT as our experimental condition, AE as an
alternative treatment comparison, and no-treatment control as a passive control. We did
not take the AE+CT group into consideration for our analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Although study authors described an RCT,
they provided no information on the
method of randomisation
Allocation concealment (selection bias) High risk Study authors did not mention allocation
concealment; for this reason, we assumed
this was not done
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Study authors described a single-blind
RCT; however, blinding referred to the out-
come assessment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Although it is not entirely clear, it appears
that evaluations were conducted by neu-
ropsychologists blinded to group assign-
ment
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Whether or not participants dropped out
andwere not seenduring the post-interven-
tion evaluation is not stated and remains
unclear
Selective reporting (reporting bias) Low risk All tests mentioned in the “Methods” sec-
tion were reported in the “Results” section
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Venturelli 2016 (Continued)
Other bias Low risk Study appears to be free of other sources of
bias
AD: Alzheimer’s disease.
ADL: activity of daily living.
AE: adverse event.
CD: control condition.
CDR: Clinical Dementia Rating Scale.
CELP: computerised errorless learning-based memory training programme.
ChEIs: cholinesterase inhibitors.
CS: cognitive stimulation.
CT: cognitive training.
DSM-IV: Diagnostical and Statistical Manual of Mental Disorders, Fourth Edition.
EEG: electroencephalography.
HRQoL: health-related quality of life.
IADLs: instrumental activities of daily living.
IPP: integrated psychostimulation programme.
LSS: lexical-semantic stimulation.
mAD: mild Alzheimer’s disease.
MCI: mild cognitive impairment.
MCP: memory and coping programme.
MMSE: Mini Mental Status Examination.
NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke - Alzheimer’s Disease and Related
Disorders Association.
NPI: non-pharmacological intervention.
OT: occupational therapist.
PET: positron emission tomography.
PF: Phonetic Fluency
PwD: Person with Dementia.
RAVLT: Rey Auditory Verbal Learning Test.
RCT: randomised controlled trial.
RO: reality orientation.
ROCF: Rey-Osterrieth Complex Figure Test.
SD: standard deviation.
SR: spaced retrieval.
SR+M: spaced retrieval with Montessori activities.
TELP: therapist-led errorless programme.
TG: Treatment Group.
TMT: Trail Making Test.
VR: virtual reality.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Actrn 2015 Does not meet intervention criteria
Actrn12616000827437p 2016 Does not meet intervention criteria
Alimova 1990 Article cannot be found
Alves 2014 Does not meet participant criteria
Anderson 2001 Includes no suitable control
Angelucci 2015 Does not meet participant criteria.
Avila 2007 Not an RCT
Baglio 2015 Does not meet intervention criteria
Baltes 1989 Does not meet participant criteria
Bamidis 2015 Not an RCT
Basak 2008 Does not meet participant criteria
Bernhardt 2002 Article cannot be found
Biasutti 2018 Does not meet participant criteria
Boron 2007 Does not meet participant criteria
Brinkman 1982 Not an RCT
Brunelle 2015 Does not meet intervention criteria
Buettner 2011 Does not meet participant criteria
Burgener 2009 Does not meet intervention criteria
Buschert 2011 Does not meet intervention criteria
Ceccato 2012 Does not meet intervention criteria
Chapman 2004 Does not meet intervention criteria
Cheng 2015 Never published
Chew 2015 Not an RCT
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(Continued)
Choi 2012 Never published
Cipriani 2006 Not an RCT
Clare 2013 Does not meet intervention criteria
Contador 2016 Not an RCT
Costa 2014 Does not meet participant criteria
Costa 2015 Never published
Danassi 2015 Never published
De Luca 2016 Includes no suitable control
De Paula 2013 Not enough information provided
Dwolatzky 2014 Not enough information provided
Eckroth-Bucher 2009 Does not meet participant criteria
Edwards 2013 Does not meet participant criteria
Faggian 2007 Does not meet participant criteria
Fane 2013 Never published
Farina 2002 Not an RCT
Farina 2006 Not an RCT
Fernandez-Calvo 2010 Does not meet intervention criteria
Fernández-Calvo 2015 Does not meet intervention criteria
Fisher 2016 Does not meet participant criteria
Gaitan 2013 Does not meet participant criteria
Giordano 2010 Not an RCT
Graessel 2011 Does not meet intervention criteria
Grohman 2006 Does not meet participant criteria
Günther 2003 Does not meet participant criteria
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(Continued)
Han 2017 Does not meet intervention criteria
Hayashi 2009 Never published
Helcer 2012 Never published
Hochhalter 2004 Not an RCT
Hofmann 2003 Not an RCT
Hopman-Rock 1999 Does not meet intervention criteria
Huntley 2017 Includes no suitable control
Hwang 2012 Not an RCT
Hwang 2015 Not an RCT
Hyer 2014 Not an RCT
Israel 1987 Does not meet participant criteria
Jang 2015 Not an RCT
Jin 2015 Not an RCT
Kanaan 2014 Not an RCT
Kang 2010 Not an RCT
Kawashima 2015 Not an RCT
Kessels 2009 Does not meet intervention criteria
Khurandy 2016 Article cannot be found
Kim 2005 Does not meet participant criteria
Kim, 2016 Does not meet intervention criteria
Kovach 2018 Does not meet participant criteria
Latorre 2010 Does not meet participant criteria
Lee, 2016 Does not meet intervention criteria
Lee, 2016a Does not meet participant criteria
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(Continued)
Maci 2012 Does not meet intervention criteria
Maci, a Does not meet intervention criteria
Meguro 2008 Does not meet intervention criteria
Middelstadt 2016 Does not meet intervention criteria
NCT 2005 Article cannot be found
NCT 2011 Article cannot be found
NCT 2012 Article cannot be found
NCT 2013 Article cannot be found
NCT 2016a Never published
Ochmann 2015 Does not meet intervention criteria
Olazaran 2004 Does not meet participant criteria
Optale 2010 Does not meet participant criteria
Oswald 1996 Not an RCT
Park 2009 Does not meet participant criteria
Pietila 2017 Article cannot be found
Poon 2005 Not enough information provided
Poptsi 2017 Does not meet intervention criteria
Quintana-Hernandez 2015 Does not meet participant criteria
Quintana-Hernandez 2016 Does not meet intervention criteria
SeungHyun 2017 Article cannot be found
Umin 2015 Article cannot be found
van Zon 2016 Not an RCT
Viola 2011 Not an RCT
Voigt-Radloff 2017 Does not meet intervention criteria
Yun 2008 Article cannot be found
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(Continued)
Zanetti 1997 Not an RCT
Zanetti 2001 Not an RCT
Zarit 1982 Does not meet participant criteria
Zhuang 2013 Does not meet participant criteria
2010 Does not meet intervention criteria.
RCT: randomised controlled trial.
Characteristics of ongoing studies [ordered by study ID]
ACTRN12618000600246
Trial name or title Optimising functional independence of older persons with dementia: Evaluation of the Interdisciplinary
Home-bAsed Reablement Program (I-HARP)
Methods A multi-centre pragmatic parallel-arm stratified randomised trial aiming to determine the effectiveness of I-
HARP on functional independence, mobility, quality of life, and depression among people with dementia,
their home environmental safety, carer burden and quality of life, and I-HARP cost-effectiveness
Participants 176 participants (person with dementia and his/her carer) will be recruited across 3 public hospitals and 2
aged care services. Participants should be over 60 years old, have mild to moderate dementia according to
FDRS, stage 4 to 5, have conversational English language ability, and have a cognitively able carer who has
at least 4 days or 7 hours per week of contact
Interventions I-HARP (an adaptation and expansion of a US reablement programme, which addresses common challenges
that frail older people commonly experience, including environmental risks for disability, functional decline,
and multi-morbidities), which consists of (1) up to 12 home visits of 1.5 hours (5 to 6× occupational therapy
(OT), 3 to 4× registered nurse (RN), plus 2 to 4 additional options of allied health support), tailored to
individual needs, (2) minor homemodification/home repairs and/or provision of assistive devices (up to value
$1000) to improve home safety, (3) 3 individual carer support sessions of 1.5 hours at beginning, middle,
and end of home visits by a case co-ordinator
Control group will be allowed to receive usual care under their hospital or community-based aged care
services, which may involve ad hoc nursing and allied health services, and home modifications, without the
components of structured cognitive rehabilitation
Outcomes Primary outcome is mean functional independence score. Secondary outcomes include quality of life, mo-
bility, depressive symptoms, health-related quality of life, carer burden, home environment safety, costs of
delivery, costs to participants (including healthcare/aged care/community services, medications, and any other
costs associated with falls and minor injuries with dementia and carer workforce participation), incidents of
unplanned hospital admission, primary care (GP) visit events, events of residential aged care home admission,
incidents of falls and other minor injuries, events of aged care service use, hours of carer paid workforce
participation, and other system costs incurred by the healthcare system
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ACTRN12618000600246 (Continued)
Starting date 23 April 2018 (first participant enrolment)
Contact information Prof Yun-Hee Jeon; yun-hee.jeon@sydney.edu.au
Notes
Leung 2017
Trial name or title Modifying cognitive trajectories in insidious cognitive decline using computerised CT: methods and current
progress of a two-phase randomised controlled trial
Methods 86memory clinic patients with documented cognitive decline (at least 0.5 SDdecline inmemory performance
between2 follow-ups) are currently recruited to a randomised, active controlled trial. Participants are randomly
assigned to supervised, multi-domain, intensive CCT for 3 months (phase A) followed by 15 months of
monthly booster training (phase B), or 3 months of active control intervention (phase A) followed by 3
months of CCTand 12 months of no-contact follow-up (phase B)
Participants Memory clinic patients with documented cognitive decline (at least 0.5 SD decline in memory performance
between 2 follow-ups)
Interventions Supervised, multi-domain, intensive CCT for 3 months (phase A) followed by 15 months of monthly booster
training (phase B), or 3 months of active control intervention (phase A) followed by 3 months of CCT and
12 months of no-contact follow-up (phase B)
Outcomes Primary outcome is change in a memory composite. Neuropsychological assessments, daily functioning
measures, and sleep quality are assessed at baseline and at the end of each phase. Additional secondary measures
include multi-modal neuroimaging, neuroeconomic decision-making, and genetic predictors of response to
training
Starting date
Contact information
Notes
NCT 2016
Trial name or title Neurostimulation and cognitive intervention in Alzheimer’s disease
Methods Randomised controlled trial; factorial assignment
Participants Adults 60 to 90 years with diagnosis of Alzheimer’s disease (according to DSM-IV and NINCDS-ADRDA),
with a score between 18 and 26 on MMSE and CDR of 1.0
Interventions Experimental: active tDCS plus real CT
• Participants will receive active transcranial direct current stimulation and real CT
Experimental: sham tDCS plus real CT
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NCT 2016 (Continued)
• Participants will receive sham transcranial direct current stimulation and real CT
Experimental: active tDCS plus placebo CT
• Participants will receive active transcranial direct current stimulation and placebo CT
Placebo comparator: sham tDCS plus placebo CT
• Participants will receive sham transcranial direct current stimulation and placebo CT
Outcomes Primary outcome is change in cognitive function assessed on the Alzheimer’s Disease Assessment Scale -
cognitive subscale (ADAS-Cog). As secondary outcomes, study authors will measure different cognitive
domains, as well as functional ability, behavioural and psychological disturbances, subjective burden among
caregivers, electrical activity of the brain, and side effects
Starting date May 2016
Contact information Dr. Suellen M Andrade; suellenandrade@gmail.com
Notes
ADAS-Cog: Alzheimer’s Disease Assessment Scale - cognitive subscale.
CCT: computerised cognitive training.
CDR: Clinical Dementia Rating Scale.
CT: cognitive training.
DSM-IV: Diagnostical and Statistical Manual of Mental Disorders, Fourth Edition.
DRS: Dementia Rating Scale
GP: general practitioner.
MMSE: Mini Mental Status Examination.
NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke - Alzheimer’s Disease and Related
Disorders Association.
OT: occupational therapist.
RN: registered nurse.
SD: standard deviation.
tDCS: transcranial direct current stimulation.
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D A T A A N D A N A L Y S E S
Comparison 1. Cognitive training vs control immediately post intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition (composite)
26 1389 Std. Mean Difference (Random, 95% CI) 0.42 [0.23, 0.61]
2 Change in a global measure of
cognition (composite)˙zero
correlation
26 1389 Std. Mean Difference (Random, 95% CI) 0.24 [0.12, 0.36]
3 Change in a global measure of
cognition
20 1288 Std. Mean Difference (IV, Random, 95% CI) 0.65 [0.26, 1.05]
4 Change in a global measure of
cognition˙zero correlation
20 1287 Std. Mean Difference (IV, Random, 95% CI) 0.27 [0.04, 0.50]
5 Change in disease progression 5 215 Std. Mean Difference (IV, Random, 95% CI) 1.07 [0.59, 1.55]
6 Change in delayed memory 11 543 Std. Mean Difference (IV, Random, 95% CI) 0.81 [0.29, 1.32]
7 Change in immediate memory 17 762 Std. Mean Difference (IV, Random, 95% CI) 0.74 [0.37, 1.12]
8 Change in attention and working
memory
12 551 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.08, 1.05]
9 Change in language (naming) 5 311 Std. Mean Difference (IV, Random, 95% CI) 0.62 [0.11, 1.12]
10 Change in verbal letter fluency 12 544 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.07, 0.50]
11 Change in verbal category
fluency
9 475 Std. Mean Difference (IV, Random, 95% CI) 0.52 [0.23, 0.81]
12 Change in executive function 11 511 Std. Mean Difference (IV, Random, 95% CI) 0.75 [0.28, 1.22]
13 Change in speed of information
processing
6 201 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.11, 0.54]
14 Change in meta cognition
(self-reported)
2 41 Std. Mean Difference (IV, Random, 95% CI) 0.50 [-0.15, 1.14]
15 Change in meta cognition
(informant-reported)
2 56 Std. Mean Difference (IV, Random, 95% CI) -0.01 [-1.29, 1.26]
16 Change in participants’ mood 8 577 Std. Mean Difference (IV, Random, 95% CI) 0.72 [-0.10, 1.54]
17 Change in capacity for activities
of daily living
10 687 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.11, 0.35]
18 Change in general health and
quality of life
5 630 Std. Mean Difference (IV, Random, 95% CI) -0.04 [-0.38, 0.29]
19 Change in behavioural and
psychological symptoms of
dementia (BPSD)
6 493 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.34, 1.22]
20 Participant burden (retention
rates)
17 1282 Odds Ratio (M-H, Random, 95% CI) 0.73 [0.37, 1.43]
21 Change in burden of care
(CAREGIVER)
2 405 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.36, 0.15]
22 Change in quality of life
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.50, 0.83]
23 Change inmood and well-being
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.98 [0.27, 1.68]
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Comparison 2. Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition (composite)
7 387 Std. Mean Difference (Random, 95% CI) 0.65 [0.11, 1.20]
2 Change in a global measure of
cognition (composite)˙zero
correlation
7 387 Std. Mean Difference (Random, 95% CI) 0.40 [0.09, 0.71]
3 Change in a global measure of
cognition
6 387 Std. Mean Difference (IV, Random, 95% CI) 1.33 [0.31, 2.34]
4 Change in a global measure of
cognition (zero correlation)
6 387 Std. Mean Difference (IV, Random, 95% CI) 0.68 [0.06, 1.30]
5 Change in disease progression 2 98 Std. Mean Difference (IV, Random, 95% CI) 0.55 [0.12, 0.98]
6 Change in disease progression
(zero correlation)
2 98 Std. Mean Difference (IV, Random, 95% CI) 0.28 [-0.14, 0.71]
7 Change in delayed memory 4 274 Std. Mean Difference (IV, Random, 95% CI) 0.97 [0.02, 1.92]
8 Change in immediate memory 7 383 Std. Mean Difference (IV, Random, 95% CI) 0.62 [0.00, 1.24]
9 Change in attention and working
memory
3 215 Std. Mean Difference (IV, Random, 95% CI) 0.50 [-0.43, 1.43]
10 Change in language (naming) 4 274 Std. Mean Difference (IV, Random, 95% CI) 0.71 [0.07, 1.34]
11 Change in verbal letter fluency 4 247 Std. Mean Difference (IV, Random, 95% CI) 0.47 [-0.28, 1.23]
12 Change in verbal category
fluency
3 213 Std. Mean Difference (IV, Random, 95% CI) 0.78 [0.38, 1.18]
13 Change in executive function 5 330 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.02, 1.10]
14 Change in speed of information
processing
2 45 Std. Mean Difference (IV, Random, 95% CI) 0.30 [-0.44, 1.04]
15 Change in meta cognition
(self-reported)
1 19 Std. Mean Difference (IV, Random, 95% CI) 0.99 [-0.01, 1.99]
16 Change in meta cognition
(informant-reported)
1 34 Std. Mean Difference (IV, Random, 95% CI) -0.06 [-0.73, 0.62]
17 Change in participants’ mood 2 30 Std. Mean Difference (IV, Random, 95% CI) 0.21 [-0.54, 0.96]
18 Change in capacity for activities
of daily living
3 64 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.50, 0.94]
19 Change in general health and
quality of life
1 117 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.39, 0.35]
20 Change in behavioural and
psychological symptoms of
dementia (BPSD)
1 11 Std. Mean Difference (IV, Random, 95% CI) -1.34 [-2.75, 0.07]
21 Change in burden of care
(CAREGIVER)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
22 Change in quality of life
(CAREGIVER)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
23 Change in mood and well-
being (CAREGIVER)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 3. Cognitive training vs alternative treatment immediately post intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition (composite)
7 769 Std. Mean Difference (Random, 95% CI) 0.21 [-0.23, 0.64]
2 Change in a global measure of
cognition (composite)˙zero
correlation
7 769 Std. Mean Difference (Random, 95% CI) -0.03 [-0.23, 0.17]
3 Change in a global measure of
cognition
7 724 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.28, 0.60]
4 Change in a global measure of
cognition˙zero correlation
7 724 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.24, 0.20]
5 Change in disease progression 3 131 Std. Mean Difference (IV, Random, 95% CI) 0.15 [-0.33, 0.63]
6 Change in delayed memory 3 147 Std. Mean Difference (IV, Random, 95% CI) 0.71 [-0.33, 1.75]
7 Change in immediate memory 3 147 Std. Mean Difference (IV, Random, 95% CI) 0.51 [-0.19, 1.21]
8 Change in attention and working
memory
2 69 Std. Mean Difference (IV, Random, 95% CI) 0.91 [-0.46, 2.27]
9 Change in language (naming) 1 16 Std. Mean Difference (IV, Random, 95% CI) -0.63 [-1.65, 0.38]
10 Change in verbal letter fluency 3 75 Std. Mean Difference (IV, Random, 95% CI) 0.34 [-0.38, 1.05]
11 Change in verbal category
fluency
2 55 Std. Mean Difference (IV, Random, 95% CI) -0.28 [-1.46, 0.89]
12 Change in executive function 4 163 Std. Mean Difference (IV, Random, 95% CI) 1.44 [-0.26, 3.14]
13 Change in speed of information
processing
2 55 Std. Mean Difference (IV, Random, 95% CI) 0.00 [-0.55, 0.55]
14 Change in meta cognition (self-
reported)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
15 Change in meta cognition
(informant-reported)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
16 Change in participants’ mood 3 543 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.29, 0.07]
17 Change in capacity for activities
of daily living
3 525 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.43, -0.07]
18 Change in general health and
quality of life
4 631 Std. Mean Difference (IV, Random, 95% CI) -0.49 [1.00, 0.02]
19 Change in behavioural and
psychological symptoms of
dementia (BPSD)
3 672 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.27, 0.06]
20 Participant burden (retention
rates)
4 639 Odds Ratio (M-H, Random, 95% CI) 0.78 [0.24, 2.57]
21 Change in burden of care
(CAREGIVER)
3 591 Std. Mean Difference (IV, Random, 95% CI) -0.15 [-0.47, 0.17]
22 Change in quality of life
(CAREGIVER)
1 88 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.74, 0.24]
23 Change inmood and well-being
(CAREGIVER)
1 88 Std. Mean Difference (IV, Random, 95% CI) 1.50 [0.96, 2.04]
121Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 4. Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition (composite)
2 73 Std. Mean Difference (Random, 95% CI) 1.31 [-1.03, 3.65]
2 Change in a global measure of
cognition (composite)˙zero
correlation
2 73 Std. Mean Difference (Random, 95% CI) 0.62 [-0.52, 1.75]
3 Change in a global measure of
cognition
2 73 Std. Mean Difference (IV, Random, 95% CI) 3.20 [-2.89, 9.29]
4 Change in disease progression
(zero correlation)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5 Change in disease progression 0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
6 Change in delayed memory 2 73 Std. Mean Difference (IV, Random, 95% CI) 0.61 [-1.07, 2.30]
7 Change in immediate memory 2 73 Std. Mean Difference (IV, Random, 95% CI) 0.75 [-0.61, 2.10]
8 Change in attention and working
memory
1 39 Std. Mean Difference (IV, Random, 95% CI) -0.05 [-0.72, 0.61]
9 Change in language (naming) 1 34 Std. Mean Difference (IV, Random, 95% CI) 1.98 [1.14, 2.82]
10 Change in verbal letter fluency 1 39 Std. Mean Difference (IV, Random, 95% CI) 0.29 [-0.38, 0.96]
11 Change in verbal category
fluency
1 39 Std. Mean Difference (IV, Random, 95% CI) -0.08 [-0.74, 0.59]
12 Change in executive function 1 39 Std. Mean Difference (IV, Random, 95% CI) -0.30 [-0.97, 0.37]
13 Change in speed of information
processing
1 39 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.77, 0.56]
14 Change in meta cognition (self-
reported)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
15 Change in meta cognition
(informant-reported)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
16 Change in participants’ mood 1 39 Std. Mean Difference (IV, Random, 95% CI) -0.66 [-1.35, 0.02]
17 Change in capacity for activities
of daily living
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
18 Change in general health and
quality of life
1 39 Std. Mean Difference (IV, Random, 95% CI) 0.33 [-0.34, 1.00]
19 Change in behavioural and
psychological symptoms of
dementia (BPSD)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
20 Change in burden of care
(CAREGIVER)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
21 Change in quality of life
(CAREGIVER)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
22 Change in mood and well-
being (CAREGIVER)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 5. Cognitive training vs control immediately post intervention - risk of bias
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition
20 1288 Std. Mean Difference (IV, Random, 95% CI) 0.65 [0.26, 1.05]
1.1 Lower risk 14 1010 Std. Mean Difference (IV, Random, 95% CI) 0.79 [0.28, 1.30]
1.2 Higher risk 6 278 Std. Mean Difference (IV, Random, 95% CI) 0.30 [-0.26, 0.87]
2 Change in a global measure of
cognition˙zero correlation
20 1287 Std. Mean Difference (IV, Random, 95% CI) 0.27 [0.04, 0.50]
2.1 Lower risk 14 1009 Std. Mean Difference (IV, Random, 95% CI) 0.33 [0.03, 0.63]
2.2 Higher risk 6 278 Std. Mean Difference (IV, Random, 95% CI) 0.07 [-0.20, 0.34]
3 Change in a global measure of
cognition (composite)
26 1389 Std. Mean Difference (Random, 95% CI) 0.42 [0.23, 0.61]
3.1 Lower risk 19 1034 Std. Mean Difference (Random, 95% CI) 0.46 [0.19, 0.72]
3.2 Higher risk 7 355 Std. Mean Difference (Random, 95% CI) 0.33 [0.12, 0.55]
4 Change in a global measure of
cognition (composite)˙zero
correlation
26 1390 Std. Mean Difference (Random, 95% CI) 0.24 [0.12, 0.36]
4.1 Lower risk 19 1035 Std. Mean Difference (Random, 95% CI) 0.23 [0.08, 0.38]
4.2 Higher risk 7 355 Std. Mean Difference (Random, 95% CI) 0.28 [0.07, 0.49]
5 Change in immediate memory 17 762 Std. Mean Difference (IV, Random, 95% CI) 0.74 [0.37, 1.12]
5.1 Lower risk 13 542 Std. Mean Difference (IV, Random, 95% CI) 0.95 [0.46, 1.44]
5.2 Higher risk 5 220 Std. Mean Difference (IV, Random, 95% CI) 0.33 [0.06, 0.60]
6 Change in delayed memory 11 543 Std. Mean Difference (IV, Random, 95% CI) 0.81 [0.29, 1.32]
6.1 Lower risk 8 413 Std. Mean Difference (IV, Random, 95% CI) 0.87 [0.16, 1.59]
6.2 Higher risk 3 130 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.21, 0.92]
7 Change in attention and working
memory
12 551 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.08, 1.05]
7.1 Lower risk 9 394 Std. Mean Difference (IV, Random, 95% CI) 0.57 [-0.03, 1.17]
7.2 Higher risk 3 157 Std. Mean Difference (IV, Random, 95% CI) 0.56 [-0.57, 1.69]
8 Change in language (naming) 5 311 Std. Mean Difference (IV, Random, 95% CI) 0.62 [0.11, 1.12]
9 Change in verbal letter fluency 12 544 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.07, 0.50]
10 Change in speed of information
processing
6 201 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.11, 0.54]
11 Change in executive function 11 511 Std. Mean Difference (IV, Random, 95% CI) 0.75 [0.28, 1.22]
12 Change in verbal category
fluency
9 475 Std. Mean Difference (IV, Random, 95% CI) 0.52 [0.23, 0.81]
12.1 Lower risk 6 318 Std. Mean Difference (IV, Random, 95% CI) 0.49 [0.06, 0.93]
12.2 Higher risk 3 157 Std. Mean Difference (IV, Random, 95% CI) 0.48 [0.16, 0.80]
13 Change in meta cognition
(self-reported)
2 41 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.87, 1.12]
14 Change in meta cognition
(informant-reported)
2 56 Std. Mean Difference (IV, Random, 95% CI) -0.65 [-1.19, -0.10]
15 Change in participants’ mood 8 576 Std. Mean Difference (IV, Random, 95% CI) 0.72 [-0.10, 1.54]
16 Change in capacity for activities
of daily living
10 705 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.10, 0.34]
16.1 Lower risk 7 516 Std. Mean Difference (IV, Random, 95% CI) 0.09 [-0.19, 0.37]
16.2 Higher risk 3 189 Std. Mean Difference (IV, Random, 95% CI) 0.18 [-0.21, 0.58]
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17 Change in general health and
quality of life
4 542 Std. Mean Difference (IV, Random, 95% CI) -0.00 [-0.42, 0.41]
18 Change in behavioural and
psychological symptoms of
dementia (BPSD)
6 493 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.34, 1.22]
19 Change in disease progression 5 215 Std. Mean Difference (IV, Random, 95% CI) 1.07 [0.59, 1.55]
20 Change in burden of care
(CAREGIVER)
2 405 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.36, 0.15]
21 Change in quality of life
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.50, 0.83]
22 Change inmood and well-being
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.98 [0.27, 1.68]
23 Participant burden (retention
rates)
17 1282 Odds Ratio (M-H, Random, 95% CI) 0.73 [0.37, 1.43]
24 Change in general health and
quality of life
5 630 Std. Mean Difference (IV, Random, 95% CI) -0.04 [-0.38, 0.29]
Comparison 6. Cognitive training vs control immediately post intervention - intervention dose
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition
20 1288 Std. Mean Difference (IV, Random, 95% CI) 0.65 [0.26, 1.05]
1.1 Up to 3 times 15 1112 Std. Mean Difference (IV, Random, 95% CI) 0.51 [0.06, 0.95]
1.2 More than 3 times 5 176 Std. Mean Difference (IV, Random, 95% CI) 1.14 [0.27, 2.01]
2 Change in a global measure of
cognition˙zero correlation
20 1287 Std. Mean Difference (IV, Random, 95% CI) 0.27 [0.04, 0.50]
2.1 Up to 3 times 15 1111 Std. Mean Difference (IV, Random, 95% CI) 0.23 [-0.01, 0.47]
2.2 More than 3 times 5 176 Std. Mean Difference (IV, Random, 95% CI) 0.42 [-0.30, 1.15]
3 Change in a global measure of
cognition (composite)
26 1389 Std. Mean Difference (Random, 95% CI) 0.42 [0.23, 0.61]
3.1 Up to 3 times 20 1138 Std. Mean Difference (Random, 95% CI) 0.33 [0.13, 0.53]
3.2 More than 3 times 6 251 Std. Mean Difference (Random, 95% CI) 0.71 [0.27, 1.14]
4 Change in a global measure of
cognition (composite)˙zero
correlation
26 1338 Std. Mean Difference (Random, 95% CI) 0.24 [0.12, 0.36]
4.1 Up to 3 times 20 1139 Std. Mean Difference (Random, 95% CI) 0.14 [0.02, 0.26]
4.2 More than 3 times 6 199 Std. Mean Difference (Random, 95% CI) 0.54 [0.28, 0.80]
5 Change in immediate memory 17 762 Std. Mean Difference (IV, Random, 95% CI) 0.74 [0.37, 1.12]
5.1 Up to 3 times 14 636 Std. Mean Difference (IV, Random, 95% CI) 0.73 [0.27, 1.19]
5.2 More than 3 times 4 126 Std. Mean Difference (IV, Random, 95% CI) 0.74 [0.29, 1.19]
6 Change in delayed memory 11 543 Std. Mean Difference (IV, Random, 95% CI) 0.81 [0.29, 1.32]
7 Change in attention and working
memory
12 551 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.08, 1.05]
8 Change in language (naming) 5 311 Std. Mean Difference (IV, Random, 95% CI) 0.62 [0.11, 1.12]
9 Change in verbal letter fluency 12 544 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.07, 0.50]
9.1 Up to 3 times 9 460 Std. Mean Difference (IV, Random, 95% CI) 0.05 [-0.13, 0.24]
9.2 More than 3 times 3 84 Std. Mean Difference (IV, Random, 95% CI) 1.00 [0.09, 1.92]
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10 Change in speed of information
processing
6 201 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.11, 0.54]
11 Change in executive function 11 511 Std. Mean Difference (IV, Random, 95% CI) 0.75 [0.28, 1.22]
11.1 Up to 3 times 8 380 Std. Mean Difference (IV, Random, 95% CI) 0.57 [0.01, 1.13]
11.2 More than 3 times 3 131 Std. Mean Difference (IV, Random, 95% CI) 1.20 [0.20, 2.20]
12 Change in verbal category
fluency
9 475 Std. Mean Difference (IV, Random, 95% CI) 0.52 [0.23, 0.81]
13 Change in meta cognition
(self-reported)
2 41 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.87, 1.12]
14 Change in meta cognition
(informant-reported)
2 56 Std. Mean Difference (IV, Random, 95% CI) -0.65 [-1.19, -0.10]
15 Change in participants’ mood 8 576 Std. Mean Difference (IV, Random, 95% CI) 0.72 [-0.10, 1.54]
16 Change in capacity for activities
of daily living
10 705 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.10, 0.34]
17 Change in disease progression 5 215 Std. Mean Difference (IV, Random, 95% CI) 1.07 [0.59, 1.55]
18 Change in behavioural and
psychological symptoms of
dementia (BPSD)
6 493 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.34, 1.22]
19 Change in attention and
working memory
12 551 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.08, 1.05]
20 Change in burden of care
(CAREGIVER)
2 405 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.36, 0.15]
21 Change in quality of life
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.50, 0.83]
22 Change inmood and well-being
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.98 [0.27, 1.68]
23 Participant burden (retention
rates)
17 1282 Odds Ratio (M-H, Random, 95% CI) 0.73 [0.37, 1.43]
23.1 Up to 3 times 14 1047 Odds Ratio (M-H, Random, 95% CI) 0.98 [0.53, 1.81]
23.2 More than 3 times 3 235 Odds Ratio (M-H, Random, 95% CI) 0.33 [0.10, 1.09]
24 Change in general health and
quality of life
5 630 Std. Mean Difference (IV, Random, 95% CI) -0.04 [-0.38, 0.29]
Comparison 7. Cognitive training vs control immediately post intervention - intervention duration
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition
20 1288 Std. Mean Difference (IV, Random, 95% CI) 0.65 [0.26, 1.05]
1.1 Up to 3 months 14 682 Std. Mean Difference (IV, Random, 95% CI) 0.49 [0.09, 0.89]
1.2 More than 3 months 6 606 Std. Mean Difference (IV, Random, 95% CI) 1.03 [0.04, 2.02]
2 Change in a global measure of
cognition˙zero correlation
20 1287 Std. Mean Difference (IV, Random, 95% CI) 0.27 [0.04, 0.50]
2.1 Up to 3 months 14 682 Std. Mean Difference (IV, Random, 95% CI) 0.15 [-0.08, 0.38]
2.2 More than 3 months 6 605 Std. Mean Difference (IV, Random, 95% CI) 0.51 [-0.04, 1.05]
3 Change in a global measure of
cognition (composite)
26 1389 Std. Mean Difference (Random, 95% CI) 0.42 [0.23, 0.61]
3.1 Up to 3 months 20 790 Std. Mean Difference (Random, 95% CI) 0.38 [0.18, 0.58]
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3.2 More than 3 months 6 599 Std. Mean Difference (Random, 95% CI) 0.54 [0.07, 1.01]
4 Change in a global measure of
cognition (composite)˙zero
correlation
26 1390 Std. Mean Difference (Random, 95% CI) 0.24 [0.12, 0.36]
4.1 Up to 3 months 20 790 Std. Mean Difference (Random, 95% CI) 0.28 [0.14, 0.42]
4.2 More than 3 months 6 600 Std. Mean Difference (Random, 95% CI) 0.21 [-0.03, 0.46]
5 Change in immediate memory 17 762 Std. Mean Difference (IV, Random, 95% CI) 0.74 [0.37, 1.12]
5.1 Up to 3 months 14 565 Std. Mean Difference (IV, Random, 95% CI) 0.75 [0.29, 1.21]
5.2 More than 3 months 3 197 Std. Mean Difference (IV, Random, 95% CI) 0.76 [0.26, 1.26]
6 Change in delayed memory 11 543 Std. Mean Difference (IV, Random, 95% CI) 0.81 [0.29, 1.32]
7 Change in attention and working
memory
12 551 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.08, 1.05]
8 Change in language (naming) 5 311 Std. Mean Difference (IV, Random, 95% CI) 0.62 [0.11, 1.12]
9 Change in verbal letter fluency 12 544 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.07, 0.50]
9.1 Up to 3 months 9 350 Std. Mean Difference (IV, Random, 95% CI) 0.03 [-0.23, 0.28]
9.2 More than 3 months 3 194 Std. Mean Difference (IV, Random, 95% CI) 0.66 [-0.05, 1.38]
10 Change in speed of information
processing
6 201 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.11, 0.54]
11 Change in executive function 11 511 Std. Mean Difference (IV, Random, 95% CI) 0.75 [0.28, 1.22]
12 Change in verbal category
fluency
9 475 Std. Mean Difference (IV, Random, 95% CI) 0.52 [0.23, 0.81]
13 Change in meta cognition
(self-reported)
2 41 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.87, 1.12]
14 Change in meta cognition
(informant-reported)
2 56 Std. Mean Difference (IV, Random, 95% CI) -0.65 [-1.19, -0.10]
15 Change in participants’ mood 8 576 Std. Mean Difference (IV, Random, 95% CI) 0.72 [-0.10, 1.54]
16 Change in capacity for activities
of daily living
10 705 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.10, 0.34]
17 Change in disease progression 5 215 Std. Mean Difference (IV, Random, 95% CI) 1.07 [0.59, 1.55]
18 Change in behavioural and
psychological symptoms of
dementia (BPSD)
6 493 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.34, 1.22]
18.1 Up to 3 months 3 92 Std. Mean Difference (IV, Random, 95% CI) 0.66 [-1.70, 3.02]
18.2 More than 3 months 3 401 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.29, 0.53]
19 Participant burden (retention
rates)
17 1282 Odds Ratio (M-H, Random, 95% CI) 0.73 [0.37, 1.43]
19.1 Up to 3 months 14 761 Odds Ratio (M-H, Random, 95% CI) 0.78 [0.35, 1.73]
19.2 More than 3 months 3 521 Odds Ratio (M-H, Random, 95% CI) 0.24 [0.02, 2.57]
20 Change in burden of care
(CAREGIVER)
2 405 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.36, 0.15]
21 Change in quality of life
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.50, 0.83]
22 Change inmood and well-being
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.98 [0.27, 1.68]
23 Change in general health and
quality of life
5 630 Std. Mean Difference (IV, Random, 95% CI) -0.04 [-0.38, 0.29]
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Comparison 8. Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition
20 1288 Std. Mean Difference (IV, Random, 95% CI) 0.65 [0.26, 1.05]
1.1 Traditional 13 975 Std. Mean Difference (IV, Random, 95% CI) 0.84 [0.30, 1.39]
1.2 Augmented 7 313 Std. Mean Difference (IV, Random, 95% CI) 0.25 [-0.21, 0.70]
2 Change in a global measure of
cognition˙zero correlation
20 1287 Std. Mean Difference (IV, Random, 95% CI) 0.27 [0.04, 0.50]
2.1 Traditional 13 974 Std. Mean Difference (IV, Random, 95% CI) 0.41 [0.11, 0.71]
2.2 Augmented 7 313 Std. Mean Difference (IV, Random, 95% CI) -0.03 [-0.33, 0.26]
3 Change in a global measure of
cognition (composite)
26 1389 Std. Mean Difference (Random, 95% CI) 0.42 [0.23, 0.61]
3.1 Traditional 17 1026 Std. Mean Difference (Random, 95% CI) 0.43 [0.18, 0.68]
3.2 Augmented 9 363 Std. Mean Difference (Random, 95% CI) 0.37 [0.10, 0.65]
4 Change in a global measure of
cognition (composite)˙zero
correlation
26 1390 Std. Mean Difference (Random, 95% CI) 0.24 [0.12, 0.36]
4.1 Traditional 17 1027 Std. Mean Difference (Random, 95% CI) 0.30 [0.12, 0.47]
4.2 Augmented 9 363 Std. Mean Difference (Random, 95% CI) 0.18 [-0.02, 0.39]
5 Change in immediate memory 17 762 Std. Mean Difference (IV, Random, 95% CI) 0.74 [0.37, 1.12]
5.1 Traditional 12 559 Std. Mean Difference (IV, Random, 95% CI) 0.82 [0.33, 1.30]
5.2 Augmented 5 203 Std. Mean Difference (IV, Random, 95% CI) 0.53 [0.04, 1.02]
6 Change in delayed memory 11 543 Std. Mean Difference (IV, Random, 95% CI) 0.81 [0.29, 1.32]
6.1 Traditional 7 383 Std. Mean Difference (IV, Random, 95% CI) 0.86 [0.15, 1.58]
6.2 Augmented 4 160 Std. Mean Difference (IV, Random, 95% CI) 0.68 [-0.11, 1.46]
7 Change in attention and working
memory
12 551 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.08, 1.05]
7.1 Traditional 8 379 Std. Mean Difference (IV, Random, 95% CI) 0.56 [-0.17, 1.30]
7.2 Augmented 4 172 Std. Mean Difference (IV, Random, 95% CI) 0.51 [0.07, 0.95]
8 Change in language (naming) 5 311 Std. Mean Difference (IV, Random, 95% CI) 0.62 [0.11, 1.12]
9 Change in verbal letter fluency 12 544 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.07, 0.50]
9.1 Traditional 8 386 Std. Mean Difference (IV, Random, 95% CI) 0.26 [-0.09, 0.62]
9.2 Augmented 4 158 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.42, 0.70]
10 Change in speed of information
processing
6 201 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.11, 0.54]
11 Change in executive function 11 511 Std. Mean Difference (IV, Random, 95% CI) 0.75 [0.28, 1.22]
11.1 Traditional 8 442 Std. Mean Difference (IV, Random, 95% CI) 0.64 [0.14, 1.14]
11.2 Augmented 3 69 Std. Mean Difference (IV, Random, 95% CI) 1.32 [-0.26, 2.91]
12 Change in verbal category
fluency
9 475 Std. Mean Difference (IV, Random, 95% CI) 0.52 [0.23, 0.81]
12.1 Traditional 6 323 Std. Mean Difference (IV, Random, 95% CI) 0.64 [0.26, 1.01]
12.2 Augmented 3 152 Std. Mean Difference (IV, Random, 95% CI) 0.33 [0.00, 0.65]
13 Change in meta cognition
(self-reported)
2 41 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.87, 1.12]
14 Change in meta cognition
(informant-reported)
2 56 Std. Mean Difference (IV, Random, 95% CI) -0.65 [-1.19, -0.10]
15 Change in participants’ mood 8 576 Std. Mean Difference (IV, Random, 95% CI) 0.72 [-0.10, 1.54]
15.1 Traditional 5 423 Std. Mean Difference (IV, Random, 95% CI) 0.90 [-0.30, 2.10]
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15.2 Augmented 3 153 Std. Mean Difference (IV, Random, 95% CI) 0.46 [-0.94, 1.86]
16 Change in capacity for activities
of daily living
10 705 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.10, 0.34]
17 Change in disease progression 5 215 Std. Mean Difference (IV, Random, 95% CI) 1.07 [0.59, 1.55]
18 Change in behavioural and
psychological symptoms of
dementia (BPSD)
6 493 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.34, 1.22]
19 Participant burden (retention
rates)
17 1282 Odds Ratio (M-H, Random, 95% CI) 0.73 [0.37, 1.43]
19.1 Traditional 10 1017 Odds Ratio (M-H, Random, 95% CI) 0.59 [0.23, 1.53]
19.2 Augmented 7 265 Odds Ratio (M-H, Random, 95% CI) 1.02 [0.27, 3.87]
20 Change in burden of care
(CAREGIVER)
2 405 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.36, 0.15]
21 Change in quality of life
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.50, 0.83]
22 Change inmood and well-being
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.98 [0.27, 1.68]
23 Change in general health and
quality of life
5 630 Std. Mean Difference (IV, Random, 95% CI) -0.04 [-0.38, 0.29]
Comparison 9. Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single
domain)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition
20 1288 Std. Mean Difference (IV, Random, 95% CI) 0.65 [0.26, 1.05]
1.1 Multidomain 16 1165 Std. Mean Difference (IV, Random, 95% CI) 0.63 [0.19, 1.07]
1.2 Single domain 4 123 Std. Mean Difference (IV, Random, 95% CI) 0.75 [-0.14, 1.63]
2 Change in a global measure of
cognition˙zero correlation
20 1287 Std. Mean Difference (IV, Random, 95% CI) 0.27 [0.04, 0.50]
2.1 Multidomain 16 1164 Std. Mean Difference (IV, Random, 95% CI) 0.25 [-0.01, 0.52]
2.2 Single domain 4 123 Std. Mean Difference (IV, Random, 95% CI) 0.37 [-0.04, 0.79]
3 Change in a global measure of
cognition (composite)
26 1389 Std. Mean Difference (Random, 95% CI) 0.42 [0.23, 0.61]
3.1 Multidomain 16 990 Std. Mean Difference (Random, 95% CI) 0.44 [0.18, 0.71]
3.2 Single domain 10 399 Std. Mean Difference (Random, 95% CI) 0.35 [0.10, 0.59]
4 Change in a global measure of
cognition (composite)˙zero
correlation
26 1390 Std. Mean Difference (Random, 95% CI) 0.24 [0.12, 0.36]
4.1 Multidomain 16 991 Std. Mean Difference (Random, 95% CI) 0.27 [0.10, 0.44]
4.2 Single domain 10 399 Std. Mean Difference (Random, 95% CI) 0.23 [0.04, 0.43]
5 Change in immediate memory 17 762 Std. Mean Difference (IV, Random, 95% CI) 0.74 [0.37, 1.12]
5.1 Multidomain 10 540 Std. Mean Difference (IV, Random, 95% CI) 0.80 [0.24, 1.35]
5.2 Single domain 7 222 Std. Mean Difference (IV, Random, 95% CI) 0.58 [0.22, 0.94]
6 Change in delayed memory 11 543 Std. Mean Difference (IV, Random, 95% CI) 0.81 [0.29, 1.32]
6.1 Multidomain 6 369 Std. Mean Difference (IV, Random, 95% CI) 1.15 [0.32, 1.97]
6.2 Single domain 5 174 Std. Mean Difference (IV, Random, 95% CI) 0.41 [-0.11, 0.94]
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7 Change in attention and working
memory
12 551 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.08, 1.05]
7.1 Multidomain 8 411 Std. Mean Difference (IV, Random, 95% CI) 0.50 [-0.14, 1.15]
7.2 Single domain 4 140 Std. Mean Difference (IV, Random, 95% CI) 0.68 [-0.14, 1.49]
8 Change in language (naming) 5 311 Std. Mean Difference (IV, Random, 95% CI) 0.62 [0.11, 1.12]
9 Change in verbal letter fluency 12 544 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.07, 0.50]
9.1 Multidomain 8 406 Std. Mean Difference (IV, Random, 95% CI) 0.37 [-0.04, 0.78]
9.2 Single domain 4 138 Std. Mean Difference (IV, Random, 95% CI) -0.04 [-0.37, 0.30]
10 Change in speed of information
processing
6 201 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.11, 0.54]
11 Change in executive function 11 511 Std. Mean Difference (IV, Random, 95% CI) 0.75 [0.28, 1.22]
11.1 Multidomain 8 408 Std. Mean Difference (IV, Random, 95% CI) 0.99 [0.44, 1.55]
11.2 Single domain 3 103 Std. Mean Difference (IV, Random, 95% CI) 0.08 [-0.53, 0.68]
12 Change in verbal category
fluency
9 475 Std. Mean Difference (IV, Random, 95% CI) 0.52 [0.23, 0.81]
12.1 Multidomain 6 371 Std. Mean Difference (IV, Random, 95% CI) 0.70 [0.38, 1.02]
12.2 Single domain 3 104 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.25, 0.52]
13 Change in meta cognition
(self-reported)
2 41 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.87, 1.12]
14 Change in meta cognition
(informant-reported)
2 56 Std. Mean Difference (IV, Random, 95% CI) -0.65 [-1.19, -0.10]
15 Change in participants’ mood 8 576 Std. Mean Difference (IV, Random, 95% CI) 0.72 [-0.10, 1.54]
16 Change in capacity for activities
of daily living
10 705 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.10, 0.34]
17 Change in disease progression 5 215 Std. Mean Difference (IV, Random, 95% CI) 1.07 [0.59, 1.55]
18 Change in behavioural and
psychological symptoms of
dementia (BPSD)
6 493 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.34, 1.22]
19 Participant burden (retention
rates)
17 1282 Odds Ratio (M-H, Random, 95% CI) 0.73 [0.37, 1.43]
19.1 Multidomain 12 988 Odds Ratio (M-H, Random, 95% CI) 0.61 [0.21, 1.81]
19.2 Single domain 5 294 Odds Ratio (M-H, Random, 95% CI) 0.66 [0.24, 1.77]
20 Change in burden of care
(CAREGIVER)
2 405 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.36, 0.15]
21 Change in quality of life
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.50, 0.83]
22 Change inmood and well-being
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.98 [0.27, 1.68]
23 Change in general health and
quality of life
5 630 Std. Mean Difference (IV, Random, 95% CI) -0.04 [-0.38, 0.29]
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Comparison 10. Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition
20 1288 Std. Mean Difference (IV, Random, 95% CI) 0.65 [0.26, 1.05]
1.1 Passive 11 912 Std. Mean Difference (IV, Random, 95% CI) 0.75 [0.22, 1.28]
1.2 Active 9 376 Std. Mean Difference (IV, Random, 95% CI) 0.54 [-0.11, 1.19]
2 Change in a global measure of
cognition˙zero correlation
20 1287 Std. Mean Difference (IV, Random, 95% CI) 0.27 [0.04, 0.50]
2.1 Passive 11 911 Std. Mean Difference (IV, Random, 95% CI) 0.27 [-0.04, 0.58]
2.2 Active 9 376 Std. Mean Difference (IV, Random, 95% CI) 0.27 [-0.10, 0.65]
3 Change in a global measure of
cognition (composite)
26 1389 Std. Mean Difference (Random, 95% CI) 0.42 [0.23, 0.61]
3.1 Passive 14 875 Std. Mean Difference (Random, 95% CI) 0.31 [0.06, 0.55]
3.2 Active 13 514 Std. Mean Difference (Random, 95% CI) 0.53 [0.26, 0.81]
4 Change in a global measure of
cognition (composite)˙zero
correlation
26 1390 Std. Mean Difference (Random, 95% CI) 0.24 [0.12, 0.36]
4.1 Passive 14 876 Std. Mean Difference (Random, 95% CI) 0.24 [0.04, 0.43]
4.2 Active 13 514 Std. Mean Difference (Random, 95% CI) 0.30 [0.13, 0.48]
5 Change in immediate memory 17 762 Std. Mean Difference (IV, Random, 95% CI) 0.74 [0.37, 1.12]
5.1 Passive 7 311 Std. Mean Difference (IV, Random, 95% CI) 0.64 [0.20, 1.08]
5.2 Active 11 451 Std. Mean Difference (IV, Random, 95% CI) 0.82 [0.25, 1.39]
6 Change in delayed memory 11 543 Std. Mean Difference (IV, Random, 95% CI) 0.81 [0.29, 1.32]
6.1 Passive 6 325 Std. Mean Difference (IV, Random, 95% CI) 0.52 [0.11, 0.94]
6.2 Active 5 218 Std. Mean Difference (IV, Random, 95% CI) 1.04 [-0.04, 2.12]
7 Change in attention and working
memory
12 551 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.08, 1.05]
7.1 Passive 4 206 Std. Mean Difference (IV, Random, 95% CI) 0.37 [-0.25, 0.99]
7.2 Active 8 345 Std. Mean Difference (IV, Random, 95% CI) 0.63 [-0.03, 1.29]
8 Change in language (naming) 5 311 Std. Mean Difference (IV, Random, 95% CI) 0.62 [0.11, 1.12]
9 Change in verbal letter fluency 12 544 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.07, 0.50]
9.1 Passive 4 263 Std. Mean Difference (IV, Random, 95% CI) 0.35 [-0.03, 0.72]
9.2 Active 8 281 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.27, 0.55]
10 Change in speed of information
processing
6 201 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.11, 0.54]
11 Change in executive function 11 511 Std. Mean Difference (IV, Random, 95% CI) 0.75 [0.28, 1.22]
11.1 Passive 6 285 Std. Mean Difference (IV, Random, 95% CI) 1.37 [0.60, 2.14]
11.2 Active 6 226 Std. Mean Difference (IV, Random, 95% CI) 0.21 [-0.11, 0.53]
12 Change in verbal category
fluency
9 475 Std. Mean Difference (IV, Random, 95% CI) 0.52 [0.23, 0.81]
13 Change in meta cognition
(self-reported)
2 41 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.87, 1.12]
14 Change in meta cognition
(informant-reported)
2 56 Std. Mean Difference (IV, Random, 95% CI) -0.65 [-1.19, -0.10]
15 Change in participants’ mood 8 576 Std. Mean Difference (IV, Random, 95% CI) 0.72 [-0.10, 1.54]
15.1 Passive 3 383 Std. Mean Difference (IV, Random, 95% CI) 1.02 [-1.07, 3.10]
15.2 Active 5 193 Std. Mean Difference (IV, Random, 95% CI) 0.58 [-0.34, 1.49]
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16 Change in capacity for activities
of daily living
10 705 Std. Mean Difference (IV, Random, 95% CI) 0.12 [-0.10, 0.34]
17 Change in disease progression 5 215 Std. Mean Difference (IV, Random, 95% CI) 1.07 [0.59, 1.55]
18 Change in behavioural and
psychological symptoms of
dementia (BPSD)
6 493 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.34, 1.22]
19 Participant burden (retention
rates)
17 1282 Odds Ratio (M-H, Random, 95% CI) 0.73 [0.37, 1.43]
19.1 Passive 9 910 Odds Ratio (M-H, Random, 95% CI) 0.49 [0.17, 1.40]
19.2 Active 8 372 Odds Ratio (M-H, Random, 95% CI) 1.17 [0.38, 3.64]
20 Change in burden of care
(CAREGIVER)
2 405 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.36, 0.15]
21 Change in quality of life
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.50, 0.83]
22 Change inmood and well-being
(CAREGIVER)
1 36 Std. Mean Difference (IV, Random, 95% CI) 0.98 [0.27, 1.68]
23 Change in general health and
quality of life
5 630 Std. Mean Difference (IV, Random, 95% CI) -0.04 [-0.38, 0.29]
Comparison 11. Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition
7 724 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.28, 0.60]
1.1 Up to 3 times 3 551 Std. Mean Difference (IV, Random, 95% CI) 0.32 [-0.48, 1.12]
1.2 More than 3 times 4 173 Std. Mean Difference (IV, Random, 95% CI) 0.13 [-0.63, 0.89]
2 Change in a global measure of
cognition˙zero correlation
7 724 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.24, 0.20]
2.1 Up to 3 times 3 551 Std. Mean Difference (IV, Random, 95% CI) 0.02 [-0.35, 0.40]
2.2 More than 3 times 4 173 Std. Mean Difference (IV, Random, 95% CI) 0.01 [-0.41, 0.43]
3 Change in a global measure of
cognition (composite)
7 769 Std. Mean Difference (Random, 95% CI) 0.21 [-0.23, 0.64]
3.1 Up to 3 times 4 636 Std. Mean Difference (Random, 95% CI) 0.23 [-0.27, 0.74]
3.2 More than 3 times 3 133 Std. Mean Difference (Random, 95% CI) 0.32 [-0.90, 1.55]
4 Change in a global measure of
cognition (composite)˙zero
correlation
7 769 Std. Mean Difference (Random, 95% CI) -0.03 [-0.23, 0.17]
4.1 Up to 3 times 4 636 Std. Mean Difference (Random, 95% CI) -0.04 [-0.22, 0.14]
4.2 More than 3 times 3 133 Std. Mean Difference (Random, 95% CI) 0.05 [-0.59, 0.70]
5 Change in immediate memory 3 147 Std. Mean Difference (IV, Random, 95% CI) 0.51 [-0.19, 1.21]
6 Change in delayed memory 3 147 Std. Mean Difference (IV, Random, 95% CI) 0.71 [-0.33, 1.75]
7 Change in attention and working
memory
2 69 Std. Mean Difference (IV, Random, 95% CI) 0.91 [-0.46, 2.27]
8 Change in language (naming) 1 16 Std. Mean Difference (IV, Random, 95% CI) -0.63 [-1.65, 0.38]
9 Change in verbal letter fluency 3 75 Std. Mean Difference (IV, Random, 95% CI) 0.34 [-0.38, 1.05]
10 Change in verbal category
fluency
2 55 Std. Mean Difference (IV, Random, 95% CI) -0.28 [-1.46, 0.89]
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11 Change in executive function 4 163 Std. Mean Difference (IV, Random, 95% CI) 1.44 [-0.26, 3.14]
12 Change in meta cognition (self-
reported)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
13 Change in meta cognition
(informant-reported)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
14 Change in participants’ mood 3 543 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.29, 0.07]
15 Change in capacity for activities
of daily living
3 525 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.43, -0.07]
16 Change in behavioural and
psychological symptoms of
dementia (BPSD)
3 672 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.27, 0.06]
17 Change in disease progression 3 131 Std. Mean Difference (IV, Random, 95% CI) 0.15 [-0.33, 0.63]
18 Participant burden (retention
rates)
4 639 Odds Ratio (M-H, Random, 95% CI) 0.78 [0.24, 2.57]
19 Change inmood and well-being
(CAREGIVER)
1 88 Std. Mean Difference (IV, Random, 95% CI) 1.50 [0.96, 2.04]
20 Change in burden of care
(CAREGIVER)
3 591 Std. Mean Difference (IV, Random, 95% CI) -0.15 [-0.47, 0.17]
21 Change in quality of life
(CAREGIVER)
1 88 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.74, 0.24]
22 Change in speed of information
processing
2 55 Std. Mean Difference (IV, Random, 95% CI) -0.21 [-0.77, 0.34]
23 Change in general health and
quality of life
4 631 Std. Mean Difference (IV, Random, 95% CI) -0.49 [1.00, 0.02]
Comparison 12. Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional
vs augmented)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition
7 724 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.28, 0.60]
1.1 Traditional 4 646 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-0.35, -0.02]
1.2 Augmented 3 78 Std. Mean Difference (IV, Random, 95% CI) 1.04 [-0.29, 2.36]
2 Change in a global measure of
cognition˙zero correlation
7 724 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.24, 0.20]
2.1 Traditional 4 646 Std. Mean Difference (IV, Random, 95% CI) -0.12 [-0.29, 0.04]
2.2 Augmented 3 78 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.18, 1.06]
3 Change in a global measure of
cognition (composite)
7 769 Std. Mean Difference (Random, 95% CI) 0.21 [-0.23, 0.64]
3.1 Traditional 4 643 Std. Mean Difference (Random, 95% CI) -0.17 [-0.34, -0.00]
3.2 Augmented 3 126 Std. Mean Difference (Random, 95% CI) 1.09 [0.14, 2.04]
4 Change in a global measure of
cognition (composite)˙zero
correlation
7 769 Std. Mean Difference (Random, 95% CI) -0.03 [-0.23, 0.17]
4.1 Traditional 4 643 Std. Mean Difference (Random, 95% CI) -0.11 [-0.28, 0.06]
4.2 Augmented 3 126 Std. Mean Difference (Random, 95% CI) 0.43 [-0.04, 0.90]
5 Change in immediate memory 3 147 Std. Mean Difference (IV, Random, 95% CI) 0.51 [-0.19, 1.21]
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6 Change in delayed memory 3 147 Std. Mean Difference (IV, Random, 95% CI) 0.71 [-0.33, 1.75]
7 Change in attention and working
memory
2 69 Std. Mean Difference (IV, Random, 95% CI) 0.91 [-0.46, 2.27]
8 Change in language (naming) 1 16 Std. Mean Difference (IV, Random, 95% CI) -0.63 [-1.65, 0.38]
9 Change in verbal letter fluency 3 75 Std. Mean Difference (IV, Random, 95% CI) 0.34 [-0.38, 1.05]
10 Change in verbal category
fluency
2 55 Std. Mean Difference (IV, Random, 95% CI) -0.28 [-1.46, 0.89]
11 Change in executive function 4 163 Std. Mean Difference (IV, Random, 95% CI) 1.44 [-0.26, 3.14]
12 Change in meta cognition (self-
reported)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
13 Change in meta cognition
(informant-reported)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
14 Change in participants’ mood 3 543 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.29, 0.07]
15 Change in capacity for activities
of daily living
3 525 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.43, -0.07]
16 Change in behavioural and
psychological symptoms of
dementia (BPSD)
3 672 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.27, 0.06]
17 Change in disease progression 3 131 Std. Mean Difference (IV, Random, 95% CI) 0.15 [-0.33, 0.63]
18 Participant burden (retention
rates)
4 639 Odds Ratio (M-H, Random, 95% CI) 0.78 [0.24, 2.57]
19 Change inmood and well-being
(CAREGIVER)
1 88 Std. Mean Difference (IV, Random, 95% CI) 1.50 [0.96, 2.04]
20 Change in burden of care
(CAREGIVER)
3 591 Std. Mean Difference (IV, Random, 95% CI) -0.15 [-0.47, 0.17]
21 Change in quality of life
(CAREGIVER)
1 88 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.74, 0.24]
22 Change in speed of information
processing
2 55 Std. Mean Difference (IV, Random, 95% CI) -0.21 [-0.77, 0.34]
23 Change in general health and
quality of life
4 631 Std. Mean Difference (IV, Random, 95% CI) -0.49 [1.00, 0.02]
Comparison 13. Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-
up period
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Change in a global measure of
cognition
6 387 Std. Mean Difference (IV, Random, 95% CI) 1.33 [0.31, 2.34]
2 Change in a global measure of
cognition (zero correlation)
6 387 Std. Mean Difference (IV, Random, 95% CI) 0.68 [0.06, 1.30]
3 Change in a global measure of
cognition (composite)
7 Std. Mean Difference (Random, 95% CI) 0.65 [0.11, 1.20]
3.1 Up to 3 months 3 Std. Mean Difference (Random, 95% CI) -0.05 [-0.54, 0.43]
3.2 More than 3 months 4 Std. Mean Difference (Random, 95% CI) 1.03 [0.33, 1.72]
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4 Change in a global measure of
cognition (composite)˙zero
correlation
7 Std. Mean Difference (Random, 95% CI) 0.40 [0.09, 0.71]
4.1 Up to 3 months 3 Std. Mean Difference (Random, 95% CI) -0.06 [-0.54, 0.42]
4.2 More than 4 months 4 Std. Mean Difference (Random, 95% CI) 0.57 [0.21, 0.93]
5 Change in disease progression
(zero correlation)
2 98 Std. Mean Difference (IV, Random, 95% CI) 0.28 [-0.14, 0.71]
6 Change in disease progression 2 98 Std. Mean Difference (IV, Random, 95% CI) 0.55 [0.12, 0.98]
7 Change in immediate memory 7 383 Std. Mean Difference (IV, Random, 95% CI) 0.62 [0.00, 1.24]
7.1 Up to 3 months 3 64 Std. Mean Difference (IV, Random, 95% CI) -0.34 [-1.12, 0.43]
7.2 More than 3 months 4 319 Std. Mean Difference (IV, Random, 95% CI) 1.14 [0.53, 1.74]
8 Change in delayed memory 4 270 Std. Mean Difference (IV, Random, 95% CI) 0.97 [0.02, 1.92]
9 Change in language (naming) 4 274 Std. Mean Difference (IV, Random, 95% CI) -0.87 [-3.81, 2.08]
10 Change in verbal letter fluency 4 247 Std. Mean Difference (IV, Random, 95% CI) 0.47 [-0.28, 1.23]
11 Change in verbal category
fluency
3 213 Std. Mean Difference (IV, Random, 95% CI) 0.78 [0.38, 1.18]
12 Change in attention and
working memory
3 215 Std. Mean Difference (IV, Random, 95% CI) 0.50 [-0.43, 1.43]
13 Change in speed of information
processing
2 45 Std. Mean Difference (IV, Random, 95% CI) 0.30 [-0.44, 1.04]
14 Change in meta cognition
(self-reported)
1 19 Std. Mean Difference (IV, Random, 95% CI) 0.99 [-0.01, 1.99]
15 Change in meta cognition
(informant-reported)
1 34 Std. Mean Difference (IV, Random, 95% CI) -0.06 [-0.73, 0.62]
16 Change in capacity for activities
of daily living
3 64 Std. Mean Difference (IV, Random, 95% CI) 0.22 [-0.50, 0.94]
17 Change in behavioural and
psychological symptoms of
dementia (BPSD)
1 11 Std. Mean Difference (IV, Random, 95% CI) -1.34 [-2.75, 0.07]
18 Change in general health and
quality of life
1 117 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.39, 0.35]
19 Change in participants’ mood 2 30 Std. Mean Difference (IV, Random, 95% CI) 0.21 [-0.54, 0.96]
20 Change in mood and well-
being (CAREGIVER)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
21 Change in burden of care
(CAREGIVER)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
22 Change in quality of life
(CAREGIVER)
0 0 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
23 Change in executive function 5 330 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.02, 1.10]
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Analysis 1.1. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 1
Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 1 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Fern ndez-Calvo 2011 (1) 30 15 -0.44 (0.42) 3.0 % -0.44 [ -1.26, 0.38 ]
Amieva 2016 165 153 -0.11 (0.11) 6.6 % -0.11 [ -0.33, 0.11 ]
Beck 1988 10 10 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Koltai 2001 (2) 14 8 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Davis 2001 19 18 0 (0.32) 4.0 % 0.0 [ -0.63, 0.63 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.8 % 0.01 [ -0.66, 0.68 ]
Boller 2011 (3) 24 12 0.13 (0.35) 3.7 % 0.13 [ -0.56, 0.82 ]
Quayhagen 2000 21 15 0.19 (0.33) 3.9 % 0.19 [ -0.46, 0.84 ]
Galante 2007 7 4 0.21 (0.63) 1.8 % 0.21 [ -1.02, 1.44 ]
Barban 2016 41 38 0.21 (0.23) 5.1 % 0.21 [ -0.24, 0.66 ]
Quayhagen 1995 (4) 13 28 0.25 (0.33) 3.9 % 0.25 [ -0.40, 0.90 ]
Neely 2009 (5) 20 9 0.26 (0.39) 3.3 % 0.26 [ -0.50, 1.02 ]
Heiss 1993 18 17 0.27 (0.34) 3.8 % 0.27 [ -0.40, 0.94 ]
Serino 2017 10 10 0.31 (0.44) 2.9 % 0.31 [ -0.55, 1.17 ]
Giuli 2016 48 47 0.37 (0.21) 5.4 % 0.37 [ -0.04, 0.78 ]
Quayhagen 1995 (6) 13 25 0.37 (0.34) 3.8 % 0.37 [ -0.30, 1.04 ]
Kim 2015 22 21 0.46 (0.32) 4.0 % 0.46 [ -0.17, 1.09 ]
Kawashima 2005 16 16 0.52 (0.36) 3.6 % 0.52 [ -0.19, 1.23 ]
Trebbastoni 2018 45 85 0.55 (0.2) 5.5 % 0.55 [ 0.16, 0.94 ]
Jelcic 2014 (7) 17 10 0.55 (0.4) 3.2 % 0.55 [ -0.23, 1.33 ]
Jelcic 2012 20 20 0.6 (0.32) 4.0 % 0.60 [ -0.03, 1.23 ]
Quintana Hernandez 2014 27 25 0.73 (0.28) 4.5 % 0.73 [ 0.18, 1.28 ]
de Vreese 1998 9 9 1.04 (0.49) 2.5 % 1.04 [ 0.08, 2.00 ]
Lee 2013 (8) 12 7 1.15 (0.53) 2.3 % 1.15 [ 0.11, 2.19 ]
-4 -2 0 2 4
Control Cognitive training
(Continued . . . )
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 40 1.32 (0.28) 4.5 % 1.32 [ 0.77, 1.87 ]
Bergamaschi 2013 16 16 1.64 (0.41) 3.1 % 1.64 [ 0.84, 2.44 ]
Mapelli 2013 10 10 2.13 (0.66) 1.6 % 2.13 [ 0.84, 3.42 ]
Total (95% CI) 704 685 100.0 % 0.42 [ 0.23, 0.61 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 62.80, df = 26 (P = 0.00007); I2 =59%
Test for overall effect: Z = 4.32 (P = 0.000015)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
(2) Two experimental groups combined.
(3) Two experimental groups combined.
(4) CT vs Active Control
(5) Two experimental groups combined.
(6) CT vs Passive Control
(7) Two experimental groups combined.
(8) Two experimental groups combined.
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Analysis 1.2. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 2
Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 2 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 153 -0.07 (0.11) 15.9 % -0.07 [ -0.29, 0.15 ]
Barban 2016 41 38 0.1 (0.22) 6.3 % 0.10 [ -0.33, 0.53 ]
Beck 1988 10 10 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Bergamaschi 2013 16 16 0.78 (0.36) 2.7 % 0.78 [ 0.07, 1.49 ]
Boller 2011 (1) 24 12 0.06 (0.35) 2.8 % 0.06 [ -0.63, 0.75 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.0 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 40 40 0.61 (0.23) 5.9 % 0.61 [ 0.16, 1.06 ]
Davis 2001 19 18 0 (0.32) 3.3 % 0.0 [ -0.63, 0.63 ]
de Vreese 1998 9 9 0.48 (0.46) 1.7 % 0.48 [ -0.42, 1.38 ]
Fern ndez-Calvo 2011 (2) 30 15 -0.29 (0.34) 3.0 % -0.29 [ -0.96, 0.38 ]
Galante 2007 7 4 0.12 (0.59) 1.1 % 0.12 [ -1.04, 1.28 ]
Giuli 2016 48 47 0.17 (0.2) 7.3 % 0.17 [ -0.22, 0.56 ]
Heiss 1993 18 17 0.15 (0.33) 3.1 % 0.15 [ -0.50, 0.80 ]
Jelcic 2012 20 20 0.28 (0.31) 3.5 % 0.28 [ -0.33, 0.89 ]
Jelcic 2014 (3) 17 10 0.27 (0.39) 2.3 % 0.27 [ -0.49, 1.03 ]
Kawashima 2005 16 16 0.23 (0.35) 2.8 % 0.23 [ -0.46, 0.92 ]
Kim 2015 22 21 0.2 (0.3) 3.7 % 0.20 [ -0.39, 0.79 ]
Koltai 2001 (4) 14 8 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Lee 2013 (5) 12 7 0.6 (0.47) 1.6 % 0.60 [ -0.32, 1.52 ]
Mapelli 2013 10 10 1.06 (0.55) 1.2 % 1.06 [ -0.02, 2.14 ]
Neely 2009 (6) 20 9 0.26 (0.39) 2.3 % 0.26 [ -0.50, 1.02 ]
Quayhagen 1995 (7) 13 28 0.55 (0.33) 3.1 % 0.55 [ -0.10, 1.20 ]
Quayhagen 1995 (8) 13 25 1.03 (0.36) 2.7 % 1.03 [ 0.32, 1.74 ]
Quayhagen 2000 21 15 0.8 (0.35) 2.8 % 0.80 [ 0.11, 1.49 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Quintana Hernandez 2014 27 25 0.46 (0.28) 4.2 % 0.46 [ -0.09, 1.01 ]
Serino 2017 10 10 0.16 (0.43) 1.9 % 0.16 [ -0.68, 1.00 ]
Trebbastoni 2018 45 85 0.26 (0.19) 7.9 % 0.26 [ -0.11, 0.63 ]
Total (95% CI) 704 685 100.0 % 0.24 [ 0.12, 0.36 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 29.59, df = 26 (P = 0.29); I2 =12%
Test for overall effect: Z = 3.89 (P = 0.000099)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
(2) Two experimental groups combined.
(3) Two experimental groups combined.
(4) Two experimental groups combined.
(5) Two experimental groups combined.
(6) Two experimental groups combined.
(7) CT vs Active control
(8) CT vs Passive control
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Analysis 1.3. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 3
Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 3 Change in a global measure of cognition
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 0.1 (2.34) 4 1.8 (1.74) 3.7 % -0.72 [ -2.00, 0.56 ]
Giuli 2016 48 0.02 (2.77) 47 1.24 (3.77) 5.7 % -0.37 [ -0.77, 0.04 ]
Koltai 2001 (1) 14 -0.21 (2.9) 8 0.75 (2.4) 4.6 % -0.34 [ -1.21, 0.54 ]
Amieva 2016 168 -8.4 (5.86) 153 -7.6 (5.43) 5.9 % -0.14 [ -0.36, 0.08 ]
Heiss 1993 18 -1.22 (4.22) 17 -0.94 (3.59) 5.1 % -0.07 [ -0.73, 0.59 ]
Davis 2001 19 0.16 (2.6) 18 0.22 (2.68) 5.2 % -0.02 [ -0.67, 0.62 ]
Lee 2013 (2) 12 2.01 (2.86) 7 2 (1.9) 4.5 % 0.00 [ -0.93, 0.94 ]
Cavallo 2016 40 -0.14 (1.04) 40 -0.16 (1.62) 5.6 % 0.01 [ -0.42, 0.45 ]
Barban 2016 42 0.1 (1.64) 39 -0.1 (1.15) 5.6 % 0.14 [ -0.30, 0.58 ]
Kallio 2018 76 -0.8 (5.19) 71 -1.6 (5.35) 5.8 % 0.15 [ -0.17, 0.48 ]
Venturelli 2016 20 -0.2 (0.97) 20 -0.4 (1.14) 5.2 % 0.19 [ -0.44, 0.81 ]
Kawashima 2005 16 0.1 (5.1) 16 -1.8 (3.75) 5.1 % 0.41 [ -0.29, 1.12 ]
Quintana Hernandez 2014 27 -4.48 (4.08) 25 -7.48 (3.49) 5.4 % 0.78 [ 0.21, 1.34 ]
Mapelli 2013 10 2.9 (2.59) 10 -0.3 (1.71) 4.3 % 1.40 [ 0.40, 2.40 ]
Jelcic 2014 (3) 17 2 (1.47) 10 -0.7 (2.41) 4.6 % 1.40 [ 0.52, 2.28 ]
Jelcic 2012 20 2 (1.68) 20 -1 (1.98) 5.0 % 1.60 [ 0.88, 2.32 ]
de Vreese 1998 9 2.77 (1.68) 9 -0.89 (2.4) 4.1 % 1.68 [ 0.57, 2.80 ]
Trebbastoni 2018 48 1.53 (1.7) 86 -2.64 (2.07) 5.6 % 2.13 [ 1.69, 2.57 ]
Fern ndez-Calvo 2011 30 1.12 (1.64) 15 -2.31 (1.16) 4.9 % 2.25 [ 1.46, 3.03 ]
Bergamaschi 2013 16 2.75 (1.81) 16 -3.57 (1.81) 4.0 % 3.40 [ 2.28, 4.53 ]
Total (95% CI) 657 631 100.0 % 0.65 [ 0.26, 1.05 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 187.26, df = 19 (P<0.00001); I2 =90%
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. Two experimental groups
combined.
(2) Two experimental groups combined.
(3) Two experimental groups combined.
Analysis 1.4. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 4
Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 4 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Venturelli 2016 20 -2 (2.13) 20 -0.4 (2.42) 5.0 % -0.69 [ -1.33, -0.05 ]
Galante 2007 7 0.1 (4.98) 4 1.8 (3.33) 2.4 % -0.35 [ -1.59, 0.90 ]
Koltai 2001 (1) 14 -0.21 (5.8) 8 0.75 (4.8) 3.8 % -0.17 [ -1.04, 0.70 ]
Giuli 2016 48 0.02 (6.16) 47 1.24 (8.42) 6.5 % -0.16 [ -0.57, 0.24 ]
Amieva 2016 168 -8.4 (8.71) 152 -7.6 (5.43) 7.5 % -0.11 [ -0.33, 0.11 ]
Heiss 1993 18 -1.22 (8.13) 17 -0.94 (7.18) 4.9 % -0.04 [ -0.70, 0.63 ]
Davis 2001 19 0.16 (5.82) 18 0.22 (5.86) 5.0 % -0.01 [ -0.65, 0.63 ]
Lee 2013 (2) 12 2.01 (6.23) 7 2 (4.18) 3.5 % 0.00 [ -0.93, 0.93 ]
Cavallo 2016 40 -0.14 (2.25) 40 -0.16 (2.75) 6.3 % 0.01 [ -0.43, 0.45 ]
Barban 2016 42 0.1 (3.3) 39 -0.1 (2.55) 6.3 % 0.07 [ -0.37, 0.50 ]
Kallio 2018 76 -0.8 (11.6) 71 -1.6 (11.95) 7.0 % 0.07 [ -0.26, 0.39 ]
Kawashima 2005 16 0.1 (11.01) 16 -1.8 (8.22) 4.7 % 0.19 [ -0.50, 0.89 ]
Quintana Hernandez 2014 27 -4.48 (6.86) 25 -7.48 (5.65) 5.5 % 0.47 [ -0.08, 1.02 ]
Mapelli 2013 10 1.07 (1.75) 10 0.33 (0.42) 3.6 % 0.56 [ -0.34, 1.45 ]
Jelcic 2014 (3) 17 2 (3.18) 10 -0.7 (5) 4.1 % 0.67 [ -0.14, 1.47 ]
Jelcic 2012 20 2 (3.62) 20 -1 (4.2) 5.0 % 0.75 [ 0.11, 1.39 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
de Vreese 1998 9 2.77 (3.48) 9 -0.89 (5.22) 3.3 % 0.79 [ -0.18, 1.75 ]
Trebbastoni 2018 48 1.53 (3.68) 86 -2.64 (4.39) 6.7 % 1.00 [ 0.63, 1.37 ]
Fern ndez-Calvo 2011 (4) 30 1.12 (3.64) 15 -2.31 (2.57) 4.9 % 1.01 [ 0.35, 1.67 ]
Bergamaschi 2013 16 2.75 (3.56) 16 -3.57 (3.58) 4.0 % 1.73 [ 0.90, 2.55 ]
Total (95% CI) 657 630 100.0 % 0.27 [ 0.04, 0.50 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 65.70, df = 19 (P<0.00001); I2 =71%
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. We multiplied the SD they
provided by 2. Two experimental groups combined.
(2) Two experimental groups combined.
(3) Two experimental groups combined.
(4) Two experimental groups combined.
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Analysis 1.5. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 5
Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 5 Change in disease progression
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fern ndez-Calvo 2011 (1) 30 -2.11 (2.24) 15 -7.07 (2.39) 16.5 % 2.13 [ 1.36, 2.90 ]
Lee 2013 (2) 12 7.59 (9.2) 7 0.86 (7.83) 13.2 % 0.74 [ -0.23, 1.70 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 14.3 % 0.57 [ -0.33, 1.46 ]
Quayhagen 1995 (3) 13 3.3 (7.5) 25 -4.4 (8.36) 17.8 % 0.93 [ 0.23, 1.64 ]
Quayhagen 1995 (4) 13 3.3 (7.5) 28 -1.7 (8.89) 18.5 % 0.58 [ -0.09, 1.25 ]
Quintana Hernandez 2014 27 -2.77 (6.39) 25 -12.28 (7.33) 19.7 % 1.37 [ 0.76, 1.97 ]
Total (95% CI) 105 110 100.0 % 1.07 [ 0.59, 1.55 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 11.99, df = 5 (P = 0.03); I2 =58%
Test for overall effect: Z = 4.40 (P = 0.000011)
Test for subgroup differences: Not applicable
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Control Cognitive training
(1) Two experimental groups combined.
(2) Two experimental groups combined.
(3) CT vs Passive
(4) CT vs Active
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Analysis 1.6. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 6
Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 1.15 (2.23) 18 1.65 (3.72) 9.4 % -0.16 [ -0.81, 0.49 ]
Boller 2011 (1) 24 -0.29 (1.58) 12 -0.08 (1.28) 9.2 % -0.14 [ -0.83, 0.56 ]
Cahn-Weiner 2003 17 -0.3 (1.05) 17 -0.8 (1.58) 9.2 % 0.36 [ -0.31, 1.04 ]
Quayhagen 2000 21 3.2 (6.89) 15 0.4 (7.55) 9.3 % 0.38 [ -0.29, 1.05 ]
Barban 2016 42 0.4 (1.17) 39 -0.1 (1.11) 10.2 % 0.43 [ -0.01, 0.88 ]
Trebbastoni 2018 45 0.06 (1.26) 85 -0.55 (1.36) 10.4 % 0.46 [ 0.09, 0.82 ]
Koltai 2001 (2) 14 0.64 (1.3) 8 -0.25 (1.8) 8.3 % 0.57 [ -0.32, 1.46 ]
Jelcic 2014 (3) 17 0.86 (2.17) 10 -1.3 (1.84) 8.5 % 1.02 [ 0.18, 1.85 ]
Jelcic 2012 20 1.5 (2.34) 20 -0.9 (2.04) 9.3 % 1.07 [ 0.40, 1.74 ]
Mapelli 2013 (4) 10 4.2 (2.35) 10 -0.8 (1.48) 6.8 % 2.44 [ 1.22, 3.65 ]
Cavallo 2016 40 1.24 (1.04) 40 -1.74 (1) 9.4 % 2.89 [ 2.26, 3.53 ]
Total (95% CI) 269 274 100.0 % 0.81 [ 0.29, 1.32 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 72.73, df = 10 (P<0.00001); I2 =86%
Test for overall effect: Z = 3.05 (P = 0.0023)
Test for subgroup differences: Not applicable
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(1) Two experimental groups combined.
(2) Two experimental groups combined.
(3) Two experimental groups combined.
(4) Cognitive training vs passive control
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Analysis 1.7. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 7
Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 7 Change in immediate memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 0.64 (1.7) 8 1.63 (2.8) 5.1 % -0.44 [ -1.32, 0.44 ]
Galante 2007 7 -0.2 (5.3) 4 1.2 (7.77) 4.0 % -0.21 [ -1.44, 1.03 ]
Jelcic 2014 (2) 17 0.66 (5.53) 10 -0.3 (4.82) 5.5 % 0.18 [ -0.61, 0.96 ]
Quayhagen 2000 21 2.29 (12.1) 15 -0.73 (12.08) 5.9 % 0.24 [ -0.42, 0.91 ]
Boller 2011 (3) 24 -0.04 (2.98) 12 -0.92 (2.93) 5.7 % 0.29 [ -0.41, 0.99 ]
Heiss 1993 18 0.41 (0.97) 17 0.09 (1) 5.8 % 0.32 [ -0.35, 0.99 ]
Cahn-Weiner 2003 17 -0.4 (2.76) 17 -1.7 (2.97) 5.8 % 0.44 [ -0.24, 1.12 ]
Davis 2001 19 1.43 (3.52) 18 -0.22 (3.71) 5.9 % 0.45 [ -0.21, 1.10 ]
Giuli 2016 48 0.65 (1.74) 47 -0.17 (1.74) 6.6 % 0.47 [ 0.06, 0.88 ]
Quayhagen 1995 (4) 13 4.7 (10.56) 28 -0.1 (7.84) 5.8 % 0.54 [ -0.13, 1.21 ]
Jelcic 2012 20 2.9 (5.62) 20 -0.2 (5.43) 6.0 % 0.55 [ -0.08, 1.18 ]
Bergamaschi 2013 16 1.12 (2) 16 -0.13 (1.63) 5.7 % 0.67 [ -0.05, 1.38 ]
Quayhagen 1995 (5) 13 4.7 (10.56) 25 -1.8 (6.19) 5.7 % 0.80 [ 0.11, 1.50 ]
Neely 2009 (6) 20 -0.1 (1.75) 9 -1.5 (1.25) 5.3 % 0.84 [ 0.02, 1.66 ]
Trebbastoni 2018 45 4.01 (4.6) 85 -0.7 (3.98) 6.7 % 1.11 [ 0.73, 1.50 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.7 (1.58) 4.6 % 1.58 [ 0.55, 2.61 ]
Lee 2013 (7) 12 8.08 (3.25) 7 1.29 (1.81) 4.0 % 2.29 [ 1.05, 3.54 ]
Cavallo 2016 40 2.26 (0.71) 40 -0.79 (1) 5.7 % 3.48 [ 2.78, 4.19 ]
Total (95% CI) 374 388 100.0 % 0.74 [ 0.37, 1.12 ]
Heterogeneity: Tau2 = 0.51; Chi2 = 90.65, df = 17 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.89 (P = 0.000098)
Test for subgroup differences: Not applicable
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(1) Two experimental groups combined.
(2) Two experimental groups combined.
(3) Two experimental groups combined.
(4) Cognitive training vs. Active control
(5) Cognitive training vs. Passive control
(6) Two experimental groups combined.
(7) Two experimental groups combined.
Analysis 1.8. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 8
Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 8 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heiss 1993 18 -0.64 (1) 17 -0.03 (0.98) 8.7 % -0.60 [ -1.28, 0.08 ]
Galante 2007 7 0.1 (0.66) 4 0.7 (1.52) 6.1 % -0.53 [ -1.79, 0.73 ]
Trebbastoni 2018 45 -0.3 (0.58) 85 -0.24 (0.65) 9.9 % -0.10 [ -0.46, 0.27 ]
Boller 2011 (1) 24 0 (1.11) 12 0.08 (0.92) 8.6 % -0.07 [ -0.77, 0.62 ]
Davis 2001 19 -0.41 (1.55) 18 -0.47 (1.56) 8.8 % 0.04 [ -0.61, 0.68 ]
Serino 2017 10 0 (0.91) 10 -0.33 (0.58) 7.8 % 0.41 [ -0.47, 1.30 ]
Giuli 2016 48 0.32 (0.9) 47 -0.2 (0.96) 9.7 % 0.55 [ 0.14, 0.96 ]
Beck 1988 (2) 10 0.7 (0.95) 10 -0.2 (1.32) 7.6 % 0.75 [ -0.16, 1.66 ]
Jelcic 2012 20 0.2 (0.55) 20 -0.4 (0.55) 8.7 % 1.07 [ 0.40, 1.74 ]
Mapelli 2013 10 1.7 (1.24) 10 -0.1 (1.29) 7.3 % 1.36 [ 0.37, 2.36 ]
Jelcic 2014 (3) 17 0.32 (1) 10 -1.35 (0.59) 7.5 % 1.85 [ 0.90, 2.80 ]
Cavallo 2016 40 1.89 (0.99) 40 -0.04 (0.89) 9.2 % 2.03 [ 1.49, 2.57 ]
Total (95% CI) 268 283 100.0 % 0.56 [ 0.08, 1.05 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 0.59; Chi2 = 71.95, df = 11 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Not applicable
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Control Cognitive training
(1) Two experimental groups combined.
(2) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
(3) Two experimental groups combined.
Analysis 1.9. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 9
Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 9 Change in language (naming)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 0.19 (1.55) 40 0.1 (1.32) 22.9 % 0.06 [ -0.38, 0.50 ]
Cahn-Weiner 2003 17 0.3 (3.55) 17 -0.1 (3.48) 18.6 % 0.11 [ -0.56, 0.78 ]
Jelcic 2012 20 3.5 (5.63) 20 -0.8 (4.61) 19.0 % 0.82 [ 0.17, 1.47 ]
Jelcic 2014 (1) 17 2.19 (2.56) 10 -0.4 (2.41) 15.8 % 1.00 [ 0.17, 1.83 ]
Trebbastoni 2018 45 2 (3.35) 85 -1.81 (3.34) 23.8 % 1.13 [ 0.75, 1.52 ]
Total (95% CI) 139 172 100.0 % 0.62 [ 0.11, 1.12 ]
Heterogeneity: Tau2 = 0.24; Chi2 = 16.29, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 2.39 (P = 0.017)
Test for subgroup differences: Not applicable
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(1) Two experimental groups combined.
Analysis 1.10. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 10
Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 10 Change in verbal letter fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Serino 2017 10 -1.6 (3.47) 10 0.2 (4.8) 6.3 % -0.41 [ -1.30, 0.48 ]
Cavallo 2016 40 1.17 (1.62) 40 1.53 (1.6) 11.6 % -0.22 [ -0.66, 0.22 ]
Davis 2001 19 0.22 (7.7) 18 1.33 (9.03) 8.8 % -0.13 [ -0.78, 0.52 ]
Cahn-Weiner 2003 17 0.3 (5.95) 17 1 (4.62) 8.4 % -0.13 [ -0.80, 0.54 ]
Barban 2016 42 1.4 (5.66) 39 1.1 (6.04) 11.6 % 0.05 [ -0.39, 0.49 ]
Jelcic 2012 20 1.7 (7.56) 20 1.3 (7.41) 9.1 % 0.05 [ -0.57, 0.67 ]
Jelcic 2014 (1) 17 2.27 (7.6) 10 1.6 (6.93) 7.3 % 0.09 [ -0.69, 0.87 ]
Kawashima 2005 16 0.1 (0.55) 16 0 (0.44) 8.2 % 0.20 [ -0.50, 0.89 ]
Trebbastoni 2018 45 -0.17 (4.89) 85 -2.03 (5) 12.6 % 0.37 [ 0.01, 0.74 ]
Galante 2007 7 3.5 (5.74) 4 -1.7 (6.97) 3.7 % 0.77 [ -0.52, 2.06 ]
Mapelli 2013 10 1.2 (1.51) 10 -0.64 (1.12) 5.5 % 1.33 [ 0.34, 2.31 ]
Bergamaschi 2013 16 1.06 (1.39) 16 -1.72 (1.97) 7.0 % 1.59 [ 0.78, 2.40 ]
Total (95% CI) 259 285 100.0 % 0.22 [ -0.07, 0.50 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 25.86, df = 11 (P = 0.01); I2 =57%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
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Analysis 1.11. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 11
Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 11 Change in verbal category fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 0 (2.98) 4 0.1 (4.16) 4.5 % -0.03 [ -1.26, 1.20 ]
Serino 2017 10 0.7 (2.91) 10 0.5 (3.99) 7.5 % 0.05 [ -0.82, 0.93 ]
Jelcic 2012 20 1.5 (5.72) 20 1 (5.78) 11.3 % 0.09 [ -0.53, 0.71 ]
Davis 2001 19 1.5 (3.67) 18 0.95 (3.37) 10.8 % 0.15 [ -0.49, 0.80 ]
Jelcic 2014 (1) 17 1.39 (4.71) 10 0.4 (5.46) 8.7 % 0.19 [ -0.59, 0.98 ]
Giuli 2016 48 0.15 (0.73) 47 -0.17 (0.67) 16.0 % 0.45 [ 0.05, 0.86 ]
Heiss 1993 18 1.66 (3.52) 17 -1.07 (3.13) 10.0 % 0.80 [ 0.11, 1.49 ]
Trebbastoni 2018 45 2.06 (4.84) 85 -2.93 (5.04) 16.6 % 1.00 [ 0.62, 1.38 ]
Cavallo 2016 40 0.34 (1.22) 40 -0.95 (1.21) 14.5 % 1.05 [ 0.58, 1.52 ]
Total (95% CI) 224 251 100.0 % 0.52 [ 0.23, 0.81 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 16.57, df = 8 (P = 0.03); I2 =52%
Test for overall effect: Z = 3.49 (P = 0.00049)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
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Analysis 1.12. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 12
Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 12 Change in executive function
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 6 (51.61) 17 33.3 (49.98) 8.9 % -0.52 [ -1.21, 0.16 ]
Galante 2007 7 -2.6 (8.27) 4 -2.3 (3.25) 6.2 % -0.04 [ -1.27, 1.19 ]
Kawashima 2005 16 15 (18) 16 -6 (197) 8.9 % 0.15 [ -0.55, 0.84 ]
Cavallo 2016 40 -0.07 (0.79) 40 -0.26 (0.71) 10.0 % 0.25 [ -0.19, 0.69 ]
Jelcic 2012 20 13.2 (18.07) 20 6.6 (16.69) 9.2 % 0.37 [ -0.25, 1.00 ]
Serino 2017 10 0.22 (2.24) 10 -0.66 (2.01) 7.9 % 0.40 [ -0.49, 1.28 ]
Neely 2009 (1) 20 -0.03 (0.15) 9 -0.16 (0.52) 8.3 % 0.41 [ -0.39, 1.20 ]
Quayhagen 1995 (2) 13 4.8 (7.28) 28 0.4 (6.6) 9.0 % 0.63 [ -0.04, 1.31 ]
Trebbastoni 2018 45 0.96 (2.07) 85 -1.3 (2.19) 10.2 % 1.05 [ 0.66, 1.43 ]
Quayhagen 1995 (3) 13 4.8 (7.28) 25 -3.6 (6.44) 8.7 % 1.22 [ 0.49, 1.95 ]
Quayhagen 2000 21 5.91 (2.31) 15 -2.6 (3.8) 7.6 % 2.76 [ 1.81, 3.71 ]
Mapelli 2013 (4) 10 2.3 (0.52) 10 -0.2 (0.79) 5.1 % 3.58 [ 2.06, 5.10 ]
Total (95% CI) 232 279 100.0 % 0.75 [ 0.28, 1.22 ]
Heterogeneity: Tau2 = 0.52; Chi2 = 58.99, df = 11 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.15 (P = 0.0017)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
(2) Cognitive training vs. Active control
(3) Cognitive training vs. Passive control
(4) Cognitive training vs. Passive control
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Analysis 1.13. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 13
Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 13 Change in speed of information processing
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Beck 1988 10 -0.3 (1.25) 10 1.1 (2.88) 11.3 % -0.60 [ -1.51, 0.30 ]
Galante 2007 7 -1.3 (10.33) 4 3.3 (5.55) 6.3 % -0.47 [ -1.72, 0.79 ]
Jelcic 2014 (1) 17 0.47 (6.9) 10 -0.4 (8.16) 14.4 % 0.11 [ -0.67, 0.90 ]
Barban 2016 36 7.7 (27.35) 33 -1.9 (27.67) 30.0 % 0.35 [ -0.13, 0.82 ]
Jelcic 2012 20 19.3 (56.5) 20 -2 (20.58) 20.3 % 0.49 [ -0.14, 1.12 ]
Cahn-Weiner 2003 17 5.2 (20.62) 17 -9.6 (31.4) 17.8 % 0.54 [ -0.14, 1.23 ]
Total (95% CI) 107 94 100.0 % 0.22 [ -0.11, 0.54 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 6.24, df = 5 (P = 0.28); I2 =20%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
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Analysis 1.14. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 14
Change in meta cognition (self-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 14 Change in meta cognition (self-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 6.43 (14.3) 8 1 (14.1) 54.5 % 0.37 [ -0.51, 1.24 ]
Lee 2013 (2) 12 0.27 (0.29) 7 0.08 (0.26) 45.5 % 0.65 [ -0.31, 1.61 ]
Total (95% CI) 26 15 100.0 % 0.50 [ -0.15, 1.14 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.18, df = 1 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. Two experimental groups
combined.
(2) Two experimental groups combined.
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Analysis 1.15. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 15
Change in meta cognition (informant-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 15 Change in meta cognition (informant-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 -4.8 (16.55) 17 6.6 (18.54) 52.5 % -0.63 [ -1.32, 0.06 ]
Koltai 2001 (1) 14 3.54 (14.7) 8 -5.75 (10.4) 47.5 % 0.67 [ -0.23, 1.56 ]
Total (95% CI) 31 25 100.0 % -0.01 [ -1.29, 1.26 ]
Heterogeneity: Tau2 = 0.68; Chi2 = 5.09, df = 1 (P = 0.02); I2 =80%
Test for overall effect: Z = 0.02 (P = 0.98)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. Two experimental groups
combined.
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Analysis 1.16. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 16
Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 16 Change in participants’ mood
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -1.21 (2.5) 8 0.13 (3) 12.2 % -0.48 [ -1.36, 0.40 ]
Bergamaschi 2013 16 -1.07 (2.98) 16 0.44 (5.09) 12.9 % -0.35 [ -1.05, 0.35 ]
Amieva 2016 164 -12.11 (12.73) 152 -10.81 (12.24) 14.1 % -0.10 [ -0.32, 0.12 ]
Davis 2001 19 0.32 (1.52) 18 0.17 (4.41) 13.1 % 0.05 [ -0.60, 0.69 ]
Lee 2013 (2) 12 -0.25 (2.23) 7 -1.86 (2.77) 11.9 % 0.63 [ -0.33, 1.59 ]
Galante 2007 7 0.5 (0.92) 4 -0.3 (0.78) 10.5 % 0.84 [ -0.47, 2.14 ]
Giuli 2016 48 -0.18 (4.4) 47 -7.32 (3.77) 13.6 % 1.73 [ 1.25, 2.20 ]
Fern ndez-Calvo 2011 (3) 30 3.2 (2) 15 -4.26 (1.85) 11.7 % 3.75 [ 2.73, 4.78 ]
Total (95% CI) 310 267 100.0 % 0.72 [ -0.10, 1.54 ]
Heterogeneity: Tau2 = 1.22; Chi2 = 99.56, df = 7 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.73 (P = 0.084)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. Two experimental groups
combined..
(2) Two experimental groups combined.
(3) Two experimental groups combined.
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Analysis 1.17. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 17
Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 17 Change in capacity for activities of daily living
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.6 (1.36) 4 0.5 (0.48) 2.7 % -0.88 [ -2.19, 0.43 ]
de Vreese 1998 9 -1.33 (4.37) 9 1.01 (3.98) 4.8 % -0.53 [ -1.48, 0.41 ]
Amieva 2016 167 -1.76 (8.46) 153 -1.22 (8.27) 24.0 % -0.06 [ -0.28, 0.16 ]
Cahn-Weiner 2003 17 -0.2 (3.16) 17 0 (3.07) 8.3 % -0.06 [ -0.74, 0.61 ]
Kim 2015 21 0 (0.86) 21 0 (1.05) 9.6 % 0.0 [ -0.60, 0.60 ]
Jelcic 2012 20 0.1 (1.05) 20 0 (1.36) 9.3 % 0.08 [ -0.54, 0.70 ]
Barban 2016 38 -0.1 (0.96) 38 -0.3 (1.08) 13.9 % 0.19 [ -0.26, 0.64 ]
Giuli 2016 48 0.26 (1.2) 47 -0.24 (1.26) 15.5 % 0.40 [ 0.00, 0.81 ]
Bergamaschi 2013 16 -0.38 (1.54) 16 -1.32 (1.46) 7.6 % 0.61 [ -0.10, 1.32 ]
Lee 2013 (1) 12 2.24 (3.33) 7 -2.14 (4.54) 4.3 % 1.10 [ 0.09, 2.11 ]
Total (95% CI) 355 332 100.0 % 0.12 [ -0.11, 0.35 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 14.29, df = 9 (P = 0.11); I2 =37%
Test for overall effect: Z = 1.04 (P = 0.30)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
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Analysis 1.18. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 18
Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 18 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 -24.76 (37.3) 18 4.77 (40.85) 14.0 % -0.74 [ -1.41, -0.07 ]
Quayhagen 2000 21 -0.38 (2.75) 67 0.13 (2.6) 18.8 % -0.19 [ -0.68, 0.30 ]
Amieva 2016 164 -6.3 (6.13) 151 -5.6 (6.35) 27.8 % -0.11 [ -0.33, 0.11 ]
Kallio 2018 76 -0.04 (0.06) 71 -0.04 (0.06) 24.4 % 0.0 [ -0.32, 0.32 ]
Kim 2015 22 3.4 (3.3) 21 0 (4.36) 15.0 % 0.87 [ 0.24, 1.49 ]
Total (95% CI) 302 328 100.0 % -0.04 [ -0.38, 0.29 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 12.93, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
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Analysis 1.19. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 19
Change in behavioural and psychological symptoms of dementia (BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 19 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -1.3 (2.22) 4 2.5 (3.9) 12.3 % -1.20 [ -2.58, 0.18 ]
Amieva 2016 165 -25.22 (23.28) 152 -21.81 (22.11) 19.5 % -0.15 [ -0.37, 0.07 ]
Quayhagen 2000 21 -0.53 (10.23) 15 -0.47 (12.91) 17.4 % -0.01 [ -0.67, 0.66 ]
Quintana Hernandez 2014 27 -8.55 (12.88) 25 -13.36 (13.48) 18.1 % 0.36 [ -0.19, 0.91 ]
Kawashima 2005 16 0.45 (1.88) 16 -0.3 (1.56) 17.1 % 0.42 [ -0.28, 1.12 ]
Fern ndez-Calvo 2011 (1) 30 2.08 (2.27) 15 -4.23 (1.33) 15.6 % 3.08 [ 2.17, 3.99 ]
Total (95% CI) 266 227 100.0 % 0.44 [ -0.34, 1.22 ]
Heterogeneity: Tau2 = 0.80; Chi2 = 51.21, df = 5 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
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Analysis 1.20. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 20
Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 20 Participant burden (retention rates)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Kallio 2018 76/76 71/71 Not estimable
Serino 2017 10/10 10/10 Not estimable
Beck 1988 10/10 10/10 Not estimable
Davis 2001 19/19 18/18 Not estimable
Jelcic 2012 20/20 20/20 Not estimable
Cavallo 2016 40/40 40/40 Not estimable
Kim 2015 22/22 21/21 Not estimable
Mapelli 2013 10/10 10/10 Not estimable
Trebbastoni 2018 48/54 86/86 4.8 % 0.04 [ 0.00, 0.78 ]
Quintana Hernandez 2014 27/32 25/25 4.7 % 0.10 [ 0.01, 1.86 ]
Koltai 2001 (1) 14/16 8/8 4.1 % 0.34 [ 0.01, 7.98 ]
Kao 2016 95/110 45/48 17.3 % 0.42 [ 0.12, 1.53 ]
Cahn-Weiner 2003 16/19 17/20 11.3 % 0.94 [ 0.17, 5.36 ]
Giuli 2016 48/51 47/50 12.3 % 1.02 [ 0.20, 5.32 ]
Amieva 2016 124/170 109/154 38.1 % 1.11 [ 0.69, 1.81 ]
Neely 2009 (2) 10/10 9/10 3.8 % 3.32 [ 0.12, 91.60 ]
Galante 2007 7/7 4/5 3.6 % 5.00 [ 0.17, 150.92 ]
Total (95% CI) 676 606 100.0 % 0.73 [ 0.37, 1.43 ]
Total events: 596 (Cognitive training), 550 (Control)
Heterogeneity: Tau2 = 0.25; Chi2 = 10.82, df = 8 (P = 0.21); I2 =26%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
Control Cognitive training
(1) Two experimental groups combined.
(2) Two experimental groups combined.
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Analysis 1.21. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 21
Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 21 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -21.31 (19.1) 152 -17.95 (19.01) 77.0 % -0.18 [ -0.40, 0.04 ]
Quayhagen 2000 21 -0.8 (4.05) 67 -1.29 (3.7) 23.0 % 0.13 [ -0.36, 0.62 ]
Total (95% CI) 186 219 100.0 % -0.11 [ -0.36, 0.15 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
Analysis 1.22. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 22
Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 22 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 -0.62 (9.8) 15 -2.8 (16.52) 100.0 % 0.16 [ -0.50, 0.83 ]
Total (95% CI) 21 15 100.0 % 0.16 [ -0.50, 0.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
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Analysis 1.23. Comparison 1 Cognitive training vs control immediately post intervention, Outcome 23
Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 1 Cognitive training vs control immediately post intervention
Outcome: 23 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 0.09 (0.06) 15 0.03 (0.06) 100.0 % 0.98 [ 0.27, 1.68 ]
Total (95% CI) 21 15 100.0 % 0.98 [ 0.27, 1.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.72 (P = 0.0065)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
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Analysis 2.1. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 1 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 1 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 17 -0.03 (0.34) 13.0 % -0.03 [ -0.70, 0.64 ]
Cavallo 2016 38 38 1.58 (0.28) 13.9 % 1.58 [ 1.03, 2.13 ]
Galante 2007 7 4 -0.23 (0.6) 9.3 % -0.23 [ -1.41, 0.95 ]
Lee 2013 (1) 12 7 0 (0.45) 11.4 % 0.0 [ -0.88, 0.88 ]
Quayhagen 1995 (2) 13 25 0.64 (0.34) 13.0 % 0.64 [ -0.03, 1.31 ]
Quayhagen 1995 (3) 13 28 0.18 (0.33) 13.2 % 0.18 [ -0.47, 0.83 ]
Trebbastoni 2018 45 85 0.49 (0.19) 15.0 % 0.49 [ 0.12, 0.86 ]
Tsantali 2017 17 21 2.49 (0.46) 11.2 % 2.49 [ 1.59, 3.39 ]
Total (95% CI) 162 225 100.0 % 0.65 [ 0.11, 1.20 ]
Heterogeneity: Tau2 = 0.48; Chi2 = 38.01, df = 7 (P<0.00001); I2 =82%
Test for overall effect: Z = 2.34 (P = 0.019)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
(2) Cognitive training vs Active control
(3) Cognitive training vs Passive control
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Analysis 2.2. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 2 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 2 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 17 0.01 (0.34) 12.1 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 38 38 0.74 (0.24) 17.0 % 0.74 [ 0.27, 1.21 ]
Galante 2007 7 4 -0.13 (0.58) 5.8 % -0.13 [ -1.27, 1.01 ]
Lee 2013 (1) 12 7 -0.13 (0.45) 8.5 % -0.13 [ -1.01, 0.75 ]
Quayhagen 1995 (2) 13 25 0.18 (0.33) 12.5 % 0.18 [ -0.47, 0.83 ]
Quayhagen 1995 (3) 13 28 0.64 (0.34) 12.1 % 0.64 [ -0.03, 1.31 ]
Trebbastoni 2018 45 85 0.23 (0.18) 20.7 % 0.23 [ -0.12, 0.58 ]
Tsantali 2017 17 21 1.27 (0.36) 11.3 % 1.27 [ 0.56, 1.98 ]
Total (95% CI) 162 225 100.0 % 0.40 [ 0.09, 0.71 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 13.22, df = 7 (P = 0.07); I2 =47%
Test for overall effect: Z = 2.56 (P = 0.010)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
(2) Cognitive training vs Passive control
(3) Cognitive training vs Active control
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Analysis 2.3. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 3 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 3 Change in a global measure of cognition
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 (1) 12 0.5 (2.85) 7 1.71 (2.02) 16.4 % -0.45 [ -1.39, 0.50 ]
Kallio 2018 68 -1.3 (5.39) 49 -1.2 (5.25) 18.7 % -0.02 [ -0.39, 0.35 ]
Cavallo 2016 36 -2.24 (1.1) 36 -3.8 (2.09) 18.3 % 0.92 [ 0.44, 1.41 ]
Galante 2007 7 -1.5 (2.28) 4 -4.7 (1.82) 13.9 % 1.37 [ -0.05, 2.79 ]
Trebbastoni 2018 45 -1.38 (2.33) 85 -5.52 (2.62) 18.6 % 1.63 [ 1.22, 2.04 ]
Tsantali 2017 17 3.8 (1) 21 -1.5 (0.97) 14.0 % 5.28 [ 3.87, 6.68 ]
Total (95% CI) 185 202 100.0 % 1.33 [ 0.31, 2.34 ]
Heterogeneity: Tau2 = 1.41; Chi2 = 80.97, df = 5 (P<0.00001); I2 =94%
Test for overall effect: Z = 2.55 (P = 0.011)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
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Analysis 2.4. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 4 Change in a global measure of cognition (zero correlation).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 4 Change in a global measure of cognition (zero correlation)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 (1) 12 0.5 (6.21) 7 1.71 (4.35) 14.5 % -0.21 [ -1.14, 0.73 ]
Kallio 2018 68 -1.3 (11.96) 49 -1.2 (11.74) 20.1 % -0.01 [ -0.38, 0.36 ]
Cavallo 2016 36 -2.24 (2.46) 36 -3.8 (4.22) 19.2 % 0.45 [ -0.02, 0.91 ]
Galante 2007 7 -1.5 (4.9) 4 -4.7 (3.41) 11.3 % 0.66 [ -0.62, 1.93 ]
Trebbastoni 2018 45 -1.38 (4.43) 85 -5.52 (5.02) 20.0 % 0.85 [ 0.48, 1.23 ]
Tsantali 2017 17 3.8 (1.89) 21 -1.5 (2.13) 15.0 % 2.56 [ 1.68, 3.44 ]
Total (95% CI) 185 202 100.0 % 0.68 [ 0.06, 1.30 ]
Heterogeneity: Tau2 = 0.46; Chi2 = 33.94, df = 5 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.16 (P = 0.031)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
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Analysis 2.5. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 5 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 5 Change in disease progression
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 (1) 12 3.17 (9.33) 7 0 (7.25) 20.8 % 0.35 [ -0.59, 1.29 ]
Quayhagen 1995 (2) 13 -2.2 (9.06) 28 -6 (10.8) 41.8 % 0.36 [ -0.30, 1.02 ]
Quayhagen 1995 (3) 13 -2.2 (9.06) 25 -12.6 (12.91) 37.4 % 0.87 [ 0.16, 1.57 ]
Total (95% CI) 38 60 100.0 % 0.55 [ 0.12, 0.98 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.26, df = 2 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 2.50 (P = 0.012)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
(2) Intervention vs. Active control
(3) Intervention vs. Passive control
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Analysis 2.6. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 6 Change in disease progression (zero correlation).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 6 Change in disease progression (zero correlation)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 (1) 12 3.17 (20.83) 7 0 (16.21) 20.4 % 0.16 [ -0.78, 1.09 ]
Quayhagen 1995 (2) 13 -2.2 (19.29) 28 -6 (21.5) 41.0 % 0.18 [ -0.48, 0.84 ]
Quayhagen 1995 (3) 13 -2.2 (19.29) 25 -12.6 (23.34) 38.6 % 0.46 [ -0.22, 1.14 ]
Total (95% CI) 38 60 100.0 % 0.28 [ -0.14, 0.71 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.43, df = 2 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
(2) Intervention vs. Active control
(3) Intervention vs. Passive control
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Analysis 2.7. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 7 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 7 Change in delayed memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Trebbastoni 2018 45 -0.39 (1.32) 85 -0.47 (1.41) 26.7 % 0.06 [ -0.30, 0.42 ]
Cahn-Weiner 2003 17 -0.2 (0.77) 17 -0.8 (1.66) 24.3 % 0.45 [ -0.23, 1.13 ]
Tsantali 2017 17 1.8 (2.5) 21 -2.2 (2.4) 23.7 % 1.60 [ 0.86, 2.35 ]
Cavallo 2016 36 -2 (1.13) 36 -4 (1.02) 25.3 % 1.84 [ 1.28, 2.39 ]
Total (95% CI) 115 159 100.0 % 0.97 [ 0.02, 1.92 ]
Heterogeneity: Tau2 = 0.85; Chi2 = 34.39, df = 3 (P<0.00001); I2 =91%
Test for overall effect: Z = 2.00 (P = 0.045)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
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Analysis 2.8. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 8 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 8 Change in immediate memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -11 (9.04) 4 3.7 (6.87) 8.2 % -1.60 [ -3.09, -0.12 ]
Lee 2013 (1) 12 3.25 (2.67) 7 3.57 (4.48) 11.5 % -0.09 [ -1.02, 0.84 ]
Cahn-Weiner 2003 17 -1.1 (2.8) 17 -1.1 (2.88) 13.1 % 0.0 [ -0.67, 0.67 ]
Quayhagen 1995 (2) 13 0.1 (10.96) 28 -2.1 (8.05) 13.2 % 0.24 [ -0.42, 0.90 ]
Quayhagen 1995 13 0.1 (10.96) 25 -6.3 (6.39) 13.0 % 0.76 [ 0.07, 1.46 ]
Trebbastoni 2018 45 2.84 (4.55) 85 -1.68 (4.5) 14.7 % 0.99 [ 0.61, 1.38 ]
Tsantali 2017 17 2 (2.95) 21 -1.9 (2.06) 12.7 % 1.53 [ 0.79, 2.27 ]
Cavallo 2016 36 -1 (0.69) 36 -3.04 (1.14) 13.6 % 2.14 [ 1.56, 2.73 ]
Total (95% CI) 160 223 100.0 % 0.62 [ 0.00, 1.24 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 46.37, df = 7 (P<0.00001); I2 =85%
Test for overall effect: Z = 1.97 (P = 0.048)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Two experimental groups combined.
(2) Cognitive training vs. Active control
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Analysis 2.9. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 9 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 9 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.3 (0.67) 4 1 (1.57) 22.3 % -1.12 [ -2.48, 0.24 ]
Trebbastoni 2018 45 -0.36 (0.54) 85 -0.73 (0.68) 39.9 % 0.58 [ 0.21, 0.95 ]
Cavallo 2016 36 -0.1 (1.03) 38 -1.55 (1.05) 37.8 % 1.38 [ 0.87, 1.89 ]
Total (95% CI) 88 127 100.0 % 0.50 [ -0.43, 1.43 ]
Heterogeneity: Tau2 = 0.53; Chi2 = 13.95, df = 2 (P = 0.00094); I2 =86%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
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Analysis 2.10. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 10 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 10 Change in language (naming)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 -0.2 (3.59) 17 0 (3.97) 23.4 % -0.05 [ -0.72, 0.62 ]
Trebbastoni 2018 45 -0.33 (3.56) 85 -2.66 (5.58) 28.6 % 0.47 [ 0.10, 0.83 ]
Cavallo 2016 36 -2 (1.93) 36 -3 (1.41) 26.9 % 0.59 [ 0.11, 1.06 ]
Tsantali 2017 17 7 (3.6) 21 -0.4 (3.56) 21.1 % 2.02 [ 1.22, 2.82 ]
Total (95% CI) 115 159 100.0 % 0.71 [ 0.07, 1.34 ]
Heterogeneity: Tau2 = 0.33; Chi2 = 16.30, df = 3 (P = 0.00099); I2 =82%
Test for overall effect: Z = 2.18 (P = 0.029)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Control Cognitive training
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Analysis 2.11. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 11 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 11 Change in verbal letter fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 -1.1 (4.07) 17 0.9 (5.42) 25.3 % -0.41 [ -1.09, 0.27 ]
Galante 2007 7 1 (3.9) 4 0.3 (7.59) 17.2 % 0.12 [ -1.11, 1.35 ]
Trebbastoni 2018 45 -2.41 (4.85) 85 -5.27 (5.2) 29.7 % 0.56 [ 0.19, 0.93 ]
Cavallo 2016 36 -3.1 (1.68) 36 -5.4 (1.55) 27.7 % 1.41 [ 0.89, 1.93 ]
Total (95% CI) 105 142 100.0 % 0.47 [ -0.28, 1.23 ]
Heterogeneity: Tau2 = 0.46; Chi2 = 18.36, df = 3 (P = 0.00037); I2 =84%
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
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Analysis 2.12. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 12 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 12 Change in verbal category fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.5 (1.99) 4 -0.2 (4.41) 9.4 % -0.09 [ -1.32, 1.14 ]
Cavallo 2016 36 -4 (1.14) 36 -4.83 (1.16) 40.0 % 0.71 [ 0.24, 1.19 ]
Trebbastoni 2018 45 -0.41 (4.78) 85 -5.34 (5.04) 50.6 % 0.99 [ 0.61, 1.37 ]
Total (95% CI) 88 125 100.0 % 0.78 [ 0.38, 1.18 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 3.06, df = 2 (P = 0.22); I2 =35%
Test for overall effect: Z = 3.83 (P = 0.00013)
Test for subgroup differences: Not applicable
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Control Cognitive training
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Analysis 2.13. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 13 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 13 Change in executive function
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 3 (50.45) 17 28.8 (60.12) 16.7 % -0.45 [ -1.14, 0.23 ]
Galante 2007 7 0.4 (4.88) 4 -0.7 (3.29) 10.4 % 0.23 [ -1.01, 1.46 ]
Quayhagen 1995 (1) 13 1.1 (6.94) 28 -1.4 (7.76) 16.9 % 0.33 [ -0.34, 0.99 ]
Quayhagen 1995 (2) 13 1.1 (6.94) 25 -3.2 (7.45) 16.6 % 0.58 [ -0.11, 1.26 ]
Trebbastoni 2018 45 -0.56 (2.24) 85 -2.66 (2.33) 20.4 % 0.91 [ 0.53, 1.29 ]
Cavallo 2016 38 -0.82 (0.81) 38 -1.95 (0.72) 18.9 % 1.46 [ 0.95, 1.97 ]
Total (95% CI) 133 197 100.0 % 0.56 [ 0.02, 1.10 ]
Heterogeneity: Tau2 = 0.33; Chi2 = 22.58, df = 5 (P = 0.00041); I2 =78%
Test for overall effect: Z = 2.04 (P = 0.042)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Control Cognitive training
(1) Cognitive training vs. Active control
(2) Cognitive training vs. Passive control
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Analysis 2.14. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 14 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 14 Change in speed of information processing
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 0 (8.89) 4 2.5 (6.72) 29.9 % -0.28 [ -1.51, 0.96 ]
Cahn-Weiner 2003 17 11.7 (21.05) 17 -1.4 (25.31) 70.1 % 0.55 [ -0.14, 1.24 ]
Total (95% CI) 24 21 100.0 % 0.30 [ -0.44, 1.04 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 1.31, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
Analysis 2.15. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 15 Change in meta cognition (self-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 15 Change in meta cognition (self-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 (1) 12 0.17 (0.29) 7 -0.12 (0.26) 100.0 % 0.99 [ -0.01, 1.99 ]
Total (95% CI) 12 7 100.0 % 0.99 [ -0.01, 1.99 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.95 (P = 0.052)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
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(1) Two experimental groups combined.
Analysis 2.16. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 16 Change in meta cognition (informant-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 16 Change in meta cognition (informant-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 -2 (16.07) 17 -1 (19.27) 100.0 % -0.06 [ -0.73, 0.62 ]
Total (95% CI) 17 17 100.0 % -0.06 [ -0.73, 0.62 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.16 (P = 0.87)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
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Analysis 2.17. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 17 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 17 Change in participants’ mood
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.1 (1.62) 4 0.2 (0.67) 37.1 % -0.20 [ -1.43, 1.03 ]
Lee 2013 (1) 12 -0.67 (2.35) 7 -1.86 (2.77) 62.9 % 0.45 [ -0.49, 1.40 ]
Total (95% CI) 19 11 100.0 % 0.21 [ -0.54, 0.96 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.68, df = 1 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Not applicable
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Control Cognitive training
(1) Two experimental groups combined.
Analysis 2.18. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 18 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 18 Change in capacity for activities of daily living
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.7 (1.43) 4 0.3 (0.36) 22.1 % -0.77 [ -2.06, 0.52 ]
Cahn-Weiner 2003 17 0.6 (3.1) 17 -0.5 (3.43) 45.9 % 0.33 [ -0.35, 1.01 ]
Lee 2013 (1) 12 1.08 (3.37) 7 -1.71 (3.82) 32.1 % 0.75 [ -0.22, 1.72 ]
Total (95% CI) 36 28 100.0 % 0.22 [ -0.50, 0.94 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 3.47, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
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(1) Two experimental groups combined.
Analysis 2.19. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 19 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 19 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Kallio 2018 68 -0.05 (0.06) 49 -0.05 (0.05) 100.0 % -0.02 [ -0.39, 0.35 ]
Total (95% CI) 68 49 100.0 % -0.02 [ -0.39, 0.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.09 (P = 0.92)
Test for subgroup differences: Not applicable
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Analysis 2.20. Comparison 2 Cognitive training vs control in the medium term (3 to 12 months post
intervention), Outcome 20 Change in behavioural and psychological symptoms of dementia (BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 2 Cognitive training vs control in the medium term (3 to 12 months post intervention)
Outcome: 20 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -1 (2.95) 4 3.8 (3.85) 100.0 % -1.34 [ -2.75, 0.07 ]
Total (95% CI) 7 4 100.0 % -1.34 [ -2.75, 0.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 1 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 1 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training
Alternative
treatment
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Amieva 2016 (1) 166 325 -0.13 (0.1) 21.9 % -0.13 [ -0.33, 0.07 ]
Brueggen 2017 8 8 -0.18 (0.48) 11.1 % -0.18 [ -1.12, 0.76 ]
de Vreese 1998 9 9 1.31 (0.5) 10.6 % 1.31 [ 0.33, 2.29 ]
Giovagnoli 2017 13 26 -0.05 (0.34) 14.9 % -0.05 [ -0.72, 0.62 ]
Mapelli 2013 10 10 1.95 (0.64) 7.9 % 1.95 [ 0.70, 3.20 ]
Quayhagen 2000 (2) 21 67 0.35 (0.33) 15.2 % 0.35 [ -0.30, 1.00 ]
Quintana Hernandez 2014 (3) 27 70 -0.45 (0.23) 18.4 % -0.45 [ -0.90, 0.00 ]
Total (95% CI) 254 515 100.0 % 0.21 [ -0.23, 0.64 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 22.34, df = 6 (P = 0.001); I2 =73%
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Three alternative treatments combined.
(3) Two alternative treatments combined.
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Analysis 3.2. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 2 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 2 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training
Alternative
treatment
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Amieva 2016 (1) 166 325 -0.09 (0.1) 55.1 % -0.09 [ -0.29, 0.11 ]
Brueggen 2017 8 8 -0.1 (0.47) 4.5 % -0.10 [ -1.02, 0.82 ]
de Vreese 1998 9 9 0.6 (0.46) 4.7 % 0.60 [ -0.30, 1.50 ]
Giovagnoli 2017 13 26 -0.04 (0.37) 7.1 % -0.04 [ -0.77, 0.69 ]
Mapelli 2013 10 10 0.93 (0.55) 3.3 % 0.93 [ -0.15, 2.01 ]
Quayhagen 2000 (2) 21 67 0.16 (0.33) 8.7 % 0.16 [ -0.49, 0.81 ]
Quintana Hernandez 2014 (3) 27 70 -0.27 (0.23) 16.7 % -0.27 [ -0.72, 0.18 ]
Total (95% CI) 254 515 100.0 % -0.03 [ -0.23, 0.17 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 6.66, df = 6 (P = 0.35); I2 =10%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Three alternative treatments combined.
(3) Two alternative treatments combined.
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Analysis 3.3. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 3 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 3 Change in a global measure of cognition
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quintana Hernandez 2014 (1) 27 -4.48 (4.08) 70 -2.94 (3.91) 18.3 % -0.39 [ -0.83, 0.06 ]
Brueggen 2017 8 0.13 (2.29) 8 1 (2.08) 10.5 % -0.38 [ -1.37, 0.62 ]
Amieva 2016 (2) 168 -8.4 (5.86) 326 -7.43 (6.03) 21.7 % -0.16 [ -0.35, 0.02 ]
Venturelli 2016 20 -0.2 (0.97) 20 -0.1 (1.38) 15.6 % -0.08 [ -0.70, 0.54 ]
Giovagnoli 2017 (3) 13 -0.16 (1.74) 26 -0.11 (3.63) 14.9 % -0.02 [ -0.68, 0.65 ]
de Vreese 1998 9 2.77 (1.68) 9 -1.45 (2.97) 9.3 % 1.67 [ 0.56, 2.78 ]
Mapelli 2013 10 2.9 (2.59) 10 -1.5 (2.3) 9.8 % 1.72 [ 0.66, 2.78 ]
Total (95% CI) 255 469 100.0 % 0.16 [ -0.28, 0.60 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 23.42, df = 6 (P = 0.00067); I2 =74%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Two alternative treatments combined.
(3) Two alternative treatments combined.
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Analysis 3.4. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 4 Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 4 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quintana Hernandez 2014 (1) 27 -4.48 (6.86) 70 -2.94 (6.66) 18.4 % -0.23 [ -0.67, 0.22 ]
Brueggen 2017 8 0.13 (5.11) 8 1 (4.64) 4.8 % -0.17 [ -1.15, 0.81 ]
Amieva 2016 (2) 168 -8.4 (8.71) 326 -7.43 (8.74) 45.9 % -0.11 [ -0.30, 0.08 ]
Venturelli 2016 20 -0.2 (2.13) 20 -0.1 (2.98) 10.9 % -0.04 [ -0.66, 0.58 ]
Giovagnoli 2017 (3) 13 -0.16 (3.45) 26 -0.11 (7.87) 9.7 % -0.01 [ -0.67, 0.66 ]
de Vreese 1998 9 2.77 (3.48) 9 -1.45 (6.53) 5.0 % 0.77 [ -0.20, 1.73 ]
Mapelli 2013 10 2.9 (5.03) 10 -1.5 (4.67) 5.4 % 0.87 [ -0.06, 1.79 ]
Total (95% CI) 255 469 100.0 % -0.02 [ -0.24, 0.20 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 7.58, df = 6 (P = 0.27); I2 =21%
Test for overall effect: Z = 0.18 (P = 0.85)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Two alternative treatments combined.
(3) Two alternative treatments combined.
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Analysis 3.5. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 5 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 5 Change in disease progression
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 4.5 (8.43) 8 -0.5 (10.08) 19.2 % 0.51 [ -0.49, 1.51 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 22.9 % 0.57 [ -0.33, 1.46 ]
Quintana Hernandez 2014 (1) 27 -2.77 (6.39) 68 -2.16 (3.77) 58.0 % -0.13 [ -0.58, 0.32 ]
Total (95% CI) 45 86 100.0 % 0.15 [ -0.33, 0.63 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 2.68, df = 2 (P = 0.26); I2 =25%
Test for overall effect: Z = 0.62 (P = 0.54)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Alternative treatment Cognitive training
(1) Two alternative treatments combined.
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Analysis 3.6. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 -0.23 (1.85) 26 -0.04 (1.91) 35.3 % -0.10 [ -0.76, 0.57 ]
Mapelli 2013 10 4.2 (2.35) 10 -0.5 (1.43) 26.9 % 2.31 [ 1.13, 3.50 ]
Quayhagen 2000 (2) 21 3.2 (6.89) 67 0.75 (7.36) 37.8 % 0.33 [ -0.16, 0.83 ]
Total (95% CI) 44 103 100.0 % 0.71 [ -0.33, 1.75 ]
Heterogeneity: Tau2 = 0.68; Chi2 = 12.21, df = 2 (P = 0.002); I2 =84%
Test for overall effect: Z = 1.34 (P = 0.18)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Three alternative treatments combined.
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Analysis 3.7. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 7 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 7 Change in immediate memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 1 (4.38) 26 0.32 (6.22) 34.9 % 0.12 [ -0.55, 0.78 ]
Quayhagen 2000 (2) 21 2.29 (12.1) 67 0.03 (9.34) 40.8 % 0.22 [ -0.27, 0.71 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.5 (1.32) 24.3 % 1.56 [ 0.53, 2.59 ]
Total (95% CI) 44 103 100.0 % 0.51 [ -0.19, 1.21 ]
Heterogeneity: Tau2 = 0.25; Chi2 = 6.02, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Three alternative treatments combined.
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Analysis 3.8. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 8 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 8 Change in attention and working memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 -0.15 (0.61) 26 -0.35 (0.91) 52.2 % 0.24 [ -0.43, 0.91 ]
Mapelli 2013 10 1.7 (1.24) 20 0.1 (0.78) 47.8 % 1.63 [ 0.76, 2.51 ]
Total (95% CI) 23 46 100.0 % 0.91 [ -0.46, 2.27 ]
Heterogeneity: Tau2 = 0.82; Chi2 = 6.15, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Alternative treatment Cognitive training
(1) Two alternative treatments combined.
Analysis 3.9. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 9 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 9 Change in language (naming)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -0.87 (1.21) 8 -0.12 (1.02) 100.0 % -0.63 [ -1.65, 0.38 ]
Total (95% CI) 8 8 100.0 % -0.63 [ -1.65, 0.38 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
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Analysis 3.10. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 10 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 10 Change in verbal letter fluency
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -3.38 (2.9) 8 -1.62 (3.48) 28.3 % -0.52 [ -1.52, 0.48 ]
Mapelli 2013 10 1.2 (1.51) 10 0.23 (1.32) 31.5 % 0.66 [ -0.25, 1.56 ]
Giovagnoli 2017 (1) 13 4 (4.7) 26 -0.58 (7.25) 40.2 % 0.69 [ 0.00, 1.37 ]
Total (95% CI) 31 44 100.0 % 0.34 [ -0.38, 1.05 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 4.22, df = 2 (P = 0.12); I2 =53%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Alternative treatment Cognitive training
(1) Two alternative treatments combined.
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Analysis 3.11. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 11 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 11 Change in verbal category fluency
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -2.38 (4.25) 8 1.5 (3.37) 44.1 % -0.96 [ -2.01, 0.10 ]
Giovagnoli 2017 (1) 13 -0.46 (5.83) 26 -1.92 (5.61) 55.9 % 0.25 [ -0.42, 0.92 ]
Total (95% CI) 21 34 100.0 % -0.28 [ -1.46, 0.89 ]
Heterogeneity: Tau2 = 0.53; Chi2 = 3.61, df = 1 (P = 0.06); I2 =72%
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
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Analysis 3.12. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 12 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 12 Change in executive function
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 -10.54 (81.59) 26 3 (106.3) 26.2 % -0.13 [ -0.80, 0.53 ]
Brueggen 2017 8 -30.71 (39.98) 8 -30.39 (46.29) 25.1 % -0.01 [ -0.99, 0.97 ]
Quayhagen 2000 (2) 21 5.91 (2.31) 67 0.49 (2.1) 26.4 % 2.50 [ 1.88, 3.12 ]
Mapelli 2013 10 2.3 (0.52) 10 -0.5 (0.9) 22.3 % 3.65 [ 2.11, 5.19 ]
Total (95% CI) 52 111 100.0 % 1.44 [ -0.26, 3.14 ]
Heterogeneity: Tau2 = 2.75; Chi2 = 47.86, df = 3 (P<0.00001); I2 =94%
Test for overall effect: Z = 1.66 (P = 0.097)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Three alternative treatments combined.
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Analysis 3.13. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 13 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 13 Change in speed of information processing
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 -12.54 (21.19) 26 -7.62 (51.33) 68.6 % -0.11 [ -0.78, 0.56 ]
Brueggen 2017 8 -15.63 (33.64) 8 -24.24 (33.5) 31.4 % 0.24 [ -0.74, 1.23 ]
Total (95% CI) 21 34 100.0 % 0.00 [ -0.55, 0.55 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.34, df = 1 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 0.00 (P = 1.0)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
Analysis 3.16. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 16 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 16 Change in participants’ mood
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 2.17 (2.92) 26 3.85 (5.7) 7.0 % -0.33 [ -1.00, 0.34 ]
Brueggen 2017 8 -0.87 (3.91) 8 -0.13 (3.35) 3.3 % -0.19 [ -1.18, 0.79 ]
Amieva 2016 (2) 164 -12.11 (12.73) 324 -10.94 (12.78) 89.7 % -0.09 [ -0.28, 0.10 ]
Total (95% CI) 185 358 100.0 % -0.11 [ -0.29, 0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.48, df = 2 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
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(1) Two alternative treatments combined.
(2) Two alternative treatments combined.
Analysis 3.17. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 17 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 17 Change in capacity for activities of daily living
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
de Vreese 1998 9 -1.33 (4.37) 9 1.11 (3.41) 3.6 % -0.59 [ -1.54, 0.36 ]
Brueggen 2017 8 -0.26 (1.16) 8 0.52 (1.53) 3.2 % -0.54 [ -1.55, 0.46 ]
Amieva 2016 (1) 167 -1.76 (8.46) 324 0.05 (7.57) 93.1 % -0.23 [ -0.42, -0.04 ]
Total (95% CI) 184 341 100.0 % -0.25 [ -0.43, -0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.88, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 2.74 (P = 0.0062)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
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Analysis 3.18. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 18 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 18 Change in general health and quality of life
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -4.37 (4.55) 8 3.13 (4.8) 12.9 % -1.52 [ -2.67, -0.36 ]
Giovagnoli 2017 (1) 13 -0.06 (12.74) 26 8.8 (6.04) 22.1 % -0.99 [ -1.69, -0.28 ]
Quayhagen 2000 (2) 21 -0.38 (2.75) 67 0.06 (3.2) 28.3 % -0.14 [ -0.63, 0.35 ]
Amieva 2016 (3) 164 -6.3 (6.13) 324 -5.67 (6.29) 36.6 % -0.10 [ -0.29, 0.09 ]
Total (95% CI) 206 425 100.0 % -0.49 [ -1.00, 0.02 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 10.91, df = 3 (P = 0.01); I2 =73%
Test for overall effect: Z = 1.90 (P = 0.058)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Three alternative treatments combined.
(3) Two alternative treatments combined.
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Analysis 3.19. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 19 Change in behavioural and psychological symptoms of dementia (BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 19 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 (1) 165 -25.22 (23.28) 324 -22.29 (23.6) 75.6 % -0.12 [ -0.31, 0.06 ]
Quintana Hernandez 2014 (2) 27 -8.55 (12.88) 68 -7.26 (10.3) 13.4 % -0.12 [ -0.56, 0.33 ]
Quayhagen 2000 (3) 21 -0.53 (10.23) 67 -0.79 (9.98) 11.1 % 0.03 [ -0.46, 0.52 ]
Total (95% CI) 213 459 100.0 % -0.11 [ -0.27, 0.06 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.32, df = 2 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 1.28 (P = 0.20)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Two alternative treatments combined.
(3) Three alternative treatments combined.
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Analysis 3.20. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 20 Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 20 Participant burden (retention rates)
Study or subgroup Cognitive training
Alternative
treatment Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Mapelli 2013 10/10 10/10 Not estimable
Quintana Hernandez 2014 (1) 27/32 67/70 31.3 % 0.24 [ 0.05, 1.08 ]
Amieva 2016 (2) 124/170 239/329 57.2 % 1.02 [ 0.67, 1.54 ]
Brueggen 2017 8/8 8/10 11.5 % 5.00 [ 0.21, 120.44 ]
Total (95% CI) 220 419 100.0 % 0.78 [ 0.24, 2.57 ]
Total events: 169 (Cognitive training), 324 (Alternative treatment)
Heterogeneity: Tau2 = 0.61; Chi2 = 4.34, df = 2 (P = 0.11); I2 =54%
Test for overall effect: Z = 0.41 (P = 0.68)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Two alternative treatments combined.
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Analysis 3.21. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 21 Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 21 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 (1) 165 -21.31 (19.1) 322 -15.24 (20.83) 62.7 % -0.30 [ -0.49, -0.11 ]
Quayhagen 2000 (2) 21 -0.8 (4.05) 67 -0.62 (4.42) 28.1 % -0.04 [ -0.53, 0.45 ]
Brueggen 2017 8 -0.75 (9.17) 8 -5.25 (7.4) 9.2 % 0.51 [ -0.49, 1.51 ]
Total (95% CI) 194 397 100.0 % -0.15 [ -0.47, 0.17 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 3.17, df = 2 (P = 0.21); I2 =37%
Test for overall effect: Z = 0.92 (P = 0.35)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
(2) Three alternative treatments combined.
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Analysis 3.22. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 22 Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 22 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 (1) 21 -0.62 (9.8) 67 2.41 (12.46) 100.0 % -0.25 [ -0.74, 0.24 ]
Total (95% CI) 21 67 100.0 % -0.25 [ -0.74, 0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.01 (P = 0.31)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Three alternative treatments combined.
Analysis 3.23. Comparison 3 Cognitive training vs alternative treatment immediately post intervention,
Outcome 23 Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 3 Cognitive training vs alternative treatment immediately post intervention
Outcome: 23 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 (1) 21 0.09 (0.06) 67 -0.05 (0.1) 100.0 % 1.50 [ 0.96, 2.04 ]
Total (95% CI) 21 67 100.0 % 1.50 [ 0.96, 2.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 5.46 (P < 0.00001)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
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(1) Three alternative treatments combined.
Analysis 4.1. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 1 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 1 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training
Alternative
treatment
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 26 0.14 (0.33) 51.1 % 0.14 [ -0.51, 0.79 ]
Tsantali 2017 17 17 2.53 (0.49) 48.9 % 2.53 [ 1.57, 3.49 ]
Total (95% CI) 30 43 100.0 % 1.31 [ -1.03, 3.65 ]
Heterogeneity: Tau2 = 2.68; Chi2 = 16.37, df = 1 (P = 0.00005); I2 =94%
Test for overall effect: Z = 1.09 (P = 0.27)
Test for subgroup differences: Not applicable
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Analysis 4.2. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 2 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 2 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training
Alternative
treatment
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 26 0.05 (0.33) 51.0 % 0.05 [ -0.60, 0.70 ]
Tsantali 2017 17 17 1.21 (0.37) 49.0 % 1.21 [ 0.48, 1.94 ]
Total (95% CI) 30 43 100.0 % 0.62 [ -0.52, 1.75 ]
Heterogeneity: Tau2 = 0.55; Chi2 = 5.47, df = 1 (P = 0.02); I2 =82%
Test for overall effect: Z = 1.07 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 4.3. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 3 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 3 Change in a global measure of cognition
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 0.38 (2.05) 26 -0.19 (4.33) 50.9 % 0.15 [ -0.52, 0.82 ]
Tsantali 2017 17 3.8 (1) 17 -1.6 (0.61) 49.1 % 6.37 [ 4.62, 8.11 ]
Total (95% CI) 30 43 100.0 % 3.20 [ -2.89, 9.29 ]
Heterogeneity: Tau2 = 18.87; Chi2 = 42.59, df = 1 (P<0.00001); I2 =98%
Test for overall effect: Z = 1.03 (P = 0.30)
Test for subgroup differences: Not applicable
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(1) Two alternative treatments combined.
Analysis 4.6. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 0 (1.79) 26 0.47 (2.06) 50.6 % -0.23 [ -0.90, 0.44 ]
Tsantali 2017 17 1.8 (2.5) 17 -1.3 (1.44) 49.4 % 1.48 [ 0.71, 2.25 ]
Total (95% CI) 30 43 100.0 % 0.61 [ -1.07, 2.30 ]
Heterogeneity: Tau2 = 1.34; Chi2 = 10.90, df = 1 (P = 0.00096); I2 =91%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Not applicable
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198Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.7. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 7 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 7 Change in immediate memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 0.31 (5.96) 26 -0.18 (7.43) 51.0 % 0.07 [ -0.60, 0.73 ]
Tsantali 2017 17 2 (2.95) 17 -1.4 (1.34) 49.0 % 1.45 [ 0.68, 2.21 ]
Total (95% CI) 30 43 100.0 % 0.75 [ -0.61, 2.10 ]
Heterogeneity: Tau2 = 0.82; Chi2 = 7.11, df = 1 (P = 0.01); I2 =86%
Test for overall effect: Z = 1.08 (P = 0.28)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Alternative treatment Cognitive training
(1) Two alternative treatments combined.
Analysis 4.8. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 8 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 8 Change in attention and working memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 -0.23 (0.61) 26 -0.19 (0.79) 100.0 % -0.05 [ -0.72, 0.61 ]
Total (95% CI) 13 26 100.0 % -0.05 [ -0.72, 0.61 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.16 (P = 0.88)
Test for subgroup differences: Not applicable
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(1) Two alternative treatments combined.
Analysis 4.9. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 9 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 9 Change in language (naming)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Tsantali 2017 17 7 (3.6) 17 0 (3.3) 100.0 % 1.98 [ 1.14, 2.82 ]
Total (95% CI) 17 17 100.0 % 1.98 [ 1.14, 2.82 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.63 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 4.10. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 10 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 10 Change in verbal letter fluency
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 2.38 (4.82) 26 0.42 (7.28) 100.0 % 0.29 [ -0.38, 0.96 ]
Total (95% CI) 13 26 100.0 % 0.29 [ -0.38, 0.96 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Not applicable
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(1) Two alternative treatments combined.
Analysis 4.11. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 11 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 11 Change in verbal category fluency
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 -1.39 (5.82) 26 -0.93 (5.9) 100.0 % -0.08 [ -0.74, 0.59 ]
Total (95% CI) 13 26 100.0 % -0.08 [ -0.74, 0.59 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.23 (P = 0.82)
Test for subgroup differences: Not applicable
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(1) Two alternative treatments combined.
Analysis 4.12. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 12 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 12 Change in executive function
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 -33.16 (100) 26 -1.61 (105.5) 100.0 % -0.30 [ -0.97, 0.37 ]
Total (95% CI) 13 26 100.0 % -0.30 [ -0.97, 0.37 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.87 (P = 0.38)
Test for subgroup differences: Not applicable
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Analysis 4.13. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 13 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 13 Change in speed of information processing
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 -6.69 (15.52) 26 -2.16 (48.63) 100.0 % -0.11 [ -0.77, 0.56 ]
Total (95% CI) 13 26 100.0 % -0.11 [ -0.77, 0.56 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.32 (P = 0.75)
Test for subgroup differences: Not applicable
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Alternative treatment Cognitive training
(1) Two alternative treatments combined.
Analysis 4.16. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 16 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 16 Change in participants’ mood
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 -0.72 (3.28) 26 2.69 (5.7) 100.0 % -0.66 [ -1.35, 0.02 ]
Total (95% CI) 13 26 100.0 % -0.66 [ -1.35, 0.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.90 (P = 0.058)
Test for subgroup differences: Not applicable
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(1) Two alternative treatments combined.
Analysis 4.18. Comparison 4 Cognitive training vs alternative treatment in the medium term (3 to 12
months post intervention), Outcome 18 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 4 Cognitive training vs alternative treatment in the medium term (3 to 12 months post intervention)
Outcome: 18 Change in general health and quality of life
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 (1) 13 8.71 (11.91) 26 5.92 (6) 100.0 % 0.33 [ -0.34, 1.00 ]
Total (95% CI) 13 26 100.0 % 0.33 [ -0.34, 1.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Not applicable
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Analysis 5.1. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 1 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 1 Change in a global measure of cognition
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Lower risk
Galante 2007 7 0.1 (2.34) 4 1.8 (1.74) 3.7 % -0.72 [ -2.00, 0.56 ]
Amieva 2016 168 -8.4 (5.86) 153 -7.6 (5.43) 5.9 % -0.14 [ -0.36, 0.08 ]
Davis 2001 19 0.16 (2.6) 18 0.22 (2.68) 5.2 % -0.02 [ -0.67, 0.62 ]
Lee 2013 12 2.01 (2.86) 7 2 (1.9) 4.5 % 0.00 [ -0.93, 0.94 ]
Cavallo 2016 40 -0.14 (1.04) 40 -0.16 (1.62) 5.6 % 0.01 [ -0.42, 0.45 ]
Kallio 2018 76 -0.8 (5.19) 71 -1.6 (5.35) 5.8 % 0.15 [ -0.17, 0.48 ]
Venturelli 2016 20 -0.2 (0.97) 20 -0.4 (1.14) 5.2 % 0.19 [ -0.44, 0.81 ]
Kawashima 2005 16 0.1 (5.1) 16 -1.8 (3.75) 5.1 % 0.41 [ -0.29, 1.12 ]
Quintana Hernandez 2014 27 -4.48 (4.08) 25 -7.48 (3.49) 5.4 % 0.78 [ 0.21, 1.34 ]
Mapelli 2013 10 2.9 (2.59) 10 -0.3 (1.71) 4.3 % 1.40 [ 0.40, 2.40 ]
Jelcic 2012 20 2 (1.68) 20 -1 (1.98) 5.0 % 1.60 [ 0.88, 2.32 ]
Trebbastoni 2018 48 1.53 (1.7) 86 -2.64 (2.07) 5.6 % 2.13 [ 1.69, 2.57 ]
Fern ndez-Calvo 2011 30 1.12 (1.64) 15 -2.31 (1.16) 4.9 % 2.25 [ 1.46, 3.03 ]
Bergamaschi 2013 16 2.75 (1.81) 16 -3.57 (1.81) 4.0 % 3.40 [ 2.28, 4.53 ]
Subtotal (95% CI) 509 501 70.2 % 0.79 [ 0.28, 1.30 ]
Heterogeneity: Tau2 = 0.80; Chi2 = 158.79, df = 13 (P<0.00001); I2 =92%
Test for overall effect: Z = 3.06 (P = 0.0022)
2 Higher risk
Giuli 2016 48 0.02 (2.77) 47 1.24 (3.77) 5.7 % -0.37 [ -0.77, 0.04 ]
Koltai 2001 (1) 14 -0.21 (2.9) 8 0.75 (2.4) 4.6 % -0.34 [ -1.21, 0.54 ]
Heiss 1993 18 -1.22 (4.22) 17 -0.94 (3.59) 5.1 % -0.07 [ -0.73, 0.59 ]
Barban 2016 42 0.1 (1.64) 39 -0.1 (1.15) 5.6 % 0.14 [ -0.30, 0.58 ]
Jelcic 2014 17 2 (1.47) 10 -0.7 (2.41) 4.6 % 1.40 [ 0.52, 2.28 ]
de Vreese 1998 9 2.77 (1.68) 9 -0.89 (2.4) 4.1 % 1.68 [ 0.57, 2.80 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 148 130 29.8 % 0.30 [ -0.26, 0.87 ]
Heterogeneity: Tau2 = 0.36; Chi2 = 22.43, df = 5 (P = 0.00043); I2 =78%
Test for overall effect: Z = 1.05 (P = 0.29)
Total (95% CI) 657 631 100.0 % 0.65 [ 0.26, 1.05 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 187.26, df = 19 (P<0.00001); I2 =90%
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Chi2 = 1.61, df = 1 (P = 0.21), I2 =38%
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Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
Analysis 5.2. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 2 Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 2 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Lower risk
Venturelli 2016 20 -2 (2.13) 20 -0.4 (2.42) 5.0 % -0.69 [ -1.33, -0.05 ]
Galante 2007 7 0.1 (4.98) 4 1.8 (3.33) 2.4 % -0.35 [ -1.59, 0.90 ]
Amieva 2016 168 -8.4 (8.71) 152 -7.6 (5.43) 7.5 % -0.11 [ -0.33, 0.11 ]
Davis 2001 19 0.16 (5.82) 18 0.22 (5.86) 5.0 % -0.01 [ -0.65, 0.63 ]
Lee 2013 12 2.01 (6.23) 7 2 (4.18) 3.5 % 0.00 [ -0.93, 0.93 ]
Cavallo 2016 40 -0.14 (2.25) 40 -0.16 (2.75) 6.3 % 0.01 [ -0.43, 0.45 ]
Kallio 2018 76 -0.8 (11.6) 71 -1.6 (11.95) 7.0 % 0.07 [ -0.26, 0.39 ]
Kawashima 2005 16 0.1 (11.01) 16 -1.8 (8.22) 4.7 % 0.19 [ -0.50, 0.89 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quintana Hernandez 2014 27 -4.48 (6.86) 25 -7.48 (5.65) 5.5 % 0.47 [ -0.08, 1.02 ]
Mapelli 2013 10 1.07 (1.75) 10 0.33 (0.42) 3.6 % 0.56 [ -0.34, 1.45 ]
Jelcic 2012 20 2 (3.62) 20 -1 (4.2) 5.0 % 0.75 [ 0.11, 1.39 ]
Trebbastoni 2018 48 1.53 (3.68) 86 -2.64 (4.39) 6.7 % 1.00 [ 0.63, 1.37 ]
Fern ndez-Calvo 2011 30 1.12 (3.64) 15 -2.31 (2.57) 4.9 % 1.01 [ 0.35, 1.67 ]
Bergamaschi 2013 16 2.75 (3.56) 16 -3.57 (3.58) 4.0 % 1.73 [ 0.90, 2.55 ]
Subtotal (95% CI) 509 500 71.1 % 0.33 [ 0.03, 0.63 ]
Heterogeneity: Tau2 = 0.23; Chi2 = 58.52, df = 13 (P<0.00001); I2 =78%
Test for overall effect: Z = 2.12 (P = 0.034)
2 Higher risk
Koltai 2001 (1) 14 -0.21 (5.8) 8 0.75 (4.8) 3.8 % -0.17 [ -1.04, 0.70 ]
Giuli 2016 48 0.02 (6.16) 47 1.24 (8.42) 6.5 % -0.16 [ -0.57, 0.24 ]
Heiss 1993 18 -1.22 (8.13) 17 -0.94 (7.18) 4.9 % -0.04 [ -0.70, 0.63 ]
Barban 2016 42 0.1 (3.3) 39 -0.1 (2.55) 6.3 % 0.07 [ -0.37, 0.50 ]
Jelcic 2014 17 2 (3.18) 10 -0.7 (5) 4.1 % 0.67 [ -0.14, 1.47 ]
de Vreese 1998 9 2.77 (3.48) 9 -0.89 (5.22) 3.3 % 0.79 [ -0.18, 1.75 ]
Subtotal (95% CI) 148 130 28.9 % 0.07 [ -0.20, 0.34 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 5.87, df = 5 (P = 0.32); I2 =15%
Test for overall effect: Z = 0.52 (P = 0.61)
Total (95% CI) 657 630 100.0 % 0.27 [ 0.04, 0.50 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 65.70, df = 19 (P<0.00001); I2 =71%
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Chi2 = 1.56, df = 1 (P = 0.21), I2 =36%
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. We multiplied the SD they
provided by 2.
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Analysis 5.3. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 3 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 3 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Lower risk
Amieva 2016 165 153 -0.11 (0.11) 6.6 % -0.11 [ -0.33, 0.11 ]
Beck 1988 10 10 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Bergamaschi 2013 16 16 1.64 (0.41) 3.1 % 1.64 [ 0.84, 2.44 ]
Boller 2011 24 12 0.13 (0.35) 3.7 % 0.13 [ -0.56, 0.82 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.8 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 40 40 1.32 (0.28) 4.5 % 1.32 [ 0.77, 1.87 ]
Davis 2001 19 18 0 (0.32) 4.0 % 0.0 [ -0.63, 0.63 ]
Fern ndez-Calvo 2011 30 15 -0.44 (0.42) 3.0 % -0.44 [ -1.26, 0.38 ]
Galante 2007 7 4 0.21 (0.63) 1.8 % 0.21 [ -1.02, 1.44 ]
Jelcic 2012 20 20 0.6 (0.32) 4.0 % 0.60 [ -0.03, 1.23 ]
Kawashima 2005 16 16 0.52 (0.36) 3.6 % 0.52 [ -0.19, 1.23 ]
Kim 2015 22 21 0.46 (0.32) 4.0 % 0.46 [ -0.17, 1.09 ]
Lee 2013 12 7 1.15 (0.53) 2.3 % 1.15 [ 0.11, 2.19 ]
Mapelli 2013 10 10 2.13 (0.66) 1.6 % 2.13 [ 0.84, 3.42 ]
Neely 2009 20 9 0.26 (0.39) 3.3 % 0.26 [ -0.50, 1.02 ]
Quayhagen 2000 21 15 0.19 (0.33) 3.9 % 0.19 [ -0.46, 0.84 ]
Quintana Hernandez 2014 27 25 0.73 (0.28) 4.5 % 0.73 [ 0.18, 1.28 ]
Serino 2017 10 10 0.31 (0.44) 2.9 % 0.31 [ -0.55, 1.17 ]
Trebbastoni 2018 45 85 0.55 (0.2) 5.5 % 0.55 [ 0.16, 0.94 ]
Subtotal (95% CI) 531 503 69.3 % 0.46 [ 0.19, 0.72 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 59.19, df = 18 (P<0.00001); I2 =70%
Test for overall effect: Z = 3.41 (P = 0.00066)
2 Higher risk
Barban 2016 41 38 0.21 (0.23) 5.1 % 0.21 [ -0.24, 0.66 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
de Vreese 1998 9 9 1.04 (0.49) 2.5 % 1.04 [ 0.08, 2.00 ]
Giuli 2016 48 47 0.37 (0.21) 5.4 % 0.37 [ -0.04, 0.78 ]
Heiss 1993 18 17 0.27 (0.34) 3.8 % 0.27 [ -0.40, 0.94 ]
Jelcic 2014 17 10 0.55 (0.4) 3.2 % 0.55 [ -0.23, 1.33 ]
Koltai 2001 14 8 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Quayhagen 1995 (1) 13 25 0.37 (0.34) 3.8 % 0.37 [ -0.30, 1.04 ]
Quayhagen 1995 (2) 13 28 0.25 (0.33) 3.9 % 0.25 [ -0.40, 0.90 ]
Subtotal (95% CI) 173 182 30.7 % 0.33 [ 0.12, 0.55 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.52, df = 7 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 3.04 (P = 0.0024)
Total (95% CI) 704 685 100.0 % 0.42 [ 0.23, 0.61 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 62.80, df = 26 (P = 0.00007); I2 =59%
Test for overall effect: Z = 4.32 (P = 0.000015)
Test for subgroup differences: Chi2 = 0.53, df = 1 (P = 0.47), I2 =0.0%
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(1) CT vs Passive Control
(2) CT vs Active Control
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Analysis 5.4. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 4 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 4 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Lower risk
Amieva 2016 166 153 -0.07 (0.11) 15.9 % -0.07 [ -0.29, 0.15 ]
Beck 1988 10 10 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Bergamaschi 2013 16 16 0.78 (0.36) 2.7 % 0.78 [ 0.07, 1.49 ]
Boller 2011 24 12 0.06 (0.35) 2.8 % 0.06 [ -0.63, 0.75 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.0 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 40 40 0.61 (0.23) 5.9 % 0.61 [ 0.16, 1.06 ]
Davis 2001 19 18 0 (0.32) 3.3 % 0.0 [ -0.63, 0.63 ]
Fern ndez-Calvo 2011 30 15 -0.29 (0.34) 3.0 % -0.29 [ -0.96, 0.38 ]
Galante 2007 7 4 0.12 (0.59) 1.1 % 0.12 [ -1.04, 1.28 ]
Jelcic 2012 20 20 0.28 (0.31) 3.5 % 0.28 [ -0.33, 0.89 ]
Kawashima 2005 16 16 0.23 (0.35) 2.8 % 0.23 [ -0.46, 0.92 ]
Kim 2015 22 21 0.2 (0.3) 3.7 % 0.20 [ -0.39, 0.79 ]
Lee 2013 12 7 0.6 (0.47) 1.6 % 0.60 [ -0.32, 1.52 ]
Mapelli 2013 10 10 1.06 (0.55) 1.2 % 1.06 [ -0.02, 2.14 ]
Neely 2009 20 9 0.26 (0.39) 2.3 % 0.26 [ -0.50, 1.02 ]
Quayhagen 2000 21 15 0.8 (0.35) 2.8 % 0.80 [ 0.11, 1.49 ]
Quintana Hernandez 2014 27 25 0.46 (0.28) 4.2 % 0.46 [ -0.09, 1.01 ]
Serino 2017 10 10 0.16 (0.43) 1.9 % 0.16 [ -0.68, 1.00 ]
Trebbastoni 2018 45 85 0.26 (0.19) 7.9 % 0.26 [ -0.11, 0.63 ]
Subtotal (95% CI) 532 503 71.5 % 0.23 [ 0.08, 0.38 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 22.13, df = 18 (P = 0.23); I2 =19%
Test for overall effect: Z = 3.01 (P = 0.0026)
2 Higher risk
Barban 2016 41 38 0.1 (0.22) 6.3 % 0.10 [ -0.33, 0.53 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
de Vreese 1998 9 9 0.48 (0.46) 1.7 % 0.48 [ -0.42, 1.38 ]
Giuli 2016 48 47 0.17 (0.2) 7.3 % 0.17 [ -0.22, 0.56 ]
Heiss 1993 18 17 0.15 (0.33) 3.1 % 0.15 [ -0.50, 0.80 ]
Jelcic 2014 17 10 0.27 (0.39) 2.3 % 0.27 [ -0.49, 1.03 ]
Koltai 2001 14 8 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Quayhagen 1995 (1) 13 25 1.03 (0.36) 2.7 % 1.03 [ 0.32, 1.74 ]
Quayhagen 1995 (2) 13 28 0.55 (0.33) 3.1 % 0.55 [ -0.10, 1.20 ]
Subtotal (95% CI) 173 182 28.5 % 0.28 [ 0.07, 0.49 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 6.85, df = 7 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 2.61 (P = 0.0090)
Total (95% CI) 705 685 100.0 % 0.24 [ 0.12, 0.36 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 29.59, df = 26 (P = 0.29); I2 =12%
Test for overall effect: Z = 3.89 (P = 0.000099)
Test for subgroup differences: Chi2 = 0.12, df = 1 (P = 0.72), I2 =0.0%
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Analysis 5.5. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 5 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 5 Change in immediate memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Lower risk
Galante 2007 7 -0.2 (5.3) 4 1.2 (7.77) 4.0 % -0.21 [ -1.44, 1.03 ]
Quayhagen 2000 21 2.29 (12.1) 15 -0.73 (12.08) 5.9 % 0.24 [ -0.42, 0.91 ]
Boller 2011 24 -0.04 (2.98) 12 -0.92 (2.93) 5.7 % 0.29 [ -0.41, 0.99 ]
Cahn-Weiner 2003 17 -0.4 (2.76) 17 -1.7 (2.97) 5.8 % 0.44 [ -0.24, 1.12 ]
Davis 2001 19 1.43 (3.52) 18 -0.22 (3.71) 5.9 % 0.45 [ -0.21, 1.10 ]
Jelcic 2012 20 2.9 (5.62) 20 -0.2 (5.43) 6.0 % 0.55 [ -0.08, 1.18 ]
Bergamaschi 2013 16 1.12 (2) 16 -0.13 (1.63) 5.7 % 0.67 [ -0.05, 1.38 ]
Quayhagen 1995 (1) 13 4.7 (10.56) 25 -1.8 (6.19) 5.7 % 0.80 [ 0.11, 1.50 ]
Neely 2009 20 -0.1 (1.75) 9 -1.5 (1.25) 5.3 % 0.84 [ 0.02, 1.66 ]
Trebbastoni 2018 45 4.01 (4.6) 85 -0.7 (3.98) 6.7 % 1.11 [ 0.73, 1.50 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.7 (1.58) 4.6 % 1.58 [ 0.55, 2.61 ]
Lee 2013 12 8.08 (3.25) 7 1.29 (1.81) 4.0 % 2.29 [ 1.05, 3.54 ]
Cavallo 2016 40 2.26 (0.71) 40 -0.79 (1) 5.7 % 3.48 [ 2.78, 4.19 ]
Subtotal (95% CI) 264 278 71.1 % 0.95 [ 0.46, 1.44 ]
Heterogeneity: Tau2 = 0.65; Chi2 = 73.98, df = 12 (P<0.00001); I2 =84%
Test for overall effect: Z = 3.80 (P = 0.00014)
2 Higher risk
Koltai 2001 14 0.64 (1.7) 8 1.63 (2.8) 5.1 % -0.44 [ -1.32, 0.44 ]
Jelcic 2014 17 0.66 (5.53) 10 -0.3 (4.82) 5.5 % 0.18 [ -0.61, 0.96 ]
Heiss 1993 18 0.41 (0.97) 17 0.09 (1) 5.8 % 0.32 [ -0.35, 0.99 ]
Giuli 2016 48 0.65 (1.74) 47 -0.17 (1.74) 6.6 % 0.47 [ 0.06, 0.88 ]
Quayhagen 1995 (2) 13 4.7 (10.56) 28 -0.1 (7.84) 5.8 % 0.54 [ -0.13, 1.21 ]
Subtotal (95% CI) 110 110 28.9 % 0.33 [ 0.06, 0.60 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.91, df = 4 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 2.38 (P = 0.018)
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 374 388 100.0 % 0.74 [ 0.37, 1.12 ]
Heterogeneity: Tau2 = 0.51; Chi2 = 90.65, df = 17 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.89 (P = 0.000098)
Test for subgroup differences: Chi2 = 4.70, df = 1 (P = 0.03), I2 =79%
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Control Cognitive training
(1) Cognitive training vs. Passive control
(2) Cognitive training vs. Active control
Analysis 5.6. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Lower risk
Davis 2001 19 1.15 (2.23) 18 1.65 (3.72) 9.4 % -0.16 [ -0.81, 0.49 ]
Boller 2011 24 -0.29 (1.58) 12 -0.08 (1.28) 9.2 % -0.14 [ -0.83, 0.56 ]
Cahn-Weiner 2003 17 -0.3 (1.05) 17 -0.8 (1.58) 9.2 % 0.36 [ -0.31, 1.04 ]
Quayhagen 2000 21 3.2 (6.89) 15 0.4 (7.55) 9.3 % 0.38 [ -0.29, 1.05 ]
Trebbastoni 2018 45 0.06 (1.26) 85 -0.55 (1.36) 10.4 % 0.46 [ 0.09, 0.82 ]
Jelcic 2012 20 1.5 (2.34) 20 -0.9 (2.04) 9.3 % 1.07 [ 0.40, 1.74 ]
Mapelli 2013 (1) 10 4.2 (2.35) 10 -0.8 (1.48) 6.8 % 2.44 [ 1.22, 3.65 ]
Cavallo 2016 40 1.24 (1.04) 40 -1.74 (1) 9.4 % 2.89 [ 2.26, 3.53 ]
Subtotal (95% CI) 196 217 73.0 % 0.87 [ 0.16, 1.59 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 0.93; Chi2 = 70.73, df = 7 (P<0.00001); I2 =90%
Test for overall effect: Z = 2.39 (P = 0.017)
2 Higher risk
Barban 2016 42 0.4 (1.17) 39 -0.1 (1.11) 10.2 % 0.43 [ -0.01, 0.88 ]
Koltai 2001 14 0.64 (1.3) 8 -0.25 (1.8) 8.3 % 0.57 [ -0.32, 1.46 ]
Jelcic 2014 17 0.86 (2.17) 10 -1.3 (1.84) 8.5 % 1.02 [ 0.18, 1.85 ]
Subtotal (95% CI) 73 57 27.0 % 0.56 [ 0.21, 0.92 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.47, df = 2 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 3.09 (P = 0.0020)
Total (95% CI) 269 274 100.0 % 0.81 [ 0.29, 1.32 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 72.73, df = 10 (P<0.00001); I2 =86%
Test for overall effect: Z = 3.05 (P = 0.0023)
Test for subgroup differences: Chi2 = 0.57, df = 1 (P = 0.45), I2 =0.0%
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Analysis 5.7. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 7 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 7 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Lower risk
Galante 2007 7 0.1 (0.66) 4 0.7 (1.52) 6.1 % -0.53 [ -1.79, 0.73 ]
Trebbastoni 2018 45 -0.3 (0.58) 85 -0.24 (0.65) 9.9 % -0.10 [ -0.46, 0.27 ]
Boller 2011 24 0 (1.11) 12 0.08 (0.92) 8.6 % -0.07 [ -0.77, 0.62 ]
Davis 2001 19 -0.41 (1.55) 18 -0.47 (1.56) 8.8 % 0.04 [ -0.61, 0.68 ]
Serino 2017 10 0 (0.91) 10 -0.33 (0.58) 7.8 % 0.41 [ -0.47, 1.30 ]
Beck 1988 (1) 10 0.7 (0.95) 10 -0.2 (1.32) 7.6 % 0.75 [ -0.16, 1.66 ]
Jelcic 2012 20 0.2 (0.55) 20 -0.4 (0.55) 8.7 % 1.07 [ 0.40, 1.74 ]
Mapelli 2013 10 1.7 (1.24) 10 -0.1 (1.29) 7.3 % 1.36 [ 0.37, 2.36 ]
Cavallo 2016 40 1.89 (0.99) 40 -0.04 (0.89) 9.2 % 2.03 [ 1.49, 2.57 ]
Subtotal (95% CI) 185 209 74.1 % 0.57 [ -0.03, 1.17 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 53.99, df = 8 (P<0.00001); I2 =85%
Test for overall effect: Z = 1.88 (P = 0.061)
2 Higher risk
Heiss 1993 18 -0.64 (1) 17 -0.03 (0.98) 8.7 % -0.60 [ -1.28, 0.08 ]
Giuli 2016 48 0.32 (0.9) 47 -0.2 (0.96) 9.7 % 0.55 [ 0.14, 0.96 ]
Jelcic 2014 17 0.32 (1) 10 -1.35 (0.59) 7.5 % 1.85 [ 0.90, 2.80 ]
Subtotal (95% CI) 83 74 25.9 % 0.56 [ -0.57, 1.69 ]
Heterogeneity: Tau2 = 0.87; Chi2 = 17.87, df = 2 (P = 0.00013); I2 =89%
Test for overall effect: Z = 0.97 (P = 0.33)
Total (95% CI) 268 283 100.0 % 0.56 [ 0.08, 1.05 ]
Heterogeneity: Tau2 = 0.59; Chi2 = 71.95, df = 11 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.98), I2 =0.0%
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Analysis 5.8. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 8 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 8 Change in language (naming)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 0.19 (1.55) 40 0.1 (1.32) 22.9 % 0.06 [ -0.38, 0.50 ]
Cahn-Weiner 2003 17 0.3 (3.55) 17 -0.1 (3.48) 18.6 % 0.11 [ -0.56, 0.78 ]
Jelcic 2012 20 3.5 (5.63) 20 -0.8 (4.61) 19.0 % 0.82 [ 0.17, 1.47 ]
Jelcic 2014 17 2.19 (2.56) 10 -0.4 (2.41) 15.8 % 1.00 [ 0.17, 1.83 ]
Trebbastoni 2018 45 2 (3.35) 85 -1.81 (3.34) 23.8 % 1.13 [ 0.75, 1.52 ]
Total (95% CI) 139 172 100.0 % 0.62 [ 0.11, 1.12 ]
Heterogeneity: Tau2 = 0.24; Chi2 = 16.29, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 2.39 (P = 0.017)
Test for subgroup differences: Not applicable
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Analysis 5.9. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 9 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 9 Change in verbal letter fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Serino 2017 10 -1.6 (3.47) 10 0.2 (4.8) 6.3 % -0.41 [ -1.30, 0.48 ]
Cavallo 2016 40 1.17 (1.62) 40 1.53 (1.6) 11.6 % -0.22 [ -0.66, 0.22 ]
Davis 2001 19 0.22 (7.7) 18 1.33 (9.03) 8.8 % -0.13 [ -0.78, 0.52 ]
Cahn-Weiner 2003 17 0.3 (5.95) 17 1 (4.62) 8.4 % -0.13 [ -0.80, 0.54 ]
Barban 2016 42 1.4 (5.66) 39 1.1 (6.04) 11.6 % 0.05 [ -0.39, 0.49 ]
Jelcic 2012 20 1.7 (7.56) 20 1.3 (7.41) 9.1 % 0.05 [ -0.57, 0.67 ]
Jelcic 2014 17 2.27 (7.6) 10 1.6 (6.93) 7.3 % 0.09 [ -0.69, 0.87 ]
Kawashima 2005 16 0.1 (0.55) 16 0 (0.44) 8.2 % 0.20 [ -0.50, 0.89 ]
Trebbastoni 2018 45 -0.17 (4.89) 85 -2.03 (5) 12.6 % 0.37 [ 0.01, 0.74 ]
Galante 2007 7 3.5 (5.74) 4 -1.7 (6.97) 3.7 % 0.77 [ -0.52, 2.06 ]
Mapelli 2013 10 1.2 (1.51) 10 -0.64 (1.12) 5.5 % 1.33 [ 0.34, 2.31 ]
Bergamaschi 2013 16 1.06 (1.39) 16 -1.72 (1.97) 7.0 % 1.59 [ 0.78, 2.40 ]
Total (95% CI) 259 285 100.0 % 0.22 [ -0.07, 0.50 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 25.86, df = 11 (P = 0.01); I2 =57%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 5.10. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 10 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 10 Change in speed of information processing
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Beck 1988 10 -0.3 (1.25) 10 1.1 (2.88) 11.3 % -0.60 [ -1.51, 0.30 ]
Galante 2007 7 -1.3 (10.33) 4 3.3 (5.55) 6.3 % -0.47 [ -1.72, 0.79 ]
Jelcic 2014 17 0.47 (6.9) 10 -0.4 (8.16) 14.4 % 0.11 [ -0.67, 0.90 ]
Barban 2016 36 7.7 (27.35) 33 -1.9 (27.67) 30.0 % 0.35 [ -0.13, 0.82 ]
Jelcic 2012 20 19.3 (56.5) 20 -2 (20.58) 20.3 % 0.49 [ -0.14, 1.12 ]
Cahn-Weiner 2003 17 5.2 (20.62) 17 -9.6 (31.4) 17.8 % 0.54 [ -0.14, 1.23 ]
Total (95% CI) 107 94 100.0 % 0.22 [ -0.11, 0.54 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 6.24, df = 5 (P = 0.28); I2 =20%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 5.11. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 11 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 11 Change in executive function
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 6 (51.61) 17 33.3 (49.98) 8.9 % -0.52 [ -1.21, 0.16 ]
Galante 2007 7 -2.6 (8.27) 4 -2.3 (3.25) 6.2 % -0.04 [ -1.27, 1.19 ]
Kawashima 2005 16 15 (18) 16 -6 (197) 8.9 % 0.15 [ -0.55, 0.84 ]
Cavallo 2016 40 -0.07 (0.79) 40 -0.26 (0.71) 10.0 % 0.25 [ -0.19, 0.69 ]
Jelcic 2012 20 13.2 (18.07) 20 6.6 (16.69) 9.2 % 0.37 [ -0.25, 1.00 ]
Serino 2017 10 0.22 (2.24) 10 -0.66 (2.01) 7.9 % 0.40 [ -0.49, 1.28 ]
Neely 2009 20 -0.03 (0.15) 9 -0.16 (0.52) 8.3 % 0.41 [ -0.39, 1.20 ]
Quayhagen 1995 (1) 13 4.8 (7.28) 28 0.4 (6.6) 9.0 % 0.63 [ -0.04, 1.31 ]
Trebbastoni 2018 45 0.96 (2.07) 85 -1.3 (2.19) 10.2 % 1.05 [ 0.66, 1.43 ]
Quayhagen 1995 (2) 13 4.8 (7.28) 25 -3.6 (6.44) 8.7 % 1.22 [ 0.49, 1.95 ]
Quayhagen 2000 21 5.91 (2.31) 15 -2.6 (3.8) 7.6 % 2.76 [ 1.81, 3.71 ]
Mapelli 2013 (3) 10 2.3 (0.52) 10 -0.2 (0.79) 5.1 % 3.58 [ 2.06, 5.10 ]
Total (95% CI) 232 279 100.0 % 0.75 [ 0.28, 1.22 ]
Heterogeneity: Tau2 = 0.52; Chi2 = 58.99, df = 11 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.15 (P = 0.0017)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Cognitive training vs. Active control
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(3) Cognitive training vs. Passive control
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Analysis 5.12. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 12 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 12 Change in verbal category fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Lower risk
Galante 2007 7 0 (2.98) 4 0.1 (4.16) 4.5 % -0.03 [ -1.26, 1.20 ]
Serino 2017 10 0.7 (2.91) 10 0.5 (3.99) 7.5 % 0.05 [ -0.82, 0.93 ]
Jelcic 2012 20 1.5 (5.72) 20 1 (5.78) 11.3 % 0.09 [ -0.53, 0.71 ]
Davis 2001 19 1.5 (3.67) 18 0.95 (3.37) 10.8 % 0.15 [ -0.49, 0.80 ]
Trebbastoni 2018 45 2.06 (4.84) 85 -2.93 (5.04) 16.6 % 1.00 [ 0.62, 1.38 ]
Cavallo 2016 40 0.34 (1.22) 40 -0.95 (1.21) 14.5 % 1.05 [ 0.58, 1.52 ]
Subtotal (95% CI) 141 177 65.3 % 0.49 [ 0.06, 0.93 ]
Heterogeneity: Tau2 = 0.18; Chi2 = 14.38, df = 5 (P = 0.01); I2 =65%
Test for overall effect: Z = 2.23 (P = 0.025)
2 Higher risk
Jelcic 2014 17 1.39 (4.71) 10 0.4 (5.46) 8.7 % 0.19 [ -0.59, 0.98 ]
Giuli 2016 48 0.15 (0.73) 47 -0.17 (0.67) 16.0 % 0.45 [ 0.05, 0.86 ]
Heiss 1993 18 1.66 (3.52) 17 -1.07 (3.13) 10.0 % 0.80 [ 0.11, 1.49 ]
Subtotal (95% CI) 83 74 34.7 % 0.48 [ 0.16, 0.80 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.35, df = 2 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 2.96 (P = 0.0031)
Total (95% CI) 224 251 100.0 % 0.52 [ 0.23, 0.81 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 16.57, df = 8 (P = 0.03); I2 =52%
Test for overall effect: Z = 3.49 (P = 0.00049)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.97), I2 =0.0%
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Analysis 5.13. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 13 Change in meta cognition (self-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 13 Change in meta cognition (self-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -6.43 (14.3) 8 -1 (14.1) 51.9 % -0.37 [ -1.24, 0.51 ]
Lee 2013 12 0.27 (0.29) 7 0.08 (0.26) 48.1 % 0.65 [ -0.31, 1.61 ]
Total (95% CI) 26 15 100.0 % 0.12 [ -0.87, 1.12 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 2.34, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 5.14. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 14 Change in meta cognition (informant-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 14 Change in meta cognition (informant-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -3.54 (14.7) 8 5.75 (10.4) 37.3 % -0.67 [ -1.56, 0.23 ]
Cahn-Weiner 2003 17 -4.8 (16.55) 17 6.6 (18.54) 62.7 % -0.63 [ -1.32, 0.06 ]
Total (95% CI) 31 25 100.0 % -0.65 [ -1.19, -0.10 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.021)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 5.15. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 15 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 15 Change in participants’ mood
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -1.21 (2.5) 8 0.13 (3) 12.2 % -0.48 [ -1.36, 0.40 ]
Bergamaschi 2013 16 -1.07 (2.98) 16 0.44 (5.09) 12.9 % -0.35 [ -1.05, 0.35 ]
Amieva 2016 164 -12.11 (12.73) 152 -10.81 (12.24) 14.1 % -0.10 [ -0.32, 0.12 ]
Davis 2001 19 0.32 (1.52) 17 0.17 (4.41) 13.1 % 0.05 [ -0.61, 0.70 ]
Lee 2013 12 -0.25 (2.23) 7 -1.86 (2.77) 11.9 % 0.63 [ -0.33, 1.59 ]
Galante 2007 7 0.5 (0.92) 4 -0.3 (0.78) 10.5 % 0.84 [ -0.47, 2.14 ]
Giuli 2016 48 -0.18 (4.4) 47 -7.32 (3.77) 13.6 % 1.73 [ 1.25, 2.20 ]
Fern ndez-Calvo 2011 30 3.2 (2) 15 -4.26 (1.85) 11.7 % 3.75 [ 2.73, 4.78 ]
Total (95% CI) 310 266 100.0 % 0.72 [ -0.10, 1.54 ]
Heterogeneity: Tau2 = 1.23; Chi2 = 99.54, df = 7 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.73 (P = 0.084)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
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Analysis 5.16. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 16 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 16 Change in capacity for activities of daily living
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Lower risk
Galante 2007 7 -0.6 (1.36) 4 0.5 (0.48) 2.6 % -0.88 [ -2.19, 0.43 ]
Amieva 2016 167 -1.76 (8.46) 153 -1.22 (8.27) 23.8 % -0.06 [ -0.28, 0.16 ]
Cahn-Weiner 2003 17 -0.2 (3.16) 17 0 (3.07) 8.1 % -0.06 [ -0.74, 0.61 ]
Kim 2015 21 0 (0.86) 21 0 (1.05) 9.4 % 0.0 [ -0.60, 0.60 ]
Jelcic 2012 20 0.1 (1.05) 38 0 (1.36) 10.9 % 0.08 [ -0.46, 0.62 ]
Bergamaschi 2013 16 -0.38 (1.54) 16 -1.32 (1.46) 7.4 % 0.61 [ -0.10, 1.32 ]
Lee 2013 12 2.24 (3.33) 7 -2.14 (4.54) 4.2 % 1.10 [ 0.09, 2.11 ]
Subtotal (95% CI) 260 256 66.4 % 0.09 [ -0.19, 0.37 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 9.51, df = 6 (P = 0.15); I2 =37%
Test for overall effect: Z = 0.62 (P = 0.53)
2 Higher risk
de Vreese 1998 9 -1.33 (4.37) 9 1.01 (3.98) 4.7 % -0.53 [ -1.48, 0.41 ]
Barban 2016 38 -0.1 (0.96) 38 -0.3 (1.08) 13.6 % 0.19 [ -0.26, 0.64 ]
Giuli 2016 48 0.26 (1.2) 47 -0.24 (1.26) 15.2 % 0.40 [ 0.00, 0.81 ]
Subtotal (95% CI) 95 94 33.6 % 0.18 [ -0.21, 0.58 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 3.23, df = 2 (P = 0.20); I2 =38%
Test for overall effect: Z = 0.92 (P = 0.36)
Total (95% CI) 355 350 100.0 % 0.12 [ -0.10, 0.34 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 14.29, df = 9 (P = 0.11); I2 =37%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Chi2 = 0.14, df = 1 (P = 0.71), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
224Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 5.17. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 17 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 17 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 -24.76 (37.3) 18 4.77 (40.85) 18.6 % -0.74 [ -1.41, -0.07 ]
Amieva 2016 164 -6.3 (6.13) 151 -5.6 (6.35) 32.4 % -0.11 [ -0.33, 0.11 ]
Kallio 2018 76 -0.04 (0.06) 71 -0.04 (0.06) 29.3 % 0.0 [ -0.32, 0.32 ]
Kim 2015 22 3.4 (3.3) 21 0 (4.36) 19.7 % 0.87 [ 0.24, 1.49 ]
Total (95% CI) 281 261 100.0 % 0.00 [ -0.42, 0.41 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 12.65, df = 3 (P = 0.01); I2 =76%
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable
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Analysis 5.18. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 18 Change in behavioural and psychological symptoms of dementia (BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 18 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -1.3 (2.22) 4 2.5 (3.9) 12.3 % -1.20 [ -2.58, 0.18 ]
Amieva 2016 165 -25.22 (23.28) 152 -21.81 (22.11) 19.5 % -0.15 [ -0.37, 0.07 ]
Quayhagen 2000 21 -0.53 (10.23) 15 -0.47 (12.91) 17.4 % -0.01 [ -0.67, 0.66 ]
Quintana Hernandez 2014 27 -8.55 (12.88) 25 -13.36 (13.48) 18.1 % 0.36 [ -0.19, 0.91 ]
Kawashima 2005 16 0.45 (1.88) 16 -0.3 (1.56) 17.1 % 0.42 [ -0.28, 1.12 ]
Fern ndez-Calvo 2011 30 2.08 (2.27) 15 -4.23 (1.33) 15.6 % 3.08 [ 2.17, 3.99 ]
Total (95% CI) 266 227 100.0 % 0.44 [ -0.34, 1.22 ]
Heterogeneity: Tau2 = 0.80; Chi2 = 51.21, df = 5 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Not applicable
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Analysis 5.19. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 19 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 19 Change in disease progression
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fern ndez-Calvo 2011 30 -2.11 (2.24) 15 -7.07 (2.39) 16.5 % 2.13 [ 1.36, 2.90 ]
Lee 2013 12 7.59 (9.2) 7 0.86 (7.83) 13.2 % 0.74 [ -0.23, 1.70 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 14.3 % 0.57 [ -0.33, 1.46 ]
Quayhagen 1995 (1) 13 3.3 (7.5) 25 -4.4 (8.36) 17.8 % 0.93 [ 0.23, 1.64 ]
Quayhagen 1995 (2) 13 3.3 (7.5) 28 -1.7 (8.89) 18.5 % 0.58 [ -0.09, 1.25 ]
Quintana Hernandez 2014 27 -2.77 (6.39) 25 -12.28 (7.33) 19.7 % 1.37 [ 0.76, 1.97 ]
Total (95% CI) 105 110 100.0 % 1.07 [ 0.59, 1.55 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 11.99, df = 5 (P = 0.03); I2 =58%
Test for overall effect: Z = 4.40 (P = 0.000011)
Test for subgroup differences: Not applicable
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Analysis 5.20. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 20 Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 20 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -21.31 (19.1) 152 -17.95 (19.01) 77.0 % -0.18 [ -0.40, 0.04 ]
Quayhagen 2000 21 -0.8 (4.05) 67 -1.29 (3.7) 23.0 % 0.13 [ -0.36, 0.62 ]
Total (95% CI) 186 219 100.0 % -0.11 [ -0.36, 0.15 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 5.21. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 21 Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 21 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 -0.62 (9.8) 15 -2.8 (16.52) 100.0 % 0.16 [ -0.50, 0.83 ]
Total (95% CI) 21 15 100.0 % 0.16 [ -0.50, 0.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 5.22. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 22 Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 22 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 0.09 (0.06) 15 0.03 (0.06) 100.0 % 0.98 [ 0.27, 1.68 ]
Total (95% CI) 21 15 100.0 % 0.98 [ 0.27, 1.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.72 (P = 0.0065)
Test for subgroup differences: Not applicable
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Analysis 5.23. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 23 Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 23 Participant burden (retention rates)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Jelcic 2012 20/20 20/20 Not estimable
Kim 2015 22/22 21/21 Not estimable
Cavallo 2016 40/40 40/40 Not estimable
Mapelli 2013 10/10 10/10 Not estimable
Serino 2017 10/10 10/10 Not estimable
Kallio 2018 76/76 71/71 Not estimable
Davis 2001 19/19 18/18 Not estimable
Beck 1988 10/10 10/10 Not estimable
Trebbastoni 2018 48/54 86/86 4.8 % 0.04 [ 0.00, 0.78 ]
Quintana Hernandez 2014 27/32 25/25 4.7 % 0.10 [ 0.01, 1.86 ]
Koltai 2001 14/16 8/8 4.1 % 0.34 [ 0.01, 7.98 ]
Kao 2016 95/110 45/48 17.3 % 0.42 [ 0.12, 1.53 ]
Cahn-Weiner 2003 16/19 17/20 11.3 % 0.94 [ 0.17, 5.36 ]
Giuli 2016 48/51 47/50 12.3 % 1.02 [ 0.20, 5.32 ]
Amieva 2016 124/170 109/154 38.1 % 1.11 [ 0.69, 1.81 ]
Neely 2009 10/10 9/10 3.8 % 3.32 [ 0.12, 91.60 ]
Galante 2007 7/7 4/5 3.6 % 5.00 [ 0.17, 150.92 ]
Total (95% CI) 676 606 100.0 % 0.73 [ 0.37, 1.43 ]
Total events: 596 (Cognitive training), 550 (Control)
Heterogeneity: Tau2 = 0.25; Chi2 = 10.82, df = 8 (P = 0.21); I2 =26%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Not applicable
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Analysis 5.24. Comparison 5 Cognitive training vs control immediately post intervention - risk of bias,
Outcome 24 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 5 Cognitive training vs control immediately post intervention - risk of bias
Outcome: 24 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 -24.76 (37.3) 18 4.77 (40.85) 14.0 % -0.74 [ -1.41, -0.07 ]
Quayhagen 2000 21 -0.38 (2.75) 67 0.13 (2.6) 18.8 % -0.19 [ -0.68, 0.30 ]
Amieva 2016 164 -6.3 (6.13) 151 -5.6 (6.35) 27.8 % -0.11 [ -0.33, 0.11 ]
Kallio 2018 76 -0.04 (0.06) 71 -0.04 (0.06) 24.4 % 0.0 [ -0.32, 0.32 ]
Kim 2015 22 3.4 (3.3) 21 0 (4.36) 15.0 % 0.87 [ 0.24, 1.49 ]
Total (95% CI) 302 328 100.0 % -0.04 [ -0.38, 0.29 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 12.93, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 6.1. Comparison 6 Cognitive training vs control immediately post intervention - intervention dose,
Outcome 1 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 1 Change in a global measure of cognition
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Galante 2007 7 0.1 (2.34) 4 1.8 (1.74) 3.7 % -0.72 [ -2.00, 0.56 ]
Giuli 2016 48 0.02 (2.77) 47 1.24 (3.77) 5.7 % -0.37 [ -0.77, 0.04 ]
Koltai 2001 (1) 14 -0.21 (2.9) 8 0.75 (2.4) 4.6 % -0.34 [ -1.21, 0.54 ]
Amieva 2016 168 -8.4 (5.86) 153 -7.6 (5.43) 5.9 % -0.14 [ -0.36, 0.08 ]
Heiss 1993 18 -1.22 (4.22) 17 -0.94 (3.59) 5.1 % -0.07 [ -0.73, 0.59 ]
Davis 2001 19 0.16 (2.6) 18 0.22 (2.68) 5.2 % -0.02 [ -0.67, 0.62 ]
Lee 2013 12 2.01 (2.86) 7 2 (1.9) 4.5 % 0.00 [ -0.93, 0.94 ]
Cavallo 2016 40 -0.14 (1.04) 40 -0.16 (1.62) 5.6 % 0.01 [ -0.42, 0.45 ]
Barban 2016 42 0.1 (1.64) 39 -0.1 (1.15) 5.6 % 0.14 [ -0.30, 0.58 ]
Kallio 2018 76 -0.8 (5.19) 71 -1.6 (5.35) 5.8 % 0.15 [ -0.17, 0.48 ]
Jelcic 2014 17 2 (1.47) 10 -0.7 (2.41) 4.6 % 1.40 [ 0.52, 2.28 ]
Jelcic 2012 20 2 (1.68) 20 -1 (1.98) 5.0 % 1.60 [ 0.88, 2.32 ]
de Vreese 1998 9 2.77 (1.68) 9 -0.89 (2.4) 4.1 % 1.68 [ 0.57, 2.80 ]
Trebbastoni 2018 48 1.53 (1.7) 86 -2.64 (2.07) 5.6 % 2.13 [ 1.69, 2.57 ]
Fern ndez-Calvo 2011 30 1.12 (1.64) 15 -2.31 (1.16) 4.9 % 2.25 [ 1.46, 3.03 ]
Subtotal (95% CI) 568 544 76.0 % 0.51 [ 0.06, 0.95 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 150.50, df = 14 (P<0.00001); I2 =91%
Test for overall effect: Z = 2.23 (P = 0.026)
2 More than 3 times
Venturelli 2016 20 -0.2 (0.97) 20 -0.4 (1.14) 5.2 % 0.19 [ -0.44, 0.81 ]
Kawashima 2005 16 0.1 (5.1) 16 -1.8 (3.75) 5.1 % 0.41 [ -0.29, 1.12 ]
Quintana Hernandez 2014 27 -4.48 (4.08) 25 -7.48 (3.49) 5.4 % 0.78 [ 0.21, 1.34 ]
Mapelli 2013 10 2.9 (2.59) 10 -0.3 (1.71) 4.3 % 1.40 [ 0.40, 2.40 ]
Bergamaschi 2013 16 2.75 (1.81) 16 -3.57 (1.81) 4.0 % 3.40 [ 2.28, 4.53 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 89 87 24.0 % 1.14 [ 0.27, 2.01 ]
Heterogeneity: Tau2 = 0.82; Chi2 = 26.74, df = 4 (P = 0.00002); I2 =85%
Test for overall effect: Z = 2.56 (P = 0.011)
Total (95% CI) 657 631 100.0 % 0.65 [ 0.26, 1.05 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 187.26, df = 19 (P<0.00001); I2 =90%
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Chi2 = 1.61, df = 1 (P = 0.20), I2 =38%
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
Analysis 6.2. Comparison 6 Cognitive training vs control immediately post intervention - intervention dose,
Outcome 2 Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 2 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Galante 2007 7 0.1 (4.98) 4 1.8 (3.33) 2.4 % -0.35 [ -1.59, 0.90 ]
Koltai 2001 (1) 14 -0.21 (5.8) 8 0.75 (4.8) 3.8 % -0.17 [ -1.04, 0.70 ]
Giuli 2016 48 0.02 (6.16) 47 1.24 (8.42) 6.5 % -0.16 [ -0.57, 0.24 ]
Amieva 2016 168 -8.4 (8.71) 152 -7.6 (5.43) 7.5 % -0.11 [ -0.33, 0.11 ]
Heiss 1993 18 -1.22 (8.13) 17 -0.94 (7.18) 4.9 % -0.04 [ -0.70, 0.63 ]
Davis 2001 19 0.16 (5.82) 18 0.22 (5.86) 5.0 % -0.01 [ -0.65, 0.63 ]
Lee 2013 12 2.01 (6.23) 7 2 (4.18) 3.5 % 0.00 [ -0.93, 0.93 ]
Cavallo 2016 40 -0.14 (2.25) 40 -0.16 (2.75) 6.3 % 0.01 [ -0.43, 0.45 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Barban 2016 42 0.1 (3.3) 39 -0.1 (2.55) 6.3 % 0.07 [ -0.37, 0.50 ]
Kallio 2018 76 -0.8 (11.6) 71 -1.6 (11.95) 7.0 % 0.07 [ -0.26, 0.39 ]
Jelcic 2014 17 2 (3.18) 10 -0.7 (5) 4.1 % 0.67 [ -0.14, 1.47 ]
Jelcic 2012 20 2 (3.62) 20 -1 (4.2) 5.0 % 0.75 [ 0.11, 1.39 ]
de Vreese 1998 9 2.77 (3.48) 9 -0.89 (5.22) 3.3 % 0.79 [ -0.18, 1.75 ]
Trebbastoni 2018 48 1.53 (3.68) 86 -2.64 (4.39) 6.7 % 1.00 [ 0.63, 1.37 ]
Fern ndez-Calvo 2011 30 1.12 (3.64) 15 -2.31 (2.57) 4.9 % 1.01 [ 0.35, 1.67 ]
Subtotal (95% CI) 568 543 77.1 % 0.23 [ -0.01, 0.47 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 43.26, df = 14 (P = 0.00008); I2 =68%
Test for overall effect: Z = 1.90 (P = 0.058)
2 More than 3 times
Venturelli 2016 20 -2 (2.13) 20 -0.4 (2.42) 5.0 % -0.69 [ -1.33, -0.05 ]
Kawashima 2005 16 0.1 (11.01) 16 -1.8 (8.22) 4.7 % 0.19 [ -0.50, 0.89 ]
Quintana Hernandez 2014 27 -4.48 (6.86) 25 -7.48 (5.65) 5.5 % 0.47 [ -0.08, 1.02 ]
Mapelli 2013 10 1.07 (1.75) 10 0.33 (0.42) 3.6 % 0.56 [ -0.34, 1.45 ]
Bergamaschi 2013 16 2.75 (3.56) 16 -3.57 (3.58) 4.0 % 1.73 [ 0.90, 2.55 ]
Subtotal (95% CI) 89 87 22.9 % 0.42 [ -0.30, 1.15 ]
Heterogeneity: Tau2 = 0.55; Chi2 = 21.30, df = 4 (P = 0.00028); I2 =81%
Test for overall effect: Z = 1.14 (P = 0.25)
Total (95% CI) 657 630 100.0 % 0.27 [ 0.04, 0.50 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 65.70, df = 19 (P<0.00001); I2 =71%
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Chi2 = 0.24, df = 1 (P = 0.62), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. We multiplied the SD they
provided by 2.
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Analysis 6.3. Comparison 6 Cognitive training vs control immediately post intervention - intervention dose,
Outcome 3 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 3 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Amieva 2016 165 153 -0.11 (0.11) 6.6 % -0.11 [ -0.33, 0.11 ]
Barban 2016 41 38 0.21 (0.23) 5.1 % 0.21 [ -0.24, 0.66 ]
Beck 1988 10 10 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.8 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 40 40 1.32 (0.28) 4.5 % 1.32 [ 0.77, 1.87 ]
Davis 2001 19 18 0 (0.32) 4.0 % 0.0 [ -0.63, 0.63 ]
de Vreese 1998 9 9 1.04 (0.49) 2.5 % 1.04 [ 0.08, 2.00 ]
Fern ndez-Calvo 2011 30 15 -0.44 (0.42) 3.0 % -0.44 [ -1.26, 0.38 ]
Galante 2007 7 4 0.21 (0.63) 1.8 % 0.21 [ -1.02, 1.44 ]
Giuli 2016 48 47 0.37 (0.21) 5.4 % 0.37 [ -0.04, 0.78 ]
Heiss 1993 18 17 0.27 (0.34) 3.8 % 0.27 [ -0.40, 0.94 ]
Jelcic 2012 20 20 0.6 (0.32) 4.0 % 0.60 [ -0.03, 1.23 ]
Jelcic 2014 17 10 0.55 (0.4) 3.2 % 0.55 [ -0.23, 1.33 ]
Kim 2015 22 21 0.46 (0.32) 4.0 % 0.46 [ -0.17, 1.09 ]
Koltai 2001 14 8 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Lee 2013 12 7 1.15 (0.53) 2.3 % 1.15 [ 0.11, 2.19 ]
Neely 2009 20 9 0.26 (0.39) 3.3 % 0.26 [ -0.50, 1.02 ]
Quayhagen 2000 21 15 0.19 (0.33) 3.9 % 0.19 [ -0.46, 0.84 ]
Serino 2017 10 10 0.31 (0.44) 2.9 % 0.31 [ -0.55, 1.17 ]
Trebbastoni 2018 45 85 0.55 (0.2) 5.5 % 0.55 [ 0.16, 0.94 ]
Subtotal (95% CI) 585 553 75.7 % 0.33 [ 0.13, 0.53 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 40.24, df = 19 (P = 0.003); I2 =53%
Test for overall effect: Z = 3.22 (P = 0.0013)
2 More than 3 times
-4 -2 0 2 4
Control Cognitive training
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Bergamaschi 2013 16 16 1.64 (0.41) 3.1 % 1.64 [ 0.84, 2.44 ]
Boller 2011 24 12 0.13 (0.35) 3.7 % 0.13 [ -0.56, 0.82 ]
Kawashima 2005 16 16 0.52 (0.36) 3.6 % 0.52 [ -0.19, 1.23 ]
Mapelli 2013 10 10 2.13 (0.66) 1.6 % 2.13 [ 0.84, 3.42 ]
Quayhagen 1995 (1) 13 28 0.25 (0.33) 3.9 % 0.25 [ -0.40, 0.90 ]
Quayhagen 1995 (2) 13 25 0.37 (0.34) 3.8 % 0.37 [ -0.30, 1.04 ]
Quintana Hernandez 2014 27 25 0.73 (0.28) 4.5 % 0.73 [ 0.18, 1.28 ]
Subtotal (95% CI) 119 132 24.3 % 0.71 [ 0.27, 1.14 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 15.41, df = 6 (P = 0.02); I2 =61%
Test for overall effect: Z = 3.16 (P = 0.0016)
Total (95% CI) 704 685 100.0 % 0.42 [ 0.23, 0.61 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 62.80, df = 26 (P = 0.00007); I2 =59%
Test for overall effect: Z = 4.32 (P = 0.000015)
Test for subgroup differences: Chi2 = 2.39, df = 1 (P = 0.12), I2 =58%
-4 -2 0 2 4
Control Cognitive training
(1) CT vs Active Control
(2) CT vs Passive Control
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Analysis 6.4. Comparison 6 Cognitive training vs control immediately post intervention - intervention dose,
Outcome 4 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 4 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Amieva 2016 166 153 -0.07 (0.11) 15.9 % -0.07 [ -0.29, 0.15 ]
Barban 2016 41 38 0.1 (0.22) 6.3 % 0.10 [ -0.33, 0.53 ]
Beck 1988 10 10 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.0 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 40 40 0.61 (0.23) 5.9 % 0.61 [ 0.16, 1.06 ]
Davis 2001 19 18 0 (0.32) 3.3 % 0.0 [ -0.63, 0.63 ]
de Vreese 1998 9 9 0.48 (0.46) 1.7 % 0.48 [ -0.42, 1.38 ]
Fern ndez-Calvo 2011 30 15 -0.29 (0.34) 3.0 % -0.29 [ -0.96, 0.38 ]
Galante 2007 7 4 0.12 (0.59) 1.1 % 0.12 [ -1.04, 1.28 ]
Giuli 2016 48 47 0.17 (0.2) 7.3 % 0.17 [ -0.22, 0.56 ]
Heiss 1993 18 17 0.15 (0.33) 3.1 % 0.15 [ -0.50, 0.80 ]
Jelcic 2012 20 20 0.28 (0.31) 3.5 % 0.28 [ -0.33, 0.89 ]
Jelcic 2014 17 10 0.27 (0.39) 2.3 % 0.27 [ -0.49, 1.03 ]
Kim 2015 22 21 0.2 (0.3) 3.7 % 0.20 [ -0.39, 0.79 ]
Koltai 2001 14 8 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Lee 2013 12 7 0.6 (0.47) 1.6 % 0.60 [ -0.32, 1.52 ]
Neely 2009 20 9 0.26 (0.39) 2.3 % 0.26 [ -0.50, 1.02 ]
Quayhagen 2000 21 15 0.8 (0.35) 2.8 % 0.80 [ 0.11, 1.49 ]
Serino 2017 10 10 0.16 (0.43) 1.9 % 0.16 [ -0.68, 1.00 ]
Trebbastoni 2018 45 85 0.26 (0.19) 7.9 % 0.26 [ -0.11, 0.63 ]
Subtotal (95% CI) 586 553 80.5 % 0.14 [ 0.02, 0.26 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 16.04, df = 19 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 2.34 (P = 0.020)
2 More than 3 times
-4 -2 0 2 4
Control Cognitive training
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Bergamaschi 2013 16 16 0.78 (0.36) 2.7 % 0.78 [ 0.07, 1.49 ]
Boller 2011 24 12 0.06 (0.35) 2.8 % 0.06 [ -0.63, 0.75 ]
Kawashima 2005 16 16 0.23 (0.35) 2.8 % 0.23 [ -0.46, 0.92 ]
Mapelli 2013 10 10 1.06 (0.55) 1.2 % 1.06 [ -0.02, 2.14 ]
Quayhagen 1995 (1) 13 25 1.03 (0.36) 2.7 % 1.03 [ 0.32, 1.74 ]
Quayhagen 1995 (2) 13 28 0.55 (0.33) 3.1 % 0.55 [ -0.10, 1.20 ]
Quintana Hernandez 2014 0 0 0.46 (0.28) 4.2 % 0.46 [ -0.09, 1.01 ]
Subtotal (95% CI) 92 107 19.5 % 0.54 [ 0.28, 0.80 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 5.94, df = 6 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 4.07 (P = 0.000046)
Total (95% CI) 678 660 100.0 % 0.24 [ 0.12, 0.36 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 29.59, df = 26 (P = 0.29); I2 =12%
Test for overall effect: Z = 3.89 (P = 0.000099)
Test for subgroup differences: Chi2 = 7.61, df = 1 (P = 0.01), I2 =87%
-4 -2 0 2 4
Control Cognitive training
(1) CT vs Passive control
(2) CT vs Active control
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Analysis 6.5. Comparison 6 Cognitive training vs control immediately post intervention - intervention dose,
Outcome 5 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 5 Change in immediate memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Koltai 2001 14 0.64 (1.7) 8 1.63 (2.8) 5.1 % -0.44 [ -1.32, 0.44 ]
Galante 2007 7 -0.2 (5.3) 4 1.2 (7.77) 4.0 % -0.21 [ -1.44, 1.03 ]
Jelcic 2014 17 0.66 (5.53) 10 -0.3 (4.82) 5.5 % 0.18 [ -0.61, 0.96 ]
Quayhagen 2000 21 2.29 (12.1) 15 -0.73 (12.08) 5.9 % 0.24 [ -0.42, 0.91 ]
Heiss 1993 18 0.41 (0.97) 17 0.09 (1) 5.8 % 0.32 [ -0.35, 0.99 ]
Cahn-Weiner 2003 17 -0.4 (2.76) 17 -1.7 (2.97) 5.8 % 0.44 [ -0.24, 1.12 ]
Davis 2001 19 1.43 (3.52) 18 -0.22 (3.71) 5.9 % 0.45 [ -0.21, 1.10 ]
Giuli 2016 48 0.65 (1.74) 47 -0.17 (1.74) 6.6 % 0.47 [ 0.06, 0.88 ]
Quayhagen 1995 (1) 13 4.7 (10.56) 28 -0.1 (7.84) 5.8 % 0.54 [ -0.13, 1.21 ]
Jelcic 2012 20 2.9 (5.62) 20 -0.2 (5.43) 6.0 % 0.55 [ -0.08, 1.18 ]
Neely 2009 20 -0.1 (1.75) 9 -1.5 (1.25) 5.3 % 0.84 [ 0.02, 1.66 ]
Trebbastoni 2018 45 4.01 (4.6) 85 -0.7 (3.98) 6.7 % 1.11 [ 0.73, 1.50 ]
Lee 2013 12 8.08 (3.25) 7 1.29 (1.81) 4.0 % 2.29 [ 1.05, 3.54 ]
Cavallo 2016 40 2.26 (0.71) 40 -0.79 (1) 5.7 % 3.48 [ 2.78, 4.19 ]
Subtotal (95% CI) 311 325 78.2 % 0.73 [ 0.27, 1.19 ]
Heterogeneity: Tau2 = 0.63; Chi2 = 86.44, df = 13 (P<0.00001); I2 =85%
Test for overall effect: Z = 3.10 (P = 0.0019)
2 More than 3 times
Boller 2011 24 -0.04 (2.98) 12 -0.92 (2.93) 5.7 % 0.29 [ -0.41, 0.99 ]
Bergamaschi 2013 16 1.12 (2) 16 -0.13 (1.63) 5.7 % 0.67 [ -0.05, 1.38 ]
Quayhagen 1995 (2) 13 4.7 (10.56) 25 -1.8 (6.19) 5.7 % 0.80 [ 0.11, 1.50 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.7 (1.58) 4.6 % 1.58 [ 0.55, 2.61 ]
Subtotal (95% CI) 63 63 21.8 % 0.74 [ 0.29, 1.19 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 4.19, df = 3 (P = 0.24); I2 =28%
Test for overall effect: Z = 3.22 (P = 0.0013)
-4 -2 0 2 4
Control Cognitive training
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 374 388 100.0 % 0.74 [ 0.37, 1.12 ]
Heterogeneity: Tau2 = 0.51; Chi2 = 90.65, df = 17 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.89 (P = 0.000098)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.97), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Cognitive training vs. Active control
(2) Cognitive training vs. Passive control
Analysis 6.6. Comparison 6 Cognitive training vs control immediately post intervention - intervention dose,
Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 1.15 (2.23) 18 1.65 (3.72) 9.4 % -0.16 [ -0.81, 0.49 ]
Boller 2011 24 -0.29 (1.58) 12 -0.08 (1.28) 9.2 % -0.14 [ -0.83, 0.56 ]
Cahn-Weiner 2003 17 -0.3 (1.05) 17 -0.8 (1.58) 9.2 % 0.36 [ -0.31, 1.04 ]
Quayhagen 2000 21 3.2 (6.89) 15 0.4 (7.55) 9.3 % 0.38 [ -0.29, 1.05 ]
Barban 2016 42 0.4 (1.17) 39 -0.1 (1.11) 10.2 % 0.43 [ -0.01, 0.88 ]
Trebbastoni 2018 45 0.06 (1.26) 85 -0.55 (1.36) 10.4 % 0.46 [ 0.09, 0.82 ]
Koltai 2001 14 0.64 (1.3) 8 -0.25 (1.8) 8.3 % 0.57 [ -0.32, 1.46 ]
Jelcic 2014 17 0.86 (2.17) 10 -1.3 (1.84) 8.5 % 1.02 [ 0.18, 1.85 ]
Jelcic 2012 20 1.5 (2.34) 20 -0.9 (2.04) 9.3 % 1.07 [ 0.40, 1.74 ]
Mapelli 2013 (1) 10 4.2 (2.35) 10 -0.8 (1.48) 6.8 % 2.44 [ 1.22, 3.65 ]
-4 -2 0 2 4
Control Cognitive training
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 1.24 (1.04) 40 -1.74 (1) 9.4 % 2.89 [ 2.26, 3.53 ]
Total (95% CI) 269 274 100.0 % 0.81 [ 0.29, 1.32 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 72.73, df = 10 (P<0.00001); I2 =86%
Test for overall effect: Z = 3.05 (P = 0.0023)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Cognitive training vs passive control
Analysis 6.7. Comparison 6 Cognitive training vs control immediately post intervention - intervention dose,
Outcome 7 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 7 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heiss 1993 18 -0.64 (1) 17 -0.03 (0.98) 8.7 % -0.60 [ -1.28, 0.08 ]
Galante 2007 7 0.1 (0.66) 4 0.7 (1.52) 6.1 % -0.53 [ -1.79, 0.73 ]
Trebbastoni 2018 45 -0.3 (0.58) 85 -0.24 (0.65) 9.9 % -0.10 [ -0.46, 0.27 ]
Boller 2011 24 0 (1.11) 12 0.08 (0.92) 8.6 % -0.07 [ -0.77, 0.62 ]
Davis 2001 19 -0.41 (1.55) 18 -0.47 (1.56) 8.8 % 0.04 [ -0.61, 0.68 ]
Serino 2017 10 0 (0.91) 10 -0.33 (0.58) 7.8 % 0.41 [ -0.47, 1.30 ]
Giuli 2016 48 0.32 (0.9) 47 -0.2 (0.96) 9.7 % 0.55 [ 0.14, 0.96 ]
Beck 1988 (1) 10 0.7 (0.95) 10 -0.2 (1.32) 7.6 % 0.75 [ -0.16, 1.66 ]
Jelcic 2012 20 0.2 (0.55) 20 -0.4 (0.55) 8.7 % 1.07 [ 0.40, 1.74 ]
Mapelli 2013 10 1.7 (1.24) 10 -0.1 (1.29) 7.3 % 1.36 [ 0.37, 2.36 ]
-4 -2 0 2 4
Control Cognitive training
(Continued . . . )
241Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Jelcic 2014 17 0.32 (1) 10 -1.35 (0.59) 7.5 % 1.85 [ 0.90, 2.80 ]
Cavallo 2016 40 1.89 (0.99) 40 -0.04 (0.89) 9.2 % 2.03 [ 1.49, 2.57 ]
Total (95% CI) 268 283 100.0 % 0.56 [ 0.08, 1.05 ]
Heterogeneity: Tau2 = 0.59; Chi2 = 71.95, df = 11 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
Analysis 6.8. Comparison 6 Cognitive training vs control immediately post intervention - intervention dose,
Outcome 8 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 8 Change in language (naming)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 0.19 (1.55) 40 0.1 (1.32) 22.9 % 0.06 [ -0.38, 0.50 ]
Cahn-Weiner 2003 17 0.3 (3.55) 17 -0.1 (3.48) 18.6 % 0.11 [ -0.56, 0.78 ]
Jelcic 2012 20 3.5 (5.63) 20 -0.8 (4.61) 19.0 % 0.82 [ 0.17, 1.47 ]
Jelcic 2014 17 2.19 (2.56) 10 -0.4 (2.41) 15.8 % 1.00 [ 0.17, 1.83 ]
Trebbastoni 2018 45 2 (3.35) 85 -1.81 (3.34) 23.8 % 1.13 [ 0.75, 1.52 ]
Total (95% CI) 139 172 100.0 % 0.62 [ 0.11, 1.12 ]
Heterogeneity: Tau2 = 0.24; Chi2 = 16.29, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 2.39 (P = 0.017)
Test for subgroup differences: Not applicable
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Analysis 6.9. Comparison 6 Cognitive training vs control immediately post intervention - intervention dose,
Outcome 9 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 9 Change in verbal letter fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Serino 2017 10 -1.6 (3.47) 10 0.2 (4.8) 6.3 % -0.41 [ -1.30, 0.48 ]
Cavallo 2016 40 1.17 (1.62) 40 1.53 (1.6) 11.6 % -0.22 [ -0.66, 0.22 ]
Davis 2001 19 0.22 (7.7) 18 1.33 (9.03) 8.8 % -0.13 [ -0.78, 0.52 ]
Cahn-Weiner 2003 17 0.3 (5.95) 17 1 (4.62) 8.4 % -0.13 [ -0.80, 0.54 ]
Barban 2016 42 1.4 (5.66) 39 1.1 (6.04) 11.6 % 0.05 [ -0.39, 0.49 ]
Jelcic 2012 20 1.7 (7.56) 20 1.3 (7.41) 9.1 % 0.05 [ -0.57, 0.67 ]
Jelcic 2014 17 2.27 (7.6) 10 1.6 (6.93) 7.3 % 0.09 [ -0.69, 0.87 ]
Trebbastoni 2018 45 -0.17 (4.89) 85 -2.03 (5) 12.6 % 0.37 [ 0.01, 0.74 ]
Galante 2007 7 3.5 (5.74) 4 -1.7 (6.97) 3.7 % 0.77 [ -0.52, 2.06 ]
Subtotal (95% CI) 217 243 79.4 % 0.05 [ -0.13, 0.24 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 7.28, df = 8 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 0.57 (P = 0.57)
2 More than 3 times
Kawashima 2005 16 0.1 (0.55) 16 0 (0.44) 8.2 % 0.20 [ -0.50, 0.89 ]
Mapelli 2013 10 1.2 (1.51) 10 -0.64 (1.12) 5.5 % 1.33 [ 0.34, 2.31 ]
Bergamaschi 2013 16 1.06 (1.39) 16 -1.72 (1.97) 7.0 % 1.59 [ 0.78, 2.40 ]
Subtotal (95% CI) 42 42 20.6 % 1.00 [ 0.09, 1.92 ]
Heterogeneity: Tau2 = 0.48; Chi2 = 7.45, df = 2 (P = 0.02); I2 =73%
Test for overall effect: Z = 2.15 (P = 0.032)
Total (95% CI) 259 285 100.0 % 0.22 [ -0.07, 0.50 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 25.86, df = 11 (P = 0.01); I2 =57%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 3.96, df = 1 (P = 0.05), I2 =75%
-2 -1 0 1 2
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Analysis 6.10. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 10 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 10 Change in speed of information processing
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Beck 1988 10 -0.3 (1.25) 10 1.1 (2.88) 11.3 % -0.60 [ -1.51, 0.30 ]
Galante 2007 7 -1.3 (10.33) 4 3.3 (5.55) 6.3 % -0.47 [ -1.72, 0.79 ]
Jelcic 2014 17 0.47 (6.9) 10 -0.4 (8.16) 14.4 % 0.11 [ -0.67, 0.90 ]
Barban 2016 36 7.7 (27.35) 33 -1.9 (27.67) 30.0 % 0.35 [ -0.13, 0.82 ]
Jelcic 2012 20 19.3 (56.5) 20 -2 (20.58) 20.3 % 0.49 [ -0.14, 1.12 ]
Cahn-Weiner 2003 17 5.2 (20.62) 17 -9.6 (31.4) 17.8 % 0.54 [ -0.14, 1.23 ]
Total (95% CI) 107 94 100.0 % 0.22 [ -0.11, 0.54 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 6.24, df = 5 (P = 0.28); I2 =20%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 6.11. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 11 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 11 Change in executive function
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Cahn-Weiner 2003 17 6 (51.61) 17 33.3 (49.98) 8.9 % -0.52 [ -1.21, 0.16 ]
Galante 2007 7 -2.6 (8.27) 4 -2.3 (3.25) 6.2 % -0.04 [ -1.27, 1.19 ]
Cavallo 2016 40 -0.07 (0.79) 40 -0.26 (0.71) 10.0 % 0.25 [ -0.19, 0.69 ]
Jelcic 2012 20 13.2 (18.07) 20 6.6 (16.69) 9.2 % 0.37 [ -0.25, 1.00 ]
Serino 2017 10 0.22 (2.24) 10 -0.66 (2.01) 7.9 % 0.40 [ -0.49, 1.28 ]
Neely 2009 20 -0.03 (0.15) 9 -0.16 (0.52) 8.3 % 0.41 [ -0.39, 1.20 ]
Trebbastoni 2018 45 0.96 (2.07) 85 -1.3 (2.19) 10.2 % 1.05 [ 0.66, 1.43 ]
Quayhagen 2000 21 5.91 (2.31) 15 -2.6 (3.8) 7.6 % 2.76 [ 1.81, 3.71 ]
Subtotal (95% CI) 180 200 68.4 % 0.57 [ 0.01, 1.13 ]
Heterogeneity: Tau2 = 0.50; Chi2 = 39.93, df = 7 (P<0.00001); I2 =82%
Test for overall effect: Z = 2.01 (P = 0.045)
2 More than 3 times
Kawashima 2005 16 15 (18) 16 -6 (197) 8.9 % 0.15 [ -0.55, 0.84 ]
Quayhagen 1995 (1) 13 4.8 (7.28) 28 0.4 (6.6) 9.0 % 0.63 [ -0.04, 1.31 ]
Quayhagen 1995 (2) 13 4.8 (7.28) 25 -3.6 (6.44) 8.7 % 1.22 [ 0.49, 1.95 ]
Mapelli 2013 (3) 10 2.3 (0.52) 10 -0.2 (0.79) 5.1 % 3.58 [ 2.06, 5.10 ]
Subtotal (95% CI) 52 79 31.6 % 1.20 [ 0.20, 2.20 ]
Heterogeneity: Tau2 = 0.83; Chi2 = 17.78, df = 3 (P = 0.00049); I2 =83%
Test for overall effect: Z = 2.34 (P = 0.019)
Total (95% CI) 232 279 100.0 % 0.75 [ 0.28, 1.22 ]
Heterogeneity: Tau2 = 0.52; Chi2 = 58.99, df = 11 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.15 (P = 0.0017)
Test for subgroup differences: Chi2 = 1.14, df = 1 (P = 0.29), I2 =12%
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(1) Cognitive training vs. Active control
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(3) Cognitive training vs. Passive control
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Analysis 6.12. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 12 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 12 Change in verbal category fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 0 (2.98) 4 0.1 (4.16) 4.5 % -0.03 [ -1.26, 1.20 ]
Serino 2017 10 0.7 (2.91) 10 0.5 (3.99) 7.5 % 0.05 [ -0.82, 0.93 ]
Jelcic 2012 20 1.5 (5.72) 20 1 (5.78) 11.3 % 0.09 [ -0.53, 0.71 ]
Davis 2001 19 1.5 (3.67) 18 0.95 (3.37) 10.8 % 0.15 [ -0.49, 0.80 ]
Jelcic 2014 17 1.39 (4.71) 10 0.4 (5.46) 8.7 % 0.19 [ -0.59, 0.98 ]
Giuli 2016 48 0.15 (0.73) 47 -0.17 (0.67) 16.0 % 0.45 [ 0.05, 0.86 ]
Heiss 1993 18 1.66 (3.52) 17 -1.07 (3.13) 10.0 % 0.80 [ 0.11, 1.49 ]
Trebbastoni 2018 45 2.06 (4.84) 85 -2.93 (5.04) 16.6 % 1.00 [ 0.62, 1.38 ]
Cavallo 2016 40 0.34 (1.22) 40 -0.95 (1.21) 14.5 % 1.05 [ 0.58, 1.52 ]
Total (95% CI) 224 251 100.0 % 0.52 [ 0.23, 0.81 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 16.57, df = 8 (P = 0.03); I2 =52%
Test for overall effect: Z = 3.49 (P = 0.00049)
Test for subgroup differences: Not applicable
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Analysis 6.13. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 13 Change in meta cognition (self-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 13 Change in meta cognition (self-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -6.43 (14.3) 8 -1 (14.1) 51.9 % -0.37 [ -1.24, 0.51 ]
Lee 2013 12 0.27 (0.29) 7 0.08 (0.26) 48.1 % 0.65 [ -0.31, 1.61 ]
Total (95% CI) 26 15 100.0 % 0.12 [ -0.87, 1.12 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 2.34, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 6.14. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 14 Change in meta cognition (informant-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 14 Change in meta cognition (informant-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -3.54 (14.7) 8 5.75 (10.4) 37.3 % -0.67 [ -1.56, 0.23 ]
Cahn-Weiner 2003 17 -4.8 (16.55) 17 6.6 (18.54) 62.7 % -0.63 [ -1.32, 0.06 ]
Total (95% CI) 31 25 100.0 % -0.65 [ -1.19, -0.10 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.021)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 6.15. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 15 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 15 Change in participants’ mood
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -1.21 (2.5) 8 0.13 (3) 12.2 % -0.48 [ -1.36, 0.40 ]
Bergamaschi 2013 16 -1.07 (2.98) 16 0.44 (5.09) 12.9 % -0.35 [ -1.05, 0.35 ]
Amieva 2016 164 -12.11 (12.73) 152 -10.81 (12.24) 14.1 % -0.10 [ -0.32, 0.12 ]
Davis 2001 19 0.32 (1.52) 17 0.17 (4.41) 13.1 % 0.05 [ -0.61, 0.70 ]
Lee 2013 12 -0.25 (2.23) 7 -1.86 (2.77) 11.9 % 0.63 [ -0.33, 1.59 ]
Galante 2007 7 0.5 (0.92) 4 -0.3 (0.78) 10.5 % 0.84 [ -0.47, 2.14 ]
Giuli 2016 48 -0.18 (4.4) 47 -7.32 (3.77) 13.6 % 1.73 [ 1.25, 2.20 ]
Fern ndez-Calvo 2011 30 3.2 (2) 15 -4.26 (1.85) 11.7 % 3.75 [ 2.73, 4.78 ]
Total (95% CI) 310 266 100.0 % 0.72 [ -0.10, 1.54 ]
Heterogeneity: Tau2 = 1.23; Chi2 = 99.54, df = 7 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.73 (P = 0.084)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
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Analysis 6.16. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 16 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 16 Change in capacity for activities of daily living
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.6 (1.36) 4 0.5 (0.48) 2.6 % -0.88 [ -2.19, 0.43 ]
de Vreese 1998 9 -1.33 (4.37) 9 1.01 (3.98) 4.7 % -0.53 [ -1.48, 0.41 ]
Amieva 2016 167 -1.76 (8.46) 153 -1.22 (8.27) 23.8 % -0.06 [ -0.28, 0.16 ]
Cahn-Weiner 2003 17 -0.2 (3.16) 17 0 (3.07) 8.1 % -0.06 [ -0.74, 0.61 ]
Kim 2015 21 0 (0.86) 21 0 (1.05) 9.4 % 0.0 [ -0.60, 0.60 ]
Jelcic 2012 20 0.1 (1.05) 38 0 (1.36) 10.9 % 0.08 [ -0.46, 0.62 ]
Barban 2016 38 -0.1 (0.96) 38 -0.3 (1.08) 13.6 % 0.19 [ -0.26, 0.64 ]
Giuli 2016 48 0.26 (1.2) 47 -0.24 (1.26) 15.2 % 0.40 [ 0.00, 0.81 ]
Bergamaschi 2013 16 -0.38 (1.54) 16 -1.32 (1.46) 7.4 % 0.61 [ -0.10, 1.32 ]
Lee 2013 12 2.24 (3.33) 7 -2.14 (4.54) 4.2 % 1.10 [ 0.09, 2.11 ]
Total (95% CI) 355 350 100.0 % 0.12 [ -0.10, 0.34 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 14.29, df = 9 (P = 0.11); I2 =37%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 6.17. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 17 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 17 Change in disease progression
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fern ndez-Calvo 2011 30 -2.11 (2.24) 15 -7.07 (2.39) 16.5 % 2.13 [ 1.36, 2.90 ]
Lee 2013 12 7.59 (9.2) 7 0.86 (7.83) 13.2 % 0.74 [ -0.23, 1.70 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 14.3 % 0.57 [ -0.33, 1.46 ]
Quayhagen 1995 (1) 13 3.3 (7.5) 28 -1.7 (8.89) 18.5 % 0.58 [ -0.09, 1.25 ]
Quayhagen 1995 (2) 13 3.3 (7.5) 25 -4.4 (8.36) 17.8 % 0.93 [ 0.23, 1.64 ]
Quintana Hernandez 2014 27 -2.77 (6.39) 25 -12.28 (7.33) 19.7 % 1.37 [ 0.76, 1.97 ]
Total (95% CI) 105 110 100.0 % 1.07 [ 0.59, 1.55 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 11.99, df = 5 (P = 0.03); I2 =58%
Test for overall effect: Z = 4.40 (P = 0.000011)
Test for subgroup differences: Not applicable
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(1) CT vs Active
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Analysis 6.18. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 18 Change in behavioural and psychological symptoms of dementia (BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 18 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -1.3 (2.22) 4 2.5 (3.9) 12.3 % -1.20 [ -2.58, 0.18 ]
Amieva 2016 165 -25.22 (23.28) 152 -21.81 (22.11) 19.5 % -0.15 [ -0.37, 0.07 ]
Quayhagen 2000 21 -0.53 (10.23) 15 -0.47 (12.91) 17.4 % -0.01 [ -0.67, 0.66 ]
Quintana Hernandez 2014 27 -8.55 (12.88) 25 -13.36 (13.48) 18.1 % 0.36 [ -0.19, 0.91 ]
Kawashima 2005 16 0.45 (1.88) 16 -0.3 (1.56) 17.1 % 0.42 [ -0.28, 1.12 ]
Fern ndez-Calvo 2011 30 2.08 (2.27) 15 -4.23 (1.33) 15.6 % 3.08 [ 2.17, 3.99 ]
Total (95% CI) 266 227 100.0 % 0.44 [ -0.34, 1.22 ]
Heterogeneity: Tau2 = 0.80; Chi2 = 51.21, df = 5 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Not applicable
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Analysis 6.19. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 19 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 19 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heiss 1993 18 -0.64 (1) 17 -0.03 (0.98) 8.7 % -0.60 [ -1.28, 0.08 ]
Galante 2007 7 0.1 (0.66) 4 0.7 (1.52) 6.1 % -0.53 [ -1.79, 0.73 ]
Trebbastoni 2018 45 -0.3 (0.58) 85 -0.24 (0.65) 9.9 % -0.10 [ -0.46, 0.27 ]
Boller 2011 24 0 (1.11) 12 0.08 (0.92) 8.6 % -0.07 [ -0.77, 0.62 ]
Davis 2001 19 -0.41 (1.55) 18 -0.47 (1.56) 8.8 % 0.04 [ -0.61, 0.68 ]
Serino 2017 10 0 (0.91) 10 -0.33 (0.58) 7.8 % 0.41 [ -0.47, 1.30 ]
Giuli 2016 48 0.32 (0.9) 47 -0.2 (0.96) 9.7 % 0.55 [ 0.14, 0.96 ]
Beck 1988 (1) 10 0.7 (0.95) 10 -0.2 (1.32) 7.6 % 0.75 [ -0.16, 1.66 ]
Jelcic 2012 20 0.2 (0.55) 20 -0.4 (0.55) 8.7 % 1.07 [ 0.40, 1.74 ]
Mapelli 2013 10 1.7 (1.24) 10 -0.1 (1.29) 7.3 % 1.36 [ 0.37, 2.36 ]
Jelcic 2014 17 0.32 (1) 10 -1.35 (0.59) 7.5 % 1.85 [ 0.90, 2.80 ]
Cavallo 2016 40 1.89 (0.99) 40 -0.04 (0.89) 9.2 % 2.03 [ 1.49, 2.57 ]
Total (95% CI) 268 283 100.0 % 0.56 [ 0.08, 1.05 ]
Heterogeneity: Tau2 = 0.59; Chi2 = 71.95, df = 11 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 6.20. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 20 Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 20 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -21.31 (19.1) 152 -17.95 (19.01) 77.0 % -0.18 [ -0.40, 0.04 ]
Quayhagen 2000 21 -0.8 (4.05) 67 -1.29 (3.7) 23.0 % 0.13 [ -0.36, 0.62 ]
Total (95% CI) 186 219 100.0 % -0.11 [ -0.36, 0.15 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 6.21. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 21 Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 21 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 -0.62 (9.8) 15 -2.8 (16.52) 100.0 % 0.16 [ -0.50, 0.83 ]
Total (95% CI) 21 15 100.0 % 0.16 [ -0.50, 0.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 6.22. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 22 Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 22 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 0.09 (0.06) 15 0.03 (0.06) 100.0 % 0.98 [ 0.27, 1.68 ]
Total (95% CI) 21 15 100.0 % 0.98 [ 0.27, 1.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.72 (P = 0.0065)
Test for subgroup differences: Not applicable
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Analysis 6.23. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 23 Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 23 Participant burden (retention rates)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Up to 3 times
Jelcic 2012 20/20 20/20 Not estimable
Cavallo 2016 40/40 40/40 Not estimable
Kim 2015 22/22 21/21 Not estimable
Serino 2017 10/10 10/10 Not estimable
Kallio 2018 76/76 71/71 Not estimable
Beck 1988 10/10 10/10 Not estimable
Davis 2001 19/19 18/18 Not estimable
Trebbastoni 2018 48/54 86/86 4.8 % 0.04 [ 0.00, 0.78 ]
Koltai 2001 14/16 8/8 4.1 % 0.34 [ 0.01, 7.98 ]
Cahn-Weiner 2003 16/19 17/20 11.3 % 0.94 [ 0.17, 5.36 ]
Giuli 2016 48/51 47/50 12.3 % 1.02 [ 0.20, 5.32 ]
Amieva 2016 124/170 109/154 38.1 % 1.11 [ 0.69, 1.81 ]
Neely 2009 10/10 9/10 3.8 % 3.32 [ 0.12, 91.60 ]
Galante 2007 7/7 4/5 3.6 % 5.00 [ 0.17, 150.92 ]
Subtotal (95% CI) 524 523 78.0 % 0.98 [ 0.53, 1.81 ]
Total events: 464 (Cognitive training), 470 (Control)
Heterogeneity: Tau2 = 0.10; Chi2 = 6.71, df = 6 (P = 0.35); I2 =11%
Test for overall effect: Z = 0.07 (P = 0.94)
2 More than 3 times
Mapelli 2013 10/10 10/10 Not estimable
Quintana Hernandez 2014 27/32 25/25 4.7 % 0.10 [ 0.01, 1.86 ]
Kao 2016 95/110 45/48 17.3 % 0.42 [ 0.12, 1.53 ]
Subtotal (95% CI) 152 83 22.0 % 0.33 [ 0.10, 1.09 ]
Total events: 132 (Cognitive training), 80 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.81, df = 1 (P = 0.37); I2 =0.0%
Test for overall effect: Z = 1.82 (P = 0.069)
0.001 0.01 0.1 1 10 100 1000
Control Cognitive training
(Continued . . . )
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(. . . Continued)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total (95% CI) 676 606 100.0 % 0.73 [ 0.37, 1.43 ]
Total events: 596 (Cognitive training), 550 (Control)
Heterogeneity: Tau2 = 0.25; Chi2 = 10.82, df = 8 (P = 0.21); I2 =26%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 2.50, df = 1 (P = 0.11), I2 =60%
0.001 0.01 0.1 1 10 100 1000
Control Cognitive training
Analysis 6.24. Comparison 6 Cognitive training vs control immediately post intervention - intervention
dose, Outcome 24 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 6 Cognitive training vs control immediately post intervention - intervention dose
Outcome: 24 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 -24.76 (37.3) 18 4.77 (40.85) 14.0 % -0.74 [ -1.41, -0.07 ]
Quayhagen 2000 21 -0.38 (2.75) 67 0.13 (2.6) 18.8 % -0.19 [ -0.68, 0.30 ]
Amieva 2016 164 -6.3 (6.13) 151 -5.6 (6.35) 27.8 % -0.11 [ -0.33, 0.11 ]
Kallio 2018 76 -0.04 (0.06) 71 -0.04 (0.06) 24.4 % 0.0 [ -0.32, 0.32 ]
Kim 2015 22 3.4 (3.3) 21 0 (4.36) 15.0 % 0.87 [ 0.24, 1.49 ]
Total (95% CI) 302 328 100.0 % -0.04 [ -0.38, 0.29 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 12.93, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 7.1. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 1 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 1 Change in a global measure of cognition
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Galante 2007 7 0.1 (2.34) 4 1.8 (1.74) 3.7 % -0.72 [ -2.00, 0.56 ]
Giuli 2016 48 0.02 (2.77) 47 1.24 (3.77) 5.7 % -0.37 [ -0.77, 0.04 ]
Koltai 2001 (1) 14 -0.21 (2.9) 8 0.75 (2.4) 4.6 % -0.34 [ -1.21, 0.54 ]
Davis 2001 19 0.16 (2.6) 18 0.22 (2.68) 5.2 % -0.02 [ -0.67, 0.62 ]
Lee 2013 12 2.01 (2.86) 7 2 (1.9) 4.5 % 0.00 [ -0.93, 0.94 ]
Cavallo 2016 40 -0.14 (1.04) 40 -0.16 (1.62) 5.6 % 0.01 [ -0.42, 0.45 ]
Barban 2016 42 0.1 (1.64) 39 -0.1 (1.15) 5.6 % 0.14 [ -0.30, 0.58 ]
Kallio 2018 76 -0.8 (5.19) 71 -1.6 (5.35) 5.8 % 0.15 [ -0.17, 0.48 ]
Venturelli 2016 20 -0.2 (0.97) 20 -0.4 (1.14) 5.2 % 0.19 [ -0.44, 0.81 ]
Mapelli 2013 10 2.9 (2.59) 10 -0.3 (1.71) 4.3 % 1.40 [ 0.40, 2.40 ]
Jelcic 2014 17 2 (1.47) 10 -0.7 (2.41) 4.6 % 1.40 [ 0.52, 2.28 ]
Jelcic 2012 20 2 (1.68) 20 -1 (1.98) 5.0 % 1.60 [ 0.88, 2.32 ]
de Vreese 1998 9 2.77 (1.68) 9 -0.89 (2.4) 4.1 % 1.68 [ 0.57, 2.80 ]
Fern ndez-Calvo 2011 30 1.12 (1.64) 15 -2.31 (1.16) 4.9 % 2.25 [ 1.46, 3.03 ]
Subtotal (95% CI) 364 318 68.9 % 0.49 [ 0.09, 0.89 ]
Heterogeneity: Tau2 = 0.43; Chi2 = 71.62, df = 13 (P<0.00001); I2 =82%
Test for overall effect: Z = 2.42 (P = 0.015)
2 More than 3 months
Amieva 2016 168 -8.4 (5.86) 153 -7.6 (5.43) 5.9 % -0.14 [ -0.36, 0.08 ]
Heiss 1993 18 -1.22 (4.22) 17 -0.94 (3.59) 5.1 % -0.07 [ -0.73, 0.59 ]
Kawashima 2005 16 0.1 (5.1) 16 -1.8 (3.75) 5.1 % 0.41 [ -0.29, 1.12 ]
Quintana Hernandez 2014 27 -4.48 (4.08) 25 -7.48 (3.49) 5.4 % 0.78 [ 0.21, 1.34 ]
Trebbastoni 2018 48 1.53 (1.7) 86 -2.64 (2.07) 5.6 % 2.13 [ 1.69, 2.57 ]
Bergamaschi 2013 16 2.75 (1.81) 16 -3.57 (1.81) 4.0 % 3.40 [ 2.28, 4.53 ]
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Control Cognitive training
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 293 313 31.1 % 1.03 [ 0.04, 2.02 ]
Heterogeneity: Tau2 = 1.41; Chi2 = 114.21, df = 5 (P<0.00001); I2 =96%
Test for overall effect: Z = 2.05 (P = 0.041)
Total (95% CI) 657 631 100.0 % 0.65 [ 0.26, 1.05 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 187.26, df = 19 (P<0.00001); I2 =90%
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Chi2 = 0.99, df = 1 (P = 0.32), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
Analysis 7.2. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 2 Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 2 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Venturelli 2016 20 -2 (2.13) 20 -0.4 (2.42) 5.0 % -0.69 [ -1.33, -0.05 ]
Galante 2007 7 0.1 (4.98) 4 1.8 (3.33) 2.4 % -0.35 [ -1.59, 0.90 ]
Koltai 2001 (1) 14 -0.21 (5.8) 8 0.75 (4.8) 3.8 % -0.17 [ -1.04, 0.70 ]
Giuli 2016 48 0.02 (6.16) 47 1.24 (8.42) 6.5 % -0.16 [ -0.57, 0.24 ]
Davis 2001 19 0.16 (5.82) 18 0.22 (5.86) 5.0 % -0.01 [ -0.65, 0.63 ]
Lee 2013 12 2.01 (6.23) 7 2 (4.18) 3.5 % 0.00 [ -0.93, 0.93 ]
Cavallo 2016 40 -0.14 (2.25) 40 -0.16 (2.75) 6.3 % 0.01 [ -0.43, 0.45 ]
Barban 2016 42 0.1 (3.3) 39 -0.1 (2.55) 6.3 % 0.07 [ -0.37, 0.50 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Kallio 2018 76 -0.8 (11.6) 71 -1.6 (11.95) 7.0 % 0.07 [ -0.26, 0.39 ]
Mapelli 2013 10 1.07 (1.75) 10 0.33 (0.42) 3.6 % 0.56 [ -0.34, 1.45 ]
Jelcic 2014 17 2 (3.18) 10 -0.7 (5) 4.1 % 0.67 [ -0.14, 1.47 ]
Jelcic 2012 20 2 (3.62) 20 -1 (4.2) 5.0 % 0.75 [ 0.11, 1.39 ]
de Vreese 1998 9 2.77 (3.48) 9 -0.89 (5.22) 3.3 % 0.79 [ -0.18, 1.75 ]
Fern ndez-Calvo 2011 30 1.12 (3.64) 15 -2.31 (2.57) 4.9 % 1.01 [ 0.35, 1.67 ]
Subtotal (95% CI) 364 318 66.7 % 0.15 [ -0.08, 0.38 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 24.85, df = 13 (P = 0.02); I2 =48%
Test for overall effect: Z = 1.29 (P = 0.20)
2 More than 3 months
Amieva 2016 168 -8.4 (8.71) 152 -7.6 (5.43) 7.5 % -0.11 [ -0.33, 0.11 ]
Heiss 1993 18 -1.22 (8.13) 17 -0.94 (7.18) 4.9 % -0.04 [ -0.70, 0.63 ]
Kawashima 2005 16 0.1 (11.01) 16 -1.8 (8.22) 4.7 % 0.19 [ -0.50, 0.89 ]
Quintana Hernandez 2014 27 -4.48 (6.86) 25 -7.48 (5.65) 5.5 % 0.47 [ -0.08, 1.02 ]
Trebbastoni 2018 48 1.53 (3.68) 86 -2.64 (4.39) 6.7 % 1.00 [ 0.63, 1.37 ]
Bergamaschi 2013 16 2.75 (3.56) 16 -3.57 (3.58) 4.0 % 1.73 [ 0.90, 2.55 ]
Subtotal (95% CI) 293 312 33.3 % 0.51 [ -0.04, 1.05 ]
Heterogeneity: Tau2 = 0.38; Chi2 = 39.28, df = 5 (P<0.00001); I2 =87%
Test for overall effect: Z = 1.82 (P = 0.069)
Total (95% CI) 657 630 100.0 % 0.27 [ 0.04, 0.50 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 65.70, df = 19 (P<0.00001); I2 =71%
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Chi2 = 1.38, df = 1 (P = 0.24), I2 =28%
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. We multiplied the SD they
provided by 2.
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Analysis 7.3. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 3 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 3 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Fern ndez-Calvo 2011 30 15 -0.44 (0.42) 3.0 % -0.44 [ -1.26, 0.38 ]
Beck 1988 10 10 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Koltai 2001 14 8 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Davis 2001 19 18 0 (0.32) 4.0 % 0.0 [ -0.63, 0.63 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.8 % 0.01 [ -0.66, 0.68 ]
Boller 2011 24 12 0.13 (0.35) 3.7 % 0.13 [ -0.56, 0.82 ]
Quayhagen 2000 21 15 0.19 (0.33) 3.9 % 0.19 [ -0.46, 0.84 ]
Galante 2007 7 4 0.21 (0.63) 1.8 % 0.21 [ -1.02, 1.44 ]
Barban 2016 41 38 0.21 (0.23) 5.1 % 0.21 [ -0.24, 0.66 ]
Quayhagen 1995 (1) 13 28 0.25 (0.33) 3.9 % 0.25 [ -0.40, 0.90 ]
Neely 2009 20 9 0.26 (0.39) 3.3 % 0.26 [ -0.50, 1.02 ]
Serino 2017 10 10 0.31 (0.44) 2.9 % 0.31 [ -0.55, 1.17 ]
Quayhagen 1995 (2) 13 25 0.37 (0.34) 3.8 % 0.37 [ -0.30, 1.04 ]
Giuli 2016 48 47 0.37 (0.21) 5.4 % 0.37 [ -0.04, 0.78 ]
Kim 2015 22 21 0.46 (0.32) 4.0 % 0.46 [ -0.17, 1.09 ]
Jelcic 2014 17 10 0.55 (0.4) 3.2 % 0.55 [ -0.23, 1.33 ]
Jelcic 2012 20 20 0.6 (0.32) 4.0 % 0.60 [ -0.03, 1.23 ]
de Vreese 1998 9 9 1.04 (0.49) 2.5 % 1.04 [ 0.08, 2.00 ]
Lee 2013 12 7 1.15 (0.53) 2.3 % 1.15 [ 0.11, 2.19 ]
Cavallo 2016 40 40 1.32 (0.28) 4.5 % 1.32 [ 0.77, 1.87 ]
Mapelli 2013 10 10 2.13 (0.66) 1.6 % 2.13 [ 0.84, 3.42 ]
Subtotal (95% CI) 417 373 72.8 % 0.38 [ 0.18, 0.58 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 32.90, df = 20 (P = 0.03); I2 =39%
Test for overall effect: Z = 3.78 (P = 0.00016)
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
2 More than 3 months
Amieva 2016 165 153 -0.11 (0.11) 6.6 % -0.11 [ -0.33, 0.11 ]
Heiss 1993 18 17 0.27 (0.34) 3.8 % 0.27 [ -0.40, 0.94 ]
Kawashima 2005 16 16 0.52 (0.36) 3.6 % 0.52 [ -0.19, 1.23 ]
Trebbastoni 2018 45 85 0.55 (0.2) 5.5 % 0.55 [ 0.16, 0.94 ]
Quintana Hernandez 2014 27 25 0.73 (0.28) 4.5 % 0.73 [ 0.18, 1.28 ]
Bergamaschi 2013 16 16 1.64 (0.41) 3.1 % 1.64 [ 0.84, 2.44 ]
Subtotal (95% CI) 287 312 27.2 % 0.54 [ 0.07, 1.01 ]
Heterogeneity: Tau2 = 0.26; Chi2 = 27.74, df = 5 (P = 0.00004); I2 =82%
Test for overall effect: Z = 2.27 (P = 0.023)
Total (95% CI) 704 685 100.0 % 0.42 [ 0.23, 0.61 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 62.80, df = 26 (P = 0.00007); I2 =59%
Test for overall effect: Z = 4.32 (P = 0.000015)
Test for subgroup differences: Chi2 = 0.38, df = 1 (P = 0.54), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) CT vs Active Control
(2) CT vs Passive Control
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Analysis 7.4. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 4 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 4 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Barban 2016 41 38 0.1 (0.22) 6.3 % 0.10 [ -0.33, 0.53 ]
Beck 1988 10 10 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Boller 2011 24 12 0.06 (0.35) 2.8 % 0.06 [ -0.63, 0.75 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.0 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 40 40 0.61 (0.23) 5.9 % 0.61 [ 0.16, 1.06 ]
Davis 2001 19 18 0 (0.32) 3.3 % 0.0 [ -0.63, 0.63 ]
de Vreese 1998 9 9 0.48 (0.46) 1.7 % 0.48 [ -0.42, 1.38 ]
Fern ndez-Calvo 2011 30 15 -0.29 (0.34) 3.0 % -0.29 [ -0.96, 0.38 ]
Galante 2007 7 4 0.12 (0.59) 1.1 % 0.12 [ -1.04, 1.28 ]
Giuli 2016 48 47 0.17 (0.2) 7.3 % 0.17 [ -0.22, 0.56 ]
Jelcic 2012 20 20 0.28 (0.31) 3.5 % 0.28 [ -0.33, 0.89 ]
Jelcic 2014 17 10 0.27 (0.39) 2.3 % 0.27 [ -0.49, 1.03 ]
Kim 2015 22 21 0.2 (0.3) 3.7 % 0.20 [ -0.39, 0.79 ]
Koltai 2001 14 8 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Lee 2013 12 7 0.6 (0.47) 1.6 % 0.60 [ -0.32, 1.52 ]
Mapelli 2013 10 10 1.06 (0.55) 1.2 % 1.06 [ -0.02, 2.14 ]
Neely 2009 20 9 0.26 (0.39) 2.3 % 0.26 [ -0.50, 1.02 ]
Quayhagen 1995 (1) 13 25 1.03 (0.36) 2.7 % 1.03 [ 0.32, 1.74 ]
Quayhagen 1995 (2) 13 28 0.55 (0.33) 3.1 % 0.55 [ -0.10, 1.20 ]
Quayhagen 2000 21 15 0.8 (0.35) 2.8 % 0.80 [ 0.11, 1.49 ]
Serino 2017 10 10 0.16 (0.43) 1.9 % 0.16 [ -0.68, 1.00 ]
Subtotal (95% CI) 417 373 63.3 % 0.28 [ 0.14, 0.42 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 18.78, df = 20 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 3.86 (P = 0.00011)
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
2 More than 3 months
Amieva 2016 166 153 -0.07 (0.11) 15.9 % -0.07 [ -0.29, 0.15 ]
Bergamaschi 2013 16 16 0.78 (0.36) 2.7 % 0.78 [ 0.07, 1.49 ]
Heiss 1993 18 17 0.15 (0.33) 3.1 % 0.15 [ -0.50, 0.80 ]
Kawashima 2005 16 16 0.23 (0.35) 2.8 % 0.23 [ -0.46, 0.92 ]
Quintana Hernandez 2014 27 25 0.46 (0.28) 4.2 % 0.46 [ -0.09, 1.01 ]
Trebbastoni 2018 45 85 0.26 (0.19) 7.9 % 0.26 [ -0.11, 0.63 ]
Subtotal (95% CI) 288 312 36.7 % 0.21 [ -0.03, 0.46 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 8.46, df = 5 (P = 0.13); I2 =41%
Test for overall effect: Z = 1.69 (P = 0.091)
Total (95% CI) 705 685 100.0 % 0.24 [ 0.12, 0.36 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 29.59, df = 26 (P = 0.29); I2 =12%
Test for overall effect: Z = 3.89 (P = 0.000099)
Test for subgroup differences: Chi2 = 0.20, df = 1 (P = 0.65), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) CT vs Passive control
(2) CT vs Active control
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Analysis 7.5. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 5 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 5 Change in immediate memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Koltai 2001 14 0.64 (1.7) 8 1.63 (2.8) 5.1 % -0.44 [ -1.32, 0.44 ]
Galante 2007 7 -0.2 (5.3) 4 1.2 (7.77) 4.0 % -0.21 [ -1.44, 1.03 ]
Jelcic 2014 17 0.66 (5.53) 10 -0.3 (4.82) 5.5 % 0.18 [ -0.61, 0.96 ]
Quayhagen 2000 21 2.29 (12.1) 15 -0.73 (12.08) 5.9 % 0.24 [ -0.42, 0.91 ]
Boller 2011 24 -0.04 (2.98) 12 -0.92 (2.93) 5.7 % 0.29 [ -0.41, 0.99 ]
Cahn-Weiner 2003 17 -0.4 (2.76) 17 -1.7 (2.97) 5.8 % 0.44 [ -0.24, 1.12 ]
Davis 2001 19 1.43 (3.52) 18 -0.22 (3.71) 5.9 % 0.45 [ -0.21, 1.10 ]
Giuli 2016 48 0.65 (1.74) 47 -0.17 (1.74) 6.6 % 0.47 [ 0.06, 0.88 ]
Quayhagen 1995 (1) 13 4.7 (10.56) 28 -0.1 (7.84) 5.8 % 0.54 [ -0.13, 1.21 ]
Jelcic 2012 20 2.9 (5.62) 20 -0.2 (5.43) 6.0 % 0.55 [ -0.08, 1.18 ]
Quayhagen 1995 (2) 13 4.7 (10.56) 25 -1.8 (6.19) 5.7 % 0.80 [ 0.11, 1.50 ]
Neely 2009 20 -0.1 (1.75) 9 -1.5 (1.25) 5.3 % 0.84 [ 0.02, 1.66 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.7 (1.58) 4.6 % 1.58 [ 0.55, 2.61 ]
Lee 2013 12 8.08 (3.25) 7 1.29 (1.81) 4.0 % 2.29 [ 1.05, 3.54 ]
Cavallo 2016 40 2.26 (0.71) 40 -0.79 (1) 5.7 % 3.48 [ 2.78, 4.19 ]
Subtotal (95% CI) 295 270 81.8 % 0.75 [ 0.29, 1.21 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 85.22, df = 14 (P<0.00001); I2 =84%
Test for overall effect: Z = 3.18 (P = 0.0015)
2 More than 3 months
Heiss 1993 18 0.41 (0.97) 17 0.09 (1) 5.8 % 0.32 [ -0.35, 0.99 ]
Bergamaschi 2013 16 1.12 (2) 16 -0.13 (1.63) 5.7 % 0.67 [ -0.05, 1.38 ]
Trebbastoni 2018 45 4.01 (4.6) 85 -0.7 (3.98) 6.7 % 1.11 [ 0.73, 1.50 ]
Subtotal (95% CI) 79 118 18.2 % 0.76 [ 0.26, 1.26 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 4.47, df = 2 (P = 0.11); I2 =55%
Test for overall effect: Z = 3.00 (P = 0.0027)
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Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 374 388 100.0 % 0.74 [ 0.37, 1.12 ]
Heterogeneity: Tau2 = 0.51; Chi2 = 90.65, df = 17 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.89 (P = 0.000098)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.97), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Cognitive training vs. Active control
(2) Cognitive training vs. Passive control
Analysis 7.6. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 1.15 (2.23) 18 1.65 (3.72) 9.4 % -0.16 [ -0.81, 0.49 ]
Boller 2011 24 -0.29 (1.58) 12 -0.08 (1.28) 9.2 % -0.14 [ -0.83, 0.56 ]
Cahn-Weiner 2003 17 -0.3 (1.05) 17 -0.8 (1.58) 9.2 % 0.36 [ -0.31, 1.04 ]
Quayhagen 2000 21 3.2 (6.89) 15 0.4 (7.55) 9.3 % 0.38 [ -0.29, 1.05 ]
Barban 2016 42 0.4 (1.17) 39 -0.1 (1.11) 10.2 % 0.43 [ -0.01, 0.88 ]
Trebbastoni 2018 45 0.06 (1.26) 85 -0.55 (1.36) 10.4 % 0.46 [ 0.09, 0.82 ]
Koltai 2001 14 0.64 (1.3) 8 -0.25 (1.8) 8.3 % 0.57 [ -0.32, 1.46 ]
Jelcic 2014 17 0.86 (2.17) 10 -1.3 (1.84) 8.5 % 1.02 [ 0.18, 1.85 ]
Jelcic 2012 20 1.5 (2.34) 20 -0.9 (2.04) 9.3 % 1.07 [ 0.40, 1.74 ]
Mapelli 2013 (1) 10 4.2 (2.35) 10 -0.8 (1.48) 6.8 % 2.44 [ 1.22, 3.65 ]
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Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 1.24 (1.04) 40 -1.74 (1) 9.4 % 2.89 [ 2.26, 3.53 ]
Total (95% CI) 269 274 100.0 % 0.81 [ 0.29, 1.32 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 72.73, df = 10 (P<0.00001); I2 =86%
Test for overall effect: Z = 3.05 (P = 0.0023)
Test for subgroup differences: Not applicable
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Control Cognitive training
(1) Cognitive training vs passive control
Analysis 7.7. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 7 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 7 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heiss 1993 18 -0.64 (1) 17 -0.03 (0.98) 8.7 % -0.60 [ -1.28, 0.08 ]
Galante 2007 7 0.1 (0.66) 4 0.7 (1.52) 6.1 % -0.53 [ -1.79, 0.73 ]
Trebbastoni 2018 45 -0.3 (0.58) 85 -0.24 (0.65) 9.9 % -0.10 [ -0.46, 0.27 ]
Boller 2011 24 0 (1.11) 12 0.08 (0.92) 8.6 % -0.07 [ -0.77, 0.62 ]
Davis 2001 19 -0.41 (1.55) 18 -0.47 (1.56) 8.8 % 0.04 [ -0.61, 0.68 ]
Serino 2017 10 0 (0.91) 10 -0.33 (0.58) 7.8 % 0.41 [ -0.47, 1.30 ]
Giuli 2016 48 0.32 (0.9) 47 -0.2 (0.96) 9.7 % 0.55 [ 0.14, 0.96 ]
Beck 1988 (1) 10 0.7 (0.95) 10 -0.2 (1.32) 7.6 % 0.75 [ -0.16, 1.66 ]
Jelcic 2012 20 0.2 (0.55) 20 -0.4 (0.55) 8.7 % 1.07 [ 0.40, 1.74 ]
Mapelli 2013 10 1.7 (1.24) 10 -0.1 (1.29) 7.3 % 1.36 [ 0.37, 2.36 ]
-4 -2 0 2 4
Control Cognitive training
(Continued . . . )
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Jelcic 2014 17 0.32 (1) 10 -1.35 (0.59) 7.5 % 1.85 [ 0.90, 2.80 ]
Cavallo 2016 40 1.89 (0.99) 40 -0.04 (0.89) 9.2 % 2.03 [ 1.49, 2.57 ]
Total (95% CI) 268 283 100.0 % 0.56 [ 0.08, 1.05 ]
Heterogeneity: Tau2 = 0.59; Chi2 = 71.95, df = 11 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
Analysis 7.8. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 8 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 8 Change in language (naming)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 0.19 (1.55) 40 0.1 (1.32) 22.9 % 0.06 [ -0.38, 0.50 ]
Cahn-Weiner 2003 17 0.3 (3.55) 17 -0.1 (3.48) 18.6 % 0.11 [ -0.56, 0.78 ]
Jelcic 2012 20 3.5 (5.63) 20 -0.8 (4.61) 19.0 % 0.82 [ 0.17, 1.47 ]
Jelcic 2014 17 2.19 (2.56) 10 -0.4 (2.41) 15.8 % 1.00 [ 0.17, 1.83 ]
Trebbastoni 2018 45 2 (3.35) 85 -1.81 (3.34) 23.8 % 1.13 [ 0.75, 1.52 ]
Total (95% CI) 139 172 100.0 % 0.62 [ 0.11, 1.12 ]
Heterogeneity: Tau2 = 0.24; Chi2 = 16.29, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 2.39 (P = 0.017)
Test for subgroup differences: Not applicable
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Analysis 7.9. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 9 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 9 Change in verbal letter fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Serino 2017 10 -1.6 (3.47) 10 0.2 (4.8) 6.3 % -0.41 [ -1.30, 0.48 ]
Cavallo 2016 40 1.17 (1.62) 40 1.53 (1.6) 11.6 % -0.22 [ -0.66, 0.22 ]
Davis 2001 19 0.22 (7.7) 18 1.33 (9.03) 8.8 % -0.13 [ -0.78, 0.52 ]
Cahn-Weiner 2003 17 0.3 (5.95) 17 1 (4.62) 8.4 % -0.13 [ -0.80, 0.54 ]
Barban 2016 42 1.4 (5.66) 39 1.1 (6.04) 11.6 % 0.05 [ -0.39, 0.49 ]
Jelcic 2012 20 1.7 (7.56) 20 1.3 (7.41) 9.1 % 0.05 [ -0.57, 0.67 ]
Jelcic 2014 17 2.27 (7.6) 10 1.6 (6.93) 7.3 % 0.09 [ -0.69, 0.87 ]
Galante 2007 7 3.5 (5.74) 4 -1.7 (6.97) 3.7 % 0.77 [ -0.52, 2.06 ]
Mapelli 2013 10 1.2 (1.51) 10 -0.64 (1.12) 5.5 % 1.33 [ 0.34, 2.31 ]
Subtotal (95% CI) 182 168 72.2 % 0.03 [ -0.23, 0.28 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 10.48, df = 8 (P = 0.23); I2 =24%
Test for overall effect: Z = 0.21 (P = 0.84)
2 More than 3 months
Kawashima 2005 16 0.1 (0.55) 16 0 (0.44) 8.2 % 0.20 [ -0.50, 0.89 ]
Trebbastoni 2018 45 -0.17 (4.89) 85 -2.03 (5) 12.6 % 0.37 [ 0.01, 0.74 ]
Bergamaschi 2013 16 1.06 (1.39) 16 -1.72 (1.97) 7.0 % 1.59 [ 0.78, 2.40 ]
Subtotal (95% CI) 77 117 27.8 % 0.66 [ -0.05, 1.38 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 8.19, df = 2 (P = 0.02); I2 =76%
Test for overall effect: Z = 1.82 (P = 0.068)
Total (95% CI) 259 285 100.0 % 0.22 [ -0.07, 0.50 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 25.86, df = 11 (P = 0.01); I2 =57%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 2.71, df = 1 (P = 0.10), I2 =63%
-2 -1 0 1 2
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Analysis 7.10. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 10 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 10 Change in speed of information processing
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Beck 1988 10 -0.3 (1.25) 10 1.1 (2.88) 11.3 % -0.60 [ -1.51, 0.30 ]
Galante 2007 7 -1.3 (10.33) 4 3.3 (5.55) 6.3 % -0.47 [ -1.72, 0.79 ]
Jelcic 2014 17 0.47 (6.9) 10 -0.4 (8.16) 14.4 % 0.11 [ -0.67, 0.90 ]
Barban 2016 36 7.7 (27.35) 33 -1.9 (27.67) 30.0 % 0.35 [ -0.13, 0.82 ]
Jelcic 2012 20 19.3 (56.5) 20 -2 (20.58) 20.3 % 0.49 [ -0.14, 1.12 ]
Cahn-Weiner 2003 17 5.2 (20.62) 17 -9.6 (31.4) 17.8 % 0.54 [ -0.14, 1.23 ]
Total (95% CI) 107 94 100.0 % 0.22 [ -0.11, 0.54 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 6.24, df = 5 (P = 0.28); I2 =20%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
270Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 7.11. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 11 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 11 Change in executive function
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 6 (51.61) 17 33.3 (49.98) 8.9 % -0.52 [ -1.21, 0.16 ]
Galante 2007 7 -2.6 (8.27) 4 -2.3 (3.25) 6.2 % -0.04 [ -1.27, 1.19 ]
Kawashima 2005 16 15 (18) 16 -6 (197) 8.9 % 0.15 [ -0.55, 0.84 ]
Cavallo 2016 40 -0.07 (0.79) 40 -0.26 (0.71) 10.0 % 0.25 [ -0.19, 0.69 ]
Jelcic 2012 20 13.2 (18.07) 20 6.6 (16.69) 9.2 % 0.37 [ -0.25, 1.00 ]
Serino 2017 10 0.22 (2.24) 10 -0.66 (2.01) 7.9 % 0.40 [ -0.49, 1.28 ]
Neely 2009 20 -0.03 (0.15) 9 -0.16 (0.52) 8.3 % 0.41 [ -0.39, 1.20 ]
Quayhagen 1995 (1) 13 4.8 (7.28) 28 0.4 (6.6) 9.0 % 0.63 [ -0.04, 1.31 ]
Trebbastoni 2018 45 0.96 (2.07) 85 -1.3 (2.19) 10.2 % 1.05 [ 0.66, 1.43 ]
Quayhagen 1995 (2) 13 4.8 (7.28) 25 -3.6 (6.44) 8.7 % 1.22 [ 0.49, 1.95 ]
Quayhagen 2000 21 5.91 (2.31) 15 -2.6 (3.8) 7.6 % 2.76 [ 1.81, 3.71 ]
Mapelli 2013 (3) 10 2.3 (0.52) 10 -0.2 (0.79) 5.1 % 3.58 [ 2.06, 5.10 ]
Total (95% CI) 232 279 100.0 % 0.75 [ 0.28, 1.22 ]
Heterogeneity: Tau2 = 0.52; Chi2 = 58.99, df = 11 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.15 (P = 0.0017)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
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(1) Cognitive training vs. Active control
(2) Cognitive training vs. Passive control
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Analysis 7.12. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 12 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 12 Change in verbal category fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 0 (2.98) 4 0.1 (4.16) 4.5 % -0.03 [ -1.26, 1.20 ]
Serino 2017 10 0.7 (2.91) 10 0.5 (3.99) 7.5 % 0.05 [ -0.82, 0.93 ]
Jelcic 2012 20 1.5 (5.72) 20 1 (5.78) 11.3 % 0.09 [ -0.53, 0.71 ]
Davis 2001 19 1.5 (3.67) 18 0.95 (3.37) 10.8 % 0.15 [ -0.49, 0.80 ]
Jelcic 2014 17 1.39 (4.71) 10 0.4 (5.46) 8.7 % 0.19 [ -0.59, 0.98 ]
Giuli 2016 48 0.15 (0.73) 47 -0.17 (0.67) 16.0 % 0.45 [ 0.05, 0.86 ]
Heiss 1993 18 1.66 (3.52) 17 -1.07 (3.13) 10.0 % 0.80 [ 0.11, 1.49 ]
Trebbastoni 2018 45 2.06 (4.84) 85 -2.93 (5.04) 16.6 % 1.00 [ 0.62, 1.38 ]
Cavallo 2016 40 0.34 (1.22) 40 -0.95 (1.21) 14.5 % 1.05 [ 0.58, 1.52 ]
Total (95% CI) 224 251 100.0 % 0.52 [ 0.23, 0.81 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 16.57, df = 8 (P = 0.03); I2 =52%
Test for overall effect: Z = 3.49 (P = 0.00049)
Test for subgroup differences: Not applicable
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Analysis 7.13. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 13 Change in meta cognition (self-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 13 Change in meta cognition (self-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -6.43 (14.3) 8 -1 (14.1) 51.9 % -0.37 [ -1.24, 0.51 ]
Lee 2013 12 0.27 (0.29) 7 0.08 (0.26) 48.1 % 0.65 [ -0.31, 1.61 ]
Total (95% CI) 26 15 100.0 % 0.12 [ -0.87, 1.12 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 2.34, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
273Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 7.14. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 14 Change in meta cognition (informant-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 14 Change in meta cognition (informant-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -3.54 (14.7) 8 5.75 (10.4) 37.3 % -0.67 [ -1.56, 0.23 ]
Cahn-Weiner 2003 17 -4.8 (16.55) 17 6.6 (18.54) 62.7 % -0.63 [ -1.32, 0.06 ]
Total (95% CI) 31 25 100.0 % -0.65 [ -1.19, -0.10 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.021)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 7.15. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 15 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 15 Change in participants’ mood
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -1.21 (2.5) 8 0.13 (3) 12.2 % -0.48 [ -1.36, 0.40 ]
Bergamaschi 2013 16 -1.07 (2.98) 16 0.44 (5.09) 12.9 % -0.35 [ -1.05, 0.35 ]
Amieva 2016 164 -12.11 (12.73) 152 -10.81 (12.24) 14.1 % -0.10 [ -0.32, 0.12 ]
Davis 2001 19 0.32 (1.52) 17 0.17 (4.41) 13.1 % 0.05 [ -0.61, 0.70 ]
Lee 2013 12 -0.25 (2.23) 7 -1.86 (2.77) 11.9 % 0.63 [ -0.33, 1.59 ]
Galante 2007 7 0.5 (0.92) 4 -0.3 (0.78) 10.5 % 0.84 [ -0.47, 2.14 ]
Giuli 2016 48 -0.18 (4.4) 47 -7.32 (3.77) 13.6 % 1.73 [ 1.25, 2.20 ]
Fern ndez-Calvo 2011 30 3.2 (2) 15 -4.26 (1.85) 11.7 % 3.75 [ 2.73, 4.78 ]
Total (95% CI) 310 266 100.0 % 0.72 [ -0.10, 1.54 ]
Heterogeneity: Tau2 = 1.23; Chi2 = 99.54, df = 7 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.73 (P = 0.084)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
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Analysis 7.16. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 16 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 16 Change in capacity for activities of daily living
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.6 (1.36) 4 0.5 (0.48) 2.6 % -0.88 [ -2.19, 0.43 ]
de Vreese 1998 9 -1.33 (4.37) 9 1.01 (3.98) 4.7 % -0.53 [ -1.48, 0.41 ]
Amieva 2016 167 -1.76 (8.46) 153 -1.22 (8.27) 23.8 % -0.06 [ -0.28, 0.16 ]
Cahn-Weiner 2003 17 -0.2 (3.16) 17 0 (3.07) 8.1 % -0.06 [ -0.74, 0.61 ]
Kim 2015 21 0 (0.86) 21 0 (1.05) 9.4 % 0.0 [ -0.60, 0.60 ]
Jelcic 2012 20 0.1 (1.05) 38 0 (1.36) 10.9 % 0.08 [ -0.46, 0.62 ]
Barban 2016 38 -0.1 (0.96) 38 -0.3 (1.08) 13.6 % 0.19 [ -0.26, 0.64 ]
Giuli 2016 48 0.26 (1.2) 47 -0.24 (1.26) 15.2 % 0.40 [ 0.00, 0.81 ]
Bergamaschi 2013 16 -0.38 (1.54) 16 -1.32 (1.46) 7.4 % 0.61 [ -0.10, 1.32 ]
Lee 2013 12 2.24 (3.33) 7 -2.14 (4.54) 4.2 % 1.10 [ 0.09, 2.11 ]
Total (95% CI) 355 350 100.0 % 0.12 [ -0.10, 0.34 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 14.29, df = 9 (P = 0.11); I2 =37%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 7.17. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 17 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 17 Change in disease progression
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fern ndez-Calvo 2011 30 -2.11 (2.24) 15 -7.07 (2.39) 16.5 % 2.13 [ 1.36, 2.90 ]
Lee 2013 12 7.59 (9.2) 7 0.86 (7.83) 13.2 % 0.74 [ -0.23, 1.70 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 14.3 % 0.57 [ -0.33, 1.46 ]
Quayhagen 1995 (1) 13 3.3 (7.5) 25 -4.4 (8.36) 17.8 % 0.93 [ 0.23, 1.64 ]
Quayhagen 1995 (2) 13 3.3 (7.5) 28 -1.7 (8.89) 18.5 % 0.58 [ -0.09, 1.25 ]
Quintana Hernandez 2014 27 -2.77 (6.39) 25 -12.28 (7.33) 19.7 % 1.37 [ 0.76, 1.97 ]
Total (95% CI) 105 110 100.0 % 1.07 [ 0.59, 1.55 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 11.99, df = 5 (P = 0.03); I2 =58%
Test for overall effect: Z = 4.40 (P = 0.000011)
Test for subgroup differences: Not applicable
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Analysis 7.18. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 18 Change in behavioural and psychological symptoms of dementia (BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 18 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Galante 2007 7 -1.3 (2.22) 4 2.5 (3.9) 12.3 % -1.20 [ -2.58, 0.18 ]
Quayhagen 2000 21 -0.53 (10.23) 15 -0.47 (12.91) 17.4 % -0.01 [ -0.67, 0.66 ]
Fern ndez-Calvo 2011 30 2.08 (2.27) 15 -4.23 (1.33) 15.6 % 3.08 [ 2.17, 3.99 ]
Subtotal (95% CI) 58 34 45.3 % 0.66 [ -1.70, 3.02 ]
Heterogeneity: Tau2 = 4.09; Chi2 = 37.87, df = 2 (P<0.00001); I2 =95%
Test for overall effect: Z = 0.55 (P = 0.59)
2 More than 3 months
Amieva 2016 165 -25.22 (23.28) 152 -21.81 (22.11) 19.5 % -0.15 [ -0.37, 0.07 ]
Quintana Hernandez 2014 27 -8.55 (12.88) 25 -13.36 (13.48) 18.1 % 0.36 [ -0.19, 0.91 ]
Kawashima 2005 16 0.45 (1.88) 16 -0.3 (1.56) 17.1 % 0.42 [ -0.28, 1.12 ]
Subtotal (95% CI) 208 193 54.7 % 0.12 [ -0.29, 0.53 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 4.66, df = 2 (P = 0.10); I2 =57%
Test for overall effect: Z = 0.57 (P = 0.57)
Total (95% CI) 266 227 100.0 % 0.44 [ -0.34, 1.22 ]
Heterogeneity: Tau2 = 0.80; Chi2 = 51.21, df = 5 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Chi2 = 0.19, df = 1 (P = 0.66), I2 =0.0%
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Analysis 7.19. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 19 Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 19 Participant burden (retention rates)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Up to 3 months
Davis 2001 19/19 18/18 Not estimable
Beck 1988 10/10 10/10 Not estimable
Jelcic 2012 20/20 20/20 Not estimable
Kim 2015 22/22 21/21 Not estimable
Cavallo 2016 40/40 40/40 Not estimable
Kallio 2018 76/76 71/71 Not estimable
Mapelli 2013 10/10 10/10 Not estimable
Serino 2017 10/10 10/10 Not estimable
Koltai 2001 14/16 8/8 4.1 % 0.34 [ 0.01, 7.98 ]
Kao 2016 95/110 45/48 17.3 % 0.42 [ 0.12, 1.53 ]
Cahn-Weiner 2003 16/19 17/20 11.3 % 0.94 [ 0.17, 5.36 ]
Giuli 2016 48/51 47/50 12.3 % 1.02 [ 0.20, 5.32 ]
Neely 2009 10/10 9/10 3.8 % 3.32 [ 0.12, 91.60 ]
Galante 2007 7/7 4/5 3.6 % 5.00 [ 0.17, 150.92 ]
Subtotal (95% CI) 420 341 52.4 % 0.78 [ 0.35, 1.73 ]
Total events: 397 (Cognitive training), 330 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.16, df = 5 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.61 (P = 0.54)
2 More than 3 months
Trebbastoni 2018 48/54 86/86 4.8 % 0.04 [ 0.00, 0.78 ]
Quintana Hernandez 2014 27/32 25/25 4.7 % 0.10 [ 0.01, 1.86 ]
Amieva 2016 124/170 109/154 38.1 % 1.11 [ 0.69, 1.81 ]
Subtotal (95% CI) 256 265 47.6 % 0.24 [ 0.02, 2.57 ]
Total events: 199 (Cognitive training), 220 (Control)
Heterogeneity: Tau2 = 3.22; Chi2 = 7.57, df = 2 (P = 0.02); I2 =74%
Test for overall effect: Z = 1.19 (P = 0.24)
0.001 0.01 0.1 1 10 100 1000
Control Cognitive training
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(. . . Continued)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total (95% CI) 676 606 100.0 % 0.73 [ 0.37, 1.43 ]
Total events: 596 (Cognitive training), 550 (Control)
Heterogeneity: Tau2 = 0.25; Chi2 = 10.82, df = 8 (P = 0.21); I2 =26%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 0.87, df = 1 (P = 0.35), I2 =0.0%
0.001 0.01 0.1 1 10 100 1000
Control Cognitive training
Analysis 7.20. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 20 Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 20 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -21.31 (19.1) 152 -17.95 (19.01) 77.0 % -0.18 [ -0.40, 0.04 ]
Quayhagen 2000 21 -0.8 (4.05) 67 -1.29 (3.7) 23.0 % 0.13 [ -0.36, 0.62 ]
Total (95% CI) 186 219 100.0 % -0.11 [ -0.36, 0.15 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 7.21. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 21 Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 21 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 -0.62 (9.8) 15 -2.8 (16.52) 100.0 % 0.16 [ -0.50, 0.83 ]
Total (95% CI) 21 15 100.0 % 0.16 [ -0.50, 0.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 7.22. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 22 Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 22 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 0.09 (0.06) 15 0.03 (0.06) 100.0 % 0.98 [ 0.27, 1.68 ]
Total (95% CI) 21 15 100.0 % 0.98 [ 0.27, 1.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.72 (P = 0.0065)
Test for subgroup differences: Not applicable
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Analysis 7.23. Comparison 7 Cognitive training vs control immediately post intervention - intervention
duration, Outcome 23 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 7 Cognitive training vs control immediately post intervention - intervention duration
Outcome: 23 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 -24.76 (37.3) 18 4.77 (40.85) 14.0 % -0.74 [ -1.41, -0.07 ]
Quayhagen 2000 21 -0.38 (2.75) 67 0.13 (2.6) 18.8 % -0.19 [ -0.68, 0.30 ]
Amieva 2016 164 -6.3 (6.13) 151 -5.6 (6.35) 27.8 % -0.11 [ -0.33, 0.11 ]
Kallio 2018 76 -0.04 (0.06) 71 -0.04 (0.06) 24.4 % 0.0 [ -0.32, 0.32 ]
Kim 2015 22 3.4 (3.3) 21 0 (4.36) 15.0 % 0.87 [ 0.24, 1.49 ]
Total (95% CI) 302 328 100.0 % -0.04 [ -0.38, 0.29 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 12.93, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 8.1. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 1 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 1 Change in a global measure of cognition
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Galante 2007 7 0.1 (2.34) 4 1.8 (1.74) 3.7 % -0.72 [ -2.00, 0.56 ]
Amieva 2016 168 -8.4 (5.86) 153 -7.6 (5.43) 5.9 % -0.14 [ -0.36, 0.08 ]
Heiss 1993 18 -1.22 (4.22) 17 -0.94 (3.59) 5.1 % -0.07 [ -0.73, 0.59 ]
Lee 2013 12 2.01 (2.86) 7 2 (1.9) 4.5 % 0.00 [ -0.93, 0.94 ]
Cavallo 2016 40 -0.14 (1.04) 40 -0.16 (1.62) 5.6 % 0.01 [ -0.42, 0.45 ]
Kallio 2018 76 -0.8 (5.19) 71 -1.6 (5.35) 5.8 % 0.15 [ -0.17, 0.48 ]
Kawashima 2005 16 0.1 (5.1) 16 -1.8 (3.75) 5.1 % 0.41 [ -0.29, 1.12 ]
Quintana Hernandez 2014 27 -4.48 (4.08) 25 -7.48 (3.49) 5.4 % 0.78 [ 0.21, 1.34 ]
Jelcic 2014 17 2 (1.47) 10 -0.7 (2.41) 4.6 % 1.40 [ 0.52, 2.28 ]
Jelcic 2012 20 2 (1.68) 20 -1 (1.98) 5.0 % 1.60 [ 0.88, 2.32 ]
Trebbastoni 2018 48 1.53 (1.7) 86 -2.64 (2.07) 5.6 % 2.13 [ 1.69, 2.57 ]
Fern ndez-Calvo 2011 30 1.12 (1.64) 15 -2.31 (1.16) 4.9 % 2.25 [ 1.46, 3.03 ]
Bergamaschi 2013 16 2.75 (1.81) 16 -3.57 (1.81) 4.0 % 3.40 [ 2.28, 4.53 ]
Subtotal (95% CI) 495 480 65.2 % 0.84 [ 0.30, 1.39 ]
Heterogeneity: Tau2 = 0.86; Chi2 = 159.70, df = 12 (P<0.00001); I2 =92%
Test for overall effect: Z = 3.04 (P = 0.0024)
2 Augmented
Giuli 2016 48 0.02 (2.77) 47 1.24 (3.77) 5.7 % -0.37 [ -0.77, 0.04 ]
Koltai 2001 (1) 14 -0.21 (2.9) 8 0.75 (2.4) 4.6 % -0.34 [ -1.21, 0.54 ]
Davis 2001 19 0.16 (2.6) 18 0.22 (2.68) 5.2 % -0.02 [ -0.67, 0.62 ]
Barban 2016 42 0.1 (1.64) 39 -0.1 (1.15) 5.6 % 0.14 [ -0.30, 0.58 ]
Venturelli 2016 20 -0.2 (0.97) 20 -0.4 (1.14) 5.2 % 0.19 [ -0.44, 0.81 ]
Mapelli 2013 10 2.9 (2.59) 10 -0.3 (1.71) 4.3 % 1.40 [ 0.40, 2.40 ]
de Vreese 1998 9 2.77 (1.68) 9 -0.89 (2.4) 4.1 % 1.68 [ 0.57, 2.80 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 162 151 34.8 % 0.25 [ -0.21, 0.70 ]
Heterogeneity: Tau2 = 0.24; Chi2 = 20.38, df = 6 (P = 0.002); I2 =71%
Test for overall effect: Z = 1.08 (P = 0.28)
Total (95% CI) 657 631 100.0 % 0.65 [ 0.26, 1.05 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 187.26, df = 19 (P<0.00001); I2 =90%
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Chi2 = 2.68, df = 1 (P = 0.10), I2 =63%
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
Analysis 8.2. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 2 Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 2 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Galante 2007 7 0.1 (4.98) 4 1.8 (3.33) 2.4 % -0.35 [ -1.59, 0.90 ]
Amieva 2016 168 -8.4 (8.71) 152 -7.6 (5.43) 7.5 % -0.11 [ -0.33, 0.11 ]
Heiss 1993 18 -1.22 (8.13) 17 -0.94 (7.18) 4.9 % -0.04 [ -0.70, 0.63 ]
Lee 2013 12 2.01 (6.23) 7 2 (4.18) 3.5 % 0.00 [ -0.93, 0.93 ]
Cavallo 2016 40 -0.14 (2.25) 40 -0.16 (2.75) 6.3 % 0.01 [ -0.43, 0.45 ]
Kallio 2018 76 -0.8 (11.6) 71 -1.6 (11.95) 7.0 % 0.07 [ -0.26, 0.39 ]
Kawashima 2005 16 0.1 (11.01) 16 -1.8 (8.22) 4.7 % 0.19 [ -0.50, 0.89 ]
Quintana Hernandez 2014 27 -4.48 (6.86) 25 -7.48 (5.65) 5.5 % 0.47 [ -0.08, 1.02 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Jelcic 2014 17 2 (3.18) 10 -0.7 (5) 4.1 % 0.67 [ -0.14, 1.47 ]
Jelcic 2012 20 2 (3.62) 20 -1 (4.2) 5.0 % 0.75 [ 0.11, 1.39 ]
Trebbastoni 2018 48 1.53 (3.68) 86 -2.64 (4.39) 6.7 % 1.00 [ 0.63, 1.37 ]
Fern ndez-Calvo 2011 30 1.12 (3.64) 15 -2.31 (2.57) 4.9 % 1.01 [ 0.35, 1.67 ]
Bergamaschi 2013 16 2.75 (3.56) 16 -3.57 (3.58) 4.0 % 1.73 [ 0.90, 2.55 ]
Subtotal (95% CI) 495 479 66.5 % 0.41 [ 0.11, 0.71 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 51.33, df = 12 (P<0.00001); I2 =77%
Test for overall effect: Z = 2.66 (P = 0.0078)
2 Augmented
Venturelli 2016 20 -2 (2.13) 20 -0.4 (2.42) 5.0 % -0.69 [ -1.33, -0.05 ]
Koltai 2001 (1) 14 -0.21 (5.8) 8 0.75 (4.8) 3.8 % -0.17 [ -1.04, 0.70 ]
Giuli 2016 48 0.02 (6.16) 47 1.24 (8.42) 6.5 % -0.16 [ -0.57, 0.24 ]
Davis 2001 19 0.16 (5.82) 18 0.22 (5.86) 5.0 % -0.01 [ -0.65, 0.63 ]
Barban 2016 42 0.1 (3.3) 39 -0.1 (2.55) 6.3 % 0.07 [ -0.37, 0.50 ]
Mapelli 2013 10 1.07 (1.75) 10 0.33 (0.42) 3.6 % 0.56 [ -0.34, 1.45 ]
de Vreese 1998 9 2.77 (3.48) 9 -0.89 (5.22) 3.3 % 0.79 [ -0.18, 1.75 ]
Subtotal (95% CI) 162 151 33.5 % -0.03 [ -0.33, 0.26 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 9.11, df = 6 (P = 0.17); I2 =34%
Test for overall effect: Z = 0.21 (P = 0.83)
Total (95% CI) 657 630 100.0 % 0.27 [ 0.04, 0.50 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 65.70, df = 19 (P<0.00001); I2 =71%
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Chi2 = 4.23, df = 1 (P = 0.04), I2 =76%
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. We multiplied the SD they
provided by 2.
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Analysis 8.3. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 3 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 3 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Traditional
Fern ndez-Calvo 2011 30 15 -0.44 (0.42) 3.0 % -0.44 [ -1.26, 0.38 ]
Amieva 2016 165 153 -0.11 (0.11) 6.6 % -0.11 [ -0.33, 0.11 ]
Beck 1988 10 10 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.8 % 0.01 [ -0.66, 0.68 ]
Boller 2011 24 12 0.13 (0.35) 3.7 % 0.13 [ -0.56, 0.82 ]
Quayhagen 2000 21 15 0.19 (0.33) 3.9 % 0.19 [ -0.46, 0.84 ]
Galante 2007 7 4 0.21 (0.63) 1.8 % 0.21 [ -1.02, 1.44 ]
Quayhagen 1995 (1) 13 28 0.25 (0.33) 3.9 % 0.25 [ -0.40, 0.90 ]
Heiss 1993 18 17 0.27 (0.34) 3.8 % 0.27 [ -0.40, 0.94 ]
Quayhagen 1995 (2) 13 25 0.37 (0.34) 3.8 % 0.37 [ -0.30, 1.04 ]
Kawashima 2005 16 16 0.52 (0.36) 3.6 % 0.52 [ -0.19, 1.23 ]
Jelcic 2014 17 10 0.55 (0.4) 3.2 % 0.55 [ -0.23, 1.33 ]
Trebbastoni 2018 45 85 0.55 (0.2) 5.5 % 0.55 [ 0.16, 0.94 ]
Jelcic 2012 20 20 0.6 (0.32) 4.0 % 0.60 [ -0.03, 1.23 ]
Quintana Hernandez 2014 27 25 0.73 (0.28) 4.5 % 0.73 [ 0.18, 1.28 ]
Lee 2013 12 7 1.15 (0.53) 2.3 % 1.15 [ 0.11, 2.19 ]
Cavallo 2016 40 40 1.32 (0.28) 4.5 % 1.32 [ 0.77, 1.87 ]
Bergamaschi 2013 16 16 1.64 (0.41) 3.1 % 1.64 [ 0.84, 2.44 ]
Subtotal (95% CI) 511 515 68.1 % 0.43 [ 0.18, 0.68 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 50.80, df = 17 (P = 0.00003); I2 =67%
Test for overall effect: Z = 3.36 (P = 0.00078)
2 Augmented
Koltai 2001 14 8 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Davis 2001 19 18 0 (0.32) 4.0 % 0.0 [ -0.63, 0.63 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Barban 2016 41 38 0.21 (0.23) 5.1 % 0.21 [ -0.24, 0.66 ]
Neely 2009 20 9 0.26 (0.39) 3.3 % 0.26 [ -0.50, 1.02 ]
Serino 2017 10 10 0.31 (0.44) 2.9 % 0.31 [ -0.55, 1.17 ]
Giuli 2016 48 47 0.37 (0.21) 5.4 % 0.37 [ -0.04, 0.78 ]
Kim 2015 22 21 0.46 (0.32) 4.0 % 0.46 [ -0.17, 1.09 ]
de Vreese 1998 9 9 1.04 (0.49) 2.5 % 1.04 [ 0.08, 2.00 ]
Mapelli 2013 10 10 2.13 (0.66) 1.6 % 2.13 [ 0.84, 3.42 ]
Subtotal (95% CI) 193 170 31.9 % 0.37 [ 0.10, 0.65 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 11.79, df = 8 (P = 0.16); I2 =32%
Test for overall effect: Z = 2.66 (P = 0.0078)
Total (95% CI) 704 685 100.0 % 0.42 [ 0.23, 0.61 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 62.80, df = 26 (P = 0.00007); I2 =59%
Test for overall effect: Z = 4.32 (P = 0.000015)
Test for subgroup differences: Chi2 = 0.09, df = 1 (P = 0.77), I2 =0.0%
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(1) CT vs Active Control
(2) CT vs Passive Control
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Analysis 8.4. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 4 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 4 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Traditional
Amieva 2016 166 153 -0.07 (0.11) 15.9 % -0.07 [ -0.29, 0.15 ]
Beck 1988 10 10 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Bergamaschi 2013 16 16 0.78 (0.36) 2.7 % 0.78 [ 0.07, 1.49 ]
Boller 2011 24 12 0.06 (0.35) 2.8 % 0.06 [ -0.63, 0.75 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.0 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 40 40 0.61 (0.23) 5.9 % 0.61 [ 0.16, 1.06 ]
Fern ndez-Calvo 2011 30 15 -0.29 (0.34) 3.0 % -0.29 [ -0.96, 0.38 ]
Galante 2007 7 4 0.12 (0.59) 1.1 % 0.12 [ -1.04, 1.28 ]
Heiss 1993 18 17 0.15 (0.33) 3.1 % 0.15 [ -0.50, 0.80 ]
Jelcic 2012 20 20 0.28 (0.31) 3.5 % 0.28 [ -0.33, 0.89 ]
Jelcic 2014 17 10 0.27 (0.39) 2.3 % 0.27 [ -0.49, 1.03 ]
Kawashima 2005 16 16 0.23 (0.35) 2.8 % 0.23 [ -0.46, 0.92 ]
Lee 2013 12 7 0.6 (0.47) 1.6 % 0.60 [ -0.32, 1.52 ]
Quayhagen 1995 (1) 13 25 1.03 (0.36) 2.7 % 1.03 [ 0.32, 1.74 ]
Quayhagen 1995 (2) 13 28 0.55 (0.33) 3.1 % 0.55 [ -0.10, 1.20 ]
Quayhagen 2000 21 15 0.8 (0.35) 2.8 % 0.80 [ 0.11, 1.49 ]
Quintana Hernandez 2014 27 25 0.46 (0.28) 4.2 % 0.46 [ -0.09, 1.01 ]
Trebbastoni 2018 45 85 0.26 (0.19) 7.9 % 0.26 [ -0.11, 0.63 ]
Subtotal (95% CI) 512 515 70.3 % 0.30 [ 0.12, 0.47 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 25.79, df = 17 (P = 0.08); I2 =34%
Test for overall effect: Z = 3.36 (P = 0.00077)
2 Augmented
Barban 2016 41 38 0.1 (0.22) 6.3 % 0.10 [ -0.33, 0.53 ]
Davis 2001 19 18 0 (0.32) 3.3 % 0.0 [ -0.63, 0.63 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
de Vreese 1998 9 9 0.48 (0.46) 1.7 % 0.48 [ -0.42, 1.38 ]
Giuli 2016 48 47 0.17 (0.2) 7.3 % 0.17 [ -0.22, 0.56 ]
Kim 2015 22 21 0.2 (0.3) 3.7 % 0.20 [ -0.39, 0.79 ]
Koltai 2001 14 8 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Mapelli 2013 10 10 1.06 (0.55) 1.2 % 1.06 [ -0.02, 2.14 ]
Neely 2009 20 9 0.26 (0.39) 2.3 % 0.26 [ -0.50, 1.02 ]
Serino 2017 10 10 0.16 (0.43) 1.9 % 0.16 [ -0.68, 1.00 ]
Subtotal (95% CI) 193 170 29.7 % 0.18 [ -0.02, 0.39 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.72, df = 8 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.74 (P = 0.081)
Total (95% CI) 705 685 100.0 % 0.24 [ 0.12, 0.36 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 29.59, df = 26 (P = 0.29); I2 =12%
Test for overall effect: Z = 3.89 (P = 0.000099)
Test for subgroup differences: Chi2 = 0.70, df = 1 (P = 0.40), I2 =0.0%
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(1) CT vs Passive control
(2) CT vs Active control
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Analysis 8.5. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 5 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 5 Change in immediate memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Galante 2007 7 -0.2 (5.3) 4 1.2 (7.77) 4.0 % -0.21 [ -1.44, 1.03 ]
Jelcic 2014 17 0.66 (5.53) 10 -0.3 (4.82) 5.5 % 0.18 [ -0.61, 0.96 ]
Quayhagen 2000 21 2.29 (12.1) 15 -0.73 (12.08) 5.9 % 0.24 [ -0.42, 0.91 ]
Boller 2011 24 -0.04 (2.98) 12 -0.92 (2.93) 5.7 % 0.29 [ -0.41, 0.99 ]
Heiss 1993 18 0.41 (0.97) 17 0.09 (1) 5.8 % 0.32 [ -0.35, 0.99 ]
Cahn-Weiner 2003 17 -0.4 (2.76) 17 -1.7 (2.97) 5.8 % 0.44 [ -0.24, 1.12 ]
Quayhagen 1995 (1) 13 4.7 (10.56) 28 -0.1 (7.84) 5.8 % 0.54 [ -0.13, 1.21 ]
Jelcic 2012 20 2.9 (5.62) 20 -0.2 (5.43) 6.0 % 0.55 [ -0.08, 1.18 ]
Bergamaschi 2013 16 1.12 (2) 16 -0.13 (1.63) 5.7 % 0.67 [ -0.05, 1.38 ]
Quayhagen 1995 (2) 13 4.7 (10.56) 25 -1.8 (6.19) 5.7 % 0.80 [ 0.11, 1.50 ]
Trebbastoni 2018 45 4.01 (4.6) 85 -0.7 (3.98) 6.7 % 1.11 [ 0.73, 1.50 ]
Lee 2013 12 8.08 (3.25) 7 1.29 (1.81) 4.0 % 2.29 [ 1.05, 3.54 ]
Cavallo 2016 40 2.26 (0.71) 40 -0.79 (1) 5.7 % 3.48 [ 2.78, 4.19 ]
Subtotal (95% CI) 263 296 72.4 % 0.82 [ 0.33, 1.30 ]
Heterogeneity: Tau2 = 0.66; Chi2 = 77.53, df = 12 (P<0.00001); I2 =85%
Test for overall effect: Z = 3.28 (P = 0.0010)
2 Augmented
Koltai 2001 14 0.64 (1.7) 8 1.63 (2.8) 5.1 % -0.44 [ -1.32, 0.44 ]
Davis 2001 19 1.43 (3.52) 18 -0.22 (3.71) 5.9 % 0.45 [ -0.21, 1.10 ]
Giuli 2016 48 0.65 (1.74) 47 -0.17 (1.74) 6.6 % 0.47 [ 0.06, 0.88 ]
Neely 2009 20 -0.1 (1.75) 9 -1.5 (1.25) 5.3 % 0.84 [ 0.02, 1.66 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.7 (1.58) 4.6 % 1.58 [ 0.55, 2.61 ]
Subtotal (95% CI) 111 92 27.6 % 0.53 [ 0.04, 1.02 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 9.31, df = 4 (P = 0.05); I2 =57%
Test for overall effect: Z = 2.14 (P = 0.032)
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 374 388 100.0 % 0.74 [ 0.37, 1.12 ]
Heterogeneity: Tau2 = 0.51; Chi2 = 90.65, df = 17 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.89 (P = 0.000098)
Test for subgroup differences: Chi2 = 0.65, df = 1 (P = 0.42), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Cognitive training vs. Active control
(2) Cognitive training vs. Passive control
Analysis 8.6. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Boller 2011 24 -0.29 (1.58) 12 -0.08 (1.28) 9.2 % -0.14 [ -0.83, 0.56 ]
Cahn-Weiner 2003 17 -0.3 (1.05) 17 -0.8 (1.58) 9.2 % 0.36 [ -0.31, 1.04 ]
Quayhagen 2000 21 3.2 (6.89) 15 0.4 (7.55) 9.3 % 0.38 [ -0.29, 1.05 ]
Trebbastoni 2018 45 0.06 (1.26) 85 -0.55 (1.36) 10.4 % 0.46 [ 0.09, 0.82 ]
Jelcic 2014 17 0.86 (2.17) 10 -1.3 (1.84) 8.5 % 1.02 [ 0.18, 1.85 ]
Jelcic 2012 20 1.5 (2.34) 20 -0.9 (2.04) 9.3 % 1.07 [ 0.40, 1.74 ]
Cavallo 2016 40 1.24 (1.04) 40 -1.74 (1) 9.4 % 2.89 [ 2.26, 3.53 ]
Subtotal (95% CI) 184 199 65.3 % 0.86 [ 0.15, 1.58 ]
Heterogeneity: Tau2 = 0.82; Chi2 = 56.07, df = 6 (P<0.00001); I2 =89%
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 2.37 (P = 0.018)
2 Augmented
Davis 2001 19 1.15 (2.23) 18 1.65 (3.72) 9.4 % -0.16 [ -0.81, 0.49 ]
Barban 2016 42 0.4 (1.17) 39 -0.1 (1.11) 10.2 % 0.43 [ -0.01, 0.88 ]
Koltai 2001 14 0.64 (1.3) 8 -0.25 (1.8) 8.3 % 0.57 [ -0.32, 1.46 ]
Mapelli 2013 (1) 10 4.2 (2.35) 10 -0.8 (1.48) 6.8 % 2.44 [ 1.22, 3.65 ]
Subtotal (95% CI) 85 75 34.7 % 0.68 [ -0.11, 1.46 ]
Heterogeneity: Tau2 = 0.48; Chi2 = 13.78, df = 3 (P = 0.003); I2 =78%
Test for overall effect: Z = 1.69 (P = 0.091)
Total (95% CI) 269 274 100.0 % 0.81 [ 0.29, 1.32 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 72.73, df = 10 (P<0.00001); I2 =86%
Test for overall effect: Z = 3.05 (P = 0.0023)
Test for subgroup differences: Chi2 = 0.12, df = 1 (P = 0.73), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Cognitive training vs passive control
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Analysis 8.7. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 7 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 7 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Heiss 1993 18 -0.64 (1) 17 -0.03 (0.98) 8.7 % -0.60 [ -1.28, 0.08 ]
Galante 2007 7 0.1 (0.66) 4 0.7 (1.52) 6.1 % -0.53 [ -1.79, 0.73 ]
Trebbastoni 2018 45 -0.3 (0.58) 85 -0.24 (0.65) 9.9 % -0.10 [ -0.46, 0.27 ]
Boller 2011 24 0 (1.11) 12 0.08 (0.92) 8.6 % -0.07 [ -0.77, 0.62 ]
Beck 1988 (1) 10 0.7 (0.95) 10 -0.2 (1.32) 7.6 % 0.75 [ -0.16, 1.66 ]
Jelcic 2012 20 0.2 (0.55) 20 -0.4 (0.55) 8.7 % 1.07 [ 0.40, 1.74 ]
Jelcic 2014 17 0.32 (1) 10 -1.35 (0.59) 7.5 % 1.85 [ 0.90, 2.80 ]
Cavallo 2016 40 1.89 (0.99) 40 -0.04 (0.89) 9.2 % 2.03 [ 1.49, 2.57 ]
Subtotal (95% CI) 181 198 66.4 % 0.56 [ -0.17, 1.30 ]
Heterogeneity: Tau2 = 0.96; Chi2 = 66.97, df = 7 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.50 (P = 0.13)
2 Augmented
Davis 2001 19 -0.41 (1.55) 18 -0.47 (1.56) 8.8 % 0.04 [ -0.61, 0.68 ]
Serino 2017 10 0 (0.91) 10 -0.33 (0.58) 7.8 % 0.41 [ -0.47, 1.30 ]
Giuli 2016 48 0.32 (0.9) 47 -0.2 (0.96) 9.7 % 0.55 [ 0.14, 0.96 ]
Mapelli 2013 10 1.7 (1.24) 10 -0.1 (1.29) 7.3 % 1.36 [ 0.37, 2.36 ]
Subtotal (95% CI) 87 85 33.6 % 0.51 [ 0.07, 0.95 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 4.96, df = 3 (P = 0.17); I2 =40%
Test for overall effect: Z = 2.29 (P = 0.022)
Total (95% CI) 268 283 100.0 % 0.56 [ 0.08, 1.05 ]
Heterogeneity: Tau2 = 0.59; Chi2 = 71.95, df = 11 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.91), I2 =0.0%
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Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 8.8. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 8 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 8 Change in language (naming)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 0.19 (1.55) 40 0.1 (1.32) 22.9 % 0.06 [ -0.38, 0.50 ]
Cahn-Weiner 2003 17 0.3 (3.55) 17 -0.1 (3.48) 18.6 % 0.11 [ -0.56, 0.78 ]
Jelcic 2012 20 3.5 (5.63) 20 -0.8 (4.61) 19.0 % 0.82 [ 0.17, 1.47 ]
Jelcic 2014 17 2.19 (2.56) 10 -0.4 (2.41) 15.8 % 1.00 [ 0.17, 1.83 ]
Trebbastoni 2018 45 2 (3.35) 85 -1.81 (3.34) 23.8 % 1.13 [ 0.75, 1.52 ]
Total (95% CI) 139 172 100.0 % 0.62 [ 0.11, 1.12 ]
Heterogeneity: Tau2 = 0.24; Chi2 = 16.29, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 2.39 (P = 0.017)
Test for subgroup differences: Not applicable
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Analysis 8.9. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 9 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 9 Change in verbal letter fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Cavallo 2016 40 1.17 (1.62) 40 1.53 (1.6) 11.6 % -0.22 [ -0.66, 0.22 ]
Cahn-Weiner 2003 17 0.3 (5.95) 17 1 (4.62) 8.4 % -0.13 [ -0.80, 0.54 ]
Jelcic 2012 20 1.7 (7.56) 20 1.3 (7.41) 9.1 % 0.05 [ -0.57, 0.67 ]
Jelcic 2014 17 2.27 (7.6) 10 1.6 (6.93) 7.3 % 0.09 [ -0.69, 0.87 ]
Kawashima 2005 16 0.1 (0.55) 16 0 (0.44) 8.2 % 0.20 [ -0.50, 0.89 ]
Trebbastoni 2018 45 -0.17 (4.89) 85 -2.03 (5) 12.6 % 0.37 [ 0.01, 0.74 ]
Galante 2007 7 3.5 (5.74) 4 -1.7 (6.97) 3.7 % 0.77 [ -0.52, 2.06 ]
Bergamaschi 2013 16 1.06 (1.39) 16 -1.72 (1.97) 7.0 % 1.59 [ 0.78, 2.40 ]
Subtotal (95% CI) 178 208 67.9 % 0.26 [ -0.09, 0.62 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 17.69, df = 7 (P = 0.01); I2 =60%
Test for overall effect: Z = 1.45 (P = 0.15)
2 Augmented
Serino 2017 10 -1.6 (3.47) 10 0.2 (4.8) 6.3 % -0.41 [ -1.30, 0.48 ]
Davis 2001 19 0.22 (7.7) 18 1.33 (9.03) 8.8 % -0.13 [ -0.78, 0.52 ]
Barban 2016 42 1.4 (5.66) 39 1.1 (6.04) 11.6 % 0.05 [ -0.39, 0.49 ]
Mapelli 2013 10 1.2 (1.51) 10 -0.64 (1.12) 5.5 % 1.33 [ 0.34, 2.31 ]
Subtotal (95% CI) 81 77 32.1 % 0.14 [ -0.42, 0.70 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 7.69, df = 3 (P = 0.05); I2 =61%
Test for overall effect: Z = 0.49 (P = 0.62)
Total (95% CI) 259 285 100.0 % 0.22 [ -0.07, 0.50 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 25.86, df = 11 (P = 0.01); I2 =57%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 0.14, df = 1 (P = 0.71), I2 =0.0%
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Analysis 8.10. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 10 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 10 Change in speed of information processing
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Beck 1988 10 -0.3 (1.25) 10 1.1 (2.88) 11.3 % -0.60 [ -1.51, 0.30 ]
Galante 2007 7 -1.3 (10.33) 4 3.3 (5.55) 6.3 % -0.47 [ -1.72, 0.79 ]
Jelcic 2014 17 0.47 (6.9) 10 -0.4 (8.16) 14.4 % 0.11 [ -0.67, 0.90 ]
Barban 2016 36 7.7 (27.35) 33 -1.9 (27.67) 30.0 % 0.35 [ -0.13, 0.82 ]
Jelcic 2012 20 19.3 (56.5) 20 -2 (20.58) 20.3 % 0.49 [ -0.14, 1.12 ]
Cahn-Weiner 2003 17 5.2 (20.62) 17 -9.6 (31.4) 17.8 % 0.54 [ -0.14, 1.23 ]
Total (95% CI) 107 94 100.0 % 0.22 [ -0.11, 0.54 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 6.24, df = 5 (P = 0.28); I2 =20%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 8.11. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 11 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 11 Change in executive function
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Cahn-Weiner 2003 17 6 (51.61) 17 33.3 (49.98) 8.9 % -0.52 [ -1.21, 0.16 ]
Galante 2007 7 -2.6 (8.27) 4 -2.3 (3.25) 6.2 % -0.04 [ -1.27, 1.19 ]
Kawashima 2005 16 15 (18) 16 -6 (197) 8.9 % 0.15 [ -0.55, 0.84 ]
Cavallo 2016 40 -0.07 (0.79) 40 -0.26 (0.71) 10.0 % 0.25 [ -0.19, 0.69 ]
Jelcic 2012 20 13.2 (18.07) 20 6.6 (16.69) 9.2 % 0.37 [ -0.25, 1.00 ]
Quayhagen 1995 (1) 13 4.8 (7.28) 28 0.4 (6.6) 9.0 % 0.63 [ -0.04, 1.31 ]
Trebbastoni 2018 45 0.96 (2.07) 85 -1.3 (2.19) 10.2 % 1.05 [ 0.66, 1.43 ]
Quayhagen 1995 (2) 13 4.8 (7.28) 25 -3.6 (6.44) 8.7 % 1.22 [ 0.49, 1.95 ]
Quayhagen 2000 21 5.91 (2.31) 15 -2.6 (3.8) 7.6 % 2.76 [ 1.81, 3.71 ]
Subtotal (95% CI) 192 250 78.7 % 0.64 [ 0.14, 1.14 ]
Heterogeneity: Tau2 = 0.45; Chi2 = 43.91, df = 8 (P<0.00001); I2 =82%
Test for overall effect: Z = 2.49 (P = 0.013)
2 Augmented
Serino 2017 10 0.22 (2.24) 10 -0.66 (2.01) 7.9 % 0.40 [ -0.49, 1.28 ]
Neely 2009 20 -0.03 (0.15) 9 -0.16 (0.52) 8.3 % 0.41 [ -0.39, 1.20 ]
Mapelli 2013 (3) 10 2.3 (0.52) 10 -0.2 (0.79) 5.1 % 3.58 [ 2.06, 5.10 ]
Subtotal (95% CI) 40 29 21.3 % 1.32 [ -0.26, 2.91 ]
Heterogeneity: Tau2 = 1.66; Chi2 = 14.63, df = 2 (P = 0.00067); I2 =86%
Test for overall effect: Z = 1.63 (P = 0.10)
Total (95% CI) 232 279 100.0 % 0.75 [ 0.28, 1.22 ]
Heterogeneity: Tau2 = 0.52; Chi2 = 58.99, df = 11 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.15 (P = 0.0017)
Test for subgroup differences: Chi2 = 0.65, df = 1 (P = 0.42), I2 =0.0%
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(1) Cognitive training vs. Active control
(2) Cognitive training vs. Passive control
(3) Cognitive training vs. Passive control
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Analysis 8.12. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 12 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 12 Change in verbal category fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Galante 2007 7 0 (2.98) 4 0.1 (4.16) 4.5 % -0.03 [ -1.26, 1.20 ]
Jelcic 2012 20 1.5 (5.72) 20 1 (5.78) 11.3 % 0.09 [ -0.53, 0.71 ]
Jelcic 2014 17 1.39 (4.71) 10 0.4 (5.46) 8.7 % 0.19 [ -0.59, 0.98 ]
Heiss 1993 18 1.66 (3.52) 17 -1.07 (3.13) 10.0 % 0.80 [ 0.11, 1.49 ]
Trebbastoni 2018 45 2.06 (4.84) 85 -2.93 (5.04) 16.6 % 1.00 [ 0.62, 1.38 ]
Cavallo 2016 40 0.34 (1.22) 40 -0.95 (1.21) 14.5 % 1.05 [ 0.58, 1.52 ]
Subtotal (95% CI) 147 176 65.7 % 0.64 [ 0.26, 1.01 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 11.12, df = 5 (P = 0.05); I2 =55%
Test for overall effect: Z = 3.29 (P = 0.00099)
2 Augmented
Serino 2017 10 0.7 (2.91) 10 0.5 (3.99) 7.5 % 0.05 [ -0.82, 0.93 ]
Davis 2001 19 1.5 (3.67) 18 0.95 (3.37) 10.8 % 0.15 [ -0.49, 0.80 ]
Giuli 2016 48 0.15 (0.73) 47 -0.17 (0.67) 16.0 % 0.45 [ 0.05, 0.86 ]
Subtotal (95% CI) 77 75 34.3 % 0.33 [ 0.00, 0.65 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.02, df = 2 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 1.99 (P = 0.047)
Total (95% CI) 224 251 100.0 % 0.52 [ 0.23, 0.81 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 16.57, df = 8 (P = 0.03); I2 =52%
Test for overall effect: Z = 3.49 (P = 0.00049)
Test for subgroup differences: Chi2 = 1.50, df = 1 (P = 0.22), I2 =33%
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Analysis 8.13. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 13 Change in meta cognition (self-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 13 Change in meta cognition (self-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -6.43 (14.3) 8 -1 (14.1) 51.9 % -0.37 [ -1.24, 0.51 ]
Lee 2013 12 0.27 (0.29) 7 0.08 (0.26) 48.1 % 0.65 [ -0.31, 1.61 ]
Total (95% CI) 26 15 100.0 % 0.12 [ -0.87, 1.12 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 2.34, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 8.14. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 14 Change in meta cognition (informant-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 14 Change in meta cognition (informant-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -3.54 (14.7) 8 5.75 (10.4) 37.3 % -0.67 [ -1.56, 0.23 ]
Cahn-Weiner 2003 17 -4.8 (16.55) 17 6.6 (18.54) 62.7 % -0.63 [ -1.32, 0.06 ]
Total (95% CI) 31 25 100.0 % -0.65 [ -1.19, -0.10 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.021)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 8.15. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 15 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 15 Change in participants’ mood
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Bergamaschi 2013 16 -1.07 (2.98) 16 0.44 (5.09) 12.9 % -0.35 [ -1.05, 0.35 ]
Amieva 2016 164 -12.11 (12.73) 152 -10.81 (12.24) 14.1 % -0.10 [ -0.32, 0.12 ]
Lee 2013 12 -0.25 (2.23) 7 -1.86 (2.77) 11.9 % 0.63 [ -0.33, 1.59 ]
Galante 2007 7 0.5 (0.92) 4 -0.3 (0.78) 10.5 % 0.84 [ -0.47, 2.14 ]
Fern ndez-Calvo 2011 30 3.2 (2) 15 -4.26 (1.85) 11.7 % 3.75 [ 2.73, 4.78 ]
Subtotal (95% CI) 229 194 61.1 % 0.90 [ -0.30, 2.10 ]
Heterogeneity: Tau2 = 1.66; Chi2 = 56.39, df = 4 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.48 (P = 0.14)
2 Augmented
Koltai 2001 (1) 14 -1.21 (2.5) 8 0.13 (3) 12.2 % -0.48 [ -1.36, 0.40 ]
Davis 2001 19 0.32 (1.52) 17 0.17 (4.41) 13.1 % 0.05 [ -0.61, 0.70 ]
Giuli 2016 48 -0.18 (4.4) 47 -7.32 (3.77) 13.6 % 1.73 [ 1.25, 2.20 ]
Subtotal (95% CI) 81 72 38.9 % 0.46 [ -0.94, 1.86 ]
Heterogeneity: Tau2 = 1.41; Chi2 = 27.63, df = 2 (P<0.00001); I2 =93%
Test for overall effect: Z = 0.65 (P = 0.52)
Total (95% CI) 310 266 100.0 % 0.72 [ -0.10, 1.54 ]
Heterogeneity: Tau2 = 1.23; Chi2 = 99.54, df = 7 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.73 (P = 0.084)
Test for subgroup differences: Chi2 = 0.22, df = 1 (P = 0.64), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
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Analysis 8.16. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 16 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 16 Change in capacity for activities of daily living
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.6 (1.36) 4 0.5 (0.48) 2.6 % -0.88 [ -2.19, 0.43 ]
de Vreese 1998 9 -1.33 (4.37) 9 1.01 (3.98) 4.7 % -0.53 [ -1.48, 0.41 ]
Amieva 2016 167 -1.76 (8.46) 153 -1.22 (8.27) 23.8 % -0.06 [ -0.28, 0.16 ]
Cahn-Weiner 2003 17 -0.2 (3.16) 17 0 (3.07) 8.1 % -0.06 [ -0.74, 0.61 ]
Kim 2015 21 0 (0.86) 21 0 (1.05) 9.4 % 0.0 [ -0.60, 0.60 ]
Jelcic 2012 20 0.1 (1.05) 38 0 (1.36) 10.9 % 0.08 [ -0.46, 0.62 ]
Barban 2016 38 -0.1 (0.96) 38 -0.3 (1.08) 13.6 % 0.19 [ -0.26, 0.64 ]
Giuli 2016 48 0.26 (1.2) 47 -0.24 (1.26) 15.2 % 0.40 [ 0.00, 0.81 ]
Bergamaschi 2013 16 -0.38 (1.54) 16 -1.32 (1.46) 7.4 % 0.61 [ -0.10, 1.32 ]
Lee 2013 12 2.24 (3.33) 7 -2.14 (4.54) 4.2 % 1.10 [ 0.09, 2.11 ]
Total (95% CI) 355 350 100.0 % 0.12 [ -0.10, 0.34 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 14.29, df = 9 (P = 0.11); I2 =37%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 8.17. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 17 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 17 Change in disease progression
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fern ndez-Calvo 2011 30 -2.11 (2.24) 15 -7.07 (2.39) 16.5 % 2.13 [ 1.36, 2.90 ]
Lee 2013 12 7.59 (9.2) 7 0.86 (7.83) 13.2 % 0.74 [ -0.23, 1.70 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 14.3 % 0.57 [ -0.33, 1.46 ]
Quayhagen 1995 (1) 13 3.3 (7.5) 25 -4.4 (8.36) 17.8 % 0.93 [ 0.23, 1.64 ]
Quayhagen 1995 (2) 13 3.3 (7.5) 28 -1.7 (8.89) 18.5 % 0.58 [ -0.09, 1.25 ]
Quintana Hernandez 2014 27 -2.77 (6.39) 25 -12.28 (7.33) 19.7 % 1.37 [ 0.76, 1.97 ]
Total (95% CI) 105 110 100.0 % 1.07 [ 0.59, 1.55 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 11.99, df = 5 (P = 0.03); I2 =58%
Test for overall effect: Z = 4.40 (P = 0.000011)
Test for subgroup differences: Not applicable
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Analysis 8.18. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 18 Change in behavioural and psychological symptoms of dementia
(BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 18 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -1.3 (2.22) 4 2.5 (3.9) 12.3 % -1.20 [ -2.58, 0.18 ]
Amieva 2016 165 -25.22 (23.28) 152 -21.81 (22.11) 19.5 % -0.15 [ -0.37, 0.07 ]
Quayhagen 2000 21 -0.53 (10.23) 15 -0.47 (12.91) 17.4 % -0.01 [ -0.67, 0.66 ]
Quintana Hernandez 2014 27 -8.55 (12.88) 25 -13.36 (13.48) 18.1 % 0.36 [ -0.19, 0.91 ]
Kawashima 2005 16 0.45 (1.88) 16 -0.3 (1.56) 17.1 % 0.42 [ -0.28, 1.12 ]
Fern ndez-Calvo 2011 30 2.08 (2.27) 15 -4.23 (1.33) 15.6 % 3.08 [ 2.17, 3.99 ]
Total (95% CI) 266 227 100.0 % 0.44 [ -0.34, 1.22 ]
Heterogeneity: Tau2 = 0.80; Chi2 = 51.21, df = 5 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Not applicable
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Analysis 8.19. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 19 Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 19 Participant burden (retention rates)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Traditional
Jelcic 2012 20/20 20/20 Not estimable
Beck 1988 10/10 10/10 Not estimable
Cavallo 2016 40/40 40/40 Not estimable
Kallio 2018 76/76 71/71 Not estimable
Trebbastoni 2018 48/54 86/86 4.8 % 0.04 [ 0.00, 0.78 ]
Quintana Hernandez 2014 27/32 25/25 4.7 % 0.10 [ 0.01, 1.86 ]
Kao 2016 95/110 45/48 17.3 % 0.42 [ 0.12, 1.53 ]
Cahn-Weiner 2003 16/19 17/20 11.3 % 0.94 [ 0.17, 5.36 ]
Amieva 2016 124/170 109/154 38.1 % 1.11 [ 0.69, 1.81 ]
Galante 2007 7/7 4/5 3.6 % 5.00 [ 0.17, 150.92 ]
Subtotal (95% CI) 538 479 79.8 % 0.59 [ 0.23, 1.53 ]
Total events: 463 (Cognitive training), 427 (Control)
Heterogeneity: Tau2 = 0.60; Chi2 = 9.87, df = 5 (P = 0.08); I2 =49%
Test for overall effect: Z = 1.08 (P = 0.28)
2 Augmented
Davis 2001 19/19 18/18 Not estimable
Mapelli 2013 10/10 10/10 Not estimable
Serino 2017 10/10 10/10 Not estimable
Kim 2015 22/22 21/21 Not estimable
Koltai 2001 14/16 8/8 4.1 % 0.34 [ 0.01, 7.98 ]
Giuli 2016 48/51 47/50 12.3 % 1.02 [ 0.20, 5.32 ]
Neely 2009 10/10 9/10 3.8 % 3.32 [ 0.12, 91.60 ]
Subtotal (95% CI) 138 127 20.2 % 1.02 [ 0.27, 3.87 ]
Total events: 133 (Cognitive training), 123 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.95, df = 2 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 0.02 (P = 0.98)
0.001 0.01 0.1 1 10 100 1000
Control Cognitive training
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(. . . Continued)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total (95% CI) 676 606 100.0 % 0.73 [ 0.37, 1.43 ]
Total events: 596 (Cognitive training), 550 (Control)
Heterogeneity: Tau2 = 0.25; Chi2 = 10.82, df = 8 (P = 0.21); I2 =26%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 0.42, df = 1 (P = 0.52), I2 =0.0%
0.001 0.01 0.1 1 10 100 1000
Control Cognitive training
Analysis 8.20. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 20 Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 20 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -21.31 (19.1) 152 -17.95 (19.01) 77.0 % -0.18 [ -0.40, 0.04 ]
Quayhagen 2000 21 -0.8 (4.05) 67 -1.29 (3.7) 23.0 % 0.13 [ -0.36, 0.62 ]
Total (95% CI) 186 219 100.0 % -0.11 [ -0.36, 0.15 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 8.21. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 21 Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 21 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 -0.62 (9.8) 15 -2.8 (16.52) 100.0 % 0.16 [ -0.50, 0.83 ]
Total (95% CI) 21 15 100.0 % 0.16 [ -0.50, 0.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 8.22. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 22 Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 22 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 0.09 (0.06) 15 0.03 (0.06) 100.0 % 0.98 [ 0.27, 1.68 ]
Total (95% CI) 21 15 100.0 % 0.98 [ 0.27, 1.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.72 (P = 0.0065)
Test for subgroup differences: Not applicable
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Analysis 8.23. Comparison 8 Cognitive training vs control immediately post intervention - type of CT
(traditional vs augmented), Outcome 23 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 8 Cognitive training vs control immediately post intervention - type of CT (traditional vs augmented)
Outcome: 23 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 -24.76 (37.3) 18 4.77 (40.85) 14.0 % -0.74 [ -1.41, -0.07 ]
Quayhagen 2000 21 -0.38 (2.75) 67 0.13 (2.6) 18.8 % -0.19 [ -0.68, 0.30 ]
Amieva 2016 164 -6.3 (6.13) 151 -5.6 (6.35) 27.8 % -0.11 [ -0.33, 0.11 ]
Kallio 2018 76 -0.04 (0.06) 71 -0.04 (0.06) 24.4 % 0.0 [ -0.32, 0.32 ]
Kim 2015 22 3.4 (3.3) 21 0 (4.36) 15.0 % 0.87 [ 0.24, 1.49 ]
Total (95% CI) 302 328 100.0 % -0.04 [ -0.38, 0.29 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 12.93, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
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Analysis 9.1. Comparison 9 Cognitive training vs control immediately post intervention - type of CT (multi-
domain vs single domain), Outcome 1 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 1 Change in a global measure of cognition
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Galante 2007 7 0.1 (2.34) 4 1.8 (1.74) 3.7 % -0.72 [ -2.00, 0.56 ]
Giuli 2016 48 0.02 (2.77) 47 1.24 (3.77) 5.7 % -0.37 [ -0.77, 0.04 ]
Koltai 2001 (1) 14 -0.21 (2.9) 8 0.75 (2.4) 4.6 % -0.34 [ -1.21, 0.54 ]
Amieva 2016 168 -8.4 (5.86) 153 -7.6 (5.43) 5.9 % -0.14 [ -0.36, 0.08 ]
Heiss 1993 18 -1.22 (4.22) 17 -0.94 (3.59) 5.1 % -0.07 [ -0.73, 0.59 ]
Cavallo 2016 40 -0.14 (1.04) 40 -0.16 (1.62) 5.6 % 0.01 [ -0.42, 0.45 ]
Barban 2016 42 0.1 (1.64) 39 -0.1 (1.15) 5.6 % 0.14 [ -0.30, 0.58 ]
Kallio 2018 76 -0.8 (5.19) 71 -1.6 (5.35) 5.8 % 0.15 [ -0.17, 0.48 ]
Venturelli 2016 20 -0.2 (0.97) 20 -0.4 (1.14) 5.2 % 0.19 [ -0.44, 0.81 ]
Kawashima 2005 16 0.1 (5.1) 16 -1.8 (3.75) 5.1 % 0.41 [ -0.29, 1.12 ]
Quintana Hernandez 2014 27 -4.48 (4.08) 25 -7.48 (3.49) 5.4 % 0.78 [ 0.21, 1.34 ]
Mapelli 2013 10 2.9 (2.59) 10 -0.3 (1.71) 4.3 % 1.40 [ 0.40, 2.40 ]
de Vreese 1998 9 2.77 (1.68) 9 -0.89 (2.4) 4.1 % 1.68 [ 0.57, 2.80 ]
Trebbastoni 2018 48 1.53 (1.7) 86 -2.64 (2.07) 5.6 % 2.13 [ 1.69, 2.57 ]
Fern ndez-Calvo 2011 30 1.12 (1.64) 15 -2.31 (1.16) 4.9 % 2.25 [ 1.46, 3.03 ]
Bergamaschi 2013 16 2.75 (1.81) 16 -3.57 (1.81) 4.0 % 3.40 [ 2.28, 4.53 ]
Subtotal (95% CI) 589 576 80.7 % 0.63 [ 0.19, 1.07 ]
Heterogeneity: Tau2 = 0.68; Chi2 = 167.63, df = 15 (P<0.00001); I2 =91%
Test for overall effect: Z = 2.81 (P = 0.0050)
2 Single domain
Davis 2001 19 0.16 (2.6) 18 0.22 (2.68) 5.2 % -0.02 [ -0.67, 0.62 ]
Lee 2013 12 2.01 (2.86) 7 2 (1.9) 4.5 % 0.00 [ -0.93, 0.94 ]
Jelcic 2014 17 2 (1.47) 10 -0.7 (2.41) 4.6 % 1.40 [ 0.52, 2.28 ]
Jelcic 2012 20 2 (1.68) 20 -1 (1.98) 5.0 % 1.60 [ 0.88, 2.32 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 68 55 19.3 % 0.75 [ -0.14, 1.63 ]
Heterogeneity: Tau2 = 0.66; Chi2 = 15.42, df = 3 (P = 0.001); I2 =81%
Test for overall effect: Z = 1.65 (P = 0.099)
Total (95% CI) 657 631 100.0 % 0.65 [ 0.26, 1.05 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 187.26, df = 19 (P<0.00001); I2 =90%
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.82), I2 =0.0%
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
Analysis 9.2. Comparison 9 Cognitive training vs control immediately post intervention - type of CT (multi-
domain vs single domain), Outcome 2 Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 2 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Venturelli 2016 20 -2 (2.13) 20 -0.4 (2.42) 5.0 % -0.69 [ -1.33, -0.05 ]
Galante 2007 7 0.1 (4.98) 4 1.8 (3.33) 2.4 % -0.35 [ -1.59, 0.90 ]
Koltai 2001 (1) 14 -0.21 (5.8) 8 0.75 (4.8) 3.8 % -0.17 [ -1.04, 0.70 ]
Giuli 2016 48 0.02 (6.16) 47 1.24 (8.42) 6.5 % -0.16 [ -0.57, 0.24 ]
Amieva 2016 168 -8.4 (8.71) 152 -7.6 (5.43) 7.5 % -0.11 [ -0.33, 0.11 ]
Heiss 1993 18 -1.22 (8.13) 17 -0.94 (7.18) 4.9 % -0.04 [ -0.70, 0.63 ]
Cavallo 2016 40 -0.14 (2.25) 40 -0.16 (2.75) 6.3 % 0.01 [ -0.43, 0.45 ]
Barban 2016 42 0.1 (3.3) 39 -0.1 (2.55) 6.3 % 0.07 [ -0.37, 0.50 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Kallio 2018 76 -0.8 (11.6) 71 -1.6 (11.95) 7.0 % 0.07 [ -0.26, 0.39 ]
Kawashima 2005 16 0.1 (11.01) 16 -1.8 (8.22) 4.7 % 0.19 [ -0.50, 0.89 ]
Quintana Hernandez 2014 27 -4.48 (6.86) 25 -7.48 (5.65) 5.5 % 0.47 [ -0.08, 1.02 ]
Mapelli 2013 10 1.07 (1.75) 10 0.33 (0.42) 3.6 % 0.56 [ -0.34, 1.45 ]
de Vreese 1998 9 2.77 (3.48) 9 -0.89 (5.22) 3.3 % 0.79 [ -0.18, 1.75 ]
Trebbastoni 2018 48 1.53 (3.68) 86 -2.64 (4.39) 6.7 % 1.00 [ 0.63, 1.37 ]
Fern ndez-Calvo 2011 30 1.12 (3.64) 15 -2.31 (2.57) 4.9 % 1.01 [ 0.35, 1.67 ]
Bergamaschi 2013 16 2.75 (3.56) 16 -3.57 (3.58) 4.0 % 1.73 [ 0.90, 2.55 ]
Subtotal (95% CI) 589 575 82.5 % 0.25 [ -0.01, 0.52 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 60.62, df = 15 (P<0.00001); I2 =75%
Test for overall effect: Z = 1.87 (P = 0.061)
2 Single domain
Davis 2001 19 0.16 (5.82) 18 0.22 (5.86) 5.0 % -0.01 [ -0.65, 0.63 ]
Lee 2013 12 2.01 (6.23) 7 2 (4.18) 3.5 % 0.00 [ -0.93, 0.93 ]
Jelcic 2014 17 2 (3.18) 10 -0.7 (5) 4.1 % 0.67 [ -0.14, 1.47 ]
Jelcic 2012 20 2 (3.62) 20 -1 (4.2) 5.0 % 0.75 [ 0.11, 1.39 ]
Subtotal (95% CI) 68 55 17.5 % 0.37 [ -0.04, 0.79 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 3.79, df = 3 (P = 0.28); I2 =21%
Test for overall effect: Z = 1.76 (P = 0.078)
Total (95% CI) 657 630 100.0 % 0.27 [ 0.04, 0.50 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 65.70, df = 19 (P<0.00001); I2 =71%
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Chi2 = 0.23, df = 1 (P = 0.63), I2 =0.0%
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. We multiplied the SD they
provided by 2.
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Analysis 9.3. Comparison 9 Cognitive training vs control immediately post intervention - type of CT (multi-
domain vs single domain), Outcome 3 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 3 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Fern ndez-Calvo 2011 30 15 -0.44 (0.42) 3.0 % -0.44 [ -1.26, 0.38 ]
Amieva 2016 165 153 -0.11 (0.11) 6.6 % -0.11 [ -0.33, 0.11 ]
Beck 1988 10 10 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.8 % 0.01 [ -0.66, 0.68 ]
Boller 2011 24 12 0.13 (0.35) 3.7 % 0.13 [ -0.56, 0.82 ]
Galante 2007 7 4 0.21 (0.63) 1.8 % 0.21 [ -1.02, 1.44 ]
Quayhagen 1995 (1) 13 28 0.25 (0.33) 3.9 % 0.25 [ -0.40, 0.90 ]
Heiss 1993 18 17 0.27 (0.34) 3.8 % 0.27 [ -0.40, 0.94 ]
Quayhagen 1995 (2) 13 25 0.37 (0.34) 3.8 % 0.37 [ -0.30, 1.04 ]
Kawashima 2005 16 16 0.52 (0.36) 3.6 % 0.52 [ -0.19, 1.23 ]
Jelcic 2014 17 10 0.55 (0.4) 3.2 % 0.55 [ -0.23, 1.33 ]
Trebbastoni 2018 45 85 0.55 (0.2) 5.5 % 0.55 [ 0.16, 0.94 ]
Jelcic 2012 20 20 0.6 (0.32) 4.0 % 0.60 [ -0.03, 1.23 ]
Quintana Hernandez 2014 27 25 0.73 (0.28) 4.5 % 0.73 [ 0.18, 1.28 ]
Lee 2013 12 7 1.15 (0.53) 2.3 % 1.15 [ 0.11, 2.19 ]
Cavallo 2016 40 40 1.32 (0.28) 4.5 % 1.32 [ 0.77, 1.87 ]
Bergamaschi 2013 16 16 1.64 (0.41) 3.1 % 1.64 [ 0.84, 2.44 ]
Subtotal (95% CI) 490 500 64.2 % 0.44 [ 0.18, 0.71 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 50.71, df = 16 (P = 0.00002); I2 =68%
Test for overall effect: Z = 3.29 (P = 0.00099)
2 Single domain
Koltai 2001 14 8 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Davis 2001 19 18 0 (0.32) 4.0 % 0.0 [ -0.63, 0.63 ]
Quayhagen 2000 21 15 0.19 (0.33) 3.9 % 0.19 [ -0.46, 0.84 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Barban 2016 41 38 0.21 (0.23) 5.1 % 0.21 [ -0.24, 0.66 ]
Neely 2009 20 9 0.26 (0.39) 3.3 % 0.26 [ -0.50, 1.02 ]
Serino 2017 10 10 0.31 (0.44) 2.9 % 0.31 [ -0.55, 1.17 ]
Giuli 2016 48 47 0.37 (0.21) 5.4 % 0.37 [ -0.04, 0.78 ]
Kim 2015 22 21 0.46 (0.32) 4.0 % 0.46 [ -0.17, 1.09 ]
de Vreese 1998 9 9 1.04 (0.49) 2.5 % 1.04 [ 0.08, 2.00 ]
Mapelli 2013 10 10 2.13 (0.66) 1.6 % 2.13 [ 0.84, 3.42 ]
Subtotal (95% CI) 214 185 35.8 % 0.35 [ 0.10, 0.59 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 11.99, df = 9 (P = 0.21); I2 =25%
Test for overall effect: Z = 2.78 (P = 0.0054)
Total (95% CI) 704 685 100.0 % 0.42 [ 0.23, 0.61 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 62.80, df = 26 (P = 0.00007); I2 =59%
Test for overall effect: Z = 4.32 (P = 0.000015)
Test for subgroup differences: Chi2 = 0.28, df = 1 (P = 0.60), I2 =0.0%
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(1) CT vs Active Control
(2) CT vs Passive Control
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Analysis 9.4. Comparison 9 Cognitive training vs control immediately post intervention - type of CT (multi-
domain vs single domain), Outcome 4 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 4 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Amieva 2016 166 153 -0.07 (0.11) 15.9 % -0.07 [ -0.29, 0.15 ]
Beck 1988 10 10 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Bergamaschi 2013 16 16 0.78 (0.36) 2.7 % 0.78 [ 0.07, 1.49 ]
Boller 2011 24 12 0.06 (0.35) 2.8 % 0.06 [ -0.63, 0.75 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.0 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 40 40 0.61 (0.23) 5.9 % 0.61 [ 0.16, 1.06 ]
Fern ndez-Calvo 2011 30 15 -0.29 (0.34) 3.0 % -0.29 [ -0.96, 0.38 ]
Galante 2007 7 4 0.12 (0.59) 1.1 % 0.12 [ -1.04, 1.28 ]
Heiss 1993 18 17 0.15 (0.33) 3.1 % 0.15 [ -0.50, 0.80 ]
Jelcic 2012 20 20 0.28 (0.31) 3.5 % 0.28 [ -0.33, 0.89 ]
Jelcic 2014 17 10 0.27 (0.39) 2.3 % 0.27 [ -0.49, 1.03 ]
Kawashima 2005 16 16 0.23 (0.35) 2.8 % 0.23 [ -0.46, 0.92 ]
Lee 2013 12 7 0.6 (0.47) 1.6 % 0.60 [ -0.32, 1.52 ]
Quayhagen 1995 (1) 13 25 1.03 (0.36) 2.7 % 1.03 [ 0.32, 1.74 ]
Quayhagen 1995 (2) 13 28 0.55 (0.33) 3.1 % 0.55 [ -0.10, 1.20 ]
Quintana Hernandez 2014 27 25 0.46 (0.28) 4.2 % 0.46 [ -0.09, 1.01 ]
Trebbastoni 2018 45 85 0.26 (0.19) 7.9 % 0.26 [ -0.11, 0.63 ]
Subtotal (95% CI) 491 500 67.5 % 0.27 [ 0.10, 0.44 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 22.90, df = 16 (P = 0.12); I2 =30%
Test for overall effect: Z = 3.07 (P = 0.0022)
2 Single domain
Barban 2016 41 38 0.1 (0.22) 6.3 % 0.10 [ -0.33, 0.53 ]
Davis 2001 19 18 0 (0.32) 3.3 % 0.0 [ -0.63, 0.63 ]
de Vreese 1998 9 9 0.48 (0.46) 1.7 % 0.48 [ -0.42, 1.38 ]
-4 -2 0 2 4
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Giuli 2016 48 47 0.17 (0.2) 7.3 % 0.17 [ -0.22, 0.56 ]
Kim 2015 22 21 0.2 (0.3) 3.7 % 0.20 [ -0.39, 0.79 ]
Koltai 2001 14 8 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Mapelli 2013 10 10 1.06 (0.55) 1.2 % 1.06 [ -0.02, 2.14 ]
Neely 2009 20 9 0.26 (0.39) 2.3 % 0.26 [ -0.50, 1.02 ]
Quayhagen 2000 21 15 0.8 (0.35) 2.8 % 0.80 [ 0.11, 1.49 ]
Serino 2017 10 10 0.16 (0.43) 1.9 % 0.16 [ -0.68, 1.00 ]
Subtotal (95% CI) 214 185 32.5 % 0.23 [ 0.04, 0.43 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 6.59, df = 9 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.020)
Total (95% CI) 705 685 100.0 % 0.24 [ 0.12, 0.36 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 29.59, df = 26 (P = 0.29); I2 =12%
Test for overall effect: Z = 3.89 (P = 0.000099)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.80), I2 =0.0%
-4 -2 0 2 4
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(1) CT vs Passive control
(2) CT vs Active control
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Analysis 9.5. Comparison 9 Cognitive training vs control immediately post intervention - type of CT (multi-
domain vs single domain), Outcome 5 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 5 Change in immediate memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Koltai 2001 14 0.64 (1.7) 8 1.63 (2.8) 5.1 % -0.44 [ -1.32, 0.44 ]
Galante 2007 7 -0.2 (5.3) 4 1.2 (7.77) 4.0 % -0.21 [ -1.44, 1.03 ]
Quayhagen 2000 21 2.29 (12.1) 15 -0.73 (12.08) 5.9 % 0.24 [ -0.42, 0.91 ]
Heiss 1993 18 0.41 (0.97) 17 0.09 (1) 5.8 % 0.32 [ -0.35, 0.99 ]
Giuli 2016 48 0.65 (1.74) 47 -0.17 (1.74) 6.6 % 0.47 [ 0.06, 0.88 ]
Quayhagen 1995 (1) 13 4.7 (10.56) 28 -0.1 (7.84) 5.8 % 0.54 [ -0.13, 1.21 ]
Bergamaschi 2013 16 1.12 (2) 16 -0.13 (1.63) 5.7 % 0.67 [ -0.05, 1.38 ]
Quayhagen 1995 (2) 13 4.7 (10.56) 25 -1.8 (6.19) 5.7 % 0.80 [ 0.11, 1.50 ]
Trebbastoni 2018 45 4.01 (4.6) 85 -0.7 (3.98) 6.7 % 1.11 [ 0.73, 1.50 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.7 (1.58) 4.6 % 1.58 [ 0.55, 2.61 ]
Cavallo 2016 40 2.26 (0.71) 40 -0.79 (1) 5.7 % 3.48 [ 2.78, 4.19 ]
Subtotal (95% CI) 245 295 61.8 % 0.80 [ 0.24, 1.35 ]
Heterogeneity: Tau2 = 0.73; Chi2 = 78.29, df = 10 (P<0.00001); I2 =87%
Test for overall effect: Z = 2.83 (P = 0.0047)
2 Single domain
Jelcic 2014 17 0.66 (5.53) 10 -0.3 (4.82) 5.5 % 0.18 [ -0.61, 0.96 ]
Boller 2011 24 -0.04 (2.98) 12 -0.92 (2.93) 5.7 % 0.29 [ -0.41, 0.99 ]
Cahn-Weiner 2003 17 -0.4 (2.76) 17 -1.7 (2.97) 5.8 % 0.44 [ -0.24, 1.12 ]
Davis 2001 19 1.43 (3.52) 18 -0.22 (3.71) 5.9 % 0.45 [ -0.21, 1.10 ]
Jelcic 2012 20 2.9 (5.62) 20 -0.2 (5.43) 6.0 % 0.55 [ -0.08, 1.18 ]
Neely 2009 20 -0.1 (1.75) 9 -1.5 (1.25) 5.3 % 0.84 [ 0.02, 1.66 ]
Lee 2013 12 8.08 (3.25) 7 1.29 (1.81) 4.0 % 2.29 [ 1.05, 3.54 ]
Subtotal (95% CI) 129 93 38.2 % 0.58 [ 0.22, 0.94 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 9.67, df = 6 (P = 0.14); I2 =38%
Test for overall effect: Z = 3.16 (P = 0.0016)
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 374 388 100.0 % 0.74 [ 0.37, 1.12 ]
Heterogeneity: Tau2 = 0.51; Chi2 = 90.65, df = 17 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.89 (P = 0.000098)
Test for subgroup differences: Chi2 = 0.41, df = 1 (P = 0.52), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Cognitive training vs. Active control
(2) Cognitive training vs. Passive control
Analysis 9.6. Comparison 9 Cognitive training vs control immediately post intervention - type of CT (multi-
domain vs single domain), Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Quayhagen 2000 21 3.2 (6.89) 15 0.4 (7.55) 9.3 % 0.38 [ -0.29, 1.05 ]
Barban 2016 42 0.4 (1.17) 39 -0.1 (1.11) 10.2 % 0.43 [ -0.01, 0.88 ]
Trebbastoni 2018 45 0.06 (1.26) 85 -0.55 (1.36) 10.4 % 0.46 [ 0.09, 0.82 ]
Koltai 2001 14 0.64 (1.3) 8 -0.25 (1.8) 8.3 % 0.57 [ -0.32, 1.46 ]
Mapelli 2013 (1) 10 4.2 (2.35) 10 -0.8 (1.48) 6.8 % 2.44 [ 1.22, 3.65 ]
Cavallo 2016 40 1.24 (1.04) 40 -1.74 (1) 9.4 % 2.89 [ 2.26, 3.53 ]
Subtotal (95% CI) 172 197 54.4 % 1.15 [ 0.32, 1.97 ]
Heterogeneity: Tau2 = 0.93; Chi2 = 56.37, df = 5 (P<0.00001); I2 =91%
Test for overall effect: Z = 2.71 (P = 0.0067)
2 Single domain
-4 -2 0 2 4
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 1.15 (2.23) 18 1.65 (3.72) 9.4 % -0.16 [ -0.81, 0.49 ]
Boller 2011 24 -0.29 (1.58) 12 -0.08 (1.28) 9.2 % -0.14 [ -0.83, 0.56 ]
Cahn-Weiner 2003 17 -0.3 (1.05) 17 -0.8 (1.58) 9.2 % 0.36 [ -0.31, 1.04 ]
Jelcic 2014 17 0.86 (2.17) 10 -1.3 (1.84) 8.5 % 1.02 [ 0.18, 1.85 ]
Jelcic 2012 20 1.5 (2.34) 20 -0.9 (2.04) 9.3 % 1.07 [ 0.40, 1.74 ]
Subtotal (95% CI) 97 77 45.6 % 0.41 [ -0.11, 0.94 ]
Heterogeneity: Tau2 = 0.23; Chi2 = 11.20, df = 4 (P = 0.02); I2 =64%
Test for overall effect: Z = 1.54 (P = 0.12)
Total (95% CI) 269 274 100.0 % 0.81 [ 0.29, 1.32 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 72.73, df = 10 (P<0.00001); I2 =86%
Test for overall effect: Z = 3.05 (P = 0.0023)
Test for subgroup differences: Chi2 = 2.15, df = 1 (P = 0.14), I2 =53%
-4 -2 0 2 4
Control Cognitive training
(1) Cognitive training vs passive control
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Analysis 9.7. Comparison 9 Cognitive training vs control immediately post intervention - type of CT (multi-
domain vs single domain), Outcome 7 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 7 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Heiss 1993 18 -0.64 (1) 17 -0.03 (0.98) 8.7 % -0.60 [ -1.28, 0.08 ]
Galante 2007 7 0.1 (0.66) 4 0.7 (1.52) 6.1 % -0.53 [ -1.79, 0.73 ]
Trebbastoni 2018 45 -0.3 (0.58) 85 -0.24 (0.65) 9.9 % -0.10 [ -0.46, 0.27 ]
Serino 2017 10 0 (0.91) 10 -0.33 (0.58) 7.8 % 0.41 [ -0.47, 1.30 ]
Giuli 2016 48 0.32 (0.9) 47 -0.2 (0.96) 9.7 % 0.55 [ 0.14, 0.96 ]
Beck 1988 (1) 10 0.7 (0.95) 10 -0.2 (1.32) 7.6 % 0.75 [ -0.16, 1.66 ]
Mapelli 2013 10 1.7 (1.24) 10 -0.1 (1.29) 7.3 % 1.36 [ 0.37, 2.36 ]
Cavallo 2016 40 1.89 (0.99) 40 -0.04 (0.89) 9.2 % 2.03 [ 1.49, 2.57 ]
Subtotal (95% CI) 188 223 66.3 % 0.50 [ -0.14, 1.15 ]
Heterogeneity: Tau2 = 0.70; Chi2 = 56.57, df = 7 (P<0.00001); I2 =88%
Test for overall effect: Z = 1.54 (P = 0.12)
2 Single domain
Boller 2011 24 0 (1.11) 12 0.08 (0.92) 8.6 % -0.07 [ -0.77, 0.62 ]
Davis 2001 19 -0.41 (1.55) 18 -0.47 (1.56) 8.8 % 0.04 [ -0.61, 0.68 ]
Jelcic 2012 20 0.2 (0.55) 20 -0.4 (0.55) 8.7 % 1.07 [ 0.40, 1.74 ]
Jelcic 2014 17 0.32 (1) 10 -1.35 (0.59) 7.5 % 1.85 [ 0.90, 2.80 ]
Subtotal (95% CI) 80 60 33.7 % 0.68 [ -0.14, 1.49 ]
Heterogeneity: Tau2 = 0.55; Chi2 = 15.13, df = 3 (P = 0.002); I2 =80%
Test for overall effect: Z = 1.63 (P = 0.10)
Total (95% CI) 268 283 100.0 % 0.56 [ 0.08, 1.05 ]
Heterogeneity: Tau2 = 0.59; Chi2 = 71.95, df = 11 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Chi2 = 0.11, df = 1 (P = 0.74), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 9.8. Comparison 9 Cognitive training vs control immediately post intervention - type of CT (multi-
domain vs single domain), Outcome 8 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 8 Change in language (naming)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 0.19 (1.55) 40 0.1 (1.32) 22.9 % 0.06 [ -0.38, 0.50 ]
Cahn-Weiner 2003 17 0.3 (3.55) 17 -0.1 (3.48) 18.6 % 0.11 [ -0.56, 0.78 ]
Jelcic 2012 20 3.5 (5.63) 20 -0.8 (4.61) 19.0 % 0.82 [ 0.17, 1.47 ]
Jelcic 2014 17 2.19 (2.56) 10 -0.4 (2.41) 15.8 % 1.00 [ 0.17, 1.83 ]
Trebbastoni 2018 45 2 (3.35) 85 -1.81 (3.34) 23.8 % 1.13 [ 0.75, 1.52 ]
Total (95% CI) 139 172 100.0 % 0.62 [ 0.11, 1.12 ]
Heterogeneity: Tau2 = 0.24; Chi2 = 16.29, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 2.39 (P = 0.017)
Test for subgroup differences: Not applicable
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Analysis 9.9. Comparison 9 Cognitive training vs control immediately post intervention - type of CT (multi-
domain vs single domain), Outcome 9 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 9 Change in verbal letter fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Serino 2017 10 -1.6 (3.47) 10 0.2 (4.8) 6.3 % -0.41 [ -1.30, 0.48 ]
Cavallo 2016 40 1.17 (1.62) 40 1.53 (1.6) 11.6 % -0.22 [ -0.66, 0.22 ]
Barban 2016 42 1.4 (5.66) 39 1.1 (6.04) 11.6 % 0.05 [ -0.39, 0.49 ]
Kawashima 2005 16 0.1 (0.55) 16 0 (0.44) 8.2 % 0.20 [ -0.50, 0.89 ]
Trebbastoni 2018 45 -0.17 (4.89) 85 -2.03 (5) 12.6 % 0.37 [ 0.01, 0.74 ]
Galante 2007 7 3.5 (5.74) 4 -1.7 (6.97) 3.7 % 0.77 [ -0.52, 2.06 ]
Mapelli 2013 10 1.2 (1.51) 10 -0.64 (1.12) 5.5 % 1.33 [ 0.34, 2.31 ]
Bergamaschi 2013 16 1.06 (1.39) 16 -1.72 (1.97) 7.0 % 1.59 [ 0.78, 2.40 ]
Subtotal (95% CI) 186 220 66.4 % 0.37 [ -0.04, 0.78 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 23.53, df = 7 (P = 0.001); I2 =70%
Test for overall effect: Z = 1.78 (P = 0.076)
2 Single domain
Davis 2001 19 0.22 (7.7) 18 1.33 (9.03) 8.8 % -0.13 [ -0.78, 0.52 ]
Cahn-Weiner 2003 17 0.3 (5.95) 17 1 (4.62) 8.4 % -0.13 [ -0.80, 0.54 ]
Jelcic 2012 20 1.7 (7.56) 20 1.3 (7.41) 9.1 % 0.05 [ -0.57, 0.67 ]
Jelcic 2014 17 2.27 (7.6) 10 1.6 (6.93) 7.3 % 0.09 [ -0.69, 0.87 ]
Subtotal (95% CI) 73 65 33.6 % -0.04 [ -0.37, 0.30 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.33, df = 3 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.84)
Total (95% CI) 259 285 100.0 % 0.22 [ -0.07, 0.50 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 25.86, df = 11 (P = 0.01); I2 =57%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 2.26, df = 1 (P = 0.13), I2 =56%
-2 -1 0 1 2
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Analysis 9.10. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 10 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 10 Change in speed of information processing
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Beck 1988 10 -0.3 (1.25) 10 1.1 (2.88) 11.3 % -0.60 [ -1.51, 0.30 ]
Galante 2007 7 -1.3 (10.33) 4 3.3 (5.55) 6.3 % -0.47 [ -1.72, 0.79 ]
Jelcic 2014 17 0.47 (6.9) 10 -0.4 (8.16) 14.4 % 0.11 [ -0.67, 0.90 ]
Barban 2016 36 7.7 (27.35) 33 -1.9 (27.67) 30.0 % 0.35 [ -0.13, 0.82 ]
Jelcic 2012 20 19.3 (56.5) 20 -2 (20.58) 20.3 % 0.49 [ -0.14, 1.12 ]
Cahn-Weiner 2003 17 5.2 (20.62) 17 -9.6 (31.4) 17.8 % 0.54 [ -0.14, 1.23 ]
Total (95% CI) 107 94 100.0 % 0.22 [ -0.11, 0.54 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 6.24, df = 5 (P = 0.28); I2 =20%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 9.11. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 11 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 11 Change in executive function
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Galante 2007 7 -2.6 (8.27) 4 -2.3 (3.25) 6.2 % -0.04 [ -1.27, 1.19 ]
Kawashima 2005 16 15 (18) 16 -6 (197) 8.9 % 0.15 [ -0.55, 0.84 ]
Cavallo 2016 40 -0.07 (0.79) 40 -0.26 (0.71) 10.0 % 0.25 [ -0.19, 0.69 ]
Serino 2017 10 0.22 (2.24) 10 -0.66 (2.01) 7.9 % 0.40 [ -0.49, 1.28 ]
Quayhagen 1995 (1) 13 4.8 (7.28) 28 0.4 (6.6) 9.0 % 0.63 [ -0.04, 1.31 ]
Trebbastoni 2018 45 0.96 (2.07) 85 -1.3 (2.19) 10.2 % 1.05 [ 0.66, 1.43 ]
Quayhagen 1995 (2) 13 4.8 (7.28) 25 -3.6 (6.44) 8.7 % 1.22 [ 0.49, 1.95 ]
Quayhagen 2000 21 5.91 (2.31) 15 -2.6 (3.8) 7.6 % 2.76 [ 1.81, 3.71 ]
Mapelli 2013 (3) 10 2.3 (0.52) 10 -0.2 (0.79) 5.1 % 3.58 [ 2.06, 5.10 ]
Subtotal (95% CI) 175 233 73.6 % 0.99 [ 0.44, 1.55 ]
Heterogeneity: Tau2 = 0.54; Chi2 = 44.45, df = 8 (P<0.00001); I2 =82%
Test for overall effect: Z = 3.51 (P = 0.00046)
2 Single domain
Cahn-Weiner 2003 17 6 (51.61) 17 33.3 (49.98) 8.9 % -0.52 [ -1.21, 0.16 ]
Jelcic 2012 20 13.2 (18.07) 20 6.6 (16.69) 9.2 % 0.37 [ -0.25, 1.00 ]
Neely 2009 20 -0.03 (0.15) 9 -0.16 (0.52) 8.3 % 0.41 [ -0.39, 1.20 ]
Subtotal (95% CI) 57 46 26.4 % 0.08 [ -0.53, 0.68 ]
Heterogeneity: Tau2 = 0.16; Chi2 = 4.48, df = 2 (P = 0.11); I2 =55%
Test for overall effect: Z = 0.25 (P = 0.80)
Total (95% CI) 232 279 100.0 % 0.75 [ 0.28, 1.22 ]
Heterogeneity: Tau2 = 0.52; Chi2 = 58.99, df = 11 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.15 (P = 0.0017)
Test for subgroup differences: Chi2 = 4.78, df = 1 (P = 0.03), I2 =79%
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(1) Cognitive training vs. Active control
(2) Cognitive training vs. Passive control
(3) Cognitive training vs. Passive control
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Analysis 9.12. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 12 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 12 Change in verbal category fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multidomain
Galante 2007 7 0 (2.98) 4 0.1 (4.16) 4.5 % -0.03 [ -1.26, 1.20 ]
Serino 2017 10 0.7 (2.91) 10 0.5 (3.99) 7.5 % 0.05 [ -0.82, 0.93 ]
Giuli 2016 48 0.15 (0.73) 47 -0.17 (0.67) 16.0 % 0.45 [ 0.05, 0.86 ]
Heiss 1993 18 1.66 (3.52) 17 -1.07 (3.13) 10.0 % 0.80 [ 0.11, 1.49 ]
Trebbastoni 2018 45 2.06 (4.84) 85 -2.93 (5.04) 16.6 % 1.00 [ 0.62, 1.38 ]
Cavallo 2016 40 0.34 (1.22) 40 -0.95 (1.21) 14.5 % 1.05 [ 0.58, 1.52 ]
Subtotal (95% CI) 168 203 69.2 % 0.70 [ 0.38, 1.02 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 9.22, df = 5 (P = 0.10); I2 =46%
Test for overall effect: Z = 4.29 (P = 0.000018)
2 Single domain
Jelcic 2012 20 1.5 (5.72) 20 1 (5.78) 11.3 % 0.09 [ -0.53, 0.71 ]
Davis 2001 19 1.5 (3.67) 18 0.95 (3.37) 10.8 % 0.15 [ -0.49, 0.80 ]
Jelcic 2014 17 1.39 (4.71) 10 0.4 (5.46) 8.7 % 0.19 [ -0.59, 0.98 ]
Subtotal (95% CI) 56 48 30.8 % 0.14 [ -0.25, 0.52 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.05, df = 2 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 0.69 (P = 0.49)
Total (95% CI) 224 251 100.0 % 0.52 [ 0.23, 0.81 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 16.57, df = 8 (P = 0.03); I2 =52%
Test for overall effect: Z = 3.49 (P = 0.00049)
Test for subgroup differences: Chi2 = 4.81, df = 1 (P = 0.03), I2 =79%
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Analysis 9.13. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 13 Change in meta cognition (self-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 13 Change in meta cognition (self-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -6.43 (14.3) 8 -1 (14.1) 51.9 % -0.37 [ -1.24, 0.51 ]
Lee 2013 12 0.27 (0.29) 7 0.08 (0.26) 48.1 % 0.65 [ -0.31, 1.61 ]
Total (95% CI) 26 15 100.0 % 0.12 [ -0.87, 1.12 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 2.34, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 9.14. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 14 Change in meta cognition (informant-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 14 Change in meta cognition (informant-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -3.54 (14.7) 8 5.75 (10.4) 37.3 % -0.67 [ -1.56, 0.23 ]
Cahn-Weiner 2003 17 -4.8 (16.55) 17 6.6 (18.54) 62.7 % -0.63 [ -1.32, 0.06 ]
Total (95% CI) 31 25 100.0 % -0.65 [ -1.19, -0.10 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.021)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 9.15. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 15 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 15 Change in participants’ mood
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -1.21 (2.5) 8 0.13 (3) 12.2 % -0.48 [ -1.36, 0.40 ]
Bergamaschi 2013 16 -1.07 (2.98) 16 0.44 (5.09) 12.9 % -0.35 [ -1.05, 0.35 ]
Amieva 2016 164 -12.11 (12.73) 152 -10.81 (12.24) 14.1 % -0.10 [ -0.32, 0.12 ]
Davis 2001 19 0.32 (1.52) 17 0.17 (4.41) 13.1 % 0.05 [ -0.61, 0.70 ]
Lee 2013 12 -0.25 (2.23) 7 -1.86 (2.77) 11.9 % 0.63 [ -0.33, 1.59 ]
Galante 2007 7 0.5 (0.92) 4 -0.3 (0.78) 10.5 % 0.84 [ -0.47, 2.14 ]
Giuli 2016 48 -0.18 (4.4) 47 -7.32 (3.77) 13.6 % 1.73 [ 1.25, 2.20 ]
Fern ndez-Calvo 2011 30 3.2 (2) 15 -4.26 (1.85) 11.7 % 3.75 [ 2.73, 4.78 ]
Total (95% CI) 310 266 100.0 % 0.72 [ -0.10, 1.54 ]
Heterogeneity: Tau2 = 1.23; Chi2 = 99.54, df = 7 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.73 (P = 0.084)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
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Analysis 9.16. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 16 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 16 Change in capacity for activities of daily living
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.6 (1.36) 4 0.5 (0.48) 2.6 % -0.88 [ -2.19, 0.43 ]
de Vreese 1998 9 -1.33 (4.37) 9 1.01 (3.98) 4.7 % -0.53 [ -1.48, 0.41 ]
Amieva 2016 167 -1.76 (8.46) 153 -1.22 (8.27) 23.8 % -0.06 [ -0.28, 0.16 ]
Cahn-Weiner 2003 17 -0.2 (3.16) 17 0 (3.07) 8.1 % -0.06 [ -0.74, 0.61 ]
Kim 2015 21 0 (0.86) 21 0 (1.05) 9.4 % 0.0 [ -0.60, 0.60 ]
Jelcic 2012 20 0.1 (1.05) 38 0 (1.36) 10.9 % 0.08 [ -0.46, 0.62 ]
Barban 2016 38 -0.1 (0.96) 38 -0.3 (1.08) 13.6 % 0.19 [ -0.26, 0.64 ]
Giuli 2016 48 0.26 (1.2) 47 -0.24 (1.26) 15.2 % 0.40 [ 0.00, 0.81 ]
Bergamaschi 2013 16 -0.38 (1.54) 16 -1.32 (1.46) 7.4 % 0.61 [ -0.10, 1.32 ]
Lee 2013 12 2.24 (3.33) 7 -2.14 (4.54) 4.2 % 1.10 [ 0.09, 2.11 ]
Total (95% CI) 355 350 100.0 % 0.12 [ -0.10, 0.34 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 14.29, df = 9 (P = 0.11); I2 =37%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 9.17. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 17 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 17 Change in disease progression
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fern ndez-Calvo 2011 30 -2.11 (2.24) 15 -7.07 (2.39) 16.5 % 2.13 [ 1.36, 2.90 ]
Lee 2013 12 7.59 (9.2) 7 0.86 (7.83) 13.2 % 0.74 [ -0.23, 1.70 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 14.3 % 0.57 [ -0.33, 1.46 ]
Quayhagen 1995 (1) 13 3.3 (7.5) 28 -1.7 (8.89) 18.5 % 0.58 [ -0.09, 1.25 ]
Quayhagen 1995 (2) 13 3.3 (7.5) 25 -4.4 (8.36) 17.8 % 0.93 [ 0.23, 1.64 ]
Quintana Hernandez 2014 27 -2.77 (6.39) 25 -12.28 (7.33) 19.7 % 1.37 [ 0.76, 1.97 ]
Total (95% CI) 105 110 100.0 % 1.07 [ 0.59, 1.55 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 11.99, df = 5 (P = 0.03); I2 =58%
Test for overall effect: Z = 4.40 (P = 0.000011)
Test for subgroup differences: Not applicable
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Analysis 9.18. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 18 Change in behavioural and psychological symptoms of dementia
(BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 18 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -1.3 (2.22) 4 2.5 (3.9) 12.3 % -1.20 [ -2.58, 0.18 ]
Amieva 2016 165 -25.22 (23.28) 152 -21.81 (22.11) 19.5 % -0.15 [ -0.37, 0.07 ]
Quayhagen 2000 21 -0.53 (10.23) 15 -0.47 (12.91) 17.4 % -0.01 [ -0.67, 0.66 ]
Quintana Hernandez 2014 27 -8.55 (12.88) 25 -13.36 (13.48) 18.1 % 0.36 [ -0.19, 0.91 ]
Kawashima 2005 16 0.45 (1.88) 16 -0.3 (1.56) 17.1 % 0.42 [ -0.28, 1.12 ]
Fern ndez-Calvo 2011 30 2.08 (2.27) 15 -4.23 (1.33) 15.6 % 3.08 [ 2.17, 3.99 ]
Total (95% CI) 266 227 100.0 % 0.44 [ -0.34, 1.22 ]
Heterogeneity: Tau2 = 0.80; Chi2 = 51.21, df = 5 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Not applicable
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Analysis 9.19. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 19 Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 19 Participant burden (retention rates)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multidomain
Mapelli 2013 10/10 10/10 Not estimable
Serino 2017 10/10 10/10 Not estimable
Kallio 2018 76/76 71/71 Not estimable
Beck 1988 10/10 10/10 Not estimable
Cavallo 2016 40/40 40/40 Not estimable
Kim 2015 22/22 21/21 Not estimable
Trebbastoni 2018 48/54 86/86 4.8 % 0.04 [ 0.00, 0.78 ]
Quintana Hernandez 2014 27/32 25/25 4.7 % 0.10 [ 0.01, 1.86 ]
Koltai 2001 14/16 8/8 4.1 % 0.34 [ 0.01, 7.98 ]
Giuli 2016 48/51 47/50 12.3 % 1.02 [ 0.20, 5.32 ]
Amieva 2016 124/170 109/154 38.1 % 1.11 [ 0.69, 1.81 ]
Galante 2007 7/7 4/5 3.6 % 5.00 [ 0.17, 150.92 ]
Subtotal (95% CI) 498 490 67.6 % 0.61 [ 0.21, 1.81 ]
Total events: 436 (Cognitive training), 441 (Control)
Heterogeneity: Tau2 = 0.71; Chi2 = 8.84, df = 5 (P = 0.12); I2 =43%
Test for overall effect: Z = 0.89 (P = 0.37)
2 Single domain
Davis 2001 19/19 18/18 Not estimable
Jelcic 2012 20/20 20/20 Not estimable
Kao 2016 95/110 45/48 17.3 % 0.42 [ 0.12, 1.53 ]
Cahn-Weiner 2003 16/19 17/20 11.3 % 0.94 [ 0.17, 5.36 ]
Neely 2009 10/10 9/10 3.8 % 3.32 [ 0.12, 91.60 ]
Subtotal (95% CI) 178 116 32.4 % 0.66 [ 0.24, 1.77 ]
Total events: 160 (Cognitive training), 109 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.53, df = 2 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.83 (P = 0.40)
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(. . . Continued)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total (95% CI) 676 606 100.0 % 0.73 [ 0.37, 1.43 ]
Total events: 596 (Cognitive training), 550 (Control)
Heterogeneity: Tau2 = 0.25; Chi2 = 10.82, df = 8 (P = 0.21); I2 =26%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.92), I2 =0.0%
0.001 0.01 0.1 1 10 100 1000
Control Cognitive training
Analysis 9.20. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 20 Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 20 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -21.31 (19.1) 152 -17.95 (19.01) 77.0 % -0.18 [ -0.40, 0.04 ]
Quayhagen 2000 21 -0.8 (4.05) 67 -1.29 (3.7) 23.0 % 0.13 [ -0.36, 0.62 ]
Total (95% CI) 186 219 100.0 % -0.11 [ -0.36, 0.15 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 9.21. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 21 Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 21 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 -0.62 (9.8) 15 -2.8 (16.52) 100.0 % 0.16 [ -0.50, 0.83 ]
Total (95% CI) 21 15 100.0 % 0.16 [ -0.50, 0.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 9.22. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 22 Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 22 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 0.09 (0.06) 15 0.03 (0.06) 100.0 % 0.98 [ 0.27, 1.68 ]
Total (95% CI) 21 15 100.0 % 0.98 [ 0.27, 1.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.72 (P = 0.0065)
Test for subgroup differences: Not applicable
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Analysis 9.23. Comparison 9 Cognitive training vs control immediately post intervention - type of CT
(multi-domain vs single domain), Outcome 23 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 9 Cognitive training vs control immediately post intervention - type of CT (multi-domain vs single domain)
Outcome: 23 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 -24.76 (37.3) 18 4.77 (40.85) 14.0 % -0.74 [ -1.41, -0.07 ]
Quayhagen 2000 21 -0.38 (2.75) 67 0.13 (2.6) 18.8 % -0.19 [ -0.68, 0.30 ]
Amieva 2016 164 -6.3 (6.13) 151 -5.6 (6.35) 27.8 % -0.11 [ -0.33, 0.11 ]
Kallio 2018 76 -0.04 (0.06) 71 -0.04 (0.06) 24.4 % 0.0 [ -0.32, 0.32 ]
Kim 2015 22 3.4 (3.3) 21 0 (4.36) 15.0 % 0.87 [ 0.24, 1.49 ]
Total (95% CI) 302 328 100.0 % -0.04 [ -0.38, 0.29 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 12.93, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 10.1. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 1 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 1 Change in a global measure of cognition
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Passive
Koltai 2001 (1) 14 -0.21 (2.9) 8 0.75 (2.4) 4.6 % -0.34 [ -1.21, 0.54 ]
Amieva 2016 168 -8.4 (5.86) 153 -7.6 (5.43) 5.9 % -0.14 [ -0.36, 0.08 ]
Barban 2016 42 0.1 (1.64) 39 -0.1 (1.15) 5.6 % 0.14 [ -0.30, 0.58 ]
Kallio 2018 76 -0.8 (5.19) 71 -1.6 (5.35) 5.8 % 0.15 [ -0.17, 0.48 ]
Venturelli 2016 20 -0.2 (0.97) 20 -0.4 (1.14) 5.2 % 0.19 [ -0.44, 0.81 ]
Kawashima 2005 16 0.1 (5.1) 16 -1.8 (3.75) 5.1 % 0.41 [ -0.29, 1.12 ]
Quintana Hernandez 2014 27 -4.48 (4.08) 25 -7.48 (3.49) 5.4 % 0.78 [ 0.21, 1.34 ]
Mapelli 2013 10 2.9 (2.59) 10 -0.3 (1.71) 4.3 % 1.40 [ 0.40, 2.40 ]
de Vreese 1998 9 2.77 (1.68) 9 -0.89 (2.4) 4.1 % 1.68 [ 0.57, 2.80 ]
Trebbastoni 2018 48 1.53 (1.7) 86 -2.64 (2.07) 5.6 % 2.13 [ 1.69, 2.57 ]
Fern ndez-Calvo 2011 30 1.12 (1.64) 15 -2.31 (1.16) 4.9 % 2.25 [ 1.46, 3.03 ]
Subtotal (95% CI) 460 452 56.5 % 0.75 [ 0.22, 1.28 ]
Heterogeneity: Tau2 = 0.69; Chi2 = 121.78, df = 10 (P<0.00001); I2 =92%
Test for overall effect: Z = 2.76 (P = 0.0058)
2 Active
Galante 2007 7 0.1 (2.34) 4 1.8 (1.74) 3.7 % -0.72 [ -2.00, 0.56 ]
Giuli 2016 48 0.02 (2.77) 47 1.24 (3.77) 5.7 % -0.37 [ -0.77, 0.04 ]
Heiss 1993 18 -1.22 (4.22) 17 -0.94 (3.59) 5.1 % -0.07 [ -0.73, 0.59 ]
Davis 2001 19 0.16 (2.6) 18 0.22 (2.68) 5.2 % -0.02 [ -0.67, 0.62 ]
Lee 2013 12 2.01 (2.86) 7 2 (1.9) 4.5 % 0.00 [ -0.93, 0.94 ]
Cavallo 2016 40 -0.14 (1.04) 40 -0.16 (1.62) 5.6 % 0.01 [ -0.42, 0.45 ]
Jelcic 2014 17 2 (1.47) 10 -0.7 (2.41) 4.6 % 1.40 [ 0.52, 2.28 ]
Jelcic 2012 20 2 (1.68) 20 -1 (1.98) 5.0 % 1.60 [ 0.88, 2.32 ]
Bergamaschi 2013 16 2.75 (1.81) 16 -3.57 (1.81) 4.0 % 3.40 [ 2.28, 4.53 ]
-4 -2 0 2 4
Control Cognitive training
(Continued . . . )
335Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 197 179 43.5 % 0.54 [ -0.11, 1.19 ]
Heterogeneity: Tau2 = 0.81; Chi2 = 64.03, df = 8 (P<0.00001); I2 =88%
Test for overall effect: Z = 1.64 (P = 0.10)
Total (95% CI) 657 631 100.0 % 0.65 [ 0.26, 1.05 ]
Heterogeneity: Tau2 = 0.67; Chi2 = 187.26, df = 19 (P<0.00001); I2 =90%
Test for overall effect: Z = 3.26 (P = 0.0011)
Test for subgroup differences: Chi2 = 0.24, df = 1 (P = 0.63), I2 =0.0%
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
Analysis 10.2. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 2 Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 2 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Passive
Venturelli 2016 20 -2 (2.13) 20 -0.4 (2.42) 5.0 % -0.69 [ -1.33, -0.05 ]
Koltai 2001 (1) 14 -0.21 (5.8) 8 0.75 (4.8) 3.8 % -0.17 [ -1.04, 0.70 ]
Amieva 2016 168 -8.4 (8.71) 152 -7.6 (5.43) 7.5 % -0.11 [ -0.33, 0.11 ]
Barban 2016 42 0.1 (3.3) 39 -0.1 (2.55) 6.3 % 0.07 [ -0.37, 0.50 ]
Kallio 2018 76 -0.8 (11.6) 71 -1.6 (11.95) 7.0 % 0.07 [ -0.26, 0.39 ]
Kawashima 2005 16 0.1 (11.01) 16 -1.8 (8.22) 4.7 % 0.19 [ -0.50, 0.89 ]
Quintana Hernandez 2014 27 -4.48 (6.86) 25 -7.48 (5.65) 5.5 % 0.47 [ -0.08, 1.02 ]
Mapelli 2013 10 1.07 (1.75) 10 0.33 (0.42) 3.6 % 0.56 [ -0.34, 1.45 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
de Vreese 1998 9 2.77 (3.48) 9 -0.89 (5.22) 3.3 % 0.79 [ -0.18, 1.75 ]
Trebbastoni 2018 48 1.53 (3.68) 86 -2.64 (4.39) 6.7 % 1.00 [ 0.63, 1.37 ]
Fern ndez-Calvo 2011 30 1.12 (3.64) 15 -2.31 (2.57) 4.9 % 1.01 [ 0.35, 1.67 ]
Subtotal (95% CI) 460 451 58.4 % 0.27 [ -0.04, 0.58 ]
Heterogeneity: Tau2 = 0.19; Chi2 = 42.90, df = 10 (P<0.00001); I2 =77%
Test for overall effect: Z = 1.70 (P = 0.089)
2 Active
Galante 2007 7 0.1 (4.98) 4 1.8 (3.33) 2.4 % -0.35 [ -1.59, 0.90 ]
Giuli 2016 48 0.02 (6.16) 47 1.24 (8.42) 6.5 % -0.16 [ -0.57, 0.24 ]
Heiss 1993 18 -1.22 (8.13) 17 -0.94 (7.18) 4.9 % -0.04 [ -0.70, 0.63 ]
Davis 2001 19 0.16 (5.82) 18 0.22 (5.86) 5.0 % -0.01 [ -0.65, 0.63 ]
Lee 2013 12 2.01 (6.23) 7 2 (4.18) 3.5 % 0.00 [ -0.93, 0.93 ]
Cavallo 2016 40 -0.14 (2.25) 40 -0.16 (2.75) 6.3 % 0.01 [ -0.43, 0.45 ]
Jelcic 2014 17 2 (3.18) 10 -0.7 (5) 4.1 % 0.67 [ -0.14, 1.47 ]
Jelcic 2012 20 2 (3.62) 20 -1 (4.2) 5.0 % 0.75 [ 0.11, 1.39 ]
Bergamaschi 2013 16 2.75 (3.56) 16 -3.57 (3.58) 4.0 % 1.73 [ 0.90, 2.55 ]
Subtotal (95% CI) 197 179 41.6 % 0.27 [ -0.10, 0.65 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 22.80, df = 8 (P = 0.004); I2 =65%
Test for overall effect: Z = 1.43 (P = 0.15)
Total (95% CI) 657 630 100.0 % 0.27 [ 0.04, 0.50 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 65.70, df = 19 (P<0.00001); I2 =71%
Test for overall effect: Z = 2.29 (P = 0.022)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.99), I2 =0.0%
-4 -2 0 2 4
Control Cognitive training
(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score. We multiplied the SD they
provided by 2.
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Analysis 10.3. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 3 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 3 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Passive
Fern ndez-Calvo 2011 30 15 -0.44 (0.42) 3.0 % -0.44 [ -1.26, 0.38 ]
Amieva 2016 165 153 -0.11 (0.11) 6.6 % -0.11 [ -0.33, 0.11 ]
Beck 1988 10 10 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Koltai 2001 14 8 -0.03 (0.43) 3.0 % -0.03 [ -0.87, 0.81 ]
Boller 2011 24 12 0.13 (0.35) 3.7 % 0.13 [ -0.56, 0.82 ]
Quayhagen 2000 21 15 0.19 (0.33) 3.9 % 0.19 [ -0.46, 0.84 ]
Barban 2016 41 38 0.21 (0.23) 5.1 % 0.21 [ -0.24, 0.66 ]
Neely 2009 20 9 0.26 (0.39) 3.3 % 0.26 [ -0.50, 1.02 ]
Quayhagen 1995 (1) 13 25 0.37 (0.34) 3.8 % 0.37 [ -0.30, 1.04 ]
Kawashima 2005 16 16 0.52 (0.36) 3.6 % 0.52 [ -0.19, 1.23 ]
Trebbastoni 2018 45 85 0.55 (0.2) 5.5 % 0.55 [ 0.16, 0.94 ]
Quintana Hernandez 2014 27 25 0.73 (0.28) 4.5 % 0.73 [ 0.18, 1.28 ]
de Vreese 1998 9 9 1.04 (0.49) 2.5 % 1.04 [ 0.08, 2.00 ]
Mapelli 2013 10 10 2.13 (0.66) 1.6 % 2.13 [ 0.84, 3.42 ]
Subtotal (95% CI) 445 430 53.2 % 0.31 [ 0.06, 0.55 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 29.98, df = 13 (P = 0.005); I2 =57%
Test for overall effect: Z = 2.46 (P = 0.014)
2 Active
Davis 2001 19 18 0 (0.32) 4.0 % 0.0 [ -0.63, 0.63 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.8 % 0.01 [ -0.66, 0.68 ]
Galante 2007 7 4 0.21 (0.63) 1.8 % 0.21 [ -1.02, 1.44 ]
Quayhagen 1995 (2) 13 28 0.25 (0.33) 3.9 % 0.25 [ -0.40, 0.90 ]
Heiss 1993 18 17 0.27 (0.34) 3.8 % 0.27 [ -0.40, 0.94 ]
Serino 2017 10 10 0.31 (0.44) 2.9 % 0.31 [ -0.55, 1.17 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Giuli 2016 48 47 0.37 (0.21) 5.4 % 0.37 [ -0.04, 0.78 ]
Kim 2015 22 21 0.46 (0.32) 4.0 % 0.46 [ -0.17, 1.09 ]
Jelcic 2014 17 10 0.55 (0.4) 3.2 % 0.55 [ -0.23, 1.33 ]
Jelcic 2012 20 20 0.6 (0.32) 4.0 % 0.60 [ -0.03, 1.23 ]
Lee 2013 12 7 1.15 (0.53) 2.3 % 1.15 [ 0.11, 2.19 ]
Cavallo 2016 40 40 1.32 (0.28) 4.5 % 1.32 [ 0.77, 1.87 ]
Bergamaschi 2013 16 16 1.64 (0.41) 3.1 % 1.64 [ 0.84, 2.44 ]
Subtotal (95% CI) 259 255 46.8 % 0.53 [ 0.26, 0.81 ]
Heterogeneity: Tau2 = 0.12; Chi2 = 24.22, df = 12 (P = 0.02); I2 =50%
Test for overall effect: Z = 3.87 (P = 0.00011)
Total (95% CI) 704 685 100.0 % 0.42 [ 0.23, 0.61 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 62.80, df = 26 (P = 0.00007); I2 =59%
Test for overall effect: Z = 4.32 (P = 0.000015)
Test for subgroup differences: Chi2 = 1.49, df = 1 (P = 0.22), I2 =33%
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(1) CT vs Passive Control
(2) CT vs Active Control
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Analysis 10.4. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 4 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 4 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Passive
Amieva 2016 166 153 -0.07 (0.11) 15.9 % -0.07 [ -0.29, 0.15 ]
Barban 2016 41 38 0.1 (0.22) 6.3 % 0.10 [ -0.33, 0.53 ]
Beck 1988 10 10 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Boller 2011 24 12 0.06 (0.35) 2.8 % 0.06 [ -0.63, 0.75 ]
de Vreese 1998 9 9 0.48 (0.46) 1.7 % 0.48 [ -0.42, 1.38 ]
Fern ndez-Calvo 2011 30 15 -0.29 (0.34) 3.0 % -0.29 [ -0.96, 0.38 ]
Kawashima 2005 16 16 0.23 (0.35) 2.8 % 0.23 [ -0.46, 0.92 ]
Koltai 2001 14 8 -0.03 (0.43) 1.9 % -0.03 [ -0.87, 0.81 ]
Mapelli 2013 10 10 1.06 (0.55) 1.2 % 1.06 [ -0.02, 2.14 ]
Neely 2009 20 9 0.26 (0.39) 2.3 % 0.26 [ -0.50, 1.02 ]
Quayhagen 1995 (1) 13 25 1.03 (0.36) 2.7 % 1.03 [ 0.32, 1.74 ]
Quayhagen 2000 21 15 0.8 (0.35) 2.8 % 0.80 [ 0.11, 1.49 ]
Quintana Hernandez 2014 27 25 0.46 (0.28) 4.2 % 0.46 [ -0.09, 1.01 ]
Trebbastoni 2018 45 85 0.26 (0.19) 7.9 % 0.26 [ -0.11, 0.63 ]
Subtotal (95% CI) 446 430 57.5 % 0.24 [ 0.04, 0.43 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 20.51, df = 13 (P = 0.08); I2 =37%
Test for overall effect: Z = 2.35 (P = 0.019)
2 Active
Bergamaschi 2013 16 16 0.78 (0.36) 2.7 % 0.78 [ 0.07, 1.49 ]
Cahn-Weiner 2003 17 17 0.01 (0.34) 3.0 % 0.01 [ -0.66, 0.68 ]
Cavallo 2016 40 40 0.61 (0.23) 5.9 % 0.61 [ 0.16, 1.06 ]
Davis 2001 19 18 0 (0.32) 3.3 % 0.0 [ -0.63, 0.63 ]
Galante 2007 7 4 0.12 (0.59) 1.1 % 0.12 [ -1.04, 1.28 ]
Giuli 2016 48 47 0.17 (0.2) 7.3 % 0.17 [ -0.22, 0.56 ]
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(. . . Continued)
Study or subgroup Cognitive training Control
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
Heiss 1993 18 17 0.15 (0.33) 3.1 % 0.15 [ -0.50, 0.80 ]
Jelcic 2012 20 20 0.28 (0.31) 3.5 % 0.28 [ -0.33, 0.89 ]
Jelcic 2014 17 10 0.27 (0.39) 2.3 % 0.27 [ -0.49, 1.03 ]
Kim 2015 22 21 0.2 (0.3) 3.7 % 0.20 [ -0.39, 0.79 ]
Lee 2013 12 7 0.6 (0.47) 1.6 % 0.60 [ -0.32, 1.52 ]
Quayhagen 1995 (2) 13 28 0.55 (0.33) 3.1 % 0.55 [ -0.10, 1.20 ]
Serino 2017 10 10 0.16 (0.43) 1.9 % 0.16 [ -0.68, 1.00 ]
Subtotal (95% CI) 259 255 42.5 % 0.30 [ 0.13, 0.48 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 7.13, df = 12 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 3.44 (P = 0.00058)
Total (95% CI) 705 685 100.0 % 0.24 [ 0.12, 0.36 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 29.59, df = 26 (P = 0.29); I2 =12%
Test for overall effect: Z = 3.89 (P = 0.000099)
Test for subgroup differences: Chi2 = 0.26, df = 1 (P = 0.61), I2 =0.0%
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(1) CT vs Passive control
(2) CT vs Active control
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Analysis 10.5. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 5 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 5 Change in immediate memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Passive
Koltai 2001 14 0.64 (1.7) 8 1.63 (2.8) 5.1 % -0.44 [ -1.32, 0.44 ]
Quayhagen 2000 21 2.29 (12.1) 15 -0.73 (12.08) 5.9 % 0.24 [ -0.42, 0.91 ]
Boller 2011 24 -0.04 (2.98) 12 -0.92 (2.93) 5.7 % 0.29 [ -0.41, 0.99 ]
Quayhagen 1995 (1) 13 4.7 (10.56) 25 -1.8 (6.19) 5.7 % 0.80 [ 0.11, 1.50 ]
Neely 2009 20 -0.1 (1.75) 9 -1.5 (1.25) 5.3 % 0.84 [ 0.02, 1.66 ]
Trebbastoni 2018 45 4.01 (4.6) 85 -0.7 (3.98) 6.7 % 1.11 [ 0.73, 1.50 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.7 (1.58) 4.6 % 1.58 [ 0.55, 2.61 ]
Subtotal (95% CI) 147 164 39.1 % 0.64 [ 0.20, 1.08 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 16.88, df = 6 (P = 0.01); I2 =64%
Test for overall effect: Z = 2.83 (P = 0.0047)
2 Active
Galante 2007 7 -0.2 (5.3) 4 1.2 (7.77) 4.0 % -0.21 [ -1.44, 1.03 ]
Jelcic 2014 17 0.66 (5.53) 10 -0.3 (4.82) 5.5 % 0.18 [ -0.61, 0.96 ]
Heiss 1993 18 0.41 (0.97) 17 0.09 (1) 5.8 % 0.32 [ -0.35, 0.99 ]
Cahn-Weiner 2003 17 -0.4 (2.76) 17 -1.7 (2.97) 5.8 % 0.44 [ -0.24, 1.12 ]
Davis 2001 19 1.43 (3.52) 18 -0.22 (3.71) 5.9 % 0.45 [ -0.21, 1.10 ]
Giuli 2016 48 0.65 (1.74) 47 -0.17 (1.74) 6.6 % 0.47 [ 0.06, 0.88 ]
Quayhagen 1995 (2) 13 4.7 (10.56) 28 -0.1 (7.84) 5.8 % 0.54 [ -0.13, 1.21 ]
Jelcic 2012 20 2.9 (5.62) 20 -0.2 (5.43) 6.0 % 0.55 [ -0.08, 1.18 ]
Bergamaschi 2013 16 1.12 (2) 16 -0.13 (1.63) 5.7 % 0.67 [ -0.05, 1.38 ]
Lee 2013 12 8.08 (3.25) 7 1.29 (1.81) 4.0 % 2.29 [ 1.05, 3.54 ]
Cavallo 2016 40 2.26 (0.71) 40 -0.79 (1) 5.7 % 3.48 [ 2.78, 4.19 ]
Subtotal (95% CI) 227 224 60.9 % 0.82 [ 0.25, 1.39 ]
Heterogeneity: Tau2 = 0.78; Chi2 = 73.77, df = 10 (P<0.00001); I2 =86%
Test for overall effect: Z = 2.82 (P = 0.0048)
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Total (95% CI) 374 388 100.0 % 0.74 [ 0.37, 1.12 ]
Heterogeneity: Tau2 = 0.51; Chi2 = 90.65, df = 17 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.89 (P = 0.000098)
Test for subgroup differences: Chi2 = 0.25, df = 1 (P = 0.62), I2 =0.0%
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Control Cognitive training
(1) Cognitive training vs. Passive control
(2) Cognitive training vs. Active control
Analysis 10.6. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Passive
Boller 2011 24 -0.29 (1.58) 12 -0.08 (1.28) 9.2 % -0.14 [ -0.83, 0.56 ]
Quayhagen 2000 21 3.2 (6.89) 15 0.4 (7.55) 9.3 % 0.38 [ -0.29, 1.05 ]
Barban 2016 42 0.4 (1.17) 39 -0.1 (1.11) 10.2 % 0.43 [ -0.01, 0.88 ]
Trebbastoni 2018 45 0.06 (1.26) 85 -0.55 (1.36) 10.4 % 0.46 [ 0.09, 0.82 ]
Koltai 2001 14 0.64 (1.3) 8 -0.25 (1.8) 8.3 % 0.57 [ -0.32, 1.46 ]
Mapelli 2013 (1) 10 4.2 (2.35) 10 -0.8 (1.48) 6.8 % 2.44 [ 1.22, 3.65 ]
Subtotal (95% CI) 156 169 54.1 % 0.52 [ 0.11, 0.94 ]
Heterogeneity: Tau2 = 0.15; Chi2 = 13.14, df = 5 (P = 0.02); I2 =62%
Test for overall effect: Z = 2.47 (P = 0.014)
2 Active
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(. . . Continued)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 1.15 (2.23) 18 1.65 (3.72) 9.4 % -0.16 [ -0.81, 0.49 ]
Cahn-Weiner 2003 17 -0.3 (1.05) 17 -0.8 (1.58) 9.2 % 0.36 [ -0.31, 1.04 ]
Jelcic 2014 17 0.86 (2.17) 10 -1.3 (1.84) 8.5 % 1.02 [ 0.18, 1.85 ]
Jelcic 2012 20 1.5 (2.34) 20 -0.9 (2.04) 9.3 % 1.07 [ 0.40, 1.74 ]
Cavallo 2016 40 1.24 (1.04) 40 -1.74 (1) 9.4 % 2.89 [ 2.26, 3.53 ]
Subtotal (95% CI) 113 105 45.9 % 1.04 [ -0.04, 2.12 ]
Heterogeneity: Tau2 = 1.40; Chi2 = 49.76, df = 4 (P<0.00001); I2 =92%
Test for overall effect: Z = 1.88 (P = 0.060)
Total (95% CI) 269 274 100.0 % 0.81 [ 0.29, 1.32 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 72.73, df = 10 (P<0.00001); I2 =86%
Test for overall effect: Z = 3.05 (P = 0.0023)
Test for subgroup differences: Chi2 = 0.76, df = 1 (P = 0.38), I2 =0.0%
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(1) Cognitive training vs passive control
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Analysis 10.7. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 7 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 7 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Passive
Trebbastoni 2018 45 -0.3 (0.58) 85 -0.24 (0.65) 9.9 % -0.10 [ -0.46, 0.27 ]
Boller 2011 24 0 (1.11) 12 0.08 (0.92) 8.6 % -0.07 [ -0.77, 0.62 ]
Beck 1988 (1) 10 0.7 (0.95) 10 -0.2 (1.32) 7.6 % 0.75 [ -0.16, 1.66 ]
Mapelli 2013 10 1.7 (1.24) 10 -0.1 (1.29) 7.3 % 1.36 [ 0.37, 2.36 ]
Subtotal (95% CI) 89 117 33.4 % 0.37 [ -0.25, 0.99 ]
Heterogeneity: Tau2 = 0.26; Chi2 = 9.47, df = 3 (P = 0.02); I2 =68%
Test for overall effect: Z = 1.16 (P = 0.24)
2 Active
Heiss 1993 18 -0.64 (1) 17 -0.03 (0.98) 8.7 % -0.60 [ -1.28, 0.08 ]
Galante 2007 7 0.1 (0.66) 4 0.7 (1.52) 6.1 % -0.53 [ -1.79, 0.73 ]
Davis 2001 19 -0.41 (1.55) 18 -0.47 (1.56) 8.8 % 0.04 [ -0.61, 0.68 ]
Serino 2017 10 0 (0.91) 10 -0.33 (0.58) 7.8 % 0.41 [ -0.47, 1.30 ]
Giuli 2016 48 0.32 (0.9) 47 -0.2 (0.96) 9.7 % 0.55 [ 0.14, 0.96 ]
Jelcic 2012 20 0.2 (0.55) 20 -0.4 (0.55) 8.7 % 1.07 [ 0.40, 1.74 ]
Jelcic 2014 17 0.32 (1) 10 -1.35 (0.59) 7.5 % 1.85 [ 0.90, 2.80 ]
Cavallo 2016 40 1.89 (0.99) 40 -0.04 (0.89) 9.2 % 2.03 [ 1.49, 2.57 ]
Subtotal (95% CI) 179 166 66.6 % 0.63 [ -0.03, 1.29 ]
Heterogeneity: Tau2 = 0.75; Chi2 = 52.53, df = 7 (P<0.00001); I2 =87%
Test for overall effect: Z = 1.88 (P = 0.060)
Total (95% CI) 268 283 100.0 % 0.56 [ 0.08, 1.05 ]
Heterogeneity: Tau2 = 0.59; Chi2 = 71.95, df = 11 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Chi2 = 0.33, df = 1 (P = 0.57), I2 =0.0%
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 10.8. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 8 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 8 Change in language (naming)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cavallo 2016 40 0.19 (1.55) 40 0.1 (1.32) 22.9 % 0.06 [ -0.38, 0.50 ]
Cahn-Weiner 2003 17 0.3 (3.55) 17 -0.1 (3.48) 18.6 % 0.11 [ -0.56, 0.78 ]
Jelcic 2012 20 3.5 (5.63) 20 -0.8 (4.61) 19.0 % 0.82 [ 0.17, 1.47 ]
Jelcic 2014 17 2.19 (2.56) 10 -0.4 (2.41) 15.8 % 1.00 [ 0.17, 1.83 ]
Trebbastoni 2018 45 2 (3.35) 85 -1.81 (3.34) 23.8 % 1.13 [ 0.75, 1.52 ]
Total (95% CI) 139 172 100.0 % 0.62 [ 0.11, 1.12 ]
Heterogeneity: Tau2 = 0.24; Chi2 = 16.29, df = 4 (P = 0.003); I2 =75%
Test for overall effect: Z = 2.39 (P = 0.017)
Test for subgroup differences: Not applicable
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Analysis 10.9. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 9 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 9 Change in verbal letter fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Passive
Barban 2016 42 1.4 (5.66) 39 1.1 (6.04) 11.6 % 0.05 [ -0.39, 0.49 ]
Kawashima 2005 16 0.1 (0.55) 16 0 (0.44) 8.2 % 0.20 [ -0.50, 0.89 ]
Trebbastoni 2018 45 -0.17 (4.89) 85 -2.03 (5) 12.6 % 0.37 [ 0.01, 0.74 ]
Mapelli 2013 10 1.2 (1.51) 10 -0.64 (1.12) 5.5 % 1.33 [ 0.34, 2.31 ]
Subtotal (95% CI) 113 150 37.9 % 0.35 [ -0.03, 0.72 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 5.62, df = 3 (P = 0.13); I2 =47%
Test for overall effect: Z = 1.79 (P = 0.074)
2 Active
Serino 2017 10 -1.6 (3.47) 10 0.2 (4.8) 6.3 % -0.41 [ -1.30, 0.48 ]
Cavallo 2016 40 1.17 (1.62) 40 1.53 (1.6) 11.6 % -0.22 [ -0.66, 0.22 ]
Davis 2001 19 0.22 (7.7) 18 1.33 (9.03) 8.8 % -0.13 [ -0.78, 0.52 ]
Cahn-Weiner 2003 17 0.3 (5.95) 17 1 (4.62) 8.4 % -0.13 [ -0.80, 0.54 ]
Jelcic 2012 20 1.7 (7.56) 20 1.3 (7.41) 9.1 % 0.05 [ -0.57, 0.67 ]
Jelcic 2014 17 2.27 (7.6) 10 1.6 (6.93) 7.3 % 0.09 [ -0.69, 0.87 ]
Galante 2007 7 3.5 (5.74) 4 -1.7 (6.97) 3.7 % 0.77 [ -0.52, 2.06 ]
Bergamaschi 2013 16 1.06 (1.39) 16 -1.72 (1.97) 7.0 % 1.59 [ 0.78, 2.40 ]
Subtotal (95% CI) 146 135 62.1 % 0.14 [ -0.27, 0.55 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 18.21, df = 7 (P = 0.01); I2 =62%
Test for overall effect: Z = 0.66 (P = 0.51)
Total (95% CI) 259 285 100.0 % 0.22 [ -0.07, 0.50 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 25.86, df = 11 (P = 0.01); I2 =57%
Test for overall effect: Z = 1.50 (P = 0.13)
Test for subgroup differences: Chi2 = 0.53, df = 1 (P = 0.46), I2 =0.0%
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Analysis 10.10. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 10 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 10 Change in speed of information processing
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Beck 1988 10 -0.3 (1.25) 10 1.1 (2.88) 11.3 % -0.60 [ -1.51, 0.30 ]
Galante 2007 7 -1.3 (10.33) 4 3.3 (5.55) 6.3 % -0.47 [ -1.72, 0.79 ]
Jelcic 2014 17 0.47 (6.9) 10 -0.4 (8.16) 14.4 % 0.11 [ -0.67, 0.90 ]
Barban 2016 36 7.7 (27.35) 33 -1.9 (27.67) 30.0 % 0.35 [ -0.13, 0.82 ]
Jelcic 2012 20 19.3 (56.5) 20 -2 (20.58) 20.3 % 0.49 [ -0.14, 1.12 ]
Cahn-Weiner 2003 17 5.2 (20.62) 17 -9.6 (31.4) 17.8 % 0.54 [ -0.14, 1.23 ]
Total (95% CI) 107 94 100.0 % 0.22 [ -0.11, 0.54 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 6.24, df = 5 (P = 0.28); I2 =20%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 10.11. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 11 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 11 Change in executive function
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Passive
Kawashima 2005 16 15 (18) 16 -6 (197) 8.9 % 0.15 [ -0.55, 0.84 ]
Neely 2009 20 -0.03 (0.15) 9 -0.16 (0.52) 8.3 % 0.41 [ -0.39, 1.20 ]
Trebbastoni 2018 45 0.96 (2.07) 85 -1.3 (2.19) 10.2 % 1.05 [ 0.66, 1.43 ]
Quayhagen 1995 (1) 13 4.8 (7.28) 25 -3.6 (6.44) 8.7 % 1.22 [ 0.49, 1.95 ]
Quayhagen 2000 21 5.91 (2.31) 15 -2.6 (3.8) 7.6 % 2.76 [ 1.81, 3.71 ]
Mapelli 2013 (2) 10 2.3 (0.52) 10 -0.2 (0.79) 5.1 % 3.58 [ 2.06, 5.10 ]
Subtotal (95% CI) 125 160 48.8 % 1.37 [ 0.60, 2.14 ]
Heterogeneity: Tau2 = 0.74; Chi2 = 32.43, df = 5 (P<0.00001); I2 =85%
Test for overall effect: Z = 3.49 (P = 0.00047)
2 Active
Cahn-Weiner 2003 17 6 (51.61) 17 33.3 (49.98) 8.9 % -0.52 [ -1.21, 0.16 ]
Galante 2007 7 -2.6 (8.27) 4 -2.3 (3.25) 6.2 % -0.04 [ -1.27, 1.19 ]
Cavallo 2016 40 -0.07 (0.79) 40 -0.26 (0.71) 10.0 % 0.25 [ -0.19, 0.69 ]
Jelcic 2012 20 13.2 (18.07) 20 6.6 (16.69) 9.2 % 0.37 [ -0.25, 1.00 ]
Serino 2017 10 0.22 (2.24) 10 -0.66 (2.01) 7.9 % 0.40 [ -0.49, 1.28 ]
Quayhagen 1995 (3) 13 4.8 (7.28) 28 0.4 (6.6) 9.0 % 0.63 [ -0.04, 1.31 ]
Subtotal (95% CI) 107 119 51.2 % 0.21 [ -0.11, 0.53 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 6.55, df = 5 (P = 0.26); I2 =24%
Test for overall effect: Z = 1.28 (P = 0.20)
Total (95% CI) 232 279 100.0 % 0.75 [ 0.28, 1.22 ]
Heterogeneity: Tau2 = 0.52; Chi2 = 58.99, df = 11 (P<0.00001); I2 =81%
Test for overall effect: Z = 3.15 (P = 0.0017)
Test for subgroup differences: Chi2 = 7.50, df = 1 (P = 0.01), I2 =87%
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Analysis 10.12. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 12 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 12 Change in verbal category fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 0 (2.98) 4 0.1 (4.16) 4.5 % -0.03 [ -1.26, 1.20 ]
Serino 2017 10 0.7 (2.91) 10 0.5 (3.99) 7.5 % 0.05 [ -0.82, 0.93 ]
Jelcic 2012 20 1.5 (5.72) 20 1 (5.78) 11.3 % 0.09 [ -0.53, 0.71 ]
Davis 2001 19 1.5 (3.67) 18 0.95 (3.37) 10.8 % 0.15 [ -0.49, 0.80 ]
Jelcic 2014 17 1.39 (4.71) 10 0.4 (5.46) 8.7 % 0.19 [ -0.59, 0.98 ]
Giuli 2016 48 0.15 (0.73) 47 -0.17 (0.67) 16.0 % 0.45 [ 0.05, 0.86 ]
Heiss 1993 18 1.66 (3.52) 17 -1.07 (3.13) 10.0 % 0.80 [ 0.11, 1.49 ]
Trebbastoni 2018 45 2.06 (4.84) 85 -2.93 (5.04) 16.6 % 1.00 [ 0.62, 1.38 ]
Cavallo 2016 40 0.34 (1.22) 40 -0.95 (1.21) 14.5 % 1.05 [ 0.58, 1.52 ]
Total (95% CI) 224 251 100.0 % 0.52 [ 0.23, 0.81 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 16.57, df = 8 (P = 0.03); I2 =52%
Test for overall effect: Z = 3.49 (P = 0.00049)
Test for subgroup differences: Not applicable
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Analysis 10.13. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 13 Change in meta cognition (self-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 13 Change in meta cognition (self-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -6.43 (14.3) 8 -1 (14.1) 51.9 % -0.37 [ -1.24, 0.51 ]
Lee 2013 12 0.27 (0.29) 7 0.08 (0.26) 48.1 % 0.65 [ -0.31, 1.61 ]
Total (95% CI) 26 15 100.0 % 0.12 [ -0.87, 1.12 ]
Heterogeneity: Tau2 = 0.30; Chi2 = 2.34, df = 1 (P = 0.13); I2 =57%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 10.14. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 14 Change in meta cognition (informant-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 14 Change in meta cognition (informant-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Koltai 2001 (1) 14 -3.54 (14.7) 8 5.75 (10.4) 37.3 % -0.67 [ -1.56, 0.23 ]
Cahn-Weiner 2003 17 -4.8 (16.55) 17 6.6 (18.54) 62.7 % -0.63 [ -1.32, 0.06 ]
Total (95% CI) 31 25 100.0 % -0.65 [ -1.19, -0.10 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.021)
Test for subgroup differences: Not applicable
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score
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Analysis 10.15. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 15 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 15 Change in participants’ mood
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Passive
Koltai 2001 (1) 14 -1.21 (2.5) 8 0.13 (3) 12.2 % -0.48 [ -1.36, 0.40 ]
Amieva 2016 164 -12.11 (12.73) 152 -10.81 (12.24) 14.1 % -0.10 [ -0.32, 0.12 ]
Fern ndez-Calvo 2011 30 3.2 (2) 15 -4.26 (1.85) 11.7 % 3.75 [ 2.73, 4.78 ]
Subtotal (95% CI) 208 175 38.0 % 1.02 [ -1.07, 3.10 ]
Heterogeneity: Tau2 = 3.25; Chi2 = 53.75, df = 2 (P<0.00001); I2 =96%
Test for overall effect: Z = 0.95 (P = 0.34)
2 Active
Bergamaschi 2013 16 -1.07 (2.98) 16 0.44 (5.09) 12.9 % -0.35 [ -1.05, 0.35 ]
Davis 2001 19 0.32 (1.52) 17 0.17 (4.41) 13.1 % 0.05 [ -0.61, 0.70 ]
Lee 2013 12 -0.25 (2.23) 7 -1.86 (2.77) 11.9 % 0.63 [ -0.33, 1.59 ]
Galante 2007 7 0.5 (0.92) 4 -0.3 (0.78) 10.5 % 0.84 [ -0.47, 2.14 ]
Giuli 2016 48 -0.18 (4.4) 47 -7.32 (3.77) 13.6 % 1.73 [ 1.25, 2.20 ]
Subtotal (95% CI) 102 91 62.0 % 0.58 [ -0.34, 1.49 ]
Heterogeneity: Tau2 = 0.91; Chi2 = 30.36, df = 4 (P<0.00001); I2 =87%
Test for overall effect: Z = 1.24 (P = 0.21)
Total (95% CI) 310 266 100.0 % 0.72 [ -0.10, 1.54 ]
Heterogeneity: Tau2 = 1.23; Chi2 = 99.54, df = 7 (P<0.00001); I2 =93%
Test for overall effect: Z = 1.73 (P = 0.084)
Test for subgroup differences: Chi2 = 0.14, df = 1 (P = 0.71), I2 =0.0%
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(1) Only the change scores (mean) were provided. It is not clear whether the SD that the authors provided belongs to the change score.
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Analysis 10.16. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 16 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 16 Change in capacity for activities of daily living
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.6 (1.36) 4 0.5 (0.48) 2.6 % -0.88 [ -2.19, 0.43 ]
de Vreese 1998 9 -1.33 (4.37) 9 1.01 (3.98) 4.7 % -0.53 [ -1.48, 0.41 ]
Amieva 2016 167 -1.76 (8.46) 153 -1.22 (8.27) 23.8 % -0.06 [ -0.28, 0.16 ]
Cahn-Weiner 2003 17 -0.2 (3.16) 17 0 (3.07) 8.1 % -0.06 [ -0.74, 0.61 ]
Kim 2015 21 0 (0.86) 21 0 (1.05) 9.4 % 0.0 [ -0.60, 0.60 ]
Jelcic 2012 20 0.1 (1.05) 38 0 (1.36) 10.9 % 0.08 [ -0.46, 0.62 ]
Barban 2016 38 -0.1 (0.96) 38 -0.3 (1.08) 13.6 % 0.19 [ -0.26, 0.64 ]
Giuli 2016 48 0.26 (1.2) 47 -0.24 (1.26) 15.2 % 0.40 [ 0.00, 0.81 ]
Bergamaschi 2013 16 -0.38 (1.54) 16 -1.32 (1.46) 7.4 % 0.61 [ -0.10, 1.32 ]
Lee 2013 12 2.24 (3.33) 7 -2.14 (4.54) 4.2 % 1.10 [ 0.09, 2.11 ]
Total (95% CI) 355 350 100.0 % 0.12 [ -0.10, 0.34 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 14.29, df = 9 (P = 0.11); I2 =37%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 10.17. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 17 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 17 Change in disease progression
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fern ndez-Calvo 2011 30 -2.11 (2.24) 15 -7.07 (2.39) 16.5 % 2.13 [ 1.36, 2.90 ]
Lee 2013 12 7.59 (9.2) 7 0.86 (7.83) 13.2 % 0.74 [ -0.23, 1.70 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 14.3 % 0.57 [ -0.33, 1.46 ]
Quayhagen 1995 (1) 13 3.3 (7.5) 25 -4.4 (8.36) 17.8 % 0.93 [ 0.23, 1.64 ]
Quayhagen 1995 (2) 13 3.3 (7.5) 28 -1.7 (8.89) 18.5 % 0.58 [ -0.09, 1.25 ]
Quintana Hernandez 2014 27 -2.77 (6.39) 25 -12.28 (7.33) 19.7 % 1.37 [ 0.76, 1.97 ]
Total (95% CI) 105 110 100.0 % 1.07 [ 0.59, 1.55 ]
Heterogeneity: Tau2 = 0.20; Chi2 = 11.99, df = 5 (P = 0.03); I2 =58%
Test for overall effect: Z = 4.40 (P = 0.000011)
Test for subgroup differences: Not applicable
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Analysis 10.18. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 18 Change in behavioural and psychological symptoms of dementia (BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 18 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -1.3 (2.22) 4 2.5 (3.9) 12.3 % -1.20 [ -2.58, 0.18 ]
Amieva 2016 165 -25.22 (23.28) 152 -21.81 (22.11) 19.5 % -0.15 [ -0.37, 0.07 ]
Quayhagen 2000 21 -0.53 (10.23) 15 -0.47 (12.91) 17.4 % -0.01 [ -0.67, 0.66 ]
Quintana Hernandez 2014 27 -8.55 (12.88) 25 -13.36 (13.48) 18.1 % 0.36 [ -0.19, 0.91 ]
Kawashima 2005 16 0.45 (1.88) 16 -0.3 (1.56) 17.1 % 0.42 [ -0.28, 1.12 ]
Fern ndez-Calvo 2011 30 2.08 (2.27) 15 -4.23 (1.33) 15.6 % 3.08 [ 2.17, 3.99 ]
Total (95% CI) 266 227 100.0 % 0.44 [ -0.34, 1.22 ]
Heterogeneity: Tau2 = 0.80; Chi2 = 51.21, df = 5 (P<0.00001); I2 =90%
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Not applicable
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Analysis 10.19. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 19 Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 19 Participant burden (retention rates)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Passive
Kallio 2018 76/76 71/71 Not estimable
Mapelli 2013 10/10 10/10 Not estimable
Beck 1988 10/10 10/10 Not estimable
Trebbastoni 2018 48/54 86/86 4.8 % 0.04 [ 0.00, 0.78 ]
Quintana Hernandez 2014 27/32 25/25 4.7 % 0.10 [ 0.01, 1.86 ]
Koltai 2001 14/16 8/8 4.1 % 0.34 [ 0.01, 7.98 ]
Kao 2016 95/110 45/48 17.3 % 0.42 [ 0.12, 1.53 ]
Amieva 2016 124/170 109/154 38.1 % 1.11 [ 0.69, 1.81 ]
Neely 2009 10/10 9/10 3.8 % 3.32 [ 0.12, 91.60 ]
Subtotal (95% CI) 488 422 72.8 % 0.49 [ 0.17, 1.40 ]
Total events: 414 (Cognitive training), 373 (Control)
Heterogeneity: Tau2 = 0.71; Chi2 = 9.86, df = 5 (P = 0.08); I2 =49%
Test for overall effect: Z = 1.33 (P = 0.18)
2 Active
Jelcic 2012 20/20 20/20 Not estimable
Davis 2001 19/19 18/18 Not estimable
Cavallo 2016 40/40 40/40 Not estimable
Kim 2015 22/22 21/21 Not estimable
Serino 2017 10/10 10/10 Not estimable
Cahn-Weiner 2003 16/19 17/20 11.3 % 0.94 [ 0.17, 5.36 ]
Giuli 2016 48/51 47/50 12.3 % 1.02 [ 0.20, 5.32 ]
Galante 2007 7/7 4/5 3.6 % 5.00 [ 0.17, 150.92 ]
Subtotal (95% CI) 188 184 27.2 % 1.17 [ 0.38, 3.64 ]
Total events: 182 (Cognitive training), 177 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.79, df = 2 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 0.28 (P = 0.78)
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(. . . Continued)
Study or subgroup Cognitive training Control Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total (95% CI) 676 606 100.0 % 0.73 [ 0.37, 1.43 ]
Total events: 596 (Cognitive training), 550 (Control)
Heterogeneity: Tau2 = 0.25; Chi2 = 10.82, df = 8 (P = 0.21); I2 =26%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 1.25, df = 1 (P = 0.26), I2 =20%
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Analysis 10.20. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 20 Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 20 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -21.31 (19.1) 152 -17.95 (19.01) 77.0 % -0.18 [ -0.40, 0.04 ]
Quayhagen 2000 21 -0.8 (4.05) 67 -1.29 (3.7) 23.0 % 0.13 [ -0.36, 0.62 ]
Total (95% CI) 186 219 100.0 % -0.11 [ -0.36, 0.15 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 10.21. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 21 Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 21 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 -0.62 (9.8) 15 -2.8 (16.52) 100.0 % 0.16 [ -0.50, 0.83 ]
Total (95% CI) 21 15 100.0 % 0.16 [ -0.50, 0.83 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 10.22. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 22 Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 22 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 0.09 (0.06) 15 0.03 (0.06) 100.0 % 0.98 [ 0.27, 1.68 ]
Total (95% CI) 21 15 100.0 % 0.98 [ 0.27, 1.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.72 (P = 0.0065)
Test for subgroup differences: Not applicable
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Analysis 10.23. Comparison 10 Cognitive training vs control immediately post intervention - type of control
(passive vs active), Outcome 23 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 10 Cognitive training vs control immediately post intervention - type of control (passive vs active)
Outcome: 23 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Davis 2001 19 -24.76 (37.3) 18 4.77 (40.85) 14.0 % -0.74 [ -1.41, -0.07 ]
Quayhagen 2000 21 -0.38 (2.75) 67 0.13 (2.6) 18.8 % -0.19 [ -0.68, 0.30 ]
Amieva 2016 164 -6.3 (6.13) 151 -5.6 (6.35) 27.8 % -0.11 [ -0.33, 0.11 ]
Kallio 2018 76 -0.04 (0.06) 71 -0.04 (0.06) 24.4 % 0.0 [ -0.32, 0.32 ]
Kim 2015 22 3.4 (3.3) 21 0 (4.36) 15.0 % 0.87 [ 0.24, 1.49 ]
Total (95% CI) 302 328 100.0 % -0.04 [ -0.38, 0.29 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 12.93, df = 4 (P = 0.01); I2 =69%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 11.1. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 1 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 1 Change in a global measure of cognition
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Amieva 2016 168 -8.4 (5.86) 326 -7.43 (6.03) 21.7 % -0.16 [ -0.35, 0.02 ]
Giovagnoli 2017 13 -0.16 (1.74) 26 -0.11 (3.63) 14.9 % -0.02 [ -0.68, 0.65 ]
de Vreese 1998 9 2.77 (1.68) 9 -1.45 (2.97) 9.3 % 1.67 [ 0.56, 2.78 ]
Subtotal (95% CI) 190 361 45.8 % 0.32 [ -0.48, 1.12 ]
Heterogeneity: Tau2 = 0.38; Chi2 = 10.20, df = 2 (P = 0.01); I2 =80%
Test for overall effect: Z = 0.79 (P = 0.43)
2 More than 3 times
Quintana Hernandez 2014 27 -4.48 (4.08) 70 -2.94 (3.91) 18.3 % -0.39 [ -0.83, 0.06 ]
Brueggen 2017 8 0.13 (2.29) 8 1 (2.08) 10.5 % -0.38 [ -1.37, 0.62 ]
Venturelli 2016 20 -0.2 (0.97) 20 -0.1 (1.38) 15.6 % -0.08 [ -0.70, 0.54 ]
Mapelli 2013 10 2.9 (2.59) 10 -1.5 (2.3) 9.8 % 1.72 [ 0.66, 2.78 ]
Subtotal (95% CI) 65 108 54.2 % 0.13 [ -0.63, 0.89 ]
Heterogeneity: Tau2 = 0.45; Chi2 = 13.21, df = 3 (P = 0.004); I2 =77%
Test for overall effect: Z = 0.34 (P = 0.74)
Total (95% CI) 255 469 100.0 % 0.16 [ -0.28, 0.60 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 23.42, df = 6 (P = 0.00067); I2 =74%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Chi2 = 0.11, df = 1 (P = 0.74), I2 =0.0%
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Analysis 11.2. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 2 Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 2 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Amieva 2016 168 -8.4 (8.71) 326 -7.43 (8.74) 45.9 % -0.11 [ -0.30, 0.08 ]
Giovagnoli 2017 13 -0.16 (3.45) 26 -0.11 (7.87) 9.7 % -0.01 [ -0.67, 0.66 ]
de Vreese 1998 9 2.77 (3.48) 9 -1.45 (6.53) 5.0 % 0.77 [ -0.20, 1.73 ]
Subtotal (95% CI) 190 361 60.6 % 0.02 [ -0.35, 0.40 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 3.11, df = 2 (P = 0.21); I2 =36%
Test for overall effect: Z = 0.12 (P = 0.91)
2 More than 3 times
Quintana Hernandez 2014 27 -4.48 (6.86) 70 -2.94 (6.66) 18.4 % -0.23 [ -0.67, 0.22 ]
Brueggen 2017 8 0.13 (5.11) 8 1 (4.64) 4.8 % -0.17 [ -1.15, 0.81 ]
Venturelli 2016 20 -0.2 (2.13) 20 -0.1 (2.98) 10.9 % -0.04 [ -0.66, 0.58 ]
Mapelli 2013 10 2.9 (5.03) 10 -1.5 (4.67) 5.4 % 0.87 [ -0.06, 1.79 ]
Subtotal (95% CI) 65 108 39.4 % 0.01 [ -0.41, 0.43 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 4.44, df = 3 (P = 0.22); I2 =32%
Test for overall effect: Z = 0.05 (P = 0.96)
Total (95% CI) 255 469 100.0 % -0.02 [ -0.24, 0.20 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 7.58, df = 6 (P = 0.27); I2 =21%
Test for overall effect: Z = 0.18 (P = 0.85)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.97), I2 =0.0%
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Analysis 11.3. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 3 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 3 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training
Alternative
treatment
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Amieva 2016 166 325 -0.13 (0.1) 21.9 % -0.13 [ -0.33, 0.07 ]
de Vreese 1998 9 9 1.31 (0.5) 10.6 % 1.31 [ 0.33, 2.29 ]
Giovagnoli 2017 13 26 -0.05 (0.34) 14.9 % -0.05 [ -0.72, 0.62 ]
Quayhagen 2000 21 67 0.35 (0.33) 15.2 % 0.35 [ -0.30, 1.00 ]
Subtotal (95% CI) 209 427 62.6 % 0.23 [ -0.27, 0.74 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 9.50, df = 3 (P = 0.02); I2 =68%
Test for overall effect: Z = 0.90 (P = 0.37)
2 More than 3 times
Brueggen 2017 8 8 -0.18 (0.48) 11.1 % -0.18 [ -1.12, 0.76 ]
Mapelli 2013 10 10 1.95 (0.64) 7.9 % 1.95 [ 0.70, 3.20 ]
Quintana Hernandez 2014 27 70 -0.45 (0.23) 18.4 % -0.45 [ -0.90, 0.00 ]
Subtotal (95% CI) 45 88 37.4 % 0.32 [ -0.90, 1.55 ]
Heterogeneity: Tau2 = 0.97; Chi2 = 12.45, df = 2 (P = 0.002); I2 =84%
Test for overall effect: Z = 0.52 (P = 0.60)
Total (95% CI) 254 515 100.0 % 0.21 [ -0.23, 0.64 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 22.34, df = 6 (P = 0.001); I2 =73%
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.89), I2 =0.0%
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Analysis 11.4. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 4 Change in a global measure of cognition (composite)˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 4 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training
Alternative
treatment
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Up to 3 times
Amieva 2016 166 325 -0.09 (0.1) 55.1 % -0.09 [ -0.29, 0.11 ]
de Vreese 1998 9 9 0.6 (0.46) 4.7 % 0.60 [ -0.30, 1.50 ]
Giovagnoli 2017 13 26 -0.04 (0.37) 7.1 % -0.04 [ -0.77, 0.69 ]
Quayhagen 2000 21 67 0.16 (0.33) 8.7 % 0.16 [ -0.49, 0.81 ]
Subtotal (95% CI) 209 427 75.5 % -0.04 [ -0.22, 0.14 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.55, df = 3 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
2 More than 3 times
Brueggen 2017 8 8 -0.1 (0.47) 4.5 % -0.10 [ -1.02, 0.82 ]
Mapelli 2013 10 10 0.93 (0.55) 3.3 % 0.93 [ -0.15, 2.01 ]
Quintana Hernandez 2014 27 70 -0.27 (0.23) 16.7 % -0.27 [ -0.72, 0.18 ]
Subtotal (95% CI) 45 88 24.5 % 0.05 [ -0.59, 0.70 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 4.05, df = 2 (P = 0.13); I2 =51%
Test for overall effect: Z = 0.16 (P = 0.87)
Total (95% CI) 254 515 100.0 % -0.03 [ -0.23, 0.17 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 6.66, df = 6 (P = 0.35); I2 =10%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Chi2 = 0.08, df = 1 (P = 0.78), I2 =0.0%
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Analysis 11.5. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 5 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 5 Change in immediate memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 1 (4.38) 26 0.32 (6.22) 34.9 % 0.12 [ -0.55, 0.78 ]
Quayhagen 2000 21 2.29 (12.1) 67 0.03 (9.34) 40.8 % 0.22 [ -0.27, 0.71 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.5 (1.32) 24.3 % 1.56 [ 0.53, 2.59 ]
Total (95% CI) 44 103 100.0 % 0.51 [ -0.19, 1.21 ]
Heterogeneity: Tau2 = 0.25; Chi2 = 6.02, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
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Analysis 11.6. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 -0.23 (1.85) 26 -0.04 (1.91) 35.3 % -0.10 [ -0.76, 0.57 ]
Mapelli 2013 10 4.2 (2.35) 10 -0.5 (1.43) 26.9 % 2.31 [ 1.13, 3.50 ]
Quayhagen 2000 21 3.2 (6.89) 67 0.75 (7.36) 37.8 % 0.33 [ -0.16, 0.83 ]
Total (95% CI) 44 103 100.0 % 0.71 [ -0.33, 1.75 ]
Heterogeneity: Tau2 = 0.68; Chi2 = 12.21, df = 2 (P = 0.002); I2 =84%
Test for overall effect: Z = 1.34 (P = 0.18)
Test for subgroup differences: Not applicable
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Analysis 11.7. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 7 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 7 Change in attention and working memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 -0.15 (0.61) 26 -0.35 (0.91) 52.2 % 0.24 [ -0.43, 0.91 ]
Mapelli 2013 10 1.7 (1.24) 20 0.1 (0.78) 47.8 % 1.63 [ 0.76, 2.51 ]
Total (95% CI) 23 46 100.0 % 0.91 [ -0.46, 2.27 ]
Heterogeneity: Tau2 = 0.82; Chi2 = 6.15, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 11.8. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 8 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 8 Change in language (naming)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -0.87 (1.21) 8 -0.12 (1.02) 100.0 % -0.63 [ -1.65, 0.38 ]
Total (95% CI) 8 8 100.0 % -0.63 [ -1.65, 0.38 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
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Analysis 11.9. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 9 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 9 Change in verbal letter fluency
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -3.38 (2.9) 8 -1.62 (3.48) 28.3 % -0.52 [ -1.52, 0.48 ]
Mapelli 2013 10 1.2 (1.51) 10 0.23 (1.32) 31.5 % 0.66 [ -0.25, 1.56 ]
Giovagnoli 2017 13 4 (4.7) 26 -0.58 (7.25) 40.2 % 0.69 [ 0.00, 1.37 ]
Total (95% CI) 31 44 100.0 % 0.34 [ -0.38, 1.05 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 4.22, df = 2 (P = 0.12); I2 =53%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Not applicable
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Analysis 11.10. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 10 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 10 Change in verbal category fluency
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -2.38 (4.25) 8 1.5 (3.37) 44.1 % -0.96 [ -2.01, 0.10 ]
Giovagnoli 2017 13 -0.46 (5.83) 26 -1.92 (5.61) 55.9 % 0.25 [ -0.42, 0.92 ]
Total (95% CI) 21 34 100.0 % -0.28 [ -1.46, 0.89 ]
Heterogeneity: Tau2 = 0.53; Chi2 = 3.61, df = 1 (P = 0.06); I2 =72%
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
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Analysis 11.11. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 11 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 11 Change in executive function
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 -10.54 (81.59) 26 3 (106.3) 26.2 % -0.13 [ -0.80, 0.53 ]
Brueggen 2017 8 -30.71 (39.98) 8 -30.39 (46.29) 25.1 % -0.01 [ -0.99, 0.97 ]
Quayhagen 2000 21 5.91 (2.31) 67 0.49 (2.1) 26.4 % 2.50 [ 1.88, 3.12 ]
Mapelli 2013 10 2.3 (0.52) 10 -0.5 (0.9) 22.3 % 3.65 [ 2.11, 5.19 ]
Total (95% CI) 52 111 100.0 % 1.44 [ -0.26, 3.14 ]
Heterogeneity: Tau2 = 2.75; Chi2 = 47.86, df = 3 (P<0.00001); I2 =94%
Test for overall effect: Z = 1.66 (P = 0.097)
Test for subgroup differences: Not applicable
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Analysis 11.14. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 14 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 14 Change in participants’ mood
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 2.17 (2.92) 26 3.85 (5.7) 7.0 % -0.33 [ -1.00, 0.34 ]
Brueggen 2017 8 -0.87 (3.91) 8 -0.13 (3.35) 3.3 % -0.19 [ -1.18, 0.79 ]
Amieva 2016 164 -12.11 (12.73) 324 -10.94 (12.78) 89.7 % -0.09 [ -0.28, 0.10 ]
Total (95% CI) 185 358 100.0 % -0.11 [ -0.29, 0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.48, df = 2 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
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Analysis 11.15. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 15 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 15 Change in capacity for activities of daily living
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
de Vreese 1998 9 -1.33 (4.37) 9 1.11 (3.41) 3.6 % -0.59 [ -1.54, 0.36 ]
Brueggen 2017 8 -0.26 (1.16) 8 0.52 (1.53) 3.2 % -0.54 [ -1.55, 0.46 ]
Amieva 2016 167 -1.76 (8.46) 324 0.05 (7.57) 93.1 % -0.23 [ -0.42, -0.04 ]
Total (95% CI) 184 341 100.0 % -0.25 [ -0.43, -0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.88, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 2.74 (P = 0.0062)
Test for subgroup differences: Not applicable
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Analysis 11.16. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 16 Change in behavioural and psychological symptoms of dementia (BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 16 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -25.22 (23.28) 324 -22.29 (23.6) 75.6 % -0.12 [ -0.31, 0.06 ]
Quintana Hernandez 2014 27 -8.55 (12.88) 68 -7.26 (10.3) 13.4 % -0.12 [ -0.56, 0.33 ]
Quayhagen 2000 21 -0.53 (10.23) 67 -0.79 (9.98) 11.1 % 0.03 [ -0.46, 0.52 ]
Total (95% CI) 213 459 100.0 % -0.11 [ -0.27, 0.06 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.32, df = 2 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 1.28 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 11.17. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 17 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 17 Change in disease progression
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 4.5 (8.43) 8 -0.5 (10.08) 19.2 % 0.51 [ -0.49, 1.51 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 22.9 % 0.57 [ -0.33, 1.46 ]
Quintana Hernandez 2014 27 -2.77 (6.39) 68 -2.16 (3.77) 58.0 % -0.13 [ -0.58, 0.32 ]
Total (95% CI) 45 86 100.0 % 0.15 [ -0.33, 0.63 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 2.68, df = 2 (P = 0.26); I2 =25%
Test for overall effect: Z = 0.62 (P = 0.54)
Test for subgroup differences: Not applicable
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Analysis 11.18. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 18 Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 18 Participant burden (retention rates)
Study or subgroup Cognitive training
Alternative
treatment Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Mapelli 2013 10/10 10/10 Not estimable
Quintana Hernandez 2014 27/32 67/70 31.3 % 0.24 [ 0.05, 1.08 ]
Amieva 2016 124/170 239/329 57.2 % 1.02 [ 0.67, 1.54 ]
Brueggen 2017 8/8 8/10 11.5 % 5.00 [ 0.21, 120.44 ]
Total (95% CI) 220 419 100.0 % 0.78 [ 0.24, 2.57 ]
Total events: 169 (Cognitive training), 324 (Alternative treatment)
Heterogeneity: Tau2 = 0.61; Chi2 = 4.34, df = 2 (P = 0.11); I2 =54%
Test for overall effect: Z = 0.41 (P = 0.68)
Test for subgroup differences: Not applicable
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Analysis 11.19. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 19 Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 19 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 0.09 (0.06) 67 -0.05 (0.1) 100.0 % 1.50 [ 0.96, 2.04 ]
Total (95% CI) 21 67 100.0 % 1.50 [ 0.96, 2.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 5.46 (P < 0.00001)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Alternative treatment Cognitive training
Analysis 11.20. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 20 Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 20 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -21.31 (19.1) 322 -15.24 (20.83) 62.7 % -0.30 [ -0.49, -0.11 ]
Quayhagen 2000 21 -0.8 (4.05) 67 -0.62 (4.42) 28.1 % -0.04 [ -0.53, 0.45 ]
Brueggen 2017 8 -0.75 (9.17) 8 -5.25 (7.4) 9.2 % 0.51 [ -0.49, 1.51 ]
Total (95% CI) 194 397 100.0 % -0.15 [ -0.47, 0.17 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 3.17, df = 2 (P = 0.21); I2 =37%
Test for overall effect: Z = 0.92 (P = 0.35)
Test for subgroup differences: Not applicable
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Analysis 11.21. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 21 Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 21 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 -0.62 (9.8) 67 2.41 (12.46) 100.0 % -0.25 [ -0.74, 0.24 ]
Total (95% CI) 21 67 100.0 % -0.25 [ -0.74, 0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.01 (P = 0.31)
Test for subgroup differences: Not applicable
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Analysis 11.22. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 22 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 22 Change in speed of information processing
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -15.63 (33.64) 8 0 (33.5) 30.9 % -0.44 [ -1.44, 0.56 ]
Giovagnoli 2017 13 -12.54 (21.19) 26 -7.62 (51.33) 69.1 % -0.11 [ -0.78, 0.56 ]
Total (95% CI) 21 34 100.0 % -0.21 [ -0.77, 0.34 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.75 (P = 0.45)
Test for subgroup differences: Not applicable
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Analysis 11.23. Comparison 11 Cognitive training vs alternative treatment immediately post intervention -
intervention dose, Outcome 23 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 11 Cognitive training vs alternative treatment immediately post intervention - intervention dose
Outcome: 23 Change in general health and quality of life
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -4.37 (4.55) 8 3.13 (4.8) 12.9 % -1.52 [ -2.67, -0.36 ]
Giovagnoli 2017 13 -0.06 (12.74) 26 8.8 (6.04) 22.1 % -0.99 [ -1.69, -0.28 ]
Quayhagen 2000 21 -0.38 (2.75) 67 0.06 (3.2) 28.3 % -0.14 [ -0.63, 0.35 ]
Amieva 2016 164 -6.3 (6.13) 324 -5.67 (6.29) 36.6 % -0.10 [ -0.29, 0.09 ]
Total (95% CI) 206 425 100.0 % -0.49 [ -1.00, 0.02 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 10.91, df = 3 (P = 0.01); I2 =73%
Test for overall effect: Z = 1.90 (P = 0.058)
Test for subgroup differences: Not applicable
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Analysis 12.1. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 1 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 1 Change in a global measure of cognition
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Quintana Hernandez 2014 27 -4.48 (4.08) 70 -2.94 (3.91) 18.3 % -0.39 [ -0.83, 0.06 ]
Brueggen 2017 8 0.13 (2.29) 8 1 (2.08) 10.5 % -0.38 [ -1.37, 0.62 ]
Amieva 2016 168 -8.4 (5.86) 326 -7.43 (6.03) 21.7 % -0.16 [ -0.35, 0.02 ]
Giovagnoli 2017 13 -0.16 (1.74) 26 -0.11 (3.63) 14.9 % -0.02 [ -0.68, 0.65 ]
Subtotal (95% CI) 216 430 65.4 % -0.19 [ -0.35, -0.02 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.22, df = 3 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 2.26 (P = 0.024)
2 Augmented
Venturelli 2016 20 -0.2 (0.97) 20 -0.1 (1.38) 15.6 % -0.08 [ -0.70, 0.54 ]
de Vreese 1998 9 2.77 (1.68) 9 -1.45 (2.97) 9.3 % 1.67 [ 0.56, 2.78 ]
Mapelli 2013 10 2.9 (2.59) 10 -1.5 (2.3) 9.8 % 1.72 [ 0.66, 2.78 ]
Subtotal (95% CI) 39 39 34.6 % 1.04 [ -0.29, 2.36 ]
Heterogeneity: Tau2 = 1.14; Chi2 = 12.48, df = 2 (P = 0.002); I2 =84%
Test for overall effect: Z = 1.54 (P = 0.12)
Total (95% CI) 255 469 100.0 % 0.16 [ -0.28, 0.60 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 23.42, df = 6 (P = 0.00067); I2 =74%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Chi2 = 3.26, df = 1 (P = 0.07), I2 =69%
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Analysis 12.2. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 2 Change in a global measure of cognition˙zero correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 2 Change in a global measure of cognition˙zero correlation
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Traditional
Quintana Hernandez 2014 27 -4.48 (6.86) 70 -2.94 (6.66) 18.4 % -0.23 [ -0.67, 0.22 ]
Brueggen 2017 8 0.13 (5.11) 8 1 (4.64) 4.8 % -0.17 [ -1.15, 0.81 ]
Amieva 2016 168 -8.4 (8.71) 326 -7.43 (8.74) 45.9 % -0.11 [ -0.30, 0.08 ]
Giovagnoli 2017 13 -0.16 (3.45) 26 -0.11 (7.87) 9.7 % -0.01 [ -0.67, 0.66 ]
Subtotal (95% CI) 216 430 78.8 % -0.12 [ -0.29, 0.04 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.35, df = 3 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.46 (P = 0.14)
2 Augmented
Venturelli 2016 20 -0.2 (2.13) 20 -0.1 (2.98) 10.9 % -0.04 [ -0.66, 0.58 ]
de Vreese 1998 9 2.77 (3.48) 9 -1.45 (6.53) 5.0 % 0.77 [ -0.20, 1.73 ]
Mapelli 2013 10 2.9 (5.03) 10 -1.5 (4.67) 5.4 % 0.87 [ -0.06, 1.79 ]
Subtotal (95% CI) 39 39 21.2 % 0.44 [ -0.18, 1.06 ]
Heterogeneity: Tau2 = 0.13; Chi2 = 3.42, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 1.39 (P = 0.16)
Total (95% CI) 255 469 100.0 % -0.02 [ -0.24, 0.20 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 7.58, df = 6 (P = 0.27); I2 =21%
Test for overall effect: Z = 0.18 (P = 0.85)
Test for subgroup differences: Chi2 = 2.95, df = 1 (P = 0.09), I2 =66%
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Analysis 12.3. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 3 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 3 Change in a global measure of cognition (composite)
Study or subgroup Cognitive training
Alternative
treatment
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Traditional
Amieva 2016 166 325 -0.13 (0.1) 21.9 % -0.13 [ -0.33, 0.07 ]
Brueggen 2017 8 8 -0.18 (0.48) 11.1 % -0.18 [ -1.12, 0.76 ]
Giovagnoli 2017 13 26 -0.05 (0.34) 14.9 % -0.05 [ -0.72, 0.62 ]
Quintana Hernandez 2014 27 70 -0.45 (0.23) 18.4 % -0.45 [ -0.90, 0.00 ]
Subtotal (95% CI) 214 429 66.3 % -0.17 [ -0.34, 0.00 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.77, df = 3 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 1.98 (P = 0.048)
2 Augmented
de Vreese 1998 9 9 1.31 (0.5) 10.6 % 1.31 [ 0.33, 2.29 ]
Mapelli 2013 10 10 1.95 (0.64) 7.9 % 1.95 [ 0.70, 3.20 ]
Quayhagen 2000 21 67 0.35 (0.33) 15.2 % 0.35 [ -0.30, 1.00 ]
Subtotal (95% CI) 40 86 33.7 % 1.09 [ 0.14, 2.04 ]
Heterogeneity: Tau2 = 0.46; Chi2 = 6.10, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 2.26 (P = 0.024)
Total (95% CI) 254 515 100.0 % 0.21 [ -0.23, 0.64 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 22.34, df = 6 (P = 0.001); I2 =73%
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Chi2 = 6.62, df = 1 (P = 0.01), I2 =85%
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Analysis 12.4. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 4 Change in a global measure of cognition (composite)˙zero
correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 4 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup Cognitive training
Alternative
treatment
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
N N IV,Random,95% CI IV,Random,95% CI
1 Traditional
Amieva 2016 166 325 -0.09 (0.1) 55.1 % -0.09 [ -0.29, 0.11 ]
Brueggen 2017 8 8 -0.1 (0.47) 4.5 % -0.10 [ -1.02, 0.82 ]
Giovagnoli 2017 13 26 -0.04 (0.37) 7.1 % -0.04 [ -0.77, 0.69 ]
Quintana Hernandez 2014 27 70 -0.27 (0.23) 16.7 % -0.27 [ -0.72, 0.18 ]
Subtotal (95% CI) 214 429 83.3 % -0.11 [ -0.28, 0.06 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.56, df = 3 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 1.30 (P = 0.19)
2 Augmented
de Vreese 1998 9 9 0.6 (0.46) 4.7 % 0.60 [ -0.30, 1.50 ]
Mapelli 2013 10 10 0.93 (0.55) 3.3 % 0.93 [ -0.15, 2.01 ]
Quayhagen 2000 21 67 0.16 (0.33) 8.7 % 0.16 [ -0.49, 0.81 ]
Subtotal (95% CI) 40 86 16.7 % 0.43 [ -0.04, 0.90 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.63, df = 2 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 1.78 (P = 0.075)
Total (95% CI) 254 515 100.0 % -0.03 [ -0.23, 0.17 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 6.66, df = 6 (P = 0.35); I2 =10%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Chi2 = 4.47, df = 1 (P = 0.03), I2 =78%
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Analysis 12.5. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 5 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 5 Change in immediate memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 1 (4.38) 26 0.32 (6.22) 34.9 % 0.12 [ -0.55, 0.78 ]
Quayhagen 2000 21 2.29 (12.1) 67 0.03 (9.34) 40.8 % 0.22 [ -0.27, 0.71 ]
Mapelli 2013 10 2.6 (2.35) 10 -0.5 (1.32) 24.3 % 1.56 [ 0.53, 2.59 ]
Total (95% CI) 44 103 100.0 % 0.51 [ -0.19, 1.21 ]
Heterogeneity: Tau2 = 0.25; Chi2 = 6.02, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
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Analysis 12.6. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 6 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 6 Change in delayed memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 -0.23 (1.85) 26 -0.04 (1.91) 35.3 % -0.10 [ -0.76, 0.57 ]
Mapelli 2013 10 4.2 (2.35) 10 -0.5 (1.43) 26.9 % 2.31 [ 1.13, 3.50 ]
Quayhagen 2000 21 3.2 (6.89) 67 0.75 (7.36) 37.8 % 0.33 [ -0.16, 0.83 ]
Total (95% CI) 44 103 100.0 % 0.71 [ -0.33, 1.75 ]
Heterogeneity: Tau2 = 0.68; Chi2 = 12.21, df = 2 (P = 0.002); I2 =84%
Test for overall effect: Z = 1.34 (P = 0.18)
Test for subgroup differences: Not applicable
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Analysis 12.7. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 7 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 7 Change in attention and working memory
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 -0.15 (0.61) 26 -0.35 (0.91) 52.2 % 0.24 [ -0.43, 0.91 ]
Mapelli 2013 10 1.7 (1.24) 20 0.1 (0.78) 47.8 % 1.63 [ 0.76, 2.51 ]
Total (95% CI) 23 46 100.0 % 0.91 [ -0.46, 2.27 ]
Heterogeneity: Tau2 = 0.82; Chi2 = 6.15, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 12.8. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 8 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 8 Change in language (naming)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -0.87 (1.21) 8 -0.12 (1.02) 100.0 % -0.63 [ -1.65, 0.38 ]
Total (95% CI) 8 8 100.0 % -0.63 [ -1.65, 0.38 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
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Analysis 12.9. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 9 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 9 Change in verbal letter fluency
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -3.38 (2.9) 8 -1.62 (3.48) 28.3 % -0.52 [ -1.52, 0.48 ]
Mapelli 2013 10 1.2 (1.51) 10 0.23 (1.32) 31.5 % 0.66 [ -0.25, 1.56 ]
Giovagnoli 2017 13 4 (4.7) 26 -0.58 (7.25) 40.2 % 0.69 [ 0.00, 1.37 ]
Total (95% CI) 31 44 100.0 % 0.34 [ -0.38, 1.05 ]
Heterogeneity: Tau2 = 0.21; Chi2 = 4.22, df = 2 (P = 0.12); I2 =53%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Not applicable
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Analysis 12.10. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 10 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 10 Change in verbal category fluency
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -2.38 (4.25) 8 1.5 (3.37) 44.1 % -0.96 [ -2.01, 0.10 ]
Giovagnoli 2017 13 -0.46 (5.83) 26 -1.92 (5.61) 55.9 % 0.25 [ -0.42, 0.92 ]
Total (95% CI) 21 34 100.0 % -0.28 [ -1.46, 0.89 ]
Heterogeneity: Tau2 = 0.53; Chi2 = 3.61, df = 1 (P = 0.06); I2 =72%
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
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Analysis 12.11. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 11 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 11 Change in executive function
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 -10.54 (81.59) 26 3 (106.3) 26.2 % -0.13 [ -0.80, 0.53 ]
Brueggen 2017 8 -30.71 (39.98) 8 -30.39 (46.29) 25.1 % -0.01 [ -0.99, 0.97 ]
Quayhagen 2000 21 5.91 (2.31) 67 0.49 (2.1) 26.4 % 2.50 [ 1.88, 3.12 ]
Mapelli 2013 10 2.3 (0.52) 10 -0.5 (0.9) 22.3 % 3.65 [ 2.11, 5.19 ]
Total (95% CI) 52 111 100.0 % 1.44 [ -0.26, 3.14 ]
Heterogeneity: Tau2 = 2.75; Chi2 = 47.86, df = 3 (P<0.00001); I2 =94%
Test for overall effect: Z = 1.66 (P = 0.097)
Test for subgroup differences: Not applicable
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Analysis 12.14. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 14 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 14 Change in participants’ mood
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Giovagnoli 2017 13 2.17 (2.92) 26 3.85 (5.7) 7.0 % -0.33 [ -1.00, 0.34 ]
Brueggen 2017 8 -0.87 (3.91) 8 -0.13 (3.35) 3.3 % -0.19 [ -1.18, 0.79 ]
Amieva 2016 164 -12.11 (12.73) 324 -10.94 (12.78) 89.7 % -0.09 [ -0.28, 0.10 ]
Total (95% CI) 185 358 100.0 % -0.11 [ -0.29, 0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.48, df = 2 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
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Analysis 12.15. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 15 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 15 Change in capacity for activities of daily living
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
de Vreese 1998 9 -1.33 (4.37) 9 1.11 (3.41) 3.6 % -0.59 [ -1.54, 0.36 ]
Brueggen 2017 8 -0.26 (1.16) 8 0.52 (1.53) 3.2 % -0.54 [ -1.55, 0.46 ]
Amieva 2016 167 -1.76 (8.46) 324 0.05 (7.57) 93.1 % -0.23 [ -0.42, -0.04 ]
Total (95% CI) 184 341 100.0 % -0.25 [ -0.43, -0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.88, df = 2 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 2.74 (P = 0.0062)
Test for subgroup differences: Not applicable
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Analysis 12.16. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 16 Change in behavioural and psychological symptoms of
dementia (BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 16 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -25.22 (23.28) 324 -22.29 (23.6) 75.6 % -0.12 [ -0.31, 0.06 ]
Quintana Hernandez 2014 27 -8.55 (12.88) 68 -7.26 (10.3) 13.4 % -0.12 [ -0.56, 0.33 ]
Quayhagen 2000 21 -0.53 (10.23) 67 -0.79 (9.98) 11.1 % 0.03 [ -0.46, 0.52 ]
Total (95% CI) 213 459 100.0 % -0.11 [ -0.27, 0.06 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.32, df = 2 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 1.28 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 12.17. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 17 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 17 Change in disease progression
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 4.5 (8.43) 8 -0.5 (10.08) 19.2 % 0.51 [ -0.49, 1.51 ]
Mapelli 2013 10 0.25 (0.5) 10 0 (0.33) 22.9 % 0.57 [ -0.33, 1.46 ]
Quintana Hernandez 2014 27 -2.77 (6.39) 68 -2.16 (3.77) 58.0 % -0.13 [ -0.58, 0.32 ]
Total (95% CI) 45 86 100.0 % 0.15 [ -0.33, 0.63 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 2.68, df = 2 (P = 0.26); I2 =25%
Test for overall effect: Z = 0.62 (P = 0.54)
Test for subgroup differences: Not applicable
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Analysis 12.18. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 18 Participant burden (retention rates).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 18 Participant burden (retention rates)
Study or subgroup Cognitive training
Alternative
treatment Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Mapelli 2013 10/10 10/10 Not estimable
Quintana Hernandez 2014 27/32 67/70 31.3 % 0.24 [ 0.05, 1.08 ]
Amieva 2016 124/170 239/329 57.2 % 1.02 [ 0.67, 1.54 ]
Brueggen 2017 8/8 8/10 11.5 % 5.00 [ 0.21, 120.44 ]
Total (95% CI) 220 419 100.0 % 0.78 [ 0.24, 2.57 ]
Total events: 169 (Cognitive training), 324 (Alternative treatment)
Heterogeneity: Tau2 = 0.61; Chi2 = 4.34, df = 2 (P = 0.11); I2 =54%
Test for overall effect: Z = 0.41 (P = 0.68)
Test for subgroup differences: Not applicable
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Analysis 12.19. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 19 Change in mood and well-being (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 19 Change in mood and well-being (CAREGIVER)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 0.09 (0.06) 67 -0.05 (0.1) 100.0 % 1.50 [ 0.96, 2.04 ]
Total (95% CI) 21 67 100.0 % 1.50 [ 0.96, 2.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 5.46 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 12.20. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 20 Change in burden of care (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 20 Change in burden of care (CAREGIVER)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Amieva 2016 165 -21.31 (19.1) 322 -15.24 (20.83) 62.7 % -0.30 [ -0.49, -0.11 ]
Quayhagen 2000 21 -0.8 (4.05) 67 -0.62 (4.42) 28.1 % -0.04 [ -0.53, 0.45 ]
Brueggen 2017 8 -0.75 (9.17) 8 -5.25 (7.4) 9.2 % 0.51 [ -0.49, 1.51 ]
Total (95% CI) 194 397 100.0 % -0.15 [ -0.47, 0.17 ]
Heterogeneity: Tau2 = 0.03; Chi2 = 3.17, df = 2 (P = 0.21); I2 =37%
Test for overall effect: Z = 0.92 (P = 0.35)
Test for subgroup differences: Not applicable
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Analysis 12.21. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 21 Change in quality of life (CAREGIVER).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 21 Change in quality of life (CAREGIVER)
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Quayhagen 2000 21 -0.62 (9.8) 67 2.41 (12.46) 100.0 % -0.25 [ -0.74, 0.24 ]
Total (95% CI) 21 67 100.0 % -0.25 [ -0.74, 0.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.01 (P = 0.31)
Test for subgroup differences: Not applicable
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Analysis 12.22. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 22 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 22 Change in speed of information processing
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -15.63 (33.64) 8 0 (33.5) 30.9 % -0.44 [ -1.44, 0.56 ]
Giovagnoli 2017 13 -12.54 (21.19) 26 -7.62 (51.33) 69.1 % -0.11 [ -0.78, 0.56 ]
Total (95% CI) 21 34 100.0 % -0.21 [ -0.77, 0.34 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.75 (P = 0.45)
Test for subgroup differences: Not applicable
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Analysis 12.23. Comparison 12 Cognitive training vs alternative treatment immediately post intervention -
type of CT (traditional vs augmented), Outcome 23 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 12 Cognitive training vs alternative treatment immediately post intervention - type of CT (traditional vs augmented)
Outcome: 23 Change in general health and quality of life
Study or subgroup Cognitive training
Alternative
treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Brueggen 2017 8 -4.37 (4.55) 8 3.13 (4.8) 12.9 % -1.52 [ -2.67, -0.36 ]
Giovagnoli 2017 13 -0.06 (12.74) 26 8.8 (6.04) 22.1 % -0.99 [ -1.69, -0.28 ]
Quayhagen 2000 21 -0.38 (2.75) 67 0.06 (3.2) 28.3 % -0.14 [ -0.63, 0.35 ]
Amieva 2016 164 -6.3 (6.13) 324 -5.67 (6.29) 36.6 % -0.10 [ -0.29, 0.09 ]
Total (95% CI) 206 425 100.0 % -0.49 [ -1.00, 0.02 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 10.91, df = 3 (P = 0.01); I2 =73%
Test for overall effect: Z = 1.90 (P = 0.058)
Test for subgroup differences: Not applicable
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Analysis 13.1. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 1 Change in a global measure of cognition.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 1 Change in a global measure of cognition
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 12 0.5 (2.85) 7 1.71 (2.02) 16.4 % -0.45 [ -1.39, 0.50 ]
Kallio 2018 68 -1.3 (5.39) 49 -1.2 (5.25) 18.7 % -0.02 [ -0.39, 0.35 ]
Cavallo 2016 36 -2.24 (1.1) 36 -3.8 (2.09) 18.3 % 0.92 [ 0.44, 1.41 ]
Galante 2007 7 -1.5 (2.28) 4 -4.7 (1.82) 13.9 % 1.37 [ -0.05, 2.79 ]
Trebbastoni 2018 45 -1.38 (2.33) 85 -5.52 (2.62) 18.6 % 1.63 [ 1.22, 2.04 ]
Tsantali 2017 17 3.8 (1) 21 -1.5 (0.97) 14.0 % 5.28 [ 3.87, 6.68 ]
Total (95% CI) 185 202 100.0 % 1.33 [ 0.31, 2.34 ]
Heterogeneity: Tau2 = 1.41; Chi2 = 80.97, df = 5 (P<0.00001); I2 =94%
Test for overall effect: Z = 2.55 (P = 0.011)
Test for subgroup differences: Not applicable
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Analysis 13.2. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 2 Change in a global measure of cognition (zero correlation).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 2 Change in a global measure of cognition (zero correlation)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 12 0.5 (6.21) 7 1.71 (4.35) 14.5 % -0.21 [ -1.14, 0.73 ]
Kallio 2018 68 -1.3 (11.96) 49 -1.2 (11.74) 20.1 % -0.01 [ -0.38, 0.36 ]
Cavallo 2016 36 -2.24 (2.46) 36 -3.8 (4.22) 19.2 % 0.45 [ -0.02, 0.91 ]
Galante 2007 7 -1.5 (4.9) 4 -4.7 (3.41) 11.3 % 0.66 [ -0.62, 1.93 ]
Trebbastoni 2018 45 -1.38 (4.43) 85 -5.52 (5.02) 20.0 % 0.85 [ 0.48, 1.23 ]
Tsantali 2017 17 3.8 (1.89) 21 -1.5 (2.13) 15.0 % 2.56 [ 1.68, 3.44 ]
Total (95% CI) 185 202 100.0 % 0.68 [ 0.06, 1.30 ]
Heterogeneity: Tau2 = 0.46; Chi2 = 33.94, df = 5 (P<0.00001); I2 =85%
Test for overall effect: Z = 2.16 (P = 0.031)
Test for subgroup differences: Not applicable
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Analysis 13.3. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 3 Change in a global measure of cognition (composite).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 3 Change in a global measure of cognition (composite)
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Cahn-Weiner 2003 -0.03 (0.34) 13.0 % -0.03 [ -0.70, 0.64 ]
Galante 2007 -0.23 (0.6) 9.3 % -0.23 [ -1.41, 0.95 ]
Lee 2013 0 (0.45) 11.4 % 0.0 [ -0.88, 0.88 ]
Subtotal (95% CI) 33.7 % -0.05 [ -0.54, 0.43 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.11, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.22 (P = 0.82)
2 More than 3 months
Cavallo 2016 1.58 (0.28) 13.9 % 1.58 [ 1.03, 2.13 ]
Quayhagen 1995 (1) 0.64 (0.34) 13.0 % 0.64 [ -0.03, 1.31 ]
Quayhagen 1995 (2) 0.18 (0.33) 13.2 % 0.18 [ -0.47, 0.83 ]
Trebbastoni 2018 0.49 (0.19) 15.0 % 0.49 [ 0.12, 0.86 ]
Tsantali 2017 2.49 (0.46) 11.2 % 2.49 [ 1.59, 3.39 ]
Subtotal (95% CI) 66.3 % 1.03 [ 0.33, 1.72 ]
Heterogeneity: Tau2 = 0.52; Chi2 = 27.59, df = 4 (P = 0.00002); I2 =86%
Test for overall effect: Z = 2.91 (P = 0.0037)
Total (95% CI) 100.0 % 0.65 [ 0.11, 1.20 ]
Heterogeneity: Tau2 = 0.48; Chi2 = 38.01, df = 7 (P<0.00001); I2 =82%
Test for overall effect: Z = 2.34 (P = 0.019)
Test for subgroup differences: Chi2 = 6.29, df = 1 (P = 0.01), I2 =84%
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Analysis 13.4. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 4 Change in a global measure of cognition (composite)˙zero
correlation.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 4 Change in a global measure of cognition (composite)˙zero correlation
Study or subgroup
Std. Mean
Difference
(SE)
Std.
Mean
Difference Weight
Std.
Mean
Difference
IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Cahn-Weiner 2003 0.01 (0.34) 12.1 % 0.01 [ -0.66, 0.68 ]
Galante 2007 -0.13 (0.58) 5.8 % -0.13 [ -1.27, 1.01 ]
Lee 2013 -0.13 (0.45) 8.5 % -0.13 [ -1.01, 0.75 ]
Subtotal (95% CI) 26.3 % -0.06 [ -0.54, 0.42 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.08, df = 2 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.23 (P = 0.82)
2 More than 4 months
Cavallo 2016 0.74 (0.24) 17.0 % 0.74 [ 0.27, 1.21 ]
Quayhagen 1995 (1) 0.64 (0.34) 12.1 % 0.64 [ -0.03, 1.31 ]
Quayhagen 1995 (2) 0.18 (0.33) 12.5 % 0.18 [ -0.47, 0.83 ]
Trebbastoni 2018 0.23 (0.18) 20.7 % 0.23 [ -0.12, 0.58 ]
Tsantali 2017 1.27 (0.36) 11.3 % 1.27 [ 0.56, 1.98 ]
Subtotal (95% CI) 73.7 % 0.57 [ 0.21, 0.93 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 8.93, df = 4 (P = 0.06); I2 =55%
Test for overall effect: Z = 3.07 (P = 0.0022)
Total (95% CI) 100.0 % 0.40 [ 0.09, 0.71 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 13.22, df = 7 (P = 0.07); I2 =47%
Test for overall effect: Z = 2.56 (P = 0.010)
Test for subgroup differences: Chi2 = 4.13, df = 1 (P = 0.04), I2 =76%
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Analysis 13.5. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 5 Change in disease progression (zero correlation).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 5 Change in disease progression (zero correlation)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 12 3.17 (20.83) 7 0 (16.21) 20.4 % 0.16 [ -0.78, 1.09 ]
Quayhagen 1995 (1) 13 -2.2 (19.29) 28 -6 (21.5) 41.0 % 0.18 [ -0.48, 0.84 ]
Quayhagen 1995 (2) 13 -2.2 (19.29) 25 -12.6 (23.34) 38.6 % 0.46 [ -0.22, 1.14 ]
Total (95% CI) 38 60 100.0 % 0.28 [ -0.14, 0.71 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.43, df = 2 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.32 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 13.6. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 6 Change in disease progression.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 6 Change in disease progression
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 12 3.17 (9.33) 7 0 (7.25) 20.8 % 0.35 [ -0.59, 1.29 ]
Quayhagen 1995 (1) 13 -2.2 (9.06) 28 -6 (10.8) 41.8 % 0.36 [ -0.30, 1.02 ]
Quayhagen 1995 (2) 13 -2.2 (9.06) 25 -12.6 (12.91) 37.4 % 0.87 [ 0.16, 1.57 ]
Total (95% CI) 38 60 100.0 % 0.55 [ 0.12, 0.98 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.26, df = 2 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 2.50 (P = 0.012)
Test for subgroup differences: Not applicable
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Analysis 13.7. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 7 Change in immediate memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 7 Change in immediate memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Up to 3 months
Galante 2007 7 -11 (9.04) 4 3.7 (6.87) 8.2 % -1.60 [ -3.09, -0.12 ]
Lee 2013 12 3.25 (2.67) 7 3.57 (4.48) 11.5 % -0.09 [ -1.02, 0.84 ]
Cahn-Weiner 2003 17 -1.1 (2.8) 17 -1.1 (2.88) 13.1 % 0.0 [ -0.67, 0.67 ]
Subtotal (95% CI) 36 28 32.8 % -0.34 [ -1.12, 0.43 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 3.82, df = 2 (P = 0.15); I2 =48%
Test for overall effect: Z = 0.87 (P = 0.38)
2 More than 3 months
Quayhagen 1995 (1) 13 0.1 (10.96) 28 -2.1 (8.05) 13.2 % 0.24 [ -0.42, 0.90 ]
Quayhagen 1995 13 0.1 (10.96) 25 -6.3 (6.39) 13.0 % 0.76 [ 0.07, 1.46 ]
Trebbastoni 2018 45 2.84 (4.55) 85 -1.68 (4.5) 14.7 % 0.99 [ 0.61, 1.38 ]
Tsantali 2017 17 2 (2.95) 21 -1.9 (2.06) 12.7 % 1.53 [ 0.79, 2.27 ]
Cavallo 2016 36 -1 (0.69) 36 -3.04 (1.14) 13.6 % 2.14 [ 1.56, 2.73 ]
Subtotal (95% CI) 124 195 67.2 % 1.14 [ 0.53, 1.74 ]
Heterogeneity: Tau2 = 0.38; Chi2 = 21.16, df = 4 (P = 0.00029); I2 =81%
Test for overall effect: Z = 3.67 (P = 0.00024)
Total (95% CI) 160 223 100.0 % 0.62 [ 0.00, 1.24 ]
Heterogeneity: Tau2 = 0.64; Chi2 = 46.37, df = 7 (P<0.00001); I2 =85%
Test for overall effect: Z = 1.97 (P = 0.048)
Test for subgroup differences: Chi2 = 8.72, df = 1 (P = 0.00), I2 =89%
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Analysis 13.8. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 8 Change in delayed memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 8 Change in delayed memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Trebbastoni 2018 45 -0.39 (1.32) 85 -0.47 (1.41) 26.8 % 0.06 [ -0.30, 0.42 ]
Cahn-Weiner 2003 17 -0.2 (0.77) 17 -0.8 (1.66) 24.4 % 0.45 [ -0.23, 1.13 ]
Tsantali 2017 17 1.8 (2.5) 17 -2.2 (2.4) 23.4 % 1.59 [ 0.81, 2.38 ]
Cavallo 2016 36 -2 (1.13) 36 -4 (1.02) 25.4 % 1.84 [ 1.28, 2.39 ]
Total (95% CI) 115 155 100.0 % 0.97 [ 0.02, 1.92 ]
Heterogeneity: Tau2 = 0.84; Chi2 = 33.73, df = 3 (P<0.00001); I2 =91%
Test for overall effect: Z = 1.99 (P = 0.046)
Test for subgroup differences: Not applicable
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Analysis 13.9. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 9 Change in language (naming).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 9 Change in language (naming)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Trebbastoni 2018 45 -33 (3.56) 85 -2.66 (5.58) 24.9 % -6.06 [ -6.89, -5.23 ]
Cahn-Weiner 2003 17 -0.2 (3.59) 17 0 (3.97) 25.0 % -0.05 [ -0.72, 0.62 ]
Cavallo 2016 36 -2 (1.93) 36 -3 (1.41) 25.2 % 0.59 [ 0.11, 1.06 ]
Tsantali 2017 17 7 (3.6) 21 -0.4 (3.56) 24.9 % 2.02 [ 1.22, 2.82 ]
Total (95% CI) 115 159 100.0 % -0.87 [ -3.81, 2.08 ]
Heterogeneity: Tau2 = 8.91; Chi2 = 231.09, df = 3 (P<0.00001); I2 =99%
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Not applicable
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Analysis 13.10. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 10 Change in verbal letter fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 10 Change in verbal letter fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 -1.1 (4.07) 17 0.9 (5.42) 25.3 % -0.41 [ -1.09, 0.27 ]
Galante 2007 7 1 (3.9) 4 0.3 (7.59) 17.2 % 0.12 [ -1.11, 1.35 ]
Trebbastoni 2018 45 -2.41 (4.85) 85 -5.27 (5.2) 29.7 % 0.56 [ 0.19, 0.93 ]
Cavallo 2016 36 -3.1 (1.68) 36 -5.4 (1.55) 27.7 % 1.41 [ 0.89, 1.93 ]
Total (95% CI) 105 142 100.0 % 0.47 [ -0.28, 1.23 ]
Heterogeneity: Tau2 = 0.46; Chi2 = 18.36, df = 3 (P = 0.00037); I2 =84%
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Not applicable
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Analysis 13.11. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 11 Change in verbal category fluency.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 11 Change in verbal category fluency
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.5 (1.99) 4 -0.2 (4.41) 9.4 % -0.09 [ -1.32, 1.14 ]
Cavallo 2016 36 -4 (1.14) 36 -4.83 (1.16) 40.0 % 0.71 [ 0.24, 1.19 ]
Trebbastoni 2018 45 -0.41 (4.78) 85 -5.34 (5.04) 50.6 % 0.99 [ 0.61, 1.37 ]
Total (95% CI) 88 125 100.0 % 0.78 [ 0.38, 1.18 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 3.06, df = 2 (P = 0.22); I2 =35%
Test for overall effect: Z = 3.83 (P = 0.00013)
Test for subgroup differences: Not applicable
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Analysis 13.12. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 12 Change in attention and working memory.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 12 Change in attention and working memory
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.3 (0.67) 4 1 (1.57) 22.3 % -1.12 [ -2.48, 0.24 ]
Trebbastoni 2018 45 -0.36 (0.54) 85 -0.73 (0.68) 39.9 % 0.58 [ 0.21, 0.95 ]
Cavallo 2016 36 -0.1 (1.03) 38 -1.55 (1.05) 37.8 % 1.38 [ 0.87, 1.89 ]
Total (95% CI) 88 127 100.0 % 0.50 [ -0.43, 1.43 ]
Heterogeneity: Tau2 = 0.53; Chi2 = 13.95, df = 2 (P = 0.00094); I2 =86%
Test for overall effect: Z = 1.05 (P = 0.29)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Control Cognitive training
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Analysis 13.13. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 13 Change in speed of information processing.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 13 Change in speed of information processing
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 0 (8.89) 4 2.5 (6.72) 29.9 % -0.28 [ -1.51, 0.96 ]
Cahn-Weiner 2003 17 11.7 (21.05) 17 -1.4 (25.31) 70.1 % 0.55 [ -0.14, 1.24 ]
Total (95% CI) 24 21 100.0 % 0.30 [ -0.44, 1.04 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 1.31, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Control Cognitive training
Analysis 13.14. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 14 Change in meta cognition (self-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 14 Change in meta cognition (self-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Lee 2013 12 0.17 (0.29) 7 -0.12 (0.26) 100.0 % 0.99 [ -0.01, 1.99 ]
Total (95% CI) 12 7 100.0 % 0.99 [ -0.01, 1.99 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.95 (P = 0.052)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Control Cognitive training
411Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 13.15. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 15 Change in meta cognition (informant-reported).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 15 Change in meta cognition (informant-reported)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 -2 (16.07) 17 -1 (19.27) 100.0 % -0.06 [ -0.73, 0.62 ]
Total (95% CI) 17 17 100.0 % -0.06 [ -0.73, 0.62 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.16 (P = 0.87)
Test for subgroup differences: Not applicable
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Analysis 13.16. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 16 Change in capacity for activities of daily living.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 16 Change in capacity for activities of daily living
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.7 (1.43) 4 0.3 (0.36) 22.1 % -0.77 [ -2.06, 0.52 ]
Cahn-Weiner 2003 17 0.6 (3.1) 17 -0.5 (3.43) 45.9 % 0.33 [ -0.35, 1.01 ]
Lee 2013 12 1.08 (3.37) 7 -1.71 (3.82) 32.1 % 0.75 [ -0.22, 1.72 ]
Total (95% CI) 36 28 100.0 % 0.22 [ -0.50, 0.94 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 3.47, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
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Analysis 13.17. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 17 Change in behavioural and psychological symptoms of dementia
(BPSD).
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 17 Change in behavioural and psychological symptoms of dementia (BPSD)
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -1 (2.95) 4 3.8 (3.85) 100.0 % -1.34 [ -2.75, 0.07 ]
Total (95% CI) 7 4 100.0 % -1.34 [ -2.75, 0.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Control Cognitive training
Analysis 13.18. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 18 Change in general health and quality of life.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 18 Change in general health and quality of life
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Kallio 2018 68 -0.05 (0.06) 49 -0.05 (0.05) 100.0 % -0.02 [ -0.39, 0.35 ]
Total (95% CI) 68 49 100.0 % -0.02 [ -0.39, 0.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.09 (P = 0.92)
Test for subgroup differences: Not applicable
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Analysis 13.19. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 19 Change in participants’ mood.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 19 Change in participants’ mood
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Galante 2007 7 -0.1 (1.62) 4 0.2 (0.67) 37.1 % -0.20 [ -1.43, 1.03 ]
Lee 2013 12 -0.67 (2.35) 7 -1.86 (2.77) 62.9 % 0.45 [ -0.49, 1.40 ]
Total (95% CI) 19 11 100.0 % 0.21 [ -0.54, 0.96 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.68, df = 1 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Not applicable
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Analysis 13.23. Comparison 13 Cognitive training vs control in the medium term (3 to 12 months post
intervention) - follow-up period, Outcome 23 Change in executive function.
Review: Cognitive training for people with mild to moderate dementia
Comparison: 13 Cognitive training vs control in the medium term (3 to 12 months post intervention) - follow-up period
Outcome: 23 Change in executive function
Study or subgroup Cognitive training Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Cahn-Weiner 2003 17 3 (50.45) 17 28.8 (60.12) 16.7 % -0.45 [ -1.14, 0.23 ]
Galante 2007 7 0.4 (4.88) 4 -0.7 (3.29) 10.4 % 0.23 [ -1.01, 1.46 ]
Quayhagen 1995 (1) 13 1.1 (6.94) 28 -1.4 (7.76) 16.9 % 0.33 [ -0.34, 0.99 ]
Quayhagen 1995 (2) 13 1.1 (6.94) 25 -3.2 (7.45) 16.6 % 0.58 [ -0.11, 1.26 ]
Trebbastoni 2018 45 -0.56 (2.24) 85 -2.66 (2.33) 20.4 % 0.91 [ 0.53, 1.29 ]
Cavallo 2016 38 -0.82 (0.81) 38 -1.95 (0.72) 18.9 % 1.46 [ 0.95, 1.97 ]
Total (95% CI) 133 197 100.0 % 0.56 [ 0.02, 1.10 ]
Heterogeneity: Tau2 = 0.33; Chi2 = 22.58, df = 5 (P = 0.00041); I2 =78%
Test for overall effect: Z = 2.04 (P = 0.042)
Test for subgroup differences: Not applicable
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(1) Cognitive training vs. Active control
(2) Cognitive training vs. Passive control
A D D I T I O N A L T A B L E S
Table 1. Summary characteristics of participants in cognitive training and control groups
Study Condition Sam-
ple size (at
baseline)
Age, mean
(SD),
range
Gender
balance
(m:f )
Education Medica-
tions
(number
or propor-
tion on
dementia-
re-
latedmed-
ication)
Baseline
MMSE
score
Retention
rates
Adverse
reactions
Beck 1988 Cognitive
training
10 74 (range
68 to 75)
5:5 Attended
college = 2
None Not
reported
100% “many
sub-
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
jects com-
plained of
tiring”
Control 10 76 (range
70 to 93)
3:7 Attended
college = 1
None Not
reported
100% Not speci-
fied
Heiss 1993 Cognitive
training
Not re-
ported (18
completed
the study)
65.9 (6.
28)
9:9 Not
reported
None 20.55 (4.
42)
Not
reported
Not speci-
fied
Control
(social sup-
port)
Not re-
ported (17
completed
the study)
66.63 (10.
17)
10:7 Not
reported
None 20.23 (4.
10)
Not
reported
Not speci-
fied
Control
(CT+pyritinol)
17 67.18 (8.
51)
Not
reported
88.88 Not
reported
21.64 (4.
55)
Not
reported
Not speci-
fied
Control
(CT+phosphatidylserine)
18 66.74 (6.
93)
Not
reported
125 Not
reported
20.88 (4.
73)
Not
reported
Not speci-
fied
Quayha-
gen
1995
Cognitive
training
25 Not
reported
Not
reported
Not
reported
Not
reported
109.8 (12.
0) DRS
Not
reported
Not speci-
fied
Passive
control
25 Not
reported
Not
reported
Not
reported
Not
reported
109.2 (11.
7) DRS
Not
reported
Not speci-
fied
Active con-
trol
28 Not
reported
not
reported
Not
reported
Not
reported
110 (12.2)
DRS
Not
reported
Not speci-
fied
de Vreese
1998
Cognitive
training
12 NA NA NA NA NA NA NA
Cognitive
train-
ing+AChE-
I
12 Not
reported
Not
reported
Not
reported
All 17.33 (3.
39)
100% Not speci-
fied
Control
(placebo
drug)
12 Not
reported
Not
reported
Not
reported
All 17.44 (4.
67)
100% Not speci-
fied
Control
(AChE-I)
12 Not
reported
Not
reported
Not
reported
All 17 (3.20) 100% Not speci-
fied
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
Quayha-
gen
2000
Cognitive
training
21 Not
reported
Not
reported
Not
reported
Not
reported
Not
assessed
Not
reported
Not speci-
fied
Passive
control
15 Not
reported
Not
reported
Not
reported
Not
reported
Not
assessed
Not
reported
Not speci-
fied
Dyadic
coun-
selling
control
29 Not
reported
Not
reported
Not
reported
Not
reported
Not
assessed
Not
reported
Not speci-
fied
Sem-
inar groups
control
22 Not
reported
Not
reported
Not
reported
Not
reported
Not
assessed
Not
reported
Not speci-
fied
Early-stage
daycare
control
16 Not
reported
Not
reported
Not
reported
Not
reported
Not
assessed
Not
reported
Not speci-
fied
Davis
2001
Cognitive
training
19 68.67 (3.
86)
10:9 15.06 (3.
86)
5 21.84 (4.
03)
100% Not speci-
fied
Control 18 72.56 (7.
62)
6:12 12.97 (2.
56)
4 22.78 (4.
45)
100% Not speci-
fied
Koltai
2001
Cogni-
tive train-
ing (group
and in-
dividual) -
shared data
16 72.9 (6.7) Not
reported
15.0 (4.0) Not
reported
22.9 (3.6) 87.5%
(missed: 2
partici-
pants from
group CT)
Not speci-
fied
Control 8 73.9 (7.2) Not
reported
15.0 (4.0) Not
reported
26.6 (2.5) 100% Not speci-
fied
Cahn-
Weiner
2003
Cognitive
training
19 77. 8 (6.9) 9:8 12.7 (2.1) All partici-
pants:
donepezil
24.3 (2.2) 89.4%
(missed: 3
partici-
pants)
Not speci-
fied
Control 20 76.0 (7.7) 5:12 13.1 (3.5) All partici-
pants:
donepezil
25.1 (1.7) 85%
(missed: 3
partici-
pants)
Not speci-
fied
Galante
2007
Cognitive
training
7 Not
reported
Not
reported
Not
reported
All 22.9 (3.1) 100% Not speci-
fied
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
Control 5 Not
reported
Not
reported
Not
reported
All 23.1 (1.8) 80%
(missed: 1
partici-
pant)
Not speci-
fied
Neely
2009
Cognitive
training
10 74.8 (6.7) 6:4 Not
reported
Not
reported
22.9 (4.
15)
100% Not speci-
fied
Control 10 77.0 (6.6) 6:4 Not
reported
Not
reported
18.6 (5.7) 90%
(missed: 1
partici-
pant)
Not speci-
fied
Kawashima
2005
Cognitive
training
16 85.1 (5.4)
(range 76
to 96)
Not
reported
Not
reported
Not
reported
19.9 (7.0) 100% Not speci-
fied
Control 16 86.3 (4.9)
(range 78
to 96)
Not
reported
Not
reported
Not
reported
19.6 (5.4) Not
reported
Not speci-
fied
Boller
2011
Cogni-
tive train-
ing (recol-
lection)
12 81.58 4:8 10.92 (2.
94)
Not
reported
24 (3.05) Not
reported
Not speci-
fied
Cogni-
tive train-
ing (recog-
nition)
12 82.67 4:8 12.08 (2.
07)
Not
reported
24.83 (2.
12)
Not
reported
Not speci-
fied
Control 12 79.33 (3.
85)
5:7 11.08 (3.
85)
Not
reported
25.83 (1.
40)
Not
reported
Not speci-
fied
Fernández-
Calvo
2011
Cogni-
tive train-
ing (BBA)
15 75.80 (4.
27)
9:6 7.46 (1.
84)
All partic-
ipants on
IaCHe
19.33 (2.
48)
Not
reported
Not speci-
fied
Cogni-
tive train-
ing (IPP)
15 75.60 (4.
55)
8:7 8.40 (2.
77)
All partic-
ipants on
IaCHe
20 (2.92) Not
reported
Not speci-
fied
Control 15 75.86 (4.
15)
8:7 7.26 (3.
34)
All partic-
ipants on
IaCHe
20.44 (1.
90)
Not
reported
Not speci-
fied
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
Goudour
2011
Cognitive
training
5 68.8 (10.
0)
2:3 9.0 (1.2) Not
reported
20.2 (2.8) Not
reported
Not speci-
fied
Control 5 70.0 (5.9) 2:3 9.6 (1.9) Not
reported
20.6 (4.1) Not
reported
Not speci-
fied
Jelcic 2012 Cognitive
training
20 82.9 (3.6) 2:18 6.7 (2.9) Not
reported
24.4 (2.8) 100% Not speci-
fied
Control 20 81.8 (5.5) 5:15 8.25 (3.6) Not
reported
25 (2.6) 100% Not speci-
fied
Bergam-
aschi
2013
Cognitive
training
16 78.19 (5.
50)
Not
reported
7.25 (3.
24)
All partici-
pants:
donepezil
5 or 10
mg/d
20.25 (2.
95)
Not
reported
Not speci-
fied
Control 16 77.72 (5.
06)
Not
reported
5.61 (2.
30)
All partici-
pants:
donepezil
5 or 10
mg/d
21.94 (2.
01)
Not
reported
Not speci-
fied
Lee 2013 Cognitive
training
(CELP)
6 Not
reported
1:6 Nil: 42.8%
< 2 years:
14.3%
3 to
6 years: 28.
6%
Secondary:
14.3%
University:
0%
Not
reported
15.3 (2.7) Not
reported
Not speci-
fied
Cognitive
training
(TELP)
6 Not
reported
3:3 Nil: 16.7%
< 2 years:
16.7%
3 to
6 years: 33.
2%
Secondary:
16.7%
University:
16.7%
Not
reported
17.6 (4.7) Not
reported
Not speci-
fied
Control 7 Reported 2:4 Nil: 33.3%
< 2 years:
Not
reported
17 (3.5) Not
reported
Not speci-
fied
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
16.7%
3 to
6 years: 16.
7%
Secondary:
33.3%
University:
0%
Mapelli
2013
Cognitive
training
10 82.6 (4.
85)
Not
reported
4.6 (1.5) Not
reported
20.1 (4.2) 100% Not speci-
fied
Control
(occupa-
tional ther-
apy)
10 84.5 (5.
06)
Not
reported
4.3 (1.82) Not
reported
19.7 (3.8) 100% Not speci-
fied
Control
(no treat-
ment)
10 84.7 (4.
42)
Not
reported
4 (1.15) Not
reported
18.8 (2.
68)
100% Not speci-
fied
Jelcic 2014 Cog-
nitve train-
ing (LSS-
tele)
7 86 (5.1) 2:5 6 (3.5) Not
reported
23.7 (2.8) Not
reported
Not speci-
fied
Cogni-
tive train-
ing (LSS-
direct)
10 82.7 (6) 3:7 6.7 (3.3) Not
reported
24.9 (2.5) Not
reported
Not speci-
fied
Control 10 82.3 (5.9) 1:9 8.7 (3.7) Not
reported
24.8 (2.7) Not
reported
Not speci-
fied
Quintana
Hernandez
2014
Cognitive
training
32 Not
reported
Not
reported
Not
reported
100%
donepezil
Not
reported
84.3% Not speci-
fied
Control
muscular
relaxation
34 Not
reported
Not
reported
Not
reported
100%
donepezil
Not
reported
97% Not speci-
fied
Con-
trol mind-
fulness
36 Not
reported
Not
reported
Not
reported
100%
donepezil
Not
reported
97.2% Not speci-
fied
Control 25 Not
reported
Not
reported
Not
reported
100%
donepezil
Not
reported
100% Not speci-
fied
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
Kim 2015 Cognitive
training
22 70.4 (7.9) 8:14 8.7 (3.8) Not
reported
23.1 (2.1) 100% Not speci-
fied
Control 21 71.4 (8.2) 7:14 8.5 (3.1) Not
reported
22.8 (1.8) 100% Not speci-
fied
Amieva
2016
Cognitive
training
170 78.5 (7.2) 69:99
(data from
168 partic-
ipants)
No
diploma:
10%
Primary
school
diploma:
34.7%
Secondary
school: 29.
4%
Baccalau-
reate
and more:
23.5%
89.4%
IaCHe,
meman-
tine
21.5 (3.2) 72.94%
(missed:
46 partici-
pants)
Not speci-
fied
Usual care 154 78.7 (6.5) 63:90
(data from
154 partic-
ipants)
No
diploma:
15.6%
Primary
school
diploma:
33.1%
Secondary
school: 29.
2%
Baccalau-
reate
and more:
20.8%
86.4%
IaCHe,
meman-
tine
21.6 (3.3) 70.78%
(missed:
45 partici-
pants)
Not speci-
fied
Reminis-
cence ther-
apy
172 78.8 (6.9) 61:108
(data from
169 partic-
ipants)
No
diploma:
16.3%
Primary
school
diploma:
33,7%
Secondary
school: 30.
8%
Baccalau-
reate
90.1%
IaCHe,
meman-
tine
21.1 (3.1) 68.60%
(missed:
54 partici-
pants)
Not speci-
fied
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
and more:
16,9%
Individu-
alised cog-
nitive reha-
bilitation
157 78.9 (6.2) 64:92
(data from
172 partic-
ipants)
No
diploma:
17.2%
Primary
school
diploma:
35.7%
Secondary
school: 26.
8%
Baccalau-
reate
and more:
19.1%
86.6%
IaCHe,
meman-
tine
21.6 (3.0) 77.07%
(missed:
36 partici-
pants)
Not speci-
fied
Cavallo
2016
Cognitive
training
40 76.5 (2.
88)
13:27 8.53 (3) 36/40 22.65 (1.
74)
100% Not speci-
fied
Control 40 76,33 (3,
83)
16:24 8.12 (2.
79)
38/40 23.05 (2.
44)
100% Not speci-
fied
Kao 2016 Cogni-
tive train-
ing (spaced
retrieval)
48 83.10 (5.
0)
33:13 Illiterate:
14 (30, 4)
Primary
school: 11
(23, 9)
High
school: 14
(30, 4)
College: 7
(15, 2)
Not
reported
12.33 (5.
41)
95.83%
(missed: 2
partici-
pants)
Not speci-
fied
Cognitive
training
(spaced re-
trieval+Montessori
activities)
52 82.69 (6.
81)
37:12 Illiterate: 9
(18, 4)
Primary
school: 13
(26, 5)
High
school: 17
(34, 6)
College:
10 (20, 4)
Not
reported
12.08 (4.
05)
94.23%
(missed: 3
partici-
pants)
Not speci-
fied
Control 48 81.82 (5.
89)
Male 29
(64, 4)
Female 16
Illiterate:
13 (28, 9)
Primary
Not
reported
11.84 (5.
49)
93.75%
(missed: 3
partici-
Not speci-
fied
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
(35, 6) school: 15
(33, 3)
High
school: 12
(26, 7)
College: 5
(11, 1)
pants)
Barban
2016
Cognitive
training
42 76.5 (5.7) 13:29 8.8 (3.6) Not
reported
23.4 (1.9) 94.79%
(from the
3 groups,
not only
PWD)
Not speci-
fied
Control 39 76.9 (5.7) 11:28 9.2 (3.7) Not
reported
23.4 (1.7) 89.14%
(from the
3 groups,
not only
PWD)
Not speci-
fied
Giuli 2016 Cognitive
training
51 76.5 (4.3) 40:60 5.9 (4.1) Not
reported
20.2 (3.7) 94.11%
(missed: 3
partici-
pants)
Not speci-
fied
Control 50 78.7 (5.9) 28:72 4.5 (2.3) Not
reported
20.3 (3.5) 94% reten-
tion
(missed: 3
partici-
pants)
Not speci-
fied
Venturelli
2016
Cognitive
training
20 86 (9) 5:15 Not
reported
No anti-
dementia
drugs
reported
14.0 (1.6) 100% Not speci-
fied
Aerobic
exercise
20 84 (7) 4:16 Not
reported
No anti-
dementia
drugs
reported
13.7 (2.3) 100% Not speci-
fied
Aerobic
exer-
cise+Cognitive
training
20 85 (8) 6:14 Not
reported
No anti-
dementia
drugs
reported
13.8 (1.5) 100% Not speci-
fied
Control 20 84 (10) 17:13 Not
reported
No anti-
dementia
drugs
14.2 (1.5) 100% Not speci-
fied
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
reported
Tsantali
2017
Cognitive
training
17 73.4 (5.7) Not
reported
9.9 (4.2) All were
on in-
hibitors of
cholinesterase,
used for
at least 2
years
23.2 (1.6) 100% Not speci-
fied
Alterna-
tive treat-
ment (cog-
ni-
tive stimu-
lation)
21 74.2 (5.6) Not
reported
9.5 (4.1) All were
on in-
hibitors of
cholinesterase,
used for
at least 2
years
23.1 (1.4) 100% Not speci-
fied
Control 17 73.3 (4.9) Not
reported
9.8 (4.0) All were
on in-
hibitors of
cholinesterase,
used for
at least 2
years
22.5 (0.9) 100% Not speci-
fied
Brueggen
2017
Cognitive
training
8 (53 to 80) 4:4 (10 to 17) 5 partici-
pants
on anti-de-
men-
tia medica-
tion
24 (3.55) 100% Not speci-
fied
Control 10 (59 to 83) 5:3 (11 to 17) All 8 par-
tic-
ipants were
on anti-de-
men-
tia medica-
tion
21.75 (3.
24)
80%
(missed: 2
partici-
pants)
Not speci-
fied
Serino
2017
VR group -
AD
10 86.60
(6.13)
1:9 9.80 (3.
97)
Not
reported
22.05 (1.
62)
100% Not speci-
fied
VR group -
normal
ageing
8 86.62 (6.
19)
4:4 9.12 (5.
05)
Not
reported
27.73 (2.
02)
100% Not speci-
fied
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
Control 10 88.70 (3.
59)
2:8 7.00 (5.
00)
Not
reported
20.79 (1.
80)
100% Not speci-
fied
Giovagnoli
2017
Cognitive
training
13 71.69 (7.
88)
3:10 6.92 (2.
46)
Not
reported
23.62 (1.
94)
100%
(4 dropped
out before
treatment)
No adverse
effects
Alterna-
tive treat-
ment (mu-
sic
therapy)
13 73.92 (7.
74)
7:6 10.46 (5.
3)
Not
reported
22.85 (6.
28)
100%
(4 dropped
out before
treatment)
No adverse
effects
Alterna-
tive treat-
ment (neu-
roeduca-
tion)
13 75.31 (5.
56)
8:5 7.31 (4.
01)
Not
reported
21.15 (3.
48)
100%
(3 dropped
out before
treatment)
No adverse
effects
Trebbas-
toni
2018
Cognitive
training
54 74.26 (6.
97)
28:26 8.64 (4.
21)
78%
AChEIs
27%
donezepil
5 mg
24%
donezepil
10 mg
20% ri-
vastigmine
9.5 mg
7% ri-
vastigmine
4.6 mg
2% me-
mantine
20 mg
22.20 (2.
37)
88.80%
(missed: 6
partici-
pants)
2
falls (group
is not re-
ported)
and
2 deaths (1
from each
group)
. Study au-
thors
stated that
these
events
were
not related
to any of
the experi-
men-
tal proce-
dures per-
formed
Control 86 76.01 (6.
46)
34:52 8.40 (4.
12)
88%
AChEIs,
40%
donepeziil
5 mg
20% ri-
22.89 (2.
72)
100% 2
falls (group
is not re-
ported)
and
2 deaths (1
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Table 1. Summary characteristics of participants in cognitive training and control groups (Continued)
vastigmine
9.5 mg
18%
donepezil
10 mg
12% ri-
vastigmine
4.6 mg
2% me-
mantine
20 mg
from each
group)
. Study au-
thors
stated that
these
events
were
not related
to any of
the experi-
men-
tal proce-
dures per-
formed
Kallio
2018
Cognitive
training
76 82.6 (5.5) 34.2%
male
32 < 8
years
60 (78.
9%) taking
AD medi-
cations; 33
(43.
4%) taking
anticholin-
ergics
21.0 (4.3) 68 of 76 Not speci-
fied
Control 71 83.6 (5.4) 21.1%
male
36 < 8
years
62 (87.
4%) taking
AD medi-
cations; 37
(52.
1%) taking
anticholin-
ergics
19.9 (3.9) 49 of 71 Not speci-
fied
Date in the table, in some cases, are reported only for those participants who completed the interventions.
AChEI: anti-cholinesterase inhibitor.
AD: Alzheimer’s disease.
BBA: Big Brain Academy.
CELP: computerised errorless learning-based memory training programme.
CT: cognitive traininng.
IPP: Integrated Psychostimulation Program.
LSS: lexical-semantic simulation.
TELP: therapist-led errorless programme.
VR: virtual reality.
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Table 2. Summary of duration of interventions and timing of assessments
Study Duration
(weeks)
Session
frequency
(per week)
Total
number of
sessions
Ses-
sion dura-
tion (min-
utes)
Total di-
rect inter-
vention
(minutes)
Total di-
rect inter-
vention
(hours)
Session
format
Adher-
ence rates
Fidelity
measures
Beck 1988 6 (cogni-
tive train-
ing)
3 18 Approx. 35 Approx.
630
Approx.
10.5
Individ-
ual, with a
research as-
sistant
Not
reported
Not
reported
NA (con-
trol)
NA NA NA NA NA NA NA NA
Heiss 1993 24 (cogni-
tive train-
ing)
2 48 60 2880 48 Individual Not
reported
Not
reported
24 (social
support)
1 24 60 1440 24 Individual Not
reported
Not
reported
24 (cogni-
tive train-
ing+pyritinol)
2 48 60 2880 48 Individual Not
reported
Not
reported
24 (cogni-
tive train-
ing+phosphatidylserine)
2 48 60 2880 48 Individual Not
reported
Not
reported
Quayha-
gen
1995
12 (cogni-
tive train-
ing)
6 72 60 4320 72 Individual Not
reported
Caregiver
and care
recipient
were
trained
together
in pro-
gramme
imple-
mentation
tech-
niques.
Return
demon-
strations
by care-
givers were
required
to validate
training
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
NA
(passive
control)
NA NA NA NA NA NA NA NA
12 (active
control)
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Not
reported
Caregiver
and care
recipient
were
trained
together
in pro-
gramme
imple-
mentation
tech-
niques.
Return
demon-
strations
by care-
givers were
required
to validate
training
de Vreese
1998
NA (cog-
nitive
training)
NA NA NA NA NA NA NA NA
12 (cogni-
tive train-
ing+ChE-
I, after 12
weeks on
drug)
2 24 45 1080 18 Individual Not
reported
Not
reported
12
(placebo
drug)
NA NA NA NA NA NA Not
reported
Not
reported
12 (AChE-
I, after 12
weeks on
drug)
NA NA NA NA NA NA Not
reported
Not
reported
Quayha-
gen
2000
8 (cogni-
tive train-
ing)
1 8 90 720 12 Individual,
with help
from care-
Not
reported
Ongo-
ing moni-
toring
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
giver of person-
nel perfor-
mance to
ensure uni-
formity
and consis-
tency
of admin-
istration of
assess-
ments or
interven-
tions
8 (dyadic
coun-
selling)
1 8 90 720 12 Dyad Not
reported
Ongo-
ing moni-
toring
of person-
nel perfor-
mance to
ensure uni-
formity
and consis-
tency
of admin-
istration of
assess-
ments or
interven-
tions
8 (seminar
groups)
1 8 90 720 12 Group Not
reported
Ongo-
ing moni-
toring
of person-
nel perfor-
mance to
ensure uni-
formity
and consis-
tency
of admin-
istration of
assess-
ments or
interven-
tions
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
8 (daycare) 7 8 240 1920 32 Group Not
reported
Ongo-
ing moni-
toring
of person-
nel perfor-
mance to
ensure uni-
formity
and consis-
tency
of admin-
istration of
assess-
ments or
interven-
tions
NA (wait-
list
control)
NA NA NA NA NA NA NA NA
Davis
2001
5 (cogni-
tive train-
ing)
1 5 60 300 5 Individual Not
reported
Not
reported
5 (control) 1 5 60 300 5 Individual Not
reported
Not
reported
Koltai
2001
5 (cogni-
tive train-
ing -
group)
1 5 60 300 5 Group Not
reported
Not
reported
6 (cogni-
tive train-
ing - indi-
vidual)
1 6 Not
reported
Not
reported
Not
reported
Individual Not
reported
Not
reported
NA (wait-
list
control)
NA NA NA NA NA NA NA NA
Cahn-
Weiner
2003
6 (cogni-
tive train-
ing)
1 6 Not
reported
Not
reported
Not
reported
Group,
with a clin-
ical
neuropsy-
chologist
1 partici-
pant did
not com-
plete the
first ses-
sion, and 2
“All
sessions
were iden-
tical for all
partici-
pants, with
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
partic-
ipants did
not com-
plete the
fourth ses-
sion
the mem-
ory group
instructor
relying on
a trainer’s
manual
with
scripts for
how
to present
the infor-
mation”
6 (control) 1 6 45 270 4.5 Group,
with a clin-
ical
neuropsy-
chologist
4 partici-
pants
missed
1 session,
and 1 par-
ticipant
missed 2
sessions
Not
reported
Galante
2007
4 (cogni-
tive train-
ing)
3 12 60 720 12 Individual,
with a neu-
ropsychol-
ogist
Not
reported
Not
reported
4 (control) 3 12 60 720 12 Individual,
with a neu-
ropsychol-
ogist
Not
reported
Not
reported
Neely
2009
8 (cogni-
tive train-
ing - col-
labora-
tive inter-
vention)
1 8 30 to 40 Approx.
280
Approx. 4.
5
Dyads,
with a re-
search as-
sistant
Not
reported
Not
reported
8 (cogni-
tive train-
ing - indi-
vidual in-
terven-
tion)
1 8 30 to 40 Approx.
280
Approx. 4.
5
Individ-
ual, with a
research as-
sistant
Not
reported
Not
reported
NA (con-
trol group)
NA NA NA NA NA NA NA NA
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
Kawashima
2005
24 (cogni-
tive train-
ing)
2 to 6 48 to 144 Approx. 20 960 to
2880
16 to 48 Individual,
with the
possibil-
ity to ask
staff mem-
bers for ad-
vice
Not
reported
Not
reported
NA (con-
trol)
NA NA NA NA NA NA Not
reported
Not
reported
Boller
2011
2 (cogni-
tive train-
ing - recol-
lection)
12 24 60 1440 24 Not
reported
Not
reported
Not
reported
2 (cogni-
tive train-
ing - recog-
nition)
12 24 60 1440 24 Not
reported
Not
reported
Not
reported
NA (con-
trol)
NA NA NA NA NA NA NA NA
Fernández-
Calvo
2011
12 (cogni-
tive train-
ing - BBA)
3 36 60 2160 36 Individual,
with
an OT and
a psycholo-
gist
Not
reported
Not
reported
12 (cogni-
tive train-
ing - IPP)
3 36 60 2160 36 Individual,
with
an OT and
a psycholo-
gist
Not
reported
Not
reported
NA (con-
trol)
NA NA NA NA NA NA NA NA
Goudour
2011
12 (cogni-
tive train-
ing)
1 12 50 600 10 Individual,
with a neu-
ropsychol-
ogist.
Not
reported
Not
reported
12
(control)
1 12 50 600 10 Individual,
with a clin-
ical psy-
chologist.
Not
reported
Not
reported
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
Jelcic 2012 12 (cogni-
tive train-
ing)
2 24 60 1440 24 Group,
pro-
vided by a
neuropsy-
chologist
Not
reported
Not
reported
12
(control)
2 24 60 1440 24 Group,
pro-
vided by a
neuropsy-
chologist
Not
reported
Not
reported
Bergam-
aschi
2013
20 (cogni-
tive train-
ing)
5 100 120 12000 200 Group, su-
pervised by
a
neuropsy-
chologist
Not
reported
Not
reported
20
(control)
Presumed
to be 5
Not
reported
Not
reported
Not
reported
Not
reported
Group Not
reported
Not
reported
Lee 2013 6 (cogni-
tive train-
ing -
CELP)
2 12 30 360 6 Individ-
ual, with a
therapist
Not
reported
Not
reported
6 (cogni-
tive train-
ing -
TELP)
2 12 30 360 6 Individ-
ual, with a
therapist
Not
reported
Not
reported
6 (active
control)
2 12 30 360 6 Not
reported
Not
reported
Not
reported
Mapelli
2013
8 (cogni-
tive train-
ing)
5 40 60 2400 40 With a
therapist
Not
reported
Not
reported
8 (control
- occupa-
tional ther-
apy)
5 40 60 2400 40 Not
reported
Not
reported
Not
reported
NA (con-
trol - usual
care)
NA NA NA NA NA NA NA NA
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
Jelcic 2014 12 (cogni-
tive train-
ing - LSS-
tele)
2 24 60 1440 24 Small
groups,
provided
by a thera-
pist
Not
reported
Not
reported
12 (cogni-
tive train-
ing - LSS-
direct)
2 24 60 1440 24 Small
groups,
provided
by a thera-
pist
Not
reported
Not
reported
12
(control)
2 24 60 1440 24 Small
groups,
provided
by a thera-
pist
Not
reported
Not
reported
Quintana
Hernandez
2014
104 (cog-
nitive
training)
3 (IPP) 288 90 25920 432 Group,
with a clin-
ical psy-
chologist
Not
reported
Not
reported
104 (mus-
cular relax-
ation)
3 288 90 25920 432 Group,
with a clin-
ical psy-
chologist
Not
reported
Not
reported
104
(mindful-
ness)
3 288 90 25920 432 Group,
with a clin-
ical psy-
chologist
Not
reported
Not
reported
NA
(passive
control)
NA NA NA NA NA NA Not
reported
Not
reported
Kim 2015 8 (cogni-
tive train-
ing)
1 8 60 480 8 Individ-
ual and in a
group
Not
reported
Not
reported
8 (control) 1 8 60 480 8 Not
reported
Not
reported
Not
reported
Amieva
2016
96 (cogni-
tive train-
ing)
1 (dur-
ing the first
3 months)
; 1 every 6
15 90 1350 22.5 Groups Not
reported
Manual
detail-
ing the
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
weeks (for
the next 21
months)
guidelines
of each
interven-
tion was
provided.
Standard-
ised pro-
cedures to
guarantee
homo-
geneity.
Profes-
sional
visits to
therapists
to ensure
that inter-
ventions
were
applied in
accordance
with pro-
tocol
NA (con-
trol - usual
care)
NA NA NA NA NA NA NA NA
96 (remi-
niscence
therapy)
1 (dur-
ing the first
3 months)
; 1 every 6
weeks (for
the next 21
months)
15 90 1350 22.5 Groups Not
reported
Manual
detail-
ing the
guidelines
of each
interven-
tion was
provided.
Standard-
ised pro-
cedures to
guarantee
homo-
geneity.
Profes-
sional
visits to
therapists
to ensure
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
that inter-
ventions
were
applied in
accordance
with pro-
tocol
96 (cogni-
tive reha-
bilitation)
1 (dur-
ing the first
3 months)
; 1 every 6
weeks (for
the next 21
months)
15 90 1350 22.5 Individual Not
reported
Manual
detail-
ing the
guidelines
of each
interven-
tion was
provided.
Standard-
ised pro-
cedures to
guarantee
homo-
geneity.
Profes-
sional
visits to
therapists
to ensure
that inter-
ventions
were
applied in
accordance
with pro-
tocol
Cavallo
2016
12 (cogni-
tive train-
ing)
3 36 30 1080 18 Individual,
with a neu-
ropsychol-
ogist
Not
reported
Not
reported
12
(control)
3 36 30 1080 18 Individual,
with a neu-
ropsychol-
ogist
Not
reported
Not
reported
Kao 2016 6 (cogni-
tive train-
ing
- spaced re-
5 30 40 1200 20 With a
trainer
Not
reported
Not
reported
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
trieval)
6 (cog-
nitive
training -
spaced re-
trieval+Montessori
activities)
5 30 40 1200 20 With a
trainer
Not
reported
Not
reported
na
(control)
NA NA NA NA NA NA NA NA
Barban
2016
12 (cogni-
tive train-
ing)
2 24 60 1440 24 Small
groups,
provided
by a cogni-
tive thera-
pist
Not
reported
Not
reported
12
(control)
NA NA NA NA NA NA NA NA
Giuli 2016 10 (cogni-
tive train-
ing)
1 10 45 450 7.5 Individ-
ually, with
home-
wrok exer-
cises with
support of
a caregiver
Not
reported
Not
reported
10
(control)
1 10 45 450 7.5 Not
reported
Not
reported
Not
reported
Venturelli
2016
12 (cogni-
tive train-
ing)
5 60 60 3600 60 Performed
in collabo-
ration with
patients’
caregivers
85±12% in
the CT
group
Not
reported
12 (aerobic
exercise)
5 60 60 3600 60 Performed
in collabo-
ration with
patients’
caregivers
78±8%
in the AE
group
Not
reported
12 (aero-
bic exer-
cise+cognitive
training)
5 60 60 3600 60 Performed
in collabo-
ration with
75±14% in
the
AE+CT
Not
reported
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
patients’
caregivers
group
NA (con-
trol)
NA NA NA NA NA NA NA NA
Tsantali
2017
16 (cogni-
tive train-
ing)
3 48 90 4320 72 Indi-
vidual with
licensed
psycholo-
gist
Not
reported
Not
reported
16 (cogni-
tive stimu-
lation)
3 48 90 4320 72 Indi-
vidual with
licensed
psycholo-
gist
Not
reported
Not
reported
16
(control)
NA NA NA NA NA NA Not
reported
Not
reported
Brueggen
2017
12 (cogni-
tive train-
ing)
5 60 Approx. 15 Approx.
900
Approx. 15 Individ-
ual home-
work, with
1 meeting
per month
100% Not
reported
12 (cogni-
tive reha-
bilitation)
2 24 60 1440 24 Small
group
guided by
a psycholo-
gist and an
occupa-
tional ther-
apist
100% (in-
cluding
only the 8
partic-
ipants who
com-
pleted the
study and
were,
therefore,
analysed)
Interven-
tion was
based on
the COR-
DIAL pro-
gramme,
via a man-
ual-guided
approach
Giovagnoli
2017
12 (cogni-
tive train-
ing)
2 24 45 1080 18 Small
groups
of 3 partic-
ipants,
guided by a
neuropsy-
chologist
Not
reported
CTwas co-
ordinated
by a neu-
ropsychol-
ogist using
de-
fined ma-
terials and
procedures
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
12 (music
therapy)
2 24 45 1080 18 Small
groups
of 3 partic-
ipants,
guided
by a music
therapist
Not
reported
Active mu-
sic therapy
was
provided
by a music
ther-
apist. Ses-
sions were
videotaped
and evalu-
ated via a
structured
assessment
12
(neuroed-
ucation)
2 24 45 1080 18 Small
groups
of 3 partic-
ipants, co-
or-
dinated by
a neurolo-
gist
Not
reported
Not
reported
Serino
2017
3-4
(VR group
- AD)
3 10 20 200 3.3 Individual
with a neu-
ropsychol-
ogist
Not
reported
Not
reported
3-4
(VR group
- normal
ageing)
3 10 20 200 3.3 Individual
with a neu-
ropsychol-
ogist
Not
reported
Not
reported
NA (con-
trol)
NA NA NA NA NA Under-
went tradi-
tional cog-
nitive reha-
bilita-
tive activi-
ties with
the neu-
ropsycho-
logical staff
NA NA
Trebbas-
toni
2018
24 (cogni-
tive train-
ing)
2 48 75 3600 60 Group 11%
(6 partici-
pants) at-
tended less
Study
authors re-
ported
high ad-
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Table 2. Summary of duration of interventions and timing of assessments (Continued)
than 80%
of sessions
of
the first pe-
riod of the
study
(from T0
to T1).
In the
second
period,
72.9%
attended
more than
95% of
sessions,
10,4%
attended
90% to
95%,
4.2%
attended
85% to
89%, and
12.5%
attended
80% to
84%
herence to
a strict pro-
tocol
NA NA NA NA NA NA NA NA NA
Kallio
2018
12 (cogni-
tive train-
ing)
2 24 45 1080 18 Group/
individual
when
required
Mean
atten-
dance at 22
(92%) ses-
sions
CTwas ad-
ministered
by trained
psychol-
ogy stu-
dents un-
der the su-
pervision
of an expe-
rienced
neuropsy-
chologist
NA (con-
trol)
NA NA NA NA NA NA NA NA
AChEI: anti-cholinesterase inhibitor.
AD: Alzheimer’s disease.
BBA: Big Brain Academy.
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CELP: computerised errorless learning-based memory training programme.
ChEI: cholinesterase inhibitor.
CT: cognitive traininng.
IPP: Integrated Psychostimulation Program.
LSS: lexical-semantic simulation.
NA: not applicable.
TELP: therapist-led errorless programme.
VR: virtual reality.
A P P E N D I C E S
Appendix 1. Sources searched and search strategies
Source Search strategy Hits retrieved
1.
CENTRAL (the Cochrane Library) http:/
/crso.cochrane.org/SearchSimple.php
[Date of most recent search: 5 July 2018]
#1 MESH DESCRIPTOR Dementia EX-
PLODE ALL TREES
#2 MESH DESCRIPTOR Neurocogni-
tive Disorders EXPLODE ALL TREES
#3 dement*:TI,AB,KY
#4 alzheimer*:TI,AB,KY
#5 (“chronic cerebrovascular”):TI,AB,KY
#6 (“organic brain disease” or “organic
brain syndrome”):TI,AB,KY
#7 (“benign senescent forgetfulness”):TI,
AB,KY
#8 (“cerebr* deteriorat*”):TI,AB,KY 4
#9 (“cerebral* insufficient*”):TI,AB,KY 0
#10 (“pick* disease”):TI,AB,KY 9
#11 PDD:TI,AB,KY 175
#12 (“Parkinson* disease dementia”):TI,
AB,KY
#13 #1 OR #2 OR #3 OR #4 OR #5 OR
#6 OR #7 OR #8 OR #9 OR #10 OR #11
OR #12
#14 MESH DESCRIPTOR Cognitive
Therapy EXPLODE ALL TREES
#15 MESH DESCRIPTOR Rehabilita-
tion Nursing EXPLODE ALL TREES
#16MESHDESCRIPTORCognitive Re-
mediation EXPLODE ALL TREES
#17 (“cognit* rehab*”):TI,AB,KY
#18 (“cognit* train*”):TI,AB,KY
Apr 2017: 695
Jul 2018: 403
442Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
#19 (“cognit* stimul*”):TI,AB,KY
#20 (“memory train*”):TI,AB,KY
#21 (“memory support*” OR “memory
aid*”):TI,AB,KY
#22 (“memory therap*”):TI,AB,KY
#23 (“memory group*”):TI,AB,KY
#24 (“memory stimul*” OR “memory
strateg*”):TI,AB,KY
#25 (“cognitive intervention*”):TI,AB,KY
#26 #14 OR #15 OR #16 OR #17 OR #
18 OR #19 OR #20 OR #21 OR #22 OR
#23 OR #24 OR #25
#27 #13 AND #26
2. MEDLINE In-process and other non-
indexed citations and MEDLINE 1950-
present (Ovid SP)
[Date of most recent search: 5 July 2018]
1 exp Dementia/
2 Delirium, Dementia, Amnestic, Cogni-
tive Disorders/
3 dement*.mp.
4 alzheimer*.mp.
5 (lewy* adj2 bod*).mp.
6 (chronic adj2 cerebrovascular).mp.
7 (“organic brain disease” or “organic brain
syndrome”).mp.
8 (cerebr* adj2 deteriorat*).mp.
9 (cerebral* adj2 insufficient*).mp.
10 (pick* adj2 disease).mp.
11 PDD.mp.
12 “Parkinson* disease dementia”.mp.
13 or/1-12
14 *Cognitive Therapy/
15 Rehabilitation Nursing/
16 Cognitive Remediation/
17 (cognit* adj2 stimulation).ti,ab.
18 (cognit* adj2 rehabilitation).ti,ab.
19 (cognit* adj2 training).ti,ab.
20 (cognit* adj2 retrain*).ti,ab.
21 “cognitive intervention*”.ti,ab.
22 “Cognitive skills ADJ2 training”.ti,ab.
23 “cognitive support”.ti,ab.
24 “Cog* retrain*”.ti,ab.
25 “memory function*”.ti,ab.
26 (memory adj2 rehabilitation).ti,ab.
27 (memory adj2 therap*).ti,ab.
28 “memory aid*”.ti,ab.
29 “memory group*”.ti,ab.
30 “Memory rehabilitation”.ti,ab.
31 “memory training”.ti,ab.
32 “memory retraining”.ti,ab.
33 “Memory rehabilitation”.ti,ab.
Apr 2017: 812
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34 “memory re-training”.ti,ab.
35 “memory support”.ti,ab.
36 “memory stimulation”.ti,ab.
37 “memory strateg*”.ti,ab.
38 “memory management”.ti,ab.
39 or/14-38
40 randomized controlled trial.pt.
41 controlled clinical trial.pt.
42 randomized.ab.
43 placebo.ab.
44 randomly.ab.
45 trial.ab.
46 groups.ab.
47 or/40-46
48 (animals not (humans and animals)).sh.
49 47 not 48
50 13 and 39 and 49
3. Embase
1974 to 2018 July 4
[Date of most recent search: 5 July 2018]
1 exp dementia/
2 dement*.mp.
3 alzheimer*.mp.
4 (lewy* adj2 bod*).mp.
5 (chronic adj2 cerebrovascular).mp.
6 (“organic brain disease” or “organic brain
syndrome”).mp.
7 (cerebr* adj2 deteriorat*).mp.
8 (cerebral* adj2 insufficient*).mp.
9 CADASIL.mp.
10 PDD.mp.
11 “Parkinson* disease dementia”.mp.
12 or/1-11
13 *Cognitive Therapy/
14 Rehabilitation Nursing/
15 Cognitive Remediation/
16 (cognit* adj2 stimulation).ti,ab.
17 (cognit* adj2 rehabilitation).ti,ab.
18 (cognit* adj2 training).ti,ab.
19 (cognit* adj2 retrain*).ti,ab.
20 “cognitive intervention*”.ti,ab.
21 “cognitive support”.ti,ab.
22 “memory function*”.ti,ab.
23 (memory adj2 rehabilitation).ti,ab.
24 (memory adj2 therap*).ti,ab.
25 “memory aid*”.ti,ab.
26 “memory aid*”.ti,ab.
27 “memory group*”.ti,ab.
28 “Memory rehabilitation”.ti,ab.
29 “memory training”.ti,ab.
30 “memory retraining”.ti,ab.
Apr 2017: 694
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31 “memory re-training”.ti,ab.
32 “memory support”.ti,ab.
33 “memory stimulation”.ti,ab.
34 “memory strateg*”.ti,ab.
35 “memory management”.ti,ab.
36 or/13-25
37 randomly.ab.
38 placebo*.ti,ab.
39 “double-blind*”.ti,ab.
40 randomized controlled trial/
41 trial.ti,ab.
42 or/37-41
43 12 and 36 and 42
4. PSYCINFO (Ovid SP)
[Date of most recent search: 5 July 2018]
1 exp Dementia/
2 dement*.mp.
3 alzheimer*.mp.
4 (chronic adj2 cerebrovascular).mp.
5 (“organic brain disease” or “organic brain
syndrome”).mp.
6 (cerebr* adj2 deteriorat*).mp.
7 (cerebral* adj2 insufficient*).mp.
8 PDD.mp.
9 “Parkinson* disease dementia”.mp.
10 or/1-9
11 exp Cognitive Therapy/
12 exp Cognitive Rehabilitation/
13 (cognit* adj2 stimulation).ti,ab.
14 (cognit* adj2 rehabilitation).ti,ab.
15 (cognit* adj2 training).ti,ab.
16 (cognit* adj2 retrain*).ti,ab.
17 “cognitive intervention*”.ti,ab.
18 “cognitive support”.ti,ab.
19 “memory function*”.ti,ab.
20 (memory adj2 rehabilitation).ti,ab.
21 (memory adj2 therap*).ti,ab.
22 “memory aid*”.ti,ab.
23 “memory group*”.ti,ab.
24 “Memory rehabilitation”.ti,ab.
25 “memory training”.ti,ab.
26 “memory retraining”.ti,ab.
27 “memory re-training”.ti,ab.
28 “memory support”.ti,ab.
29 “memory stimulation”.ti,ab.
30 “memory strateg*”.ti,ab.
31 “memory management”.ti,ab.
32 or/11-31
33 randomly.ab.
34 randomi?ed.ab.
Apr 2017: 556
Jul 2018: 64
445Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
35 placebo*.ti,ab.
36 trial.ti,ab.
37 RCT.ti,ab.
38 groups.ab.
39 or/33-38
40 10 and 32 and 39
5. CINAHL (EBSCOhost)
[Date of most recent search: 5 July 2018]
1 MH “Dementia+”
2MH“Delirium”) or (MH“Delirium,De-
mentia, Amnestic, Cognitive Disorders”
3 MH “Wernicke’s Encephalopathy”
4 TX dement*
5 TX alzheimer*
6 TX alzheimer*
7 TX deliri*
8 TX chronic N2 cerebrovascular
9 TX “organic brain disease” or “organic
brain syndrome”
10 TX “normal pressure hydrocephalus”
and “shunt*”
11 TX “benign senescent forgetfulness”
12 TX cerebr* N2 deteriorat*
13 TX cerebral* N2 insufficient*
14 TX pick* N2 disease
15 TX creutzfeldt or jcd or cjd
16 TX huntington*
17 TX binswanger*
18 TX korsako*
19 TX PDD
20 TX “Parkinson* disease dementia”
21 (S1 OR S2 OR S3 OR S4 OR S5 OR
S6 OR S7 OR S8 OR S9 OR S10 OR S11
OR S12OR S13OR S14OR S15OR S16
OR S17 OR S18 OR S19 OR S20)
22 MH “Rehabilitation, Cognitive”
23 (MH “Rehabilitation Nursing”)
24 (MH “Cognitive Therapy”)
25 TX (cognit* rehab*)
26 TX (cognit* train*)
27 TX (memory train*)
28 TX (memory support*)
29 TX (memory stimul*)
30 TX (cognitive intervention*)
31 (S22 OR S23OR S24OR S25 OR S26
OR S27 OR S28 OR S29 OR S30)
32 S21 AND S31
33 MH “Clinical Trials”
34 TX trial
35 TX “single-blind*”
Apr 2017: 448
Jul 2018: 98
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36 TX “double-blind*”
37 TX “treatment as usual”
38 TX randomly
39 S33 OR S34 OR S35 OR S36 OR S37
OR S38
40 S32 AND S39
6. ISI Web of Science Core Collection -
Web of Science (1945-present)
[Date of most recent search: 5 July 2018]
(dement* OR VCI OR “vascular cognitive
impairment*” OR VaD OR alzheimer*)
AND TOPIC: (“cognit* train*” OR “cog-
nit* rehab*” OR “memory aid*” OR
“memory train*” OR “memory support*”
OR “memory stimul*”) AND TOPIC:
(randomly OR placebo OR trial OR RCT
OR randomized OR randomised)
Timespan: All years.
Search language=Auto
Apr 2017: 510
Jul 2018: 125
7. LILACS (BIREME)
[Date of most recent search: 5 July 2018]
memory [Words] and demenc$ OR de-
ment$ OR alzheimer$ [Words] and ran-
domly OR randomised OR randomized
OR trial OR ensaio clínico [Words]
Apr 2017: 22
Jul 2018: 0
8. ClinicalTrials.gov
(www.clinicaltrials.gov)
[Date of most recent search: 5 July 2018]
Interventional Studies | dementia OR
alzheimers OR AD OR alzheimer’s OR
alzheimer | “cognitive rehabilitation” OR
“cognitive training”
Apr 2017: 50
Jul 2018: 12
9) ICTRP
[Date of most recent search: 5 July 2018]
dementia OR alzheimers OR AD OR
alzheimer’s OR alzheimer AND “cognitive
rehabilitation” OR “cognitive training”
Apr 2017: 76
Jul 2018: 27
TOTAL before de-duplication Apr 2017: 3863
Jul 2018: 1059
TOTAL: 4922
C O N T R I B U T I O N S O F A U T H O R S
Alex Bahar-Fuchs drafted the protocol, screened and selected studies for inclusion, supervised the data extraction process and data entry
into RevMan, rated studies for risk of bias, graded the evidence, and wrote the manuscript.
Anthony Martyr screened and selected studies for inclusion, rated studies for risk of bias, conducted the data check, and contributed
to writing of the manuscript.
Anita MY Goh screened and selected studies for inclusion, rated studies for risk of bias, extracted data, and contributed to writing of
the manuscript.
Linda Clare assisted in resolving issues related to study selection and risk of bias, and contributed to writing of the manuscript.
447Cognitive training for people with mild to moderate dementia (Review)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Julieta Sabates screened and selected studies for inclusion, conducted the data extraction process, completed the relevant tables, rated
studies for risk of bias, conducted analyses, graded the evidence, and contributed to writing of the manuscript.
D E C L A R A T I O N S O F I N T E R E S T
Alex Bahar-Fuchs: none known.
Anthony Martyr: none known.
Anita MY Goh: none known.
Linda Clare: none known.
Julieta Sabates: none known.
S O U R C E S O F S U P P O R T
Internal sources
• Cochrane Incentive Award, UK.
External sources
• NIHR, UK.
This review was supported by the National Institute for Health Research (NIHR), via Cochrane infrastructure funding Cochrane to
the Cochrane Dementia and Cognitive Improvement Group. The views and opinions expressed therein are those of the authors and do
not necessarily reflect those of the Systematic Reviews Programme, NIHR, the National Health Service, or the Department of Health
• National Health and Medical Research Council of Australia, Australia.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
In our protocol, we stated that our primary outcome - global cognition - would be assessed using an available screening measure from
each study (e.g.MMSE), and that global cognition would be measured by a composite score computed by us from all cognitive measures
in a study serving as a secondary outcome. However, after further consideration, we determined that global cognition as reflected in
the composite measure should be our primary outcome. The reasons behind this decision include the fact that a composite score based
on all cognitive measures is a more reliable and less biased indicator of global cognition than a single screening measure, the fact that
it makes use of all available cognitive data from each trial, and the fact that the composite was calculated for all studies; therefore the
meta-analysis is based on larger numbers of studies and participants, increasing statistical power and our confidence in the findings.
Global cognition as measured by a screening measure was included as a secondary/sensitivity analysis for this outcome. The findings
of the two approaches were comparable.
In addition, in the protocol we stated that we would examine changes in measure of clinical disease severity only in the medium term
(3 to 12 months post treatment). However, for completeness, we also included results of analysis of this outcome immediately after the
intervention as a secondary outcome.
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